RESULT_COUNT: 1070,PAGE_SIZE: 10000,CURRENT_PAGE: 1,TOTAL_PAGES: 1,API_CALL_CREDITS: 1
TICKER,FIGI_TICKER,FIGI,TITLE,PUBLICATION_DATE,URL,SUMMARY
VRTX,VRTX:UW,BBG000C1SD31,Is a Beat in the Cards for Vertex (VRTX) in Q3 Earnings?,2017-10-20 14:49:02 +0000,https://finance.yahoo.com/news/beat-cards-vertex-vrtx-q3-144902485.html?.tsrc=rss,Vertex&apos;s (VRTX) Kalydeco is expected to generate increased revenues following its label expansion in the third quarter of 2017.
VRTX,VRTX:UW,BBG000C1SD31,4 of the Most Efficient Stocks to Buy Now,2017-10-20 14:29:02 +0000,https://finance.yahoo.com/news/4-most-efficient-stocks-buy-142902710.html?.tsrc=rss,Companies with favorable efficiency levels are likely to be on investors&apos; radar irrespective of market conditions.
VRTX,VRTX:UW,BBG000C1SD31,"Zacks Industry Outlook Highlights: Novo, Vertex Pharmaceuticals, Celgene and Ligand Pharmaceuticals",2017-10-18 13:55:01 +0000,https://finance.yahoo.com/news/zacks-industry-outlook-highlights-novo-135501090.html?.tsrc=rss,"Zacks Industry Outlook Highlights: Novo, Vertex Pharmaceuticals, Celgene and Ligand Pharmaceuticals"
VRTX,VRTX:UW,BBG000C1SD31,What's in the Cards for Novartis (NVS) This Earnings Season?,2017-10-18 12:52:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6_mqVaaECPQ/whats-in-the-cards-for-novartis-nvs-this-earnings-season-cm861145,Swiss pharmaceutical company Novartis AG NVS is scheduled to report third quarter 2017 results on Oct 24 Novartis stock has rallied 22 1 year to date compared with the industry s 21 4 gain In the last quarter Novartis delivered a positive earnings surprise of 4 3
VRTX,VRTX:UW,BBG000C1SD31,See what the IHS Markit Score report has to say about Vertex Pharmaceuticals Inc.,2017-10-18 12:07:08 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120708075.html?.tsrc=rss,Vertex Pharmaceuticals Inc NASDAQ/NGS:VRTX
VRTX,VRTX:UW,BBG000C1SD31,Innovative Pipelines & Regulatory Catalysts to Drive Pharma Stocks,2017-10-17 22:52:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/G3L8_TQwCK8/innovative-pipelines-regulatory-catalysts-to-drive-pharma-stocks-cm861063,Although pharma and biotech stocks had gone through a rough patch due to the drug pricing controversy the sector is showing signs of recovery with investors being more comfortable with the drug pricing scenario and focusing on the fundamentals of the sector instead Innovation mergers
VRTX,VRTX:UW,BBG000C1SD31,Innovative Pipelines & Regulatory Catalysts to Drive Pharma Stocks,2017-10-17 19:55:07 +0000,https://finance.yahoo.com/news/innovative-pipelines-regulatory-catalysts-drive-195507406.html?.tsrc=rss,Innovative Pipelines & Regulatory Catalysts to Drive Pharma Stocks
VRTX,VRTX:UW,BBG000C1SD31,This Pharma Stock Is Up 111% and Investors Are Wondering What's Next,2017-10-17 14:54:09 +0000,http://finance.yahoo.com/r/f1a7e9fe-b5ac-392f-92ac-07ebef87d84b/question-for-vertex-bulls-is-how-to-build-on-a-20-billion-rally?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"Vertex Pharmaceuticals Inc., on the brink of a breakthrough that could treat nearly all patients with cystic fibrosis, has done everything an investor could ask for in 2017, including double its market ..."
VRTX,VRTX:UW,BBG000C1SD31,"Vertex Announces 10-Year, $500 Million Corporate Giving Commitment",2017-10-17 10:15:00 +0000,https://finance.yahoo.com/news/vertex-announces-10-500-million-101500329.html?.tsrc=rss,"Vertex Pharmaceuticals Incorporated today announced a 10-year, $500 million corporate giving commitment focused on providing patient and caregiver support including access to our medicines; expanding our commitment to science, technology, engineering, arts and math education; developing young physicians and scientists; and investing in our communities."
VRTX,VRTX:UW,BBG000C1SD31,Vertex to Announce Third Quarter 2017 Financial Results on October 25,2017-10-16 20:01:00 +0000,https://finance.yahoo.com/news/vertex-announce-third-quarter-2017-200100277.html?.tsrc=rss,"Vertex Pharmaceuticals Incorporated will report its third quarter 2017 financial results on Wednesday, October 25, 2017 after the financial markets close. The company will host a conference call and webcast at 4:30 p.m."
VRTX,VRTX:UW,BBG000C1SD31,Wall Street analysts expect gains of up to 64% on their favorite health-care stocks,2017-10-16 18:31:52 +0000,http://finance.yahoo.com/r/7922c894-e9ef-3677-bbda-e2074fc248b0/Story.aspx?guid=F534D23A-B002-11E7-95DA-6300F441E5C2&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"There may be short-term volatility because of the health-care overhaul in Washington, but the long-term thesis is intact. By Phil van Doorn."
VRTX,VRTX:UW,BBG000C1SD31,"Nasdaq 100 Movers: JBHT, WYNN",2017-10-16 16:20:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vlMpZJ4ea4M/nasdaq-100-movers-jbht-wynn-cm860117,In early trading on Monday shares of Wynn Resorts WYNN topped the list of the day s best performing components of the Nasdaq 100 index trading up 3 5 Year to date Wynn Resorts registers a 70 3 gain And the worst performing Nasdaq 100 component thus far on the day is J B
VRTX,VRTX:UW,BBG000C1SD31,The 1 Stock You've Been Overlooking for Your Roth IRA,2017-10-15 12:16:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cr8uFZ4IVNw/the-1-stock-youve-been-overlooking-for-your-roth-ira-cm859880,Opening a Roth IRA account was one of your best moves in preparing for retirement I m assuming this applies to you If you don t have a Roth IRA get one This article will wait on you until you ve got one set up Seriously Roth IRAs are great retirement tools that many
VRTX,VRTX:UW,BBG000C1SD31,The 1 Stock You&apos;ve Been Overlooking for Your Roth IRA,2017-10-15 11:03:00 +0000,https://finance.yahoo.com/news/1-stock-apos-ve-overlooking-110300493.html?.tsrc=rss,It has a virtual monopoly right now and is expected to grow earnings by nearly 70% annually.
VRTX,VRTX:UW,BBG000C1SD31,"Rhenman & Partners Asset Management AB Buys Arena Pharmaceuticals Inc, Vertex ...",2017-10-14 19:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dI2fm6sZbJ4/rhenman-partners-asset-management-ab-buys-arena-pharmaceuticals-inc-vertex-cm859858,Rhenman Partners Asset Management AB New Purchases ARNA BSX LOXO MYOK JUNO NVO DERM RARX NLNK AGIO Added Positions VRTX ADMS PTLA GKOS AGN HZNP ABMD ESRX ITCI ANTM Reduced Positions PFE NVCR GILD BIIB HCA LLY MRK INCY
VRTX,VRTX:UW,BBG000C1SD31,"Vertex Pharmaceuticals, USG and J. Jill highlighted as Zacks Bull and Bear of the Day",2017-10-13 13:17:01 +0000,https://finance.yahoo.com/news/vertex-pharmaceuticals-usg-j-jill-131701498.html?.tsrc=rss,"Vertex Pharmaceuticals, USG and J. Jill highlighted as Zacks Bull and Bear of the Day"
VRTX,VRTX:UW,BBG000C1SD31,Bull of the Day: Vertex Pharmaceuticals (VRTX),2017-10-13 11:00:11 +0000,https://finance.yahoo.com/news/bull-day-vertex-pharmaceuticals-vrtx-110011360.html?.tsrc=rss,Bull of the Day: Vertex Pharmaceuticals (VRTX)
VRTX,VRTX:UW,BBG000C1SD31,Pres Trump believes he has the cure for Obamacare,2017-10-12 14:31:44 +0000,https://finance.yahoo.com/video/pres-trump-believes-cure-obamacare-143144493.html?.tsrc=rss,"President Trump's healthcare bill may have died in Congress, but that's not stopping him from making changes to Obamacare. Later today, the president is expected to  sign an executive order that would let Americans buy insurance across state lines. Yahoo Finance’s Alexis Christoforous and Editor-in-Chief Andy Serwer figure out if the the president’s move will help lower premiums."
VRTX,VRTX:UW,BBG000C1SD31,Is a Beat in Store for Abbott (ABT) This Earnings Season?,2017-10-11 15:18:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PPlua9kumsY/is-a-beat-in-store-for-abbott-abt-this-earnings-season-cm858121,We expect Abbott ABT to surpass expectations when it reports third quarter 2017 results on Oct 18 before the market opens Last quarter Abbott delivered a positive earnings surprise of 3 3 Abbott s strong and impressive earnings track record reflects its estimate beats in each of the
VRTX,VRTX:UW,BBG000C1SD31,"Biotech Stock Roundup: Amgen's Imlygic Data Promising, Regeneron Scores Win in PCSK9 Lawsuit",2017-10-11 14:17:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/p4s3Nz7jdEo/biotech-stock-roundup-amgens-imlygic-data-promising-regeneron-scores-win-in-pcsk9-lawsuit-cm858027,Companies like Amgen AMGN and Regeneron REGN were in the news with Amgen providing pipeline and regulatory updates while Regeneron and partner Sanofi got some good news with an appeals court ruling in their favor in the PCSK9 inhibitor lawsuit against Amgen Recap of the Week s Most
VRTX,VRTX:UW,BBG000C1SD31,"Vertex Pharmaceuticals, Inc. – Value Analysis (NASDAQ:VRTX) : October 10, 2017",2017-10-10 16:20:39 +0000,http://finance.yahoo.com/r/67572f8f-f4a9-31ce-a30f-b2c0bca67301/vertex-pharmaceuticals-inc-value-analysis-nasdaqvrtx-october-10-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Vertex Pharmaceuticals, Inc. a score of 59. Our analysis is based on comparing Vertex Pharmaceuticals, Inc. with the following peers – Gilead Sciences, Inc., AbbVie, Inc., Merck & Co., Inc., Bristol-Myers Squibb Company, Johnson & Johnson, Enzon Pharmaceuticals, Inc., Enanta Pharmaceuticals, Inc. and SciClone Pharmaceuticals, Inc. (GILD-US, ... Read more
<b>(Read more...)</b>"
VRTX,VRTX:UW,BBG000C1SD31,5 Pharma & Biotech Stocks That Could Be Big Winners in Q3 Earnings,2017-10-10 16:17:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wP2vD6cg5FA/5-pharma-biotech-stocks-that-could-be-big-winners-in-q3-earnings-cm857590,Pharma and biotech stocks started 2017 on a strong note with this part of the market remaining in favor as the year progresses So far this year the Nasdaq Biotechnology Index and the NYSE ARCA Pharmaceutical Index are up 25 6 and 14 6 respectively With investors being more
VRTX,VRTX:UW,BBG000C1SD31,Amgen Label Expansion Application for Prolia Accepted by FDA,2017-10-10 15:00:03 +0000,https://finance.yahoo.com/news/amgen-label-expansion-application-prolia-150003122.html?.tsrc=rss,Amgen (AMGN) announced that the FDA has accepted its regulatory application in the U.S. seeking label expansion for Prolia for treating patients with glucocorticoid-induced osteoporosis (GIOP).
VRTX,VRTX:UW,BBG000C1SD31,5 Pharma & Biotech Stocks That Could Be Big Winners in Q3 Earnings,2017-10-10 14:01:02 +0000,https://finance.yahoo.com/news/5-pharma-biotech-stocks-could-140102820.html?.tsrc=rss,Here is a look at 5 pharma and biotech stocks including Pfizer (PFE) that are expected to post a positive earnings surprise in Q3.
VRTX,VRTX:UW,BBG000C1SD31,Why the Earnings Streak Will Continue for Vertex Pharmaceuticals (VRTX),2017-10-10 12:30:12 +0000,https://finance.yahoo.com/news/why-earnings-streak-continue-vertex-123012235.html?.tsrc=rss,Vertex Pharmaceuticals (VRTX) is in a good position to beat earnings at its next report as it has a favorable Zacks Rank and positive Earnings ESP.
VRTX,VRTX:UW,BBG000C1SD31,"Forget Teva (TEVA), Buy These 5 Drug Stocks Instead",2017-10-09 14:20:02 +0000,https://finance.yahoo.com/news/forget-teva-teva-buy-5-142002954.html?.tsrc=rss,"With another challenge cropping up for Teva (TEVA) in the form of earlier-than-expected generic competition for the 40 mg dose of Copaxone, here is a look at 5 drug stocks that look better-positioned."
VRTX,VRTX:UW,BBG000C1SD31,"Vertex Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : VRTX-US : October 9, 2017",2017-10-09 12:14:42 +0000,http://finance.yahoo.com/r/538018a0-ce05-3d12-ad6a-3a7d89cbe69a/vertex-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bullish-manner-vrtx-us-october-9-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Vertex Pharmaceuticals, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish ... Read more
<b>(Read more...)</b>"
VRTX,VRTX:UW,BBG000C1SD31,"Biotech Stock Roundup: Endocyte Shoots up on Deal, Amgen-AbbVie Settle Humira Litigation",2017-10-04 13:35:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/16yERSlxjHE/biotech-stock-roundup-endocyte-shoots-up-on-deal-amgen-abbvie-settle-humira-litigation-cm855016,Companies like Amgen AMGN and Endocyte ECYT were in the news with Amgen signing a deal with AbbVie ABBV related to the entry of its biosimilar version of Humira and Endocyte signing an in licensing deal which could prove to be transformational for the company Recap of the Week s
VRTX,VRTX:UW,BBG000C1SD31,Alexion on the Street: Analyst Recommendations in October,2017-10-04 11:44:26 +0000,http://finance.yahoo.com/r/c49592e2-16f8-37d0-b1b5-43caa49a7a02/alexion-on-the-street-analyst-recommendations-in-october?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In August 2017, the EC (European Commission) approved the label expansion of Alexion Pharmaceuticals' (ALXN) Soliris."
VRTX,VRTX:UW,BBG000C1SD31,"FEX, TROW, HPE, VRTX: Large Outflows Detected at ETF",2017-10-03 17:54:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BaDgl4O_-lU/fex-trow-hpe-vrtx-large-outflows-detected-at-etf-cm854700,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the First Trust Large Cap Core AlphaDEX Fund Symbol FEX where we have detected an approximate 24 8 million dollar outflow that s a 1 6 decrease week over
VRTX,VRTX:UW,BBG000C1SD31,3 Top-Ranked Big Biotech Stocks to Buy Now,2017-10-03 13:30:01 +0000,https://finance.yahoo.com/news/3-top-ranked-big-biotech-133001290.html?.tsrc=rss,"With biotech stocks on a tear, here we have picked three of the biggest biotech companies which look well poised for growth and can be added to one&apos;s portfolio"
VRTX,VRTX:UW,BBG000C1SD31,Stocks Open Mixed; Musk Talks Mars; Zogenix Soars On Drug News,2017-09-29 14:33:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nsW8GzeUal4/stocks-open-mixed-musk-talks-mars-zogenix-soars-on-drug-news-cm852982,The Nasdaq composite climbed 0 3 at the open Friday while the S amp P 500 added 0 1 and the Dow Jones industrial average slipped 0 1 as Wall Street continued to debate the likelihood of meaningful tax reform ibd display video id 2324386 width 50 float
VRTX,VRTX:UW,BBG000C1SD31,3 Reasons To Like Vertex Pharma Shares,2017-09-29 12:56:55 +0000,https://finance.yahoo.com/news/3-reasons-vertex-pharma-shares-125655337.html?.tsrc=rss,"Analysts at BTIG laid out the bullish case for owning shares of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX ) — a ""storied"" company with a strong growth outlook. BTIG's Dane Leone initiates ..."
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharmaceuticals: The Gilead Sciences of Cystic Fibrosis?,2017-09-28 11:41:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7BrsgBfGrI8/vertex-pharmaceuticals-the-gilead-sciences-of-cystic-fibrosis-cm852317,In only a year Vertex Pharmaceuticals NASDAQ VRTX has grown from a market cap of around 20 billion to knocking on the door of a 40 billion market cap The biotech isn t finished growing Wall Street analysts project Vertex will increase earnings by nearly 70 annually over the
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharmaceuticals: The Gilead Sciences of Cystic Fibrosis?,2017-09-28 10:02:00 +0000,http://finance.yahoo.com/r/adf89135-f2fb-3fc6-83a1-a07784449ac6/vertex-pharmaceuticals-the-gilead-sciences-of-cyst.aspx?yptr=yahoo&.tsrc=rss,Gilead might have a biotech equivalent of &quot;Mini-me.&quot;
VRTX,VRTX:UW,BBG000C1SD31,"Top Stock Reports for Goldman Sachs, PepsiCo and Johnson & Johnson",2017-09-27 20:40:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/d6GDff4zJCo/top-stock-reports-for-goldman-sachs-pepsico-and-johnson-johnson-cm852171,Wednesday September 27 2017 The Zacks Research Daily presents the best research output of our analyst team Today s Research Daily features new research reports on 12 major stocks including Goldman Sachs Group Inc GS PepsiCo Inc PEP and Johnson amp Johnson JNJ These
VRTX,VRTX:UW,BBG000C1SD31,"Top Stock Reports for Goldman Sachs, PepsiCo and Johnson & Johnson",2017-09-27 18:07:06 +0000,https://finance.yahoo.com/news/top-stock-reports-goldman-sachs-180706540.html?.tsrc=rss,"Top Stock Reports for Goldman Sachs, PepsiCo and Johnson & Johnson"
VRTX,VRTX:UW,BBG000C1SD31,"Biotech Stock Roundup: Amgen Reiterates 2017 Outlook, Intercept Hit by Ocaliva Safety Issues",2017-09-26 14:58:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6C9OfC7mLhw/biotech-stock-roundup-amgen-reiterates-2017-outlook-intercept-hit-by-ocaliva-safety-issues-cm850980,Biotech stocks like Amgen AMGN and Intercept Pharmaceuticals ICPT were in the news with Amgen providing an update on the impact of Hurricane Maria while Intercept continues to be impacted by Ocaliva safety concerns Recap of the Week s Most Important Stories Amgen Maintains
VRTX,VRTX:UW,BBG000C1SD31,3 Highest-Growth Stocks in the Market Today,2017-09-25 12:50:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mOnpl33F34E/3-highest-growth-stocks-in-the-market-today-cm850240,Which stocks claim the highest growth rates in the entire market The answer depends on how you define growth There are several kinds of growth sales earnings stock price cash flow and more Growth also requires a definition of time frame The highest growth stocks over the
VRTX,VRTX:UW,BBG000C1SD31,3 Highest-Growth Stocks in the Market Today,2017-09-25 11:04:00 +0000,http://finance.yahoo.com/r/ea9f6fe8-39c2-3580-b3f2-71d0e7929f28/3-highest-growth-stocks-in-the-market-today-2.aspx?yptr=yahoo&.tsrc=rss,One of them you can watch -- literally.
VRTX,VRTX:UW,BBG000C1SD31,3 Monster Biotech Stocks in the Making,2017-09-24 14:47:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FyF3LstFq3A/3-monster-biotech-stocks-in-the-making-cm850149,Were the biggest biotechs in the world today always so big Of course not They all started out as much smaller companies Along the way each of today s big biotechs had a successful product that helped them launch yet another successful product They made a few acquisitions to drive
VRTX,VRTX:UW,BBG000C1SD31,3 Monster Biotech Stocks in the Making,2017-09-24 13:09:00 +0000,http://finance.yahoo.com/r/a6e5ceb3-18b3-357a-8851-0cf528211cee/3-monster-biotech-stocks-in-the-making.aspx?yptr=yahoo&.tsrc=rss,They&apos;ve got successful drugs. They&apos;re profitable. All these biotechs need to become huge is a little luck and time.
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharmaceuticals: Going From &apos;Crisis&apos; To Blockbuster,2017-09-22 23:30:26 +0000,http://finance.yahoo.com/r/8564e0b3-76fe-34c9-b5d3-7e018d538b74/vertex-plans-to-eradicate-cystic-fibrosis-and-go-from-there?src=A00220&yptr=yahoo&.tsrc=rss,Vertex is nearing the end of its journey in cystic fibrosis with likely approval of a triple pill in the next couple of years.
VRTX,VRTX:UW,BBG000C1SD31,Vertex to Present at the Leerink Partners Roundtable Series on September 27,2017-09-21 20:01:00 +0000,https://finance.yahoo.com/news/vertex-present-leerink-partners-roundtable-200100019.html?.tsrc=rss,"Vertex Pharmaceuticals Incorporated today announced that management will present at the Leerink Partners Roundtable Series: Rare Disease & Immuno-Oncology on Wednesday, September 27, 2017 at 11:30 a.m."
VRTX,VRTX:UW,BBG000C1SD31,Vertex's Rocky September Causes Vetr To Urge Sell,2017-09-21 12:13:49 +0000,https://finance.yahoo.com/news/vertexs-rocky-september-causes-vetr-121349761.html?.tsrc=rss,"The Vetr crowd on Wednesday downgraded its rating of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX ) from 5 stars (Strong Buy), issued 15 days ago, to 1 star (Strong Sell). Crowd sentiment at the time ..."
VRTX,VRTX:UW,BBG000C1SD31,"Biotech Stock Roundup: FDA Nod for First Cancer Biosimilar, HALO up on Deals, Raised Outlook",2017-09-20 14:40:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WunUELYk5dA/biotech-stock-roundup-fda-nod-for-first-cancer-biosimilar-halo-up-on-deals-raised-outlook-cm848300,A key development this week was the FDA approval of the first cancer biosimilar Amgen AMGN and Allergan s Mvasi a biosimilar version of Roche s blockbuster cancer drug Avastin Other updates include important data presentations from companies like Nabriva Therapeutics NBRV and AbbVie
VRTX,VRTX:UW,BBG000C1SD31,Vertex Announces Upcoming Presentations of Data at 2017 North American Cystic Fibrosis Conference,2017-09-19 14:50:00 +0000,https://finance.yahoo.com/news/vertex-announces-upcoming-presentations-data-145000427.html?.tsrc=rss,"Vertex Pharmaceuticals Incorporated today announced that 11 abstracts from its cystic fibrosis research and development program will be presented at the annual North American Cystic Fibrosis Conference in Indianapolis, November 2 to 4, 2017."
VRTX,VRTX:UW,BBG000C1SD31,"The Zacks Analyst Blog Highlights: iShares Core S&P 500 ETF, Vertex Pharmaceuticals, Align Technology, NRG Energy and Activision Blizzard",2017-09-19 13:42:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VTEexIuuci4/the-zacks-analyst-blog-highlights-ishares-core-sp-500-etf-vertex-pharmaceuticals-align-technology-nrg-energy-and-activision-blizzard-cm847599,For Immediate Release Chicago IL September 19 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the
VRTX,VRTX:UW,BBG000C1SD31,"The Zacks Analyst Blog Highlights: iShares Core S&P 500 ETF, Vertex Pharmaceuticals, Align Technology, NRG Energy and Activision Blizzard",2017-09-19 11:08:11 +0000,https://finance.yahoo.com/news/zacks-analyst-blog-highlights-ishares-110811727.html?.tsrc=rss,"The Zacks Analyst Blog Highlights: iShares Core S&P 500 ETF, Vertex Pharmaceuticals, Align Technology, NRG Energy and Activision Blizzard"
VRTX,VRTX:UW,BBG000C1SD31,Both stocks and bonds could drop during the next bear market: trader,2017-09-18 18:12:52 +0000,https://finance.yahoo.com/news/stocks-bonds-drop-next-bear-market-trader-201252944.html?.tsrc=rss,"When investors follow sustained moves in either direction, they develop the &quot;floating index syndrome.&quot;"
VRTX,VRTX:UW,BBG000C1SD31,5 Top-Performing Stocks Driving S&P 500 ETF Higher,2017-09-18 17:34:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pTVYVr0Ixrs/5-top-performing-stocks-driving-sp-500-etf-higher-cm847218,After weeks of shaky trading the Wall Street continued its second largest bull run dodging the list of woes including geopolitical tension Washington turmoil elevated valuations the aftermath of hurricanes Harvey amp Irma as well as rounds of downbeat economic data In particular
VRTX,VRTX:UW,BBG000C1SD31,"Analysts have raised, or lowered, their price targets the most on these U.S. stocks",2017-09-18 16:28:53 +0000,http://finance.yahoo.com/r/afd0d0ee-3730-3e21-8200-4971b36c8481/Story.aspx?guid=E03E5450-9702-11E7-8322-8D161F05D678&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"They’re bullish on Vertex Pharmaceuticals, Boeing and Nvidia, and bearish on Foot Locker, Chipotle and Advance Auto Parts."
VRTX,VRTX:UW,BBG000C1SD31,5 Top-Performing Stocks Driving S&P 500 ETF Higher,2017-09-18 15:42:03 +0000,https://finance.yahoo.com/news/5-top-performing-stocks-driving-154203620.html?.tsrc=rss,Inside the top performing stocks of IVV.
VRTX,VRTX:UW,BBG000C1SD31,"Biotech Stock Roundup: Alexion to Cut Jobs, Streamline Operations, Kura Up on Cancer Data",2017-09-13 14:42:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rSbtx0U56bg/biotech-stock-roundup-alexion-to-cut-jobs-streamline-operations-kura-up-on-cancer-data-cm845038,There were quite a few major developments this week with Alexion Pharmaceuticals ALXN announcing a restructuring plan that will see the company cutting jobs and streamlining operations Meanwhile data was presented by companies like Regeneron Pharmaceuticals REGN AbbVie ABBV and Kura
VRTX,VRTX:UW,BBG000C1SD31,4 Biotech Stocks for the Long-Term,2017-09-13 14:05:30 +0000,https://finance.yahoo.com/news/4-biotech-stocks-long-term-140530574.html?.tsrc=rss,"Biotech stocks have been a favorite of fast money, too, since it moves faster than the Standard & Poor’s 500 – in both directions.  Some stocks, such as Vertex Pharmaceuticals (NASDAQ:VRTX), are already up triple-digit percentages this year.  Or, they may be emerging from long trading ranges where uncertainty previously ruled."
VRTX,VRTX:UW,BBG000C1SD31,"Noteworthy ETF Outflows: FEX, VRTX, PYPL, TROW",2017-09-12 16:35:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LWm3U6p64zk/noteworthy-etf-outflows-fex-vrtx-pypl-trow-cm844398,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the First Trust Large Cap Core AlphaDEX Fund Symbol FEX where we have detected an approximate 24 4 million dollar outflow that s a 1 6 decrease week over
VRTX,VRTX:UW,BBG000C1SD31,"Nasdaq 100 Movers: ALXN, PAYX",2017-09-12 15:35:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wVo05WkUxN8/nasdaq-100-movers-alxn-payx-cm844302,In early trading on Tuesday shares of Paychex PAYX topped the list of the day s best performing components of the Nasdaq 100 index trading up 2 2 Year to date Paychex has lost about 3 7 of its value And the worst performing Nasdaq 100 component thus far on the day is
VRTX,VRTX:UW,BBG000C1SD31,2 Views on Vertex Pharmaceuticals Stock: Short Term vs. Long Term,2017-09-12 13:36:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wnSwdiJxJCY/2-views-on-vertex-pharmaceuticals-stock-short-term-vs-long-term-cm844171,There s a lot for investors to really like about Vertex Pharmaceuticals NASDAQ VRTX The company reached profitability earlier this year It has reported a string of positive clinical results for its cystic fibrosis drugs And oh yes the stock has more than doubled so far in
VRTX,VRTX:UW,BBG000C1SD31,See what the IHS Markit Score report has to say about Vertex Pharmaceuticals Inc.,2017-09-12 12:04:54 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120454268.html?.tsrc=rss,Vertex Pharmaceuticals Inc NASDAQ/NGS:VRTX
VRTX,VRTX:UW,BBG000C1SD31,2 Views on Vertex Pharmaceuticals Stock: Short Term vs. Long Term,2017-09-12 12:03:00 +0000,http://finance.yahoo.com/r/563ef42a-6b9a-34fb-bd83-ed565701ae95/2-views-on-vertex-pharmaceuticals-stock-short-term.aspx?yptr=yahoo&.tsrc=rss,Do the opportunities outweigh the challenges for the this cystic fibrosis-focused biotech?
VRTX,VRTX:UW,BBG000C1SD31,Top Biotech Stock Near Buy Zone After FDA Drug Approval,2017-09-11 21:29:05 +0000,http://finance.yahoo.com/r/fa1baa96-d0e4-394d-a998-75965e57c481/top-biotech-stock-vertex-pharmaceuticals-fda-approval-cystic-fibrosis-drug?src=A00220&yptr=yahoo&.tsrc=rss,"Boosted by a biotech boom, promising cystic fibrosis drug trial results and a new FDA approval, Vertex Pharmaceuticals may be ready to climb."
VRTX,VRTX:UW,BBG000C1SD31,Apple&apos;s iPhone Launch; 4 Top Stocks Near Buys: Tuesday&apos;s Investing Action Plan,2017-09-11 20:08:52 +0000,http://finance.yahoo.com/r/b1a8ec44-c092-33ca-b743-2ff0dcdfd604/apples-iphone-launch-4-top-stocks-near-buys-tuesdays-investing-action-plan?src=A00220&yptr=yahoo&.tsrc=rss,"Apple finally releases its next-generation smartphone on Tuesday. Investors and consumers will want to know about the latest features, and whether the iPhones will be late."
VRTX,VRTX:UW,BBG000C1SD31,See what the IHS Markit Score report has to say about Vertex Pharmaceuticals Inc.,2017-09-11 14:09:54 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-140954623.html?.tsrc=rss,Vertex Pharmaceuticals Inc NASDAQ/NGS:VRTX
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharma. To Present At Morgan Stanley Conference; Webcast At 1:40 PM ET,2017-09-11 12:41:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RLZBELZQAU8/vertex-pharma-to-present-at-morgan-stanley-conference-webcast-at-140-pm-et-20170911-00933,Vertex Pharma. To Present At Morgan Stanley Conference; Webcast At 1:40 PM ET
VRTX,VRTX:UW,BBG000C1SD31,Vertex to Present at the Morgan Stanley Healthcare Conference on September 11,2017-09-07 20:01:00 +0000,https://finance.yahoo.com/news/vertex-present-morgan-stanley-healthcare-200100096.html?.tsrc=rss,"Vertex Pharmaceuticals Incorporated today announced that management will present at the Morgan Stanley Healthcare Conference on Monday, September 11, 2017 at 1:40 p.m."
VRTX,VRTX:UW,BBG000C1SD31,"Notable Thursday Option Activity: OXY, VRTX, AIG",2017-09-07 19:52:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7WvvUNqcEbo/notable-thursday-option-activity-oxy-vrtx-aig-cm842521,Looking at options trading activity among components of the S amp P 500 index there is noteworthy activity today in Occidental Petroleum Corp Symbol OXY where a total volume of 24 611 contracts has been traded thus far today a contract volume which is representative of approximately 2
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharmaceuticals Could Be Headed Higher Once Again,2017-09-06 17:31:00 +0000,http://finance.yahoo.com/r/cedb3b71-d7ae-341f-ae9b-22f466b664d6/vertex-pharmaceuticals-could-be-headed-higher-once-again?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Trade from the long side, but have a sell stop below $149 in case of a reversal."
VRTX,VRTX:UW,BBG000C1SD31,Nasdaq 100 Biotechnology: Beyond Pure Tech; Still Pure Innovation,2017-09-06 15:12:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7XYkrK6D_uI/nasdaq-100-biotechnology-beyond-pure-tech-still-pure-innovation-cm841662,"Shutterstock photo    While the pure technology sector is the engine of innovation for much of what we consider the highest technology advancements of our age, there is a host of other industries represented in the Nasdaq-100 that are trailblazing. These companies that lie outside the pure tech sphere are some of"
VRTX,VRTX:UW,BBG000C1SD31,"Biotech Stock Roundup: Cellectis Down on Clinical Hold, Insmed Soars on Positive Data",2017-09-06 13:54:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Y3pWS9mQ1Ck/biotech-stock-roundup-cellectis-down-on-clinical-hold-insmed-soars-on-positive-data-cm841553,It was a relatively slow week for the biotech sector though key pipeline updates were provided by companies like Cellectis CLLS and Insmed INSM While Insmed skyrocketed on positive data on its lead pipeline candidate Cellectis was hit by a clinical hold on a couple of phase I
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharma surges 1% after news of new CFO,2017-09-06 12:29:53 +0000,http://finance.yahoo.com/r/b496ed0b-06bc-335f-a288-ade8f17aa4cc/Story.aspx?guid=42859E04-6DB2-43F5-93C5-371D70D27564&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Vertex Pharmaceuticals Inc. shares surged 1.2% in premarket trade Wednesday after the company announced that Tom Graney would be its new chief financial officer and senior vice president, starting September ..."
VRTX,VRTX:UW,BBG000C1SD31,Vertex Appoints Tom Graney as Senior Vice President and Chief Financial Officer,2017-09-06 12:05:00 +0000,https://finance.yahoo.com/news/vertex-appoints-tom-graney-senior-120500067.html?.tsrc=rss,"Vertex Pharmaceuticals Incorporated today announced the appointment of Tom Graney to the role of Senior Vice President and Chief Financial Officer . Mr. Graney will begin his role with Vertex on September 13, 2017 and will report to Executive Vice President and Chief Operating Officer Ian Smith."
VRTX,VRTX:UW,BBG000C1SD31,Behind Bioverativ’s Analyst Recommendations This September,2017-09-06 11:37:49 +0000,http://finance.yahoo.com/r/06c943b4-ba2f-31ed-8397-34d58f7e0de5/behind-bioverativs-analyst-recommendations-this-september?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Of the 12 analysts tracking Bioverativ (BIVV), three recommend a “strong buy” for the stock, while one recommends a “buy,” and seven recommend a ""hold."""
VRTX,VRTX:UW,BBG000C1SD31,3 Growth Stocks for the 21st Century,2017-09-05 20:51:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VwmpAhG9wv4/3-growth-stocks-for-the-21st-century-cm841212,Three technologies stand at the forefront of making the 21st century uniquely different from any other e commerce mobile communications and biotechnology Although each of these technologies actually began in the late 20th century they ve truly become a way of life for billions
VRTX,VRTX:UW,BBG000C1SD31,3 Growth Stocks for the 21st Century,2017-09-05 19:34:00 +0000,http://finance.yahoo.com/r/67437e0d-aeab-38c4-9540-bfb172f11791/3-growth-stocks-for-the-21st-century.aspx?yptr=yahoo&.tsrc=rss,"Looking for growth stocks for the future? Check out MercadoLibre, American Tower, and Vertex Pharmaceuticals."
VRTX,VRTX:UW,BBG000C1SD31,4 Biotech Stocks That More Than Doubled This Year,2017-09-05 18:49:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MKeRpA6t2eo/4-biotech-stocks-that-more-than-doubled-this-year-cm841184,InvestorPlace Stock Market News Stock Advice amp Trading Tips The second quarter reporting cycle has almost ended with only nine S amp P 500 stocks left to report as of Aug 25 2017 All the sectors excluding Auto and Conglomerates have recorded earnings growth in
VRTX,VRTX:UW,BBG000C1SD31,Sarepta: Time to Buy?,2017-09-05 16:31:00 +0000,http://finance.yahoo.com/r/8b68ff46-cd26-37a4-b0b6-8361070015a7/sarepta-time-to-buy-1504629099?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"What could drive shares of Sarepta Therapeutics (SRPT) higher?  Back in July, my colleague Andrew Bary noted thatExondys 51, the company’s controversial drug for Duchenne muscular dystrophy (DMD), is gaining traction, which could push the stock price higher.  Credit Suisse analyst Alethia Young and her team say the company could release top-line data from an early stage study of its experimental drug SRP-4053 before releasing the full data later this year."
VRTX,VRTX:UW,BBG000C1SD31,Alexion: Quite a Comeback,2017-09-05 15:50:00 +0000,http://finance.yahoo.com/r/76e782ab-6a7d-3e0d-abae-bfafcc337361/alexion-quite-a-comeback-1504626651?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"J.P. Morgan analyst Anupam Rama and his team are rethinking their stance on Alexion Pharmaceuticals (ALXN).  Today, Rama has reversed course, resuming a bullish stance on Alexion, restoring his previous Overweight rating and lifting his price target from $163 a share to $175 a share.  On the 2Q earnings call, Alexion prudently set low expectations for the 2H17 earnings and we believe Street focus is shifting to 2H17 / 1H18 clinical catalysts as key drivers over the next 6-12 months."
VRTX,VRTX:UW,BBG000C1SD31,4 Biotech Stocks That More Than Doubled This Year,2017-09-01 15:29:03 +0000,https://finance.yahoo.com/news/4-biotech-stocks-more-doubled-152903280.html?.tsrc=rss,The biotech sector has been witnessing an uptrend this year with impressive performance in both the quarters. Shares of quite a few companies have more than doubled so far this year riding this trend.
VRTX,VRTX:UW,BBG000C1SD31,Don’t Sell Facebook Inc (FB) Stock Just Because It’s Losing the Teen Crowd,2017-09-01 13:54:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GgaXe4e8Ns8/dont-sell-facebook-inc-fb-stock-just-because-its-losing-the-teen-crowd-cm840232,InvestorPlace Stock Market News Stock Advice amp Trading Tips Last week internet advertising news site eMarketer shared what bodes well for Snapchat parent Snap Inc NYSE SNAP and could be alarming for Facebook Inc NASDAQ FB shareholders That is teens are less
VRTX,VRTX:UW,BBG000C1SD31,How Are Orkambi and Kalydeco Positioned after 2Q17?,2017-09-01 13:07:44 +0000,http://finance.yahoo.com/r/e74cbf3f-d4e7-34e5-820b-f75b46f646de/how-are-orkambi-and-kalydeco-positioned-after-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2Q17, Vertex Pharmaceuticals’ (VRTX) Orkambi generated revenues of around $324 million, which reflected a whopping ~32% growth on a year-over-year (or YoY) basis and ~10% growth on a quarter-over-quarter ..."
VRTX,VRTX:UW,BBG000C1SD31,Vertex Presented Successful Results for Cystic Fibrosis Treatment,2017-09-01 11:38:01 +0000,http://finance.yahoo.com/r/8fd231e4-e291-3f28-9fcc-e1985066dce6/vertex-presented-successful-results-for-cystic-fibrosis-treatment?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Vertex Pharmaceuticals’ peers that are actively conducting research and development for CF drugs include Pfizer (PFE), PTC Therapeutics (PTCT), Proteostasis Therapeutics (PTI), Novartis, and Roche."
VRTX,VRTX:UW,BBG000C1SD31,Vertex Saw Successful Results from VX-440 Phase 2 Study,2017-08-31 18:35:59 +0000,http://finance.yahoo.com/r/b964fe23-0597-3211-9972-d012edc714fd/vertex-saw-successful-results-from-vx-440-phase-2-study?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,The positive data from the clinical trials will likely help Vertex Pharmaceuticals commercialize the drug.
VRTX,VRTX:UW,BBG000C1SD31,How Vertex Pharmaceuticals Performed in 2Q17,2017-08-31 17:06:00 +0000,http://finance.yahoo.com/r/5a172f0c-5ca4-3f23-a116-5af4cf9898ff/how-vertex-pharmaceuticals-performed-in-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2Q17, Vertex Pharmaceuticals (VRTX) generated revenues of around $544 million, a ~26% increase on a year-over-year (or YoY) basis and a ~13% increase on a quarter-over-quarter basis."
VRTX,VRTX:UW,BBG000C1SD31,What Analysts Recommend for Vertex Pharmaceuticals after 2Q17,2017-08-31 15:14:33 +0000,http://finance.yahoo.com/r/b4a0ea88-acd7-3ff5-93f7-9d8ca5fcd8e1/what-analysts-recommend-for-vertex-pharmaceuticals-after-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Around 80% of the analysts tracking Vertex Pharmaceuticals in August 2017 gave the stock some form of a “buy” rating.
VRTX,VRTX:UW,BBG000C1SD31,"Biotech Stock Roundup: CAR-T in Focus on Gilead-Kite Deal, Incyte Up on Baricitinib Update",2017-08-31 14:55:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Fr6yNe5WHj0/biotech-stock-roundup-car-t-in-focus-on-gilead-kite-deal-incyte-up-on-baricitinib-update-cm839673,CAR T stocks were in the news this week with key biotech player Gilead Sciences GILD announcing its intention to acquire Kite Pharma KITE one of the most advanced players in the CAR T therapy market Moreover the FDA approved Novartis Kymriah yesterday making it the first CAR T therapy
VRTX,VRTX:UW,BBG000C1SD31,"XBI, EXEL, ALXN, VRTX: ETF Inflow Alert",2017-08-30 16:52:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7J8CNknYz9I/xbi-exel-alxn-vrtx-etf-inflow-alert-cm839245,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the SPDR S amp P Biotech ETF Symbol XBI where we have detected an approximate 334 6 million dollar inflow that s a 9 1 increase week over week in outstanding
VRTX,VRTX:UW,BBG000C1SD31,3 Reasons to Be Cautious on Vertex Pharmaceuticals Incorporated (VRTX) Stock,2017-08-29 22:48:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/olltIQ64dt0/3-reasons-to-be-cautious-on-vertex-pharmaceuticals-incorporated-vrtx-stock-cm838888,InvestorPlace Stock Market News Stock Advice amp Trading Tips Biotech companies are a great source for finding huge gainers And yes a clear example of this is Vertex Pharmaceuticals Incorporated NASDAQ VRTX For the year so far the shares are up a sizzling 109 to 153
VRTX,VRTX:UW,BBG000C1SD31,"Why Micron Technology, Inc. (MU) Stock Suddenly Looks So Sunny",2017-08-29 18:48:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wdAUaex-FxQ/why-micron-technology-inc-mu-stock-suddenly-looks-so-sunny-cm838787,InvestorPlace Stock Market News Stock Advice amp Trading Tips After rallying more than 250 between May 2016 160 and this past June it wasn t difficult to deem Micron Technology Inc NASDAQ MU a stock that was overdue for a pullback 160 Until that May June rally MU
VRTX,VRTX:UW,BBG000C1SD31,3 Reasons to Be Cautious on Vertex Pharmaceuticals Incorporated (VRTX) Stock,2017-08-29 18:15:27 +0000,https://finance.yahoo.com/news/3-reasons-cautious-vertex-pharmaceuticals-181527876.html?.tsrc=rss,"Biotech companies are a great source for finding huge gainers.  Founded in the late 1980s, Vertex Pharmaceuticals pioneered groundbreaking therapies for cystic fibrosis.  It was back in early 2012 that Vertex Pharmaceuticals received FDA approval for its drug, Kalydeco."
VRTX,VRTX:UW,BBG000C1SD31,Analyst Recommendations for Regeneron Pharmaceuticals in August,2017-08-29 17:59:04 +0000,http://finance.yahoo.com/r/222b1ea6-7dea-30e9-9848-77c730981f72/analyst-recommendations-for-regeneron-pharmaceuticals-in-august?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Twenty-five analysts were analyzing Regeneron Pharmaceuticals in August 2017. Seven of them recommended a “strong buy,” and five recommended a “buy.”"
VRTX,VRTX:UW,BBG000C1SD31,See what the IHS Markit Score report has to say about Vertex Pharmaceuticals Inc.,2017-08-29 12:06:00 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120600321.html?.tsrc=rss,Vertex Pharmaceuticals Inc NASDAQ/NGS:VRTX
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharmaceuticals (VRTX) Down 5.2% Since Earnings Report: Can It Rebound?,2017-08-29 09:50:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nu6XEIbKZds/vertex-pharmaceuticals-vrtx-down-52-since-earnings-report-can-it-rebound-cm838274,A month has gone by since the last earnings report for Vertex Pharmaceuticals Incorporated VRTX Shares have lost about 5 2 in that time frame underperforming the market Will the recent negative trend continue leading up to the stock s next earnings release or is it due for a
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharmaceuticals Incorporated (VRTX) Stock Could Burn Investors,2017-08-29 09:00:04 +0000,https://finance.yahoo.com/news/vertex-pharmaceuticals-incorporated-vrtx-stock-090004930.html?.tsrc=rss,"Giving credit where it’s due, Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is arguably the leading name in cystic fibrosis treatments.  Its CF drugs — Kalydeco and Orkambia — may not yet be approved to treat the full range of cystic fibrosis, still, considering the swath of CF sufferers for whom the drugs are approved, the two treatments command the six-figure prices that the market is willing to pay.  Might that be possible, or even likely, for VRTX stock?"
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharmaceuticals (VRTX) Down 5.2% Since Earnings Report: Can It Rebound?,2017-08-29 07:34:07 +0000,https://finance.yahoo.com/news/vertex-pharmaceuticals-vrtx-down-5-073407645.html?.tsrc=rss,Vertex Pharmaceuticals (VRTX) reported earnings about a month ago. What&apos;s next for the stock? We take a look at earnings estimates for some clues.
VRTX,VRTX:UW,BBG000C1SD31,See what the IHS Markit Score report has to say about Vertex Pharmaceuticals Inc.,2017-08-28 12:05:57 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120557738.html?.tsrc=rss,Vertex Pharmaceuticals Inc NASDAQ/NGS:VRTX
VRTX,VRTX:UW,BBG000C1SD31,Vertex's Cystic Fibrosis Combo Gets Priority Review in U.S.,2017-08-25 16:41:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/k1QgDXo3Fvg/vertexs-cystic-fibrosis-combo-gets-priority-review-in-us-cm837196,Vertex Pharmaceuticals Incorporated VRTX announced that its regulatory applications for tezacaftor ivacaftor Kalydeco combination have been accepted by the FDA and the European Medicines Agency EMA for review The regulatory applications have been filed to seek approval of Kalydeco
VRTX,VRTX:UW,BBG000C1SD31,Vertex&apos;s Cystic Fibrosis Combo Gets Priority Review in U.S.,2017-08-25 14:51:02 +0000,https://finance.yahoo.com/news/vertex-apos-cystic-fibrosis-combo-145102490.html?.tsrc=rss,Vertex Pharmaceuticals&apos; (VRTX) regulatory applications for tezacaftor/ivacaftor (Kalydeco) combination have been accepted by the FDA and EMA for review.
VRTX,VRTX:UW,BBG000C1SD31,"ADMS Soars On FDA Nod, EARS Gets An Earful, Thumbs Up For BIIB's Humira Biosim",2017-08-25 02:37:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/r3NZwQRzQNs/adms-soars-on-fda-nod-ears-gets-an-earful-thumbs-up-for-biibs-humira-biosim-20170825-00064,"ADMS Soars On FDA Nod, EARS Gets An Earful, Thumbs Up For BIIB's Humira Biosim"
VRTX,VRTX:UW,BBG000C1SD31,4 of the Highest-Growth Stocks in Biotech Today,2017-08-24 16:39:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qgR39DTR7ek/4-of-the-highest-growth-stocks-in-biotech-today-cm836626,Investing in the biotech industry can be a risky business In most instances the deck is stacked against a company succeeding The vast majority of preclinical studies will fail to reach human trials and there s no guarantee that a compound in clinical trials will reach pharmacy
VRTX,VRTX:UW,BBG000C1SD31,Vertex Announces Acceptance of its Applications for Review of the Tezacaftor/Ivacaftor Combination Treatment in People with Cystic Fibrosis by the FDA and EMA,2017-08-24 15:30:00 +0000,https://finance.yahoo.com/news/vertex-announces-acceptance-applications-review-153000138.html?.tsrc=rss,Vertex Pharmaceuticals Incorporated today announced the acceptance of its applications for the use of the tezacaftor/ivacaftor combination treatment in people with cystic fibrosis ages 12 and older who have two copies of the F508del mutation or one F508del mutation and one residual function mutation that is responsive to tezacaftor/ivacaftor by the U.S.
VRTX,VRTX:UW,BBG000C1SD31,4 of the Highest-Growth Stocks in Biotech Today,2017-08-24 14:35:00 +0000,http://finance.yahoo.com/r/2c003ae5-c604-3e98-b01c-63fda8d763e8/4-of-the-highest-growth-stocks-in-biotech-today.aspx?yptr=yahoo&.tsrc=rss,"How does a compound annual growth rate of 50%, 60%, or 70% sound?"
VRTX,VRTX:UW,BBG000C1SD31,"Commit To Buy Vertex Pharmaceuticals At $100, Earn 4.5% Using Options",2017-08-23 16:39:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7wjTIBXZPxI/commit-to-buy-vertex-pharmaceuticals-at-100-earn-45-using-options-cm836015,Investors eyeing a purchase of Vertex Pharmaceuticals Inc Symbol VRTX stock but tentative about paying the going market price of 153 13 share might benefit from considering selling puts among the alternative strategies at their disposal One interesting put contract in particular is
VRTX,VRTX:UW,BBG000C1SD31,Lab-made &quot;mini organs&quot; helping doctors treat cystic fibrosis,2017-08-23 16:30:26 +0000,http://finance.yahoo.com/r/eaa0e935-34a4-3486-90e9-92106c8bbb9b/lab-made-mini-organs-helping-073223814.html?.tsrc=rss,"UTRECHT, Netherlands (AP) — Els van der Heijden, who has cystic fibrosis, was finding it ever harder to breathe as her lungs filled with thick, sticky mucus. Despite taking more than a dozen pills and inhalers a day, the 53-year-old had to stop working and scale back doing the thing she loved best, horseback riding."
VRTX,VRTX:UW,BBG000C1SD31,"Lab-made ""mini organs"" helping doctors treat cystic fibrosis",2017-08-23 16:30:26 +0000,https://finance.yahoo.com/news/lab-made-mini-organs-helping-073223814.html?.tsrc=rss,"Els van der Heijden, who has cystic fibrosis, was finding it ever harder to breathe as her lungs filled with thick, sticky mucus. Despite taking more than a dozen pills and inhalers a day, the 53-year-old ..."
VRTX,VRTX:UW,BBG000C1SD31,"Biotech Stock Roundup: EU Label Expansion for Alexion, BIIB Facing Drug Price Probe",2017-08-23 13:42:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rTLUDBHEcDc/biotech-stock-roundup-eu-label-expansion-for-alexion-biib-facing-drug-price-probe-cm835901,Alexion Pharmaceuticals ALXN got a boost with the EU approving its key revenue driver Soliris for an additional indication Meanwhile Biogen BIIB was in the news with an investigation being launched into the rising prices of multiple sclerosis MS drugs The investigation has been launched
VRTX,VRTX:UW,BBG000C1SD31,"Market Close Report: NASDAQ Composite index closes at 6,297.48 up 84.35 points",2017-08-22 20:50:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zw7OntsOiiU/market-close-report-nasdaq-composite-index-closes-at-629748-up-8435-points-cm835661,Tuesday s session closes with the NASDAQ Composite Index at 6 297 48 The total shares traded for the NASDAQ was over 1 6 billion Tuesday s session closes with the NASDAQ Composite Index at 6 297 48 The total shares traded for the NASDAQ was over 1 6 billion Advancers stocks led declining by 2
VRTX,VRTX:UW,BBG000C1SD31,"Tuesday Sector Leaders: Technology & Communications, Healthcare",2017-08-22 19:39:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PpnK0JwZjl4/tuesday-sector-leaders-technology-communications-healthcare-cm835572,The best performing sector as of midday Tuesday is the Technology amp Communications sector up 1 4 Within that group Activision Blizzard Inc Symbol ATVI and KLA Tencor Corp Symbol KLAC are two large stocks leading the way showing a gain of 3 4 and 3 2 respectively
VRTX,VRTX:UW,BBG000C1SD31,"Noteworthy ETF Inflows: XBI, EXEL, ALXN, VRTX",2017-08-22 16:40:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9eaHHlBLeXc/noteworthy-etf-inflows-xbi-exel-alxn-vrtx-cm835446,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the SPDR S amp P Biotech ETF Symbol XBI where we have detected an approximate 37 7 million dollar inflow that s a 1 1 increase week over week in outstanding
VRTX,VRTX:UW,BBG000C1SD31,"Nasdaq 100 Movers: MYL, VRTX",2017-08-22 15:38:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6Pd-XLgrhp8/nasdaq-100-movers-myl-vrtx-cm835284,In early trading on Tuesday shares of Vertex Pharmaceuticals topped the list of the day s best performing components of the Nasdaq 100 index trading up 2 3 Year to date Vertex Pharmaceuticals registers a 106 9 gain And the worst performing Nasdaq 100 component thus far on the day
VRTX,VRTX:UW,BBG000C1SD31,Trade of the Day: Freeport-McMoRan Inc (FCX) Stock Is Rally-Ready,2017-08-22 15:37:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZCjvCaEyu10/trade-of-the-day-freeport-mcmoran-inc-fcx-stock-is-rally-ready-cm835404,InvestorPlace Stock Market News Stock Advice amp Trading Tips Shares of Freeport McMoRan Inc 160 NYSE FCX has displayed promising price action this summer and currently sits in the green for the year to the tune of about 11 7 While the broader U S stock market seems
VRTX,VRTX:UW,BBG000C1SD31,See what the IHS Markit Score report has to say about Vertex Pharmaceuticals Inc.,2017-08-22 12:06:04 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120604872.html?.tsrc=rss,Vertex Pharmaceuticals Inc NASDAQ/NGS:VRTX
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharmaceuticals Incorporated (VRTX) Stock Is Too Expensive,2017-08-21 21:39:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/u9e3qkHzC8Q/vertex-pharmaceuticals-incorporated-vrtx-stock-is-too-expensive-cm835009,InvestorPlace Stock Market News Stock Advice amp Trading Tips Vertex Pharmaceuticals Incorporated NASDAQ VRTX has turned in triple digit gains so far this year after news that the firm is on the verge of having several new cystic fibrosis treatments FDA approved That s a
VRTX,VRTX:UW,BBG000C1SD31,Gilead: Where's the Urgency?,2017-08-21 18:19:00 +0000,http://finance.yahoo.com/r/bb794600-8341-394e-995c-1cd0d81a7012/gilead-wheres-the-urgency-1503339549?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,Gilead Sciences (GILD) has gained 13% during the past three months as investors have started to bet that the beaten-down biotech stock has finally found a bottom.  The iShares Nasdaq Biotechnology ETF (IBB) has dipped 0.1% to $303.67.
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharmaceuticals Incorporated (VRTX) Stock Is Too Expensive,2017-08-21 17:31:46 +0000,https://finance.yahoo.com/news/vertex-pharmaceuticals-incorporated-vrtx-stock-173146754.html?.tsrc=rss,"Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has turned in triple-digit gains so far this year after news that the firm is on the verge of having several new cystic fibrosis treatments FDA approved.  At $149.38 per share, VRTX stock is expensive, but the question is whether or not the stock is too expensive.  Have we already missed the boat or does the pharmaceutical company really have the growth potential that investors believe it does."
VRTX,VRTX:UW,BBG000C1SD31,See what the IHS Markit Score report has to say about Vertex Pharmaceuticals Inc.,2017-08-21 12:06:21 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120621675.html?.tsrc=rss,Vertex Pharmaceuticals Inc NASDAQ/NGS:VRTX
VRTX,VRTX:UW,BBG000C1SD31,The 3 Best Stocks in Healthcare,2017-08-17 13:03:00 +0000,http://finance.yahoo.com/r/6d995e84-ff4d-395d-95ed-734247228a48/the-3-best-stocks-in-healthcare.aspx?yptr=yahoo&.tsrc=rss,"Why Align Technology, Celgene, and Vertex stand at the top of all healthcare stocks."
VRTX,VRTX:UW,BBG000C1SD31,"Biotech Stock Roundup: Regeneron Drops RSV Antibody, Gilead HIV Drug Gets Priority Review",2017-08-16 13:39:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FDwjiDI9TQI/biotech-stock-roundup-regeneron-drops-rsv-antibody-gilead-hiv-drug-gets-priority-review-cm832739,With earnings season drawing to a close focus is back on pipeline and regulatory updates While Regeneron Pharmaceuticals REGN which has several pipeline catalysts lined up for the second half of the year reported data on one of its late stage pipeline candidates Gilead Sciences GILD
VRTX,VRTX:UW,BBG000C1SD31,3 Stocks That Could Put Alibaba's Returns to Shame,2017-08-16 13:37:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GCgis7embfU/3-stocks-that-could-put-alibabas-returns-to-shame-cm832609,If you ve bought products on e commerce sites like Amazon NASDAQ AMZN there s a good chance you ve bought something that was made in China courtesy of a manufacturer found by using Alibaba NYSE BABA Alibaba s manufacturing might has catapulted its share price
VRTX,VRTX:UW,BBG000C1SD31,3 Stocks That Could Put Alibaba&apos;s Returns to Shame,2017-08-16 12:00:00 +0000,http://finance.yahoo.com/r/6f4c389a-30db-3de8-8f44-99beb4b1a297/3-stocks-that-could-put-alibabas-returns-to-shame.aspx?yptr=yahoo&.tsrc=rss,"Shares in Shopify, Sodastream, and Vertex Pharmaceuticals are on a tear, and each may prove to be a better investment than Alibaba."
VRTX,VRTX:UW,BBG000C1SD31,"ETFs with exposure to Vertex Pharmaceuticals, Inc. : August 15, 2017",2017-08-15 21:20:48 +0000,http://finance.yahoo.com/r/6f540098-b649-3ee2-9b33-3ee1b007fce1/etfs-with-exposure-to-vertex-pharmaceuticals-inc-august-15-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Vertex Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to VRTX-US. Comparing the performance and risk of Vertex Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
VRTX,VRTX:UW,BBG000C1SD31,Why Gilead Sciences Might Not Make an Oncology Acquisition,2017-08-15 20:22:00 +0000,http://finance.yahoo.com/r/7073c7dc-fc6b-3075-8dbd-f9d84ffe0986/why-gilead-sciences-might-not-make-an-oncology-acq.aspx?yptr=yahoo&.tsrc=rss,Gilead Sciences&apos; CEO hints that buying a biotech with an oncology focus might not happen. Here&apos;s what this could mean for the big biotech.
VRTX,VRTX:UW,BBG000C1SD31,Hot Fidelity Fund Owns Stocks Like Tencent That Jump In Stock Market,2017-08-14 23:34:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PJEnzW8akGM/hot-fidelity-fund-owns-stocks-like-tencent-that-jump-in-stock-market-cm830843,Can a Boston area 160 team enter the winners circle if the star takes a break It worked for Super Bowl champ Tom Brady and the New England Patriots last year Fidelity Investments hopes the same is true for its Growth Discovery Fund FDSVX when Jason Weiner takes a five month
VRTX,VRTX:UW,BBG000C1SD31,"3 Big Stock Charts for Monday: Nvidia Corporation (NVDA), Micron Technology, Inc. (MU) and Western Digital Corp (WDC)",2017-08-14 20:35:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UeVUq7YSm9k/3-big-stock-charts-for-monday-nvidia-corporation-nvda-micron-technology-inc-mu-and-western-digital-corp-wdc-cm831906,InvestorPlace Stock Market News Stock Advice amp Trading Tips There are days like today when you feel like there s no way the market will go back down Things are settling from a geopolitical perspective earnings have been great stocks are bouncing from technical
VRTX,VRTX:UW,BBG000C1SD31,Is TJX Companies Inc (TJX) Stock Ready to Shine Again?,2017-08-14 19:35:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yiHF5HqTi4Q/is-tjx-companies-inc-tjx-stock-ready-to-shine-again-cm831871,InvestorPlace Stock Market News Stock Advice amp Trading Tips Off brand behemoth TJX Companies Inc 160 NYSE TJX is due to report its second quarter results Tuesday morning While investors tend to do a lot of buying and selling on the back of such announcements second
VRTX,VRTX:UW,BBG000C1SD31,Hot Fidelity Fund Owns Stocks Like Tencent That Jumped Friday,2017-08-14 14:35:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RBhxUISdkSc/hot-fidelity-fund-owns-stocks-like-tencent-that-jumped-friday-cm830843,Can a Boston area 160 team enter the winners circle if the star takes a break It worked for Super Bowl champ Tom Brady and the New England Patriots last year Fidelity Investments hopes the same is true for its Growth Discovery Fund FDSVX when Jason Weiner takes a five month
VRTX,VRTX:UW,BBG000C1SD31,Why Vertex Pharmaceuticals Incorporated (VRTX) Stock Isn’t Worth the Risk,2017-08-14 14:25:16 +0000,https://finance.yahoo.com/news/why-vertex-pharmaceuticals-incorporated-vrtx-142516760.html?.tsrc=rss,"Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is enjoying a phenomenal 2017, up over 110% year-to-date.  Vertex Pharmaceuticals specializes in cystic fibrosis (CF) treatment.  Since its early days, Vertex has grown to become the world leader in CF treatment innovations, offering multiple patient options."
VRTX,VRTX:UW,BBG000C1SD31,3 'Strong Buy' Biotech Stocks You Should Watch,2017-08-14 12:55:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/J21ybI75RXE/3-strong-buy-biotech-stocks-you-should-watch-cm831519,"The volatile biotech sector is rebounding with attractive stock valuations and renewed political confidence. Investors believe that President Trump is unlikely to introduce tough controls on drug prices, and could even streamline the lengthy drug-approval process by the Food & Drug Administration (FDA). We can see"
VRTX,VRTX:UW,BBG000C1SD31,Edited Transcript of VRTX earnings conference call or presentation 26-Jul-17 9:15pm GMT,2017-08-13 12:00:50 +0000,https://finance.yahoo.com/news/edited-transcript-vrtx-earnings-conference-070104926.html?.tsrc=rss,Q2 2017 Vertex Pharmaceuticals Inc Earnings Call
VRTX,VRTX:UW,BBG000C1SD31,"Market Close Report: NASDAQ Composite index closes at 6,256.56 up 39.69 points",2017-08-11 20:49:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Xd_D_sqksyw/market-close-report-nasdaq-composite-index-closes-at-625656-up-3969-points-cm831182,Friday s session closes with the NASDAQ Composite Index at 6 256 56 The total shares traded for the NASDAQ was over 1 88 billion Friday s session closes with the NASDAQ Composite Index at 6 256 56 The total shares traded for the NASDAQ was over 1 88 billion Advancers stocks led declining by 1
VRTX,VRTX:UW,BBG000C1SD31,Hot Fidelity Fund Owns These 3 Stocks That Jumped Friday,2017-08-11 20:36:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6ys_fjrMRCE/hot-fidelity-fund-owns-these-3-stocks-that-jumped-friday-cm830843,Can a Boston area 160 team enter the winners circle if the star takes a break It worked for Super Bowl champ Tom Brady and the New England Patriots last year Fidelity Investments hopes the same is true for its Growth Discovery Fund FDSVX when Jason Weiner takes a five month
VRTX,VRTX:UW,BBG000C1SD31,"Friday Sector Leaders: Technology & Communications, Healthcare",2017-08-11 20:35:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qni8QLnXgP4/friday-sector-leaders-technology-communications-healthcare-cm831124,Looking at the sectors faring best as of midday Friday shares of Technology amp Communications companies are outperforming other sectors higher by 1 0 Within that group Tripadvisor Inc Symbol TRIP and Autodesk Inc Symbol ADSK are two large stocks leading the way showing a gain
VRTX,VRTX:UW,BBG000C1SD31,CD 2016-CD1 Mortgage Trust -- Moody's Affirms Eight Classes of CD 2016-CD1,2017-08-11 15:44:07 +0000,http://finance.yahoo.com/r/8542bde2-e3b2-3777-8b1f-7adfad2a4ca1/viewresearchdoc.aspx?docid=PR_371230&WT.mc_id=AM~WWFob29fRmluYW5jZTQyX1NCX0NWX1JhdGluZ19OZXdzX0FsbF9Fbmc=~20170811_PR_371230&yptr=yahoo&.tsrc=rss,Rating Action: Moody's Affirms Eight Classes of CD 2016- CD1. Global Credit Research- 11 Aug 2017. Approximately $594.1 Million of Structured Securities Affected.
VRTX,VRTX:UW,BBG000C1SD31,Can Hot Fidelity Fund Keep Its Edge With Star Manager On Break?,2017-08-11 14:35:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BIX_Kx_16hY/can-hot-fidelity-fund-keep-its-edge-with-star-manager-on-break-cm830843,Can a Boston area 160 team enter the winners circle if the star takes a break It worked for Super Bowl champ Tom Brady and the New England Patriots last year Fidelity Investments hopes the same is true for its Growth Discovery Fund FDSVX when Jason Weiner takes a five month
VRTX,VRTX:UW,BBG000C1SD31,See what the IHS Markit Score report has to say about Vertex Pharmaceuticals Inc.,2017-08-11 12:04:47 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120447763.html?.tsrc=rss,Vertex Pharmaceuticals Inc NASDAQ/NGS:VRTX
VRTX,VRTX:UW,BBG000C1SD31,"IHS Markit Score downgrades Vertex Pharmaceuticals Inc to 64 out of 100, ranking positively in only one out of three available IHS Markit categories.",2017-08-10 12:04:56 +0000,https://finance.yahoo.com/news/ihs-markit-score-downgrades-vertex-120456656.html?.tsrc=rss,Vertex Pharmaceuticals Inc NASDAQ/NGS:VRTX
VRTX,VRTX:UW,BBG000C1SD31,"Biotech Stock Roundup: Q2 Earnings from Regeneron, Kite & More, FibroGen Up on IPF Data",2017-08-09 14:40:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/--rt8-jvMo4/biotech-stock-roundup-q2-earnings-from-regeneron-kite-more-fibrogen-up-on-ipf-data-cm829359,Regeneron REGN and several mid and small cap biotech stocks reported earnings results while companies like Dynavax DVAX and AbbVie ABBV provided regulatory updates Recap of the Week s Most Important Stories A Look at Earnings Results Regeneron reported a strong quarter with
VRTX,VRTX:UW,BBG000C1SD31,Why Vertex Pharmaceuticals Incorporated (VRTX) Will Keep Rolling Higher,2017-08-09 01:00:38 +0000,https://finance.yahoo.com/news/why-vertex-pharmaceuticals-incorporated-vrtx-010038677.html?.tsrc=rss,"InvestorPlace - Stock Market News, Stock Advice &#38; Trading Tips"
VRTX,VRTX:UW,BBG000C1SD31,"For Vertex Pharmaceuticals, Can One Billion-Dollar Breakthrough Beget Another?",2017-08-08 13:45:00 +0000,http://finance.yahoo.com/r/a5f3bd85-6c8b-335d-ae3f-adf1fe0e288f/vertex-pharmaceuticals-and-the-price-of-inspiration?utm_source=yahoo&utm_medium=partner&utm_campaign=yahoofeed&partner=yahoomag&yptr=yahoo&.tsrc=rss,"Vertex Pharmaceuticals' new $200,000-a-year cystic fibrosis drug could help 90% of patients breathe. It's an amazing--and amazingly profitable--innovation. But will that windfall spur the 28-year-old startup to do it again?"
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharmaceuticals vs. Regeneron Pharmaceuticals: Which Company Reported Better Earnings,2017-08-05 00:01:00 +0000,http://finance.yahoo.com/r/b477c667-8dfa-37bd-961e-9ec15c858c0a/vertex-pharmaceuticals-vs-regeneron-pharmaceutical.aspx?yptr=yahoo&.tsrc=rss,Vertex Pharmaceuticals and Regeneron Pharmaceuticals are enjoying rapid sales and profit growth this year. Did one of them execute on their strategy better than the other last quarter?
VRTX,VRTX:UW,BBG000C1SD31,Why Vertex Pharmaceuticals Skyrocketed 17.8% in July,2017-08-03 23:45:00 +0000,http://finance.yahoo.com/r/9d234a0a-7df5-3e24-98a0-54502cdbfe36/why-vertex-pharmaceuticals-skyrocketed-178-in-july.aspx?yptr=yahoo&.tsrc=rss,The company reported mid-stage trial data that suggests it may be able to treat even more cystic fibrosis patients someday.
VRTX,VRTX:UW,BBG000C1SD31,"Should You Buy Vertex Pharmaceuticals Incorporated (VRTX) Stock? 3 Pros, 3 Cons",2017-08-03 13:46:02 +0000,https://finance.yahoo.com/news/buy-vertex-pharmaceuticals-incorporated-vrtx-134602120.html?.tsrc=rss,"Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has shined bright within the biotech industry this year.  VRTX stock has more than doubled over the past 12 months.  Then the company added more fuel to the fire last month, with new drug data results coming in favorably."
VRTX,VRTX:UW,BBG000C1SD31,Corporate News Blog - Vertex Pharma Announces Approval from the FDA For KALYDECO in More Than 600 Patients Suffering from Cystic Fibrosis,2017-08-03 11:10:00 +0000,https://finance.yahoo.com/news/corporate-news-blog-vertex-pharma-111000064.html?.tsrc=rss,"Research Desk Line-up: Seattle Genetics Post Earnings Coverage LONDON, UK / ACCESSWIRE / August 3, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for ..."
VRTX,VRTX:UW,BBG000C1SD31,Vertex’s latest FDA nod could boost sales by $150M: analyst,2017-08-02 16:35:08 +0000,http://finance.yahoo.com/r/b787d599-a457-392f-8b77-5aa124265100/vertex-s-latest-fda-nod-could-boost-sales-by-150m.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Vertex Pharmaceuticals could see its annual revenue increase by more than $150 million following an FDA decision on Tuesday that will allow hundreds of new patients to use its cystic fibrosis drug Kalydeco, according to one analyst.  The FDA initially approved Kalydeco in 2012 for cystic fibrosis patients with one specific type of genetic mutation that causes the lung disease, but it has since gradually expanded the approval to cover additional patients.  The latest boost came on Tuesday, when Vertex (VRTX) said that the FDA had approved Kalydeco for use in more than 600 patients who have any of five different mutations."
VRTX,VRTX:UW,BBG000C1SD31,"Biotech Stock Roundup: Q2 Earnings from Gilead, CELG & More, Dynavax Up on Panel Vote",2017-08-02 13:58:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ygn6jRG4Qg4/biotech-stock-roundup-q2-earnings-from-gilead-celg-more-dynavax-up-on-panel-vote-cm825704,Major biotech stocks like Gilead GILD Celgene CELG Alexion AbbVie ABBV and Vertex VRTX reported second quarter results over the last few days Companies like Gilead and Amgen AMGN also provided regulatory updates 160 Recap of the Week s Most Important Stories A Look at
VRTX,VRTX:UW,BBG000C1SD31,"Biotech Stock Roundup: Q2 Earnings from Gilead, CELG & More, Dynavax Up on Panel Vote",2017-08-02 12:32:12 +0000,https://finance.yahoo.com/news/biotech-stock-roundup-q2-earnings-123212689.html?.tsrc=rss,Companies like Gilead (GILD) topped expectations in the second quarter while Dynavax shot up on a positive FDA advisory panel vote.
VRTX,VRTX:UW,BBG000C1SD31,"Vertex Pharmaceuticals, Inc. :VRTX-US: Earnings Analysis: Q2, 2017 By the Numbers : August 1, 2017",2017-08-01 16:09:47 +0000,http://finance.yahoo.com/r/4e576b19-71e6-30be-b503-572fe204bf24/vertex-pharmaceuticals-inc-vrtx-us-earnings-analysis-q2-2017-by-the-numbers-august-1-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Vertex Pharmaceuticals, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Vertex Pharmaceuticals, Inc. – Gilead Sciences, Inc., AbbVie, Inc., Merck & Co., Inc., Bristol-Myers Squibb Company and Johnson & Johnson (GILD-US, ABBV-US, MRK-US, BMY-US and JNJ-US) that have ... Read more
<b>(Read more...)</b>"
VRTX,VRTX:UW,BBG000C1SD31,FDA Approves KALYDECO® (ivacaftor) for More Than 600 People Ages 2 and Older With Cystic Fibrosis Who Have Certain Residual Function Mutations,2017-08-01 12:01:00 +0000,https://finance.yahoo.com/news/fda-approves-kalydeco-ivacaftor-more-120100068.html?.tsrc=rss,Vertex Pharmaceuticals Incorporated today announced that the U.S. Food and Drug Administration has approved KALYDECO® for use in more than 600 people with cystic fibrosis ages 2 and older who have one of five residual function mutations that result in a splicing defect in the cystic fibrosis transmembrane conductance regulator gene.
VRTX,VRTX:UW,BBG000C1SD31,"Noteworthy ETF Outflows: FEX, VRTX, LRCX, BG",2017-07-28 16:01:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gcY5BD4auhU/noteworthy-etf-outflows-fex-vrtx-lrcx-bg-cm823260,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the First Trust Large Cap Core AlphaDEX Fund Symbol FEX where we have detected an approximate 16 2 million dollar outflow that s a 1 0 decrease week over
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharmaceuticals Incorporated Chugs Along,2017-07-28 14:00:00 +0000,http://finance.yahoo.com/r/10ba470e-aa77-3940-bd55-cdcd3cc6be8e/vertex-pharmaceuticals-incorporated-chugs-along.aspx?yptr=yahoo&.tsrc=rss,"The biotech continues to sell more of its cystic fibrosis drugs, using the profits to fund development of more drugs. Rinse and repeat."
VRTX,VRTX:UW,BBG000C1SD31,"Vertex Pharmaceuticals: Looking East, West and to the Quants",2017-07-27 20:50:00 +0000,http://finance.yahoo.com/r/0e15be84-8cbf-3253-a121-6199af8e0b50/vertex-pharmaceuticals-looking-east-west-and-to-the-quants.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Let's examine VRTX's sharp decline today.
VRTX,VRTX:UW,BBG000C1SD31,Biotech Fever Cools As These Players Dip On Longer-Term Views,2017-07-27 20:29:27 +0000,http://finance.yahoo.com/r/e0e84444-b923-3d34-8f46-b359808f2173/biotech-fever-cools-as-these-players-dip-on-longer-term-views?src=A00220&yptr=yahoo&.tsrc=rss,"Biotech stocks toppled midday Thursday, in-line with broader indexes, and included pitfalls from large players like Vertex, United and Spark."
VRTX,VRTX:UW,BBG000C1SD31,"Thursday Sector Laggards: Healthcare, Technology & Communications",2017-07-27 19:57:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nSDo-1gaSKA/thursday-sector-laggards-healthcare-technology-communications-cm822790,The worst performing sector as of midday Thursday is the Healthcare sector showing a 1 0 loss Within that group Vertex Pharmaceuticals Inc Symbol VRTX and Bristol Myers Squibb Co Symbol BMY are two of the day s laggards showing a loss of 5 6 and 3 5 respectively Among
VRTX,VRTX:UW,BBG000C1SD31,"Vertex Pharmaceuticals: Looking East, West and to the Quants",2017-07-27 18:50:00 +0000,http://finance.yahoo.com/r/82bac0f9-c411-334f-81c1-2f6de1bfed17/vertex-pharmaceuticals-looking-east-west-and-quants?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Let's examine VRTX's sharp decline today.
VRTX,VRTX:UW,BBG000C1SD31,"Pharma Stocks to Watch for Earnings on Jul 28: ABBV, MRK",2017-07-27 17:04:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/r5d88A5Qm7A/pharma-stocks-to-watch-for-earnings-on-jul-28-abbv-mrk-cm822646,The second quarter reporting cycle is in full swing The quarter undoubtedly is off to a strong start As of Jul 26 2017 171 S amp P 500 members accounting for 44 1 of the index s total market capitalization reported results according to Earnings Preview Total earnings for these
VRTX,VRTX:UW,BBG000C1SD31,"Zacks.com featured highlights: Farmers & Merchants Bancorp, Advanced Energy Industries, NVR, Vertex Pharmaceuticals and Sanderson Farms",2017-07-27 16:06:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JbGwP5nej8Y/zackscom-featured-highlights-farmers-merchants-bancorp-advanced-energy-industries-nvr-vertex-pharmaceuticals-and-sanderson-farms-cm822523,For Immediate Release Chicago IL July 27 2017 Stocks in this week s article include Farmers amp Merchants Bancorp Inc NASDAQ FMAO Free Report Advanced Energy Industries Inc NASDAQ AEIS Free Report NVR Inc NYSE NVR Free Report Vertex
VRTX,VRTX:UW,BBG000C1SD31,"Zacks.com featured highlights: Farmers & Merchants Bancorp, Advanced Energy Industries, NVR, Vertex Pharmaceuticals and Sanderson Farms",2017-07-27 13:54:01 +0000,https://finance.yahoo.com/news/zacks-com-featured-highlights-farmers-135401622.html?.tsrc=rss,"Zacks.com featured highlights: Farmers & Merchants Bancorp, Advanced Energy Industries, NVR, Vertex Pharmaceuticals and Sanderson Farms"
VRTX,VRTX:UW,BBG000C1SD31,Vertex (VRTX) Q2 Earnings Top on Solid Cystic Fibrosis Sales,2017-07-27 12:59:12 +0000,https://finance.yahoo.com/news/vertex-vrtx-q2-earnings-top-125912725.html?.tsrc=rss,"Vertex Pharmaceuticals Incorporated&apos;s (VRTX) Q2 results were encouraging, as it topped earnings and revenues expectations backed by higher sales of both its CF drugs."
VRTX,VRTX:UW,BBG000C1SD31,"J.P. Morgan Elevates Price Targets on Gilead Sciences, Inc. (GILD) and Vertex Pharmaceuticals Incorporated (VRTX) After Glowing 2Q Performance",2017-07-27 12:06:21 +0000,https://finance.yahoo.com/news/j-p-morgan-elevates-price-120621355.html?.tsrc=rss,"J.P. Morgan analyst Cory Kasimov is getting more upbeat on two biotech players on the heels of aces from both handed over with second quarterly results yesterday.  Between Gilead Sciences, Inc. (NASDAQ:GILD) showing it remains a force to be reckoned with in the HIV sphere even in face of a derailing HCV segment and Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) exciting cystic fibrosis prospects, the analyst has every confidence these two stocks are one to watch in the biotech-verse.  Gilead delivered a reassuring second-quarter print yesterday that has Kasimov highlighting promise for this biotech giant- even with its HCV weakness."
VRTX,VRTX:UW,BBG000C1SD31,Trending: Corn Falls Due to Heavy Northeast Rains,2017-07-27 12:00:00 +0000,https://finance.yahoo.com/news/trending-corn-falls-due-heavy-120000502.html?.tsrc=rss,"ETFdb.com analyzes the search patterns of our visitors each week. By sharing these trends with our readers, we hope to provide insights into what the financial world is concerned about and how to position your portfolio."
VRTX,VRTX:UW,BBG000C1SD31,Vertex tops Street 2Q forecasts,2017-07-27 02:55:10 +0000,https://finance.yahoo.com/news/vertex-tops-street-2q-forecasts-213229277.html?.tsrc=rss,"On a per-share basis, the Boston-based company said it had profit of 7 cents. Earnings, adjusted for stock option expense and non-recurring costs, came to 39 cents per share. The results surpassed Wall ..."
VRTX,VRTX:UW,BBG000C1SD31,"Vertex Sinks Late Despite Crushing Sales, Profit Expectations",2017-07-26 21:20:03 +0000,http://finance.yahoo.com/r/4b970618-32f4-3d07-83d6-d16a5c8423cb/vertex-crushes-second-quarter-sales-profit-expectations?src=A00220&yptr=yahoo&.tsrc=rss,Vertex Pharmaceuticals sank more than 1% late Wednesday even after the biotech topped second-quarter expectations.
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharma's quarterly profit beats estimates,2017-07-26 20:28:05 +0000,https://finance.yahoo.com/news/vertex-pharmas-quarterly-profit-beats-202805879.html?.tsrc=rss,"Vertex Pharmaceuticals Inc reported a better-than-expected profit for the third straight quarter, helped by improved sales of its cystic fibrosis drugs. Net profit attributable to Vertex was $18 million, ..."
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharma reports quarterly profit,2017-07-26 20:08:48 +0000,https://finance.yahoo.com/news/vertex-pharma-reports-quarterly-profit-200848075.html?.tsrc=rss,"Vertex Pharmaceuticals Inc reported a quarterly profit, compared with a year-ago loss, helped by higher sales of its cystic fibrosis drugs. The company's net profit was $18 million, or 7 cents per share, ..."
VRTX,VRTX:UW,BBG000C1SD31,Vertex Reports Second-Quarter 2017 Financial Results,2017-07-26 20:01:00 +0000,https://finance.yahoo.com/news/vertex-reports-second-quarter-2017-200100211.html?.tsrc=rss,"Vertex Pharmaceuticals Incorporated today reported consolidated financial results for the second quarter ended June 30, 2017. Vertex reiterated its full-year 2017 financial guidance for ORKAMBI® and KALYDECO® net revenues and updated its guidance for combined GAAP and non-GAAP R&D and SG&A expenses."
VRTX,VRTX:UW,BBG000C1SD31,"Earnings Reaction History: Vertex Pharmaceuticals Incorporated, 40.0% Follow-Through Indicator, 2.6% Sensitive",2017-07-26 19:17:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YL1tW4y4ud0/earnings-reaction-history-vertex-pharmaceuticals-incorporated-400-follow-through-indicator-26-sensitive-cm821959,Expected Earnings Release 07 26 2017 After hoursExpected Earnings Release 07 26 2017 After hours Avg Extended Hours Dollar Volume 15 385 054Avg Extended Hours Dollar Volume 15 385 054 Vertex Pharmaceuticals Incorporated VRTX is due to issue its quarterly earnings report in
VRTX,VRTX:UW,BBG000C1SD31,"After-Hours Earnings Report for July 26, 2017 :  FB, GILD, PYPL, SU, LVS, VRTX, PSA, LRCX, EW, DFS, ABX, NOW",2017-07-26 19:03:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BDPdNFvXUno/after-hours-earnings-report-for-july-26-2017-fb-gild-pypl-su-lvs-vrtx-psa-lrcx-ew-dfs-abx-now-cm821937,The following companies are expected to report earnings after hours on 07 26 2017 Visit our Earnings Calendar for a full list of expected earnings releases Facebook Inc FB is reporting for the quarter ending June 30 2017 The internet services company
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharmaceuticals Inc. Q2 Income Climbs 71%,2017-07-26 16:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-HVYrizVVRM/vertex-pharmaceuticals-inc-q2-income-climbs-71-20170726-01780,Vertex Pharmaceuticals Inc. Q2 Income Climbs 71%
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharmaceuticals Inc. Q2 Income Climbs 71%,2017-07-26 16:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VA_fCngNpdY/vertex-pharmaceuticals-inc-q2-income-climbs-71%25-20170726-01780,Vertex Pharmaceuticals Inc. Q2 Income Climbs 71%
VRTX,VRTX:UW,BBG000C1SD31,Investor Network: Vertex Pharmaceuticals Incorporated to Host Earnings Call,2017-07-26 15:15:00 +0000,https://finance.yahoo.com/news/investor-network-vertex-pharmaceuticals-incorporated-151500836.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / July 26, 2017 / Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX ) will be discussing their earnings results in their Q2 Earnings Call to be held on Wednesday, July 26, 2017 ..."
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharmaceuticals Q2 17 Earnings Conference Call At 5:15 PM ET,2017-07-26 15:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tF50ELfPcVo/vertex-pharmaceuticals-q2-17-earnings-conference-call-at-515-pm-et-20170726-01404,Vertex Pharmaceuticals Q2 17 Earnings Conference Call At 5:15 PM ET
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharmaceuticals’ Focus on Innovative Combination Regimens,2017-07-26 14:39:18 +0000,http://finance.yahoo.com/r/7cd0b2c8-4f65-3f34-ac13-489b4df11949/vertex-pharmaceuticals-continues-focus-innovative-combination-regimens-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"On March 28, 2017, Vertex Pharmaceutical (VRTX) released data from a phase 3 trial, EVOLVE."
VRTX,VRTX:UW,BBG000C1SD31,5 Top Efficient Stocks to Buy for a Winning Portfolio,2017-07-26 14:02:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/D29ubpVt340/5-top-efficient-stocks-to-buy-for-a-winning-portfolio-cm821611,Efficiency the ability to transform inputs into outputs is a potential indicator of a company s financial health Companies with favorable efficiency levels are likely to be on investors radar irrespective of market conditions This is because a company with a favorable efficiency level
VRTX,VRTX:UW,BBG000C1SD31,Why Vertex Pharmaceuticals Could Expand Its Addressable Market,2017-07-26 13:09:41 +0000,http://finance.yahoo.com/r/79c82865-9de5-3420-b86b-590478d29fab/tezacaftor-ivacaftor-combination-regimen-may-expand-vertex-pharmaceuticals-addressable-market?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"On March 29, 2017, Vertex Pharmaceuticals released positive data from two phase 3 trials, Evolve and Expand."
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharmaceuticals: Robust Growth Trends for Kalydeco in 2017,2017-07-26 11:42:49 +0000,http://finance.yahoo.com/r/bcaaf812-c6b6-3c59-8085-10ef312a6a81/vertex-pharmaceuticals-expects-robust-growth-trends-kalydeco-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 1Q17, Vertex Pharmaceuticals’ (VRTX) Kalydeco reported revenues close to $186 million, of which $102 million came from the US market."
VRTX,VRTX:UW,BBG000C1SD31,Gilead Faces 6th Quarter of Falling Revenue,2017-07-26 10:00:00 +0000,http://finance.yahoo.com/r/4c8fc31b-51e8-30cc-92a7-932e1b0b0235/gilead-faces-6th-quarter-falling-revenue?partner=YahooSA&yptr=yahoo&.tsrc=rss,"Gilead Sciences, Inc.'s revenue is estimated to decline by just over 18% when it reports its Q2 results."
VRTX,VRTX:UW,BBG000C1SD31,Top Stock Picks for the Week of July 24th,2017-07-25 21:58:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/usMJSUwf70Y/top-stock-picks-for-the-week-of-july-24th-cm821232,Facebook Inc FB 160 operates a social networking website worldwide 160 This Zacks Rank 1 Strong Buy stock with a Growth score of A has ample growth catalysts Not the least of which are earnings estimates that continue to rise A strong balance sheet and significant cash flow
VRTX,VRTX:UW,BBG000C1SD31,Vertex: Why Label Expansion Could Boost Orkambi Sales in 2017,2017-07-25 21:36:12 +0000,http://finance.yahoo.com/r/82d2da6e-e3b7-32bc-a476-73dce7827640/continued-label-expansion-may-boost-orkambis-sales-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,ertex Pharmaceuticals’ Orkambi also secured U.S. Food and Drug Administration’s (or FDA) approval for CF patients in the age group of six to 11 years in September 2016.
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharmaceuticals Cystic Fibrosis Market Could Expand,2017-07-25 20:06:15 +0000,http://finance.yahoo.com/r/3d030232-db50-3194-a64e-82c8f3c428e0/vertex-pharmaceuticals-may-witness-expansion-addressable-cystic-fibrosis-market-size?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Vertex Pharmaceuticals’ (VRTX) drugs, Orkambi (lumacaftor/ivacaftor) and Kalydeco (ivacaftor), are capable of treating around 30,000 cystic fibrosis (or CF) patients."
VRTX,VRTX:UW,BBG000C1SD31,Top Stock Picks for the Week of July 24th,2017-07-25 20:01:08 +0000,https://finance.yahoo.com/news/top-stock-picks-week-july-200108041.html?.tsrc=rss,A Couple of Healthy Companies to Consider.
VRTX,VRTX:UW,BBG000C1SD31,Vertex and Concert Pharmaceuticals Complete Asset Purchase Agreement for CTP-656,2017-07-25 20:01:00 +0000,https://finance.yahoo.com/news/vertex-concert-pharmaceuticals-complete-asset-200100077.html?.tsrc=rss,"Vertex Pharmaceuticals Incorporated and Concert Pharmaceuticals, Inc. today announced the completion of their previously announced asset purchase agreement."
VRTX,VRTX:UW,BBG000C1SD31,Wall Street’s Latest Recommendations for Vertex Pharmaceuticals,2017-07-25 18:10:24 +0000,http://finance.yahoo.com/r/479ce4d3-03a8-3d82-a829-5bb790439af2/analysts-recommendations-vertex-pharmaceuticals-peers-july-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Since July 17, 2017, Vertex Pharmaceuticals’ (VRTX) stock price has recorded a solid rise of around 26.3%."
VRTX,VRTX:UW,BBG000C1SD31,"Drug Stocks Q2 Earnings Releases on Jul 26: GILD, VRTX, GSK",2017-07-25 18:03:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LVJd7sECmpI/drug-stocks-q2-earnings-releases-on-jul-26-gild-vrtx-gsk-cm820959,We are entering the peak period of the second quarter reporting cycle this week The quarter undoubtedly is off to a strong start As of Jul 21 2017 97 S amp P 500 members accounting for 28 1 of the index s total market capitalization reported results according to 160 Earnings
VRTX,VRTX:UW,BBG000C1SD31,Will Radius Health (RDUS) Disappoint this Earnings Season?,2017-07-25 16:13:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3RxFKiS2wzE/will-radius-health-rdus-disappoint-this-earnings-season-cm820920,Radius Health Inc RDUS is scheduled to report second quarter 2017 financial results on Aug 3 Radius Health s shares have outperformed the industry in the year so far The stock has gained 13 7 during this time period against a 6 8 industry s gain Radius Health has a
VRTX,VRTX:UW,BBG000C1SD31,Can Intercept (ICPT) Beat Estimates this Earnings Season?,2017-07-25 16:08:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nd1RV9KvWW4/can-intercept-icpt-beat-estimates-this-earnings-season-cm821036,Intercept Pharmaceuticals Inc ICPT is scheduled to report second quarter 2017 results on Jul 31 In the last reported quarter the company beat expectations by 15 4 Let s see how things are shaping up for this announcement Intercept s share price movement in the year so far
VRTX,VRTX:UW,BBG000C1SD31,What's in the Cards for Geron (GERN) this Earnings Season?,2017-07-25 16:05:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Mh5KxSX0lJU/whats-in-the-cards-for-geron-gern-this-earnings-season-cm821021,Geron Corporation GERN is expected to report second quarter 2017 results next week The company s earnings came in line with the Zacks Consensus Estimate in the last reported quarter Let s see how things are shaping up for the upcoming announcement Geron s shares outperformed the industry
VRTX,VRTX:UW,BBG000C1SD31,"Drug Stocks Q2 Earnings Releases on Jul 26: GILD, VRTX, GSK",2017-07-25 15:18:03 +0000,https://finance.yahoo.com/news/drug-stocks-q2-earnings-releases-151803505.html?.tsrc=rss,We have three pharma giants that are set to report second-quarter results on Jul 26. Let&apos;s see how things are shaping up for this quarter.
VRTX,VRTX:UW,BBG000C1SD31,DST Systems (DST) Q2 Earnings: Is a Surprise in Store?,2017-07-25 15:09:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dEScHB2a6mw/dst-systems-dst-q2-earnings-is-a-surprise-in-store-cm820737,DST Systems Inc DST is set to report second quarter 2017 results on Jul 27 Last quarter the company delivered a positive earnings surprise of 15 87 Notably DST Systemsoutperformed the Zacks Consensus Estimate in all the trailing four quarters with an average positive earnings surprise
VRTX,VRTX:UW,BBG000C1SD31,Gigamon (GIMO) to Report Q2 Earnings: What's in the Cards?,2017-07-25 15:09:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vlkvKFsvErc/gigamon-gimo-to-report-q2-earnings-whats-in-the-cards-cm820946,Gigamon Inc GIMO is scheduled to report second quarter 2017 results on Jul 27 Last quarter the company posted a positive earnings surprise of 25 Let s see how things are shaping up for this announcement Factors to Consider Gigamon is engaged in providing intelligent Traffic
VRTX,VRTX:UW,BBG000C1SD31,Why Vertex Pharmaceuticals (VRTX) Might Surprise This Earnings Season,2017-07-25 14:04:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RfKjvDdW27o/why-vertex-pharmaceuticals-vrtx-might-surprise-this-earnings-season-cm820788,Investors are always looking for stocks that are poised to beat at earnings season and Vertex Pharmaceuticals Incorporated VRTX may be one such company The firm has earnings coming up pretty soon and events are shaping up quite nicely for their report That is because Vertex Pharmaceuticals
VRTX,VRTX:UW,BBG000C1SD31,Xilinx (XLNX) to Post Q1 Earnings: What's in the Cards?,2017-07-25 14:03:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-V6Fk6dHZcg/xilinx-xlnx-to-post-q1-earnings-whats-in-the-cards-cm820779,Xilinx Inc XLNX is slated to report first quarter 2018 results on Jul 26 Last quarter the company posted a positive earnings surprise of 5 56 Notably Xilinx outperformed the Zacks Consensus Estimate in all the preceding four quarters with an average positive earnings surprise of 8
VRTX,VRTX:UW,BBG000C1SD31,Why Vertex Pharmaceuticals (VRTX) Might Surprise This Earnings Season,2017-07-25 12:47:12 +0000,https://finance.yahoo.com/news/why-vertex-pharmaceuticals-vrtx-might-124712302.html?.tsrc=rss,Vertex Pharmaceuticals (VRTX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
VRTX,VRTX:UW,BBG000C1SD31,"Vertex Energy, Inc. to Release Second Quarter 2017 Financial Results on August 8, 2017",2017-07-25 11:00:00 +0000,https://finance.yahoo.com/news/vertex-energy-inc-release-second-110000559.html?.tsrc=rss,"HOUSTON, July 25, 2017-- Vertex Energy, Inc., a refiner and marketer of high-quality specialty hydrocarbon products, announced today that it will release its financial results for the second quarter ended ..."
VRTX,VRTX:UW,BBG000C1SD31,"Gainers & Losers Of July 24: WBMD, NDRM, PETS, AEZS, VTVT...",2017-07-24 20:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YLCpR5FdIZI/gainers--losers-of-july-24-wbmd-ndrm-pets-aezs-vtvt-20170724-01388,"Gainers & Losers Of July 24: WBMD, NDRM, PETS, AEZS, VTVT..."
VRTX,VRTX:UW,BBG000C1SD31,Top Ranked Momentum Stocks to Buy for July 24th,2017-07-24 17:10:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uHtzH_p-FCI/top-ranked-momentum-stocks-to-buy-for-july-24th-cm820372,Here are four stocks with buy rank and strong momentum characteristics for investors to consider today July 24th Arena Pharmaceuticals Inc ARNA This biopharmaceutical company has a Zacks Rank 2 Buy and witnessed the Zacks Consensus Estimate for its current year earnings rising 11
VRTX,VRTX:UW,BBG000C1SD31,What's in the Cards for Exelixis (EXEL) in Q2 Earnings?,2017-07-24 17:09:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tPDyd3kQAmk/whats-in-the-cards-for-exelixis-exel-in-q2-earnings-cm820318,Exelixis Inc EXEL is scheduled to report second quarter 2017 results on Aug 2 after the market closes Exelixis track record is outstanding The company has surpassed expectations in all the four trailing quarters with an average positive earnings surprise of 512 1
VRTX,VRTX:UW,BBG000C1SD31,Is Celgene (CELG) Poised For a Beat This Earnings Season?,2017-07-24 16:09:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xNhWO-IuSHA/is-celgene-celg-poised-for-a-beat-this-earnings-season-cm820167,Celgene Corporation CELG is scheduled to report second quarter 2017 results on Jul 27 before the opening bell Last quarter the company beat expectations by 4 08 Celgene has outperformed the Zacksclassified industry in the year so far The stock has gained 19 during this
VRTX,VRTX:UW,BBG000C1SD31,Top Ranked Momentum Stocks to Buy for July 24th,2017-07-24 14:18:02 +0000,https://finance.yahoo.com/news/top-ranked-momentum-stocks-buy-141802005.html?.tsrc=rss,Top Ranked Momentum Stocks to Buy for July 24th
VRTX,VRTX:UW,BBG000C1SD31,What's in the Offing for F5 Networks (FFIV) in Q3 Earnings?,2017-07-24 14:09:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xyF0enHd-0I/whats-in-the-offing-for-f5-networks-ffiv-in-q3-earnings-cm820124,F5 Networks Inc FFIV is set to report third quarter 2017 results on Jul 26 Last quarter the company posted a negative earnings surprise of 3 95 Notably F5 Networks outperformed the Zacks Consensus Estimate in two of the trailing four quarters with an average positive earnings surprise
VRTX,VRTX:UW,BBG000C1SD31,Equifax (EFX) to Post Q2 Earnings: What's in the Cards?,2017-07-24 14:09:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wfP80az4KXo/equifax-efx-to-post-q2-earnings-whats-in-the-cards-cm820122,Equifax Inc EFX is scheduled to report second quarter 2017 results on Jul 26 Last quarter the company posted a positive earnings surprise of 2 13 Notably Equifax outperformed the Zacks Consensus Estimate in the trailing four quarters with an average positive earnings surprise of 4
VRTX,VRTX:UW,BBG000C1SD31,"Zacks.com featured highlights: Vertex Pharmaceuticals, AGCO, Owens Corning, Five9 and Axcelis Technologies",2017-07-24 13:30:01 +0000,https://finance.yahoo.com/news/zacks-com-featured-highlights-vertex-133001184.html?.tsrc=rss,"Zacks.com featured highlights: Vertex Pharmaceuticals, AGCO, Owens Corning, Five9 and Axcelis Technologies"
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharmaceuticals Inc (VRTX) CEO & President Jeffrey M Leiden Sold $34.9 million of Shares,2017-07-22 23:02:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3NIO0CTfjjE/vertex-pharmaceuticals-inc-vrtx-ceo-president-jeffrey-m-leiden-sold-349-million-of-shares-cm819811,CEO amp President of Vertex Pharmaceuticals Inc VRTX Jeffrey M Leiden sold 216 624 shares of VRTX on 07 21 2017 at an average price of 160 96 a share The total sale was 34 9 million CEO President of Vertex Pharmaceuticals Inc VRTX Jeffrey M Leiden sold 216 624 shares of VRTX
VRTX,VRTX:UW,BBG000C1SD31,"Biotechs On A Hot Streak, And Could Be &apos;Cooking With Gas&apos;",2017-07-21 20:14:03 +0000,http://finance.yahoo.com/r/a8195dfd-eb98-3013-9614-baa8c81e7481/biotechs-on-a-hot-streak-and-could-be-cooking-with-gas?src=A00220&yptr=yahoo&.tsrc=rss,IBD&apos;s 439-company Biotech industry group is now ranked fourth out of 197. How far can the rally go?
VRTX,VRTX:UW,BBG000C1SD31,Is a Beat in the Cards for Vertex (VRTX) in Q2 Earnings?,2017-07-21 18:46:06 +0000,https://finance.yahoo.com/news/beat-cards-vertex-vrtx-q2-184606728.html?.tsrc=rss,Impressive performance of Vertex Pharmaceuticals&apos; (VRTX) cystic fibrosis drugs Kalydeco and Orkambi may drive the stock to an earnings beat in Q2.
VRTX,VRTX:UW,BBG000C1SD31,Will Gilead Beat 2Q Earnings? Perhaps…But Does It Matter?,2017-07-21 17:38:00 +0000,http://finance.yahoo.com/r/160bc290-317e-38d7-a838-bece487a56a4/will-gilead-beat-2q-earnings-perhapsbut-does-it-matter-1500658730?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Is Gilead Sciences (GILD) poised for a beat next week?  Guggenheim analyst Tony Butler sees Gilead earning $2.15 a share, a penny above the consensus forecast compiled by sell-side analyst, with operating revenue of $6.54 billion beating the $6.31 billion expected by the Street.  Butler’s estimates for the full 2017 calendar year are also above consensus, with per-share earnings of $8.28 on operating revenue of $25.4 billion."
VRTX,VRTX:UW,BBG000C1SD31,What's in the Offing for Bristol-Myers (BMY) in Q2 Earnings?,2017-07-21 17:08:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ml7WPn97Riw/whats-in-the-offing-for-bristol-myers-bmy-in-q2-earnings-cm819391,Bristol Myers Squibb Company BMY is scheduled to report first quarter 2017 results on Jul 27 before the opening bell Last quarter the company beat earnings estimates by 16 7 Bristol Myers Squibb Company Price and EPS Surprise Bristol Myers Squibb Company Price and
VRTX,VRTX:UW,BBG000C1SD31,What&apos;s in the Offing for Bristol-Myers (BMY) in Q2 Earnings?,2017-07-21 15:23:03 +0000,https://finance.yahoo.com/news/apos-offing-bristol-myers-bmy-152303937.html?.tsrc=rss,"Bristol-Myers Squibb Company (BMY) is scheduled to report first-quarter 2017 results on Jul 27, before the opening bell. Last quarter, the company beat earnings estimates by 16.7%."
VRTX,VRTX:UW,BBG000C1SD31,"Vertex Pharma, A10 Networks, Microsoft, Visa and eBay highlighted as Zacks Bull and Bear of the Day",2017-07-21 15:11:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0Iyyc_zFrcw/vertex-pharma-a10-networks-microsoft-visa-and-ebay-highlighted-as-zacks-bull-and-bear-of-the-day-cm819196,For Immediate Release Chicago IL July 21 2017 Zacks Equity Research highlights Vertex Pharma NASDAQ VRTX Free Report as the Bull of the Day A10 Networks Inc NYSE ATEN Free Report as the Bear of the Day In addition Zacks Equity Research provides analysis on
VRTX,VRTX:UW,BBG000C1SD31,Can Merck (MRK) Pull Off a Surprise this Earnings Season?,2017-07-21 14:10:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kmWAucRLU3g/can-merck-mrk-pull-off-a-surprise-this-earnings-season-cm819281,Merck amp Co Inc MRK will be reporting second quarter 2017 earnings on Jul 28 before market opens Last quarter the company delivered a positive earnings surprise of 6 02 Merck s performance has been pretty impressive with the company exceeding earnings expectations consistently
VRTX,VRTX:UW,BBG000C1SD31,"Stock Market News for July 21, 2017",2017-07-21 13:46:01 +0000,https://finance.yahoo.com/news/stock-market-news-july-21-134601986.html?.tsrc=rss,Deal between Sears and Amazon weighed on home improvement retailers on Thursday
VRTX,VRTX:UW,BBG000C1SD31,Bull of the Day: Vertex Pharma (VRTX),2017-07-21 13:07:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/giyBpvnsIxU/bull-of-the-day-vertex-pharma-vrtx-cm819187,Cystic Fibrosis CF is a rare genetic disease that causes persistent lung infections and limits the infected person s ability to breathe 160 According to the CF Foundation In the lungs the mucus clogs the airways and traps bacteria leading to infections extensive lung damage
VRTX,VRTX:UW,BBG000C1SD31,Seres Therapeutics (MCRB) Catches Eye: Stock Gains 9.2%,2017-07-21 12:20:12 +0000,https://finance.yahoo.com/news/seres-therapeutics-mcrb-catches-eye-122012751.html?.tsrc=rss,"Seres Therapeutics, Inc. (MCRB) shares rose a little above 9% in the last trading session."
VRTX,VRTX:UW,BBG000C1SD31,5 Stock Picks with Earnings Beat Potential,2017-07-21 07:54:07 +0000,https://finance.yahoo.com/news/5-stock-picks-earnings-beat-075407207.html?.tsrc=rss,Inside the top-ranked stocks that can beat earnings estimates in their next releases.
VRTX,VRTX:UW,BBG000C1SD31,Trade Philip Morris International Inc. (PM) Stock While It’s Up in Smoke,2017-07-20 20:06:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EeEfFI2d1Ng/trade-philip-morris-international-inc-pm-stock-while-its-up-in-smoke-cm818948,InvestorPlace Stock Market News Stock Advice amp Trading Tips Living in the U S especially on the West Coast I was under the impression that smoking was on its way out Boy was I wrong Source Taber Andrew Bain Via Flickr I recently went to Europe and the Middle East and
VRTX,VRTX:UW,BBG000C1SD31,Vertex Becomes an Overnight Biotech M&A Darling,2017-07-20 18:00:10 +0000,http://finance.yahoo.com/r/07dcf41f-f303-35e2-80cd-0f269a31992e/vertex-cystic-fibrosis-combo-trial-data-make-it-m-a-bait?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,New trial data for cystic fibrosis drug cocktails boost its sales outlook.
VRTX,VRTX:UW,BBG000C1SD31,"Sarepta (SRPT) Q2 Loss Narrows, Ups Exondys 51 Sales View",2017-07-20 17:06:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Levo9K_I7JY/sarepta-srpt-q2-loss-narrows-ups-exondys-51-sales-view-cm818801,Sarepta Therapeutics Inc SRPT reported narrower than expected loss in the second quarter of 2017 The biotech also increased its 2017 sales outlook for Exondys 51 a treatment for Duchenne muscular dystrophy DMD and its only marketed drug Shares were up almost 15 in after hours trading
VRTX,VRTX:UW,BBG000C1SD31,S&P Stealth Outperformers: Health Care,2017-07-20 16:00:00 +0000,http://finance.yahoo.com/r/96933f98-f87c-3341-81e4-0952c247302f/sp-stealth-outperformers-health-care?partner=YahooSA&yptr=yahoo&.tsrc=rss,"It's well-known that technology stocks are leading the advance in the S&P 500, but health care stocks are close behind."
VRTX,VRTX:UW,BBG000C1SD31,Biotech Stocks on Fire After Vertex News,2017-07-20 14:19:00 +0000,http://finance.yahoo.com/r/8ea725c6-d89d-3bd2-b902-bd5e244ddb1a/biotech-stocks-fire-after-vertex-news?partner=YahooSA&yptr=yahoo&.tsrc=rss,Vertex Pharmaceuticals research results ignited a strong biotech sector advance that could gain traction in coming weeks.
VRTX,VRTX:UW,BBG000C1SD31,Is Gilead (GILD) Poised for a Beat This Earnings Season?,2017-07-20 14:08:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Dj8ghdNt3vo/is-gilead-gild-poised-for-a-beat-this-earnings-season-cm818541,Gilead Sciences Inc GILD is scheduled to report second quarter 2017 results on Jul 26 after the market closes Last quarter the company beat expectations by 0 92 Gilead Sciences Inc Price and EPS Surprise Gilead Sciences Inc Price and EPS
VRTX,VRTX:UW,BBG000C1SD31,Buy Vertex Pharmaceuticals Incorporated (VRTX) Stock Like Its 20% Gain Never Happened,2017-07-20 14:01:54 +0000,https://finance.yahoo.com/news/buy-vertex-pharmaceuticals-incorporated-vrtx-140154970.html?.tsrc=rss,Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) had an incredible day on Wednesday spiking over 20% on a favorable headline regarding drug trials.  This is especially true when the stock jumps as much as VRTX stock jumped on Wednesday.  Compare this to the recent jump in Alibaba Group Holding Ltd (NYSE:BABA) where management actually gave us the math behind the higher valuations.
VRTX,VRTX:UW,BBG000C1SD31,"Company News for July 20, 2017",2017-07-20 13:40:01 +0000,https://finance.yahoo.com/news/company-news-july-20-2017-134001404.html?.tsrc=rss,"Companies In The News are: VRTX,DISCA,UAL,CCI"
VRTX,VRTX:UW,BBG000C1SD31,"Biotech Bulletin of the Week: Gilead Sciences, Inc. (GILD), Vertex Pharmaceuticals Incorporated (VRTX), and Keryx Biopharmaceuticals (KERX)",2017-07-20 12:49:35 +0000,https://finance.yahoo.com/news/biotech-bulletin-week-gilead-sciences-124935286.html?.tsrc=rss,"Gilead Sciences, Inc. (NASDAQ:GILD) just scored a green light from the FDA for its triple Vosevi combination of sofosbuvir, velpatasvir and voxilapreviri, designed to treat hepatitis C. So why does Leerink analyst Geoff Porges remain unimpressed with the biotech giant, even on the heels of agency approval?  Porges believes in the competition arena, Gilead is ultimately ""disadvantaged"" when heading up against AbbVie's rival hepatitis C drug Maviret.  Sidelined on Gilead's HCV prospects, the analyst rates a Hold on Gilead stock, with a price target of $74, which implies a slight upside from current levels."
VRTX,VRTX:UW,BBG000C1SD31,Today's Research Reports on Stocks to Watch: Vertex Pharmaceuticals and Aeterna Zentaris,2017-07-20 12:20:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-122000451.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / July 20, 2017 / Both Vertex Pharmaceuticals and Aeterna Zentaris saw their share prices pop on Wednesday and received price target increases from Maxim. Vertex stormed ahead ..."
VRTX,VRTX:UW,BBG000C1SD31,[$$] Vertex Shares Haven’t Hit Their Apex,2017-07-20 04:40:03 +0000,http://finance.yahoo.com/r/61916a16-7302-38ca-8c88-321b3a3a8b32/vertex-shares-havent-hit-their-apex-1500477563?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,"The ferocious rally in Vertex Pharmaceuticals shares on results in early stage data for its new cystic fibrosis treatment will surely tempt some investors to exit. That may not be wise, though, as the ..."
VRTX,VRTX:UW,BBG000C1SD31,"Asian shares rally, helped by Wall Street, Japan trade data",2017-07-20 04:05:56 +0000,https://finance.yahoo.com/news/us-stocks-keep-rising-health-142436543.html?.tsrc=rss,Asian share benchmarks rose Thursday after an overnight advance on Wall Street fueled by strong corporate earnings. Strong trade data and expectations for continued lavish monetary stimulus from Japan's ...
VRTX,VRTX:UW,BBG000C1SD31,"Asian shares rally, helped by Wall Street, Japan trade data",2017-07-20 04:05:56 +0000,http://finance.yahoo.com/r/a2c8536b-3d50-3b47-a1b9-f0258365b113/us-stocks-keep-rising-health-142436543.html?.tsrc=rss,"SEOUL, South Korea (AP) — Asian share benchmarks rose Thursday after an overnight advance on Wall Street fueled by strong corporate earnings. Strong trade data and expectations for continued lavish monetary stimulus from Japan's central bank pushed Tokyo's Nikkei 225 index up 0.6 percent."
VRTX,VRTX:UW,BBG000C1SD31,"Gainers & Losers Of July 19: AEZS, VRTX, AGRX, PTI, INO...",2017-07-19 22:41:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MzSv0ApsfJs/gainers--losers-of-july-19-aezs-vrtx-agrx-pti-ino-20170719-01462,"Gainers & Losers Of July 19: AEZS, VRTX, AGRX, PTI, INO..."
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharmaceuticals Stock Is Soaring: Here's Why It's Still Not Too Late to Buy,2017-07-19 22:03:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8AWuR-WP-a4/vertex-pharmaceuticals-stock-is-soaring-heres-why-its-still-not-too-late-to-buy-cm818365,Just last week I wrote why you d be smart to buy Vertex Pharmaceuticals NASDAQ VRTX stock At that time Vertex was up around 70 for the year My argument then was that the stock was still undervalued even with a forward earnings multiple of 41 because of its growth
VRTX,VRTX:UW,BBG000C1SD31,GLOBAL MARKETS-World stocks tally 9th day of gains as earnings pick up,2017-07-19 21:00:07 +0000,https://finance.yahoo.com/news/global-markets-world-stocks-tally-210007714.html?.tsrc=rss,"A broad barometer of global  stocks rose for a ninth straight session on Wednesday as  earnings season in the United States and Europe heated up, while  the dollar clawed back from 10-month lows and oil prices jumped.  The S&P 500, Dow industrials and Nasdaq marked record  closing highs in the United States, tracking strong performances  by major European stock indexes as the tech sector gave a boost  in both regions.  “In the U.S., the earnings season seems to be surprising a  little bit on the upside,"" said Bruce McCain, chief investment  strategist at Key Private Bank in Cleveland."
VRTX,VRTX:UW,BBG000C1SD31,What Happened in the Stock Market Today,2017-07-19 20:54:00 +0000,http://finance.yahoo.com/r/0678477b-5782-362d-800a-35ac3d771ed7/what-happened-in-the-stock-market-today.aspx?yptr=yahoo&.tsrc=rss,"On a record day for indexes, shares of Vertex Pharmaceuticals soared on drug trial results and CSX slumped despite a surprisingly good quarter."
VRTX,VRTX:UW,BBG000C1SD31,"Market Close Report: Historical high reached as NASDAQ Composite Index closes at 6,385.04.",2017-07-19 20:48:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/d3u-pY4J9kc/market-close-report-historical-high-reached-as-nasdaq-composite-index-closes-at-638504-cm818356,Wednesday s session closes with the NASDAQ Composite Index reaching a historical high The index closed at 6 385 04 up 40 73 for the day The index had a previous high 6344 30525 on 07 18 2017 The total shares traded for the NASDAQ was over 1 86 billion Wednesday s session closes with the
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharmaceuticals Stock Is Soaring: Here&apos;s Why It&apos;s Still Not Too Late to Buy,2017-07-19 20:44:00 +0000,http://finance.yahoo.com/r/eac133e3-011c-3abc-aab0-779d11f6a550/vertex-pharmaceuticals-stock-is-soaring-heres-why.aspx?yptr=yahoo&.tsrc=rss,Is Vertex stock too expensive after its huge gains? Not at all.
VRTX,VRTX:UW,BBG000C1SD31,Morgan Stanley and Vertex jump while McCormick slides,2017-07-19 20:43:23 +0000,https://finance.yahoo.com/news/morgan-stanley-vertex-jump-while-204323836.html?.tsrc=rss,"Stocks that moved substantially or traded heavily Wednesday: Morgan Stanley, up $1.48 to $46.62 The investment bank had a solid second quarter and its trading desks did better than its competitors. McCormick ..."
VRTX,VRTX:UW,BBG000C1SD31,"Health Care Sector Update for 07/19/2017: VRTX,AEZS,CYCC",2017-07-19 20:42:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ng8pXUNCV0s/health-care-sector-update-for-07192017-vrtxaezscycc-cm818350,Top Health Care StocksTop Health Care Stocks JNJ 0 54 JNJ 0 54 PFE 0 78 PFE 0 78 ABT 1 40 ABT 1 40 MRK 0 32 MRK 0 32 AMGN 0 96 AMGN 0 96 Health care stocks led all sectors except for energy companies today with the NYSE Health Care Index rising over 0 3 while shares of health
VRTX,VRTX:UW,BBG000C1SD31,"Maxim Hikes Price Targets on 2 Biotech Stocks: AEterna Zentaris Inc. (USA) (AEZS), Vertex Pharmaceuticals Incorporated (VRTX)",2017-07-19 20:33:05 +0000,https://finance.yahoo.com/news/maxim-hikes-price-targets-2-203305968.html?.tsrc=rss,"Many investors hope to win big on biotech stocks as shares can skyrocket when there is good news. Maxim analysts explain why there are plenty of promising developments in store for AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) and Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), while raising their price targets. Let’s take a closer look."
VRTX,VRTX:UW,BBG000C1SD31,"Biotech is moving beyond the &apos;disaster&apos; of the past 2 years, says Michael Yee",2017-07-19 20:30:03 +0000,https://finance.yahoo.com/news/biotech-moving-beyond-apos-disaster-203003160.html?.tsrc=rss,"As bad headlines fade and Vertex rises, biotechnology is on the upswing, says Jefferies&apos; Michael Yee."
VRTX,VRTX:UW,BBG000C1SD31,"Biotech is moving beyond the 'disaster' of the past 2 years, says Michael Yee",2017-07-19 20:30:03 +0000,http://finance.yahoo.com/r/7bcbc022-d084-33e6-9717-aece6a83ec86/104596517?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104596517&yptr=yahoo&.tsrc=rss,"As bad headlines fade and Vertex rises, biotechnology is on the upswing, says Jefferies' Michael Yee."
VRTX,VRTX:UW,BBG000C1SD31,Nasdaq Makes It Nine; This Industry&apos;s Surprise Rally Lifts S&P 500,2017-07-19 20:26:16 +0000,http://finance.yahoo.com/r/335f6096-6442-3c4c-a5d2-ed4af296976e/nasdaq-makes-it-nine-this-industrys-surprise-rally-lifts-sp-500?src=A00220&yptr=yahoo&.tsrc=rss,"The Nasdaq hammered out a ninth straight advance on Wednesday, rising 0.6% to seize a new high and record its longest advance since February 2015."
VRTX,VRTX:UW,BBG000C1SD31,Vertex Hits Record High On Results Of Cystic Fibrosis Trial,2017-07-19 20:22:22 +0000,http://finance.yahoo.com/r/c3b41d7c-ab48-32af-a67d-f455cbbde526/vertex-hits-record-high-on-results-of-cystic-fibrosis-trial?src=A00220&yptr=yahoo&.tsrc=rss,"Vertex blasted to a record high Wednesday on trial data for regimens that should have cystic fibrosis patients &quot;breathing easy,&quot; an analyst says."
VRTX,VRTX:UW,BBG000C1SD31,GLOBAL MARKETS-World stocks tally 9th day of gains as earnings pick up,2017-07-19 20:18:29 +0000,https://finance.yahoo.com/news/global-markets-world-stocks-tally-201829247.html?.tsrc=rss,"A broad barometer of global  stocks posted a ninth straight session of gains on Wednesday as  earnings season in the United States and Europe heated up, while  the dollar clawed back from 10-month lows and oil prices jumped.  The S&P 500 and Nasdaq marked record highs in the United  States, picking up from strong performances by major European  stock indexes, with the tech sector giving a boost in both  regions.  The global index gained 0.46  percent, setting a record high for a fifth straight session."
VRTX,VRTX:UW,BBG000C1SD31,"US STOCKS-S&P, Nasdaq at records as Vertex rallies; IBM slips",2017-07-19 19:40:37 +0000,https://finance.yahoo.com/news/us-stocks-p-nasdaq-records-194037267.html?.tsrc=rss,"The Nasdaq Composite and the  S&P 500 hit record highs on Wednesday, powered by technology  stocks and a more than 20 percent jump in Vertex  Pharmaceuticals, while gains on the Dow were capped by a sharp  drop in IBM shares.  Vertex jumped as much as 26.4 percent to an  all-time high of $167 a day after it reported positive results  for its cystic fibrosis treatment."
VRTX,VRTX:UW,BBG000C1SD31,Why Vertex Pharmaceuticals Incorporated Stock Is Soaring Today,2017-07-19 19:05:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1oERco2lWTk/why-vertex-pharmaceuticals-incorporated-stock-is-soaring-today-cm818271,What happened Shares of rare disease drugmaker Vertex Pharmaceuticals NASDAQ VRTX 160 are on the rise this morning thanks to the extremely positive data readouts for three trials assessing three different triple combination drug regimens in individuals with an
VRTX,VRTX:UW,BBG000C1SD31,Jefferies' Michael Yee: Still a valuation call in biotech,2017-07-19 18:51:00 +0000,https://finance.yahoo.com/video/jefferies-michael-yee-still-valuation-185100724.html?.tsrc=rss,"Michael Yee, Jefferies managing director, discusses the run in biotech stocks as Vertex soars today."
VRTX,VRTX:UW,BBG000C1SD31,[$$] Vertex Shares Haven't Hit Their Apex,2017-07-19 18:47:25 +0000,http://finance.yahoo.com/r/61916a16-7302-38ca-8c88-321b3a3a8b32/vertex-shares-havent-hit-their-apex-1500477563?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"The ferocious rally in Vertex Pharmaceuticals shares on results in early stage data for its new cystic fibrosis treatment will surely tempt some investors to exit. That may not be wise, though, as the ..."
VRTX,VRTX:UW,BBG000C1SD31,Biotech Stocks On Verge Of Next Major Move Up,2017-07-19 18:30:00 +0000,http://finance.yahoo.com/r/74265b46-fc00-3b3b-8947-f074312d4fd1/biotech-stocks-verge-next-major-move?partner=YahooSA&yptr=yahoo&.tsrc=rss,A biotech breakout may be fueled by positive medical data and earnings
VRTX,VRTX:UW,BBG000C1SD31,Here's Why Vertex Pharmaceuticals (VRTX) Soared Today,2017-07-19 18:03:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5Z5KOXVU2Ls/heres-why-vertex-pharmaceuticals-vrtx-soared-today-cm818209,Shares of Vertex Pharmaceuticals Incorporated VRTX soared 24 in morning trading on Wednesday after the company released positive results for its cystic fibrosis treatments The pharmaceutical company said yesterday after hours that its cystic fibrosis treatments improved lung function by 9 6
VRTX,VRTX:UW,BBG000C1SD31,GLOBAL MARKETS-World stocks climb for 9th day as earnings kick in,2017-07-19 18:01:45 +0000,https://finance.yahoo.com/news/global-markets-world-stocks-climb-180145066.html?.tsrc=rss,"A gauge of global stocks  climbed for a ninth straight session on Wednesday as earnings  season heated up in the United States and Europe, while the  dollar bounced modestly off 10-month lows.  The S&P 500 and Nasdaq tallied intraday record highs in the  U.S., picking up from strong performances by major European  stock indexes, with the tech sector giving a boost in both  regions.  “In the U.S., the earnings season seems to be surprising a  little bit on the upside,"" said Bruce McCain, chief investment  strategist at Key Private Bank in Cleveland."
VRTX,VRTX:UW,BBG000C1SD31,Vertex Wins Big in Mid-Stage Cystic Fibrosis Trial,2017-07-19 17:39:38 +0000,https://finance.yahoo.com/news/vertex-wins-big-mid-stage-173938528.html?.tsrc=rss,Shares of Vertex Pharmaceuticals shot up after the company announced dramatic results from its early and mid-stage trials in cystic fibrosis. The stock pushed to an all-time high on the back of these results....
VRTX,VRTX:UW,BBG000C1SD31,"US STOCKS-Tech lifts Nasdaq, S&P to record; IBM weighs on Dow",2017-07-19 17:10:20 +0000,https://finance.yahoo.com/news/us-stocks-tech-lifts-nasdaq-171020237.html?.tsrc=rss,"The Nasdaq and the S&P were trading at  record levels in early afternoon on Wednesday, powered by  technology stocks, while gains on the Dow were capped by a sharp  drop in shares of IBM.  IBM fell 4.7 percent to a one-year low after the  company's quarterly revenue came in below expectations."
VRTX,VRTX:UW,BBG000C1SD31,"The Zacks Analyst Blog Highlights: Apple, JPMorgan, Celgene, PayPal and Vertex Pharmaceuticals",2017-07-19 17:05:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yrM-fJX4YQ8/the-zacks-analyst-blog-highlights-apple-jpmorgan-celgene-paypal-and-vertex-pharmaceuticals-cm818188,For Immediate Release Chicago IL July 19 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog include
VRTX,VRTX:UW,BBG000C1SD31,"3 Stocks to Watch on Wednesday: Vertex Pharmaceuticals Incorporated (VRTX), CSX Corporation (CSX) and International Business Machines Corp. (IBM)",2017-07-19 17:04:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OonwtEAaTI8/3-stocks-to-watch-on-wednesday-vertex-pharmaceuticals-incorporated-vrtx-csx-corporation-csx-and-international-business-machines-corp-ibm-cm818232,InvestorPlace Stock Market News Stock Advice amp Trading Tips Tuesday was a slightly better day for the broader markets in a session that also saw gold gain 0 7 and crude oil surge 0 8 While the Dow Jones Industrial Average dropped by 0 3 the S amp P 500 Index
VRTX,VRTX:UW,BBG000C1SD31,"Micron Technology, Inc. (MU) Stock Is About to Break Out",2017-07-19 17:04:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RUpL7yx3duI/micron-technology-inc-mu-stock-is-about-to-break-out-cm818230,InvestorPlace Stock Market News Stock Advice amp Trading Tips Tech wreck What tech wreck With the Nasdaq scoring its eighth straight up day weakness in the tech sector is now a distant memory So much for the argument that the sector was topping Momentum lovers will be happy to
VRTX,VRTX:UW,BBG000C1SD31,Vertex Growth Expected to Continue with Life-Changing Cystic Fibrosis Treatment,2017-07-19 17:04:00 +0000,http://finance.yahoo.com/r/48689518-a1b4-35e9-b7d4-16ae1b1d9ef3/vertex-growth-expected-to-continue-with-life-changing-cystic-fibrosis-treatment.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Remarkable data was released from Vertex's triple regiment combination trials.
VRTX,VRTX:UW,BBG000C1SD31,Why Vertex Pharmaceuticals Incorporated Stock Is Soaring Today,2017-07-19 17:02:00 +0000,http://finance.yahoo.com/r/ab8bf1e4-2a7b-3700-8781-2f0bcf798ec7/why-vertex-pharmaceuticals-incorporated-stock-is-s.aspx?yptr=yahoo&.tsrc=rss,Vertex&apos;s cystic fibrosis franchise keeps rolling with yet another string of positive clinical data readouts.
VRTX,VRTX:UW,BBG000C1SD31,"Vertex: Up, Up, and Away!",2017-07-19 16:53:00 +0000,http://finance.yahoo.com/r/76c7277b-fee3-3449-80f5-a95f7eb6b682/vertex-up-up-and-away-1500483226?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Vertex Pharmaceuticals (VRTX) have jumped more than 20% today after the company released positive results from a trial of its cystic fibrosis drug.  UBS analyst Carter Gould cited the stock's big gain today, which left the stock with ""full"" valuation, for the cut.  BMO's Do Kim, who rates Vertex Outperform, explains why: We are raising our PT to $180 from $132, following strong triple combo Phase II data in het-min. Our probability of success for the triple increases to 95% (from 70%) and assumes a lower competitive environment, as the triple sets a much higher efficacy hurdle for all classes of CF."
VRTX,VRTX:UW,BBG000C1SD31,Vertex leads biotech after cystic fibrosis drug data,2017-07-19 16:49:00 +0000,https://finance.yahoo.com/video/vertex-leads-biotech-cystic-fibrosis-164900935.html?.tsrc=rss,The “Fast Money Halftime Report” traders discuss their picks for the biotech sector as Vertex leads.
VRTX,VRTX:UW,BBG000C1SD31,Vertex (VRTX) Triple Combination CF Studies Data Positive,2017-07-19 16:06:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/i5oT8kavhNc/vertex-vrtx-triple-combination-cf-studies-data-positive-cm818097,Vertex Pharmaceuticals Incorporated VRTX announced data from three studies wherein three different triple combination regimens were evaluated for the treatment of cystic fibrosis CF These led to pronounced improvements in lung function Shares of the company surged more than 25 in after
VRTX,VRTX:UW,BBG000C1SD31,"S&P 500 Movers: NTRS, VRTX",2017-07-19 16:05:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1i_S3IoOLGE/sp-500-movers-ntrs-vrtx-cm818096,In early trading on Wednesday shares of Vertex Pharmaceuticals VRTX topped the list of the day s best performing components of the S amp P 500 index trading up 24 1 Year to date Vertex Pharmaceuticals registers a 122 6 gain And the worst performing S amp P 500 component thus
VRTX,VRTX:UW,BBG000C1SD31,"Nasdaq 100 Movers: CSX, VRTX",2017-07-19 16:05:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tutEv6Zx5XE/nasdaq-100-movers-csx-vrtx-cm818091,In early trading on Wednesday shares of Vertex Pharmaceuticals VRTX topped the list of the day s best performing components of the Nasdaq 100 index trading up 24 6 Year to date Vertex Pharmaceuticals registers a 123 5 gain And the worst performing Nasdaq 100 component thus far
VRTX,VRTX:UW,BBG000C1SD31,Here&apos;s Why Vertex Pharmaceuticals (VRTX) Soared Today,2017-07-19 16:00:04 +0000,https://finance.yahoo.com/news/apos-why-vertex-pharmaceuticals-vrtx-160004446.html?.tsrc=rss,Shares of Vertex Pharmaceuticals Incorporated (VRTX) soared 24% in morning trading on Wednesday after the company released positive results for its cystic fibrosis treatments.
VRTX,VRTX:UW,BBG000C1SD31,Story Stocks from Briefing.com,2017-07-19 15:53:33 +0000,https://finance.yahoo.com/news/story-stocks-briefing-com-175403381.html?.tsrc=rss,Story Stocks from Briefing.com
VRTX,VRTX:UW,BBG000C1SD31,GLOBAL MARKETS-World stocks run win streak to 9 days as earnings heat up,2017-07-19 15:41:54 +0000,https://finance.yahoo.com/news/global-markets-world-stocks-run-154154072.html?.tsrc=rss,"A gauge of global stocks  climbed for a ninth straight session on Wednesday after a slew  of corporate earnings reports in the United States and Europe,  while the dollar bounced moderately off of 10-month lows.  The S&P 500 and Nasdaq hit intraday record highs, picking up  from strong performances by major European stock indexes.  The global  index gained 0.33 percent, setting a record high for a fifth  straight session."
VRTX,VRTX:UW,BBG000C1SD31,A Decade Of Sales Growth Lies Ahead For Vertex Pharmaceuticals,2017-07-19 15:23:02 +0000,https://finance.yahoo.com/news/decade-sales-growth-lies-ahead-152302084.html?.tsrc=rss,"Following strong Phase I and II data on Tuesday from three different triple combo regimens for cystic fibrosis, shares of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX ) rocketed 30 percent Wednesday ..."
VRTX,VRTX:UW,BBG000C1SD31,"Valeant Pharmaceuticals Intl Inc (VRX) In Good Debt Shape, Vertex Pharmaceuticals Incorporated (VRTX) Wows with Triple CF Combo Success",2017-07-19 14:54:47 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-intl-inc-vrx-145447424.html?.tsrc=rss,"As such, finding the giant right ""on track"" to settle $5 billion debt reduction commitments even before the beginning of 2018, the analyst reiterates a Buy rating on shares of VRX with a $35 price target, which represents a 102% increase from where the stock is currently trading."
VRTX,VRTX:UW,BBG000C1SD31,"The Zacks Analyst Blog Highlights: Apple, JPMorgan, Celgene, PayPal and Vertex Pharmaceuticals",2017-07-19 14:54:02 +0000,https://finance.yahoo.com/news/zacks-analyst-blog-highlights-apple-145402612.html?.tsrc=rss,"The Zacks Analyst Blog Highlights: Apple, JPMorgan, Celgene, PayPal and Vertex Pharmaceuticals"
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharma shares surge 21% after cystic fibrosis study results leaves Wall Street 'speechless',2017-07-19 14:53:23 +0000,http://finance.yahoo.com/r/cf46d540-cc59-360f-8b5d-e2878c7143be/104595322?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104595322&yptr=yahoo&.tsrc=rss,The biotech said its three-drug cocktails boosted a measure of lung function in patients with cystic fibrosis by 9.6 percentage points or more.
VRTX,VRTX:UW,BBG000C1SD31,Vertex Shares Jump on Strong Trials of New Drugs,2017-07-19 14:42:24 +0000,http://finance.yahoo.com/r/756581c1-0c66-37e2-b10d-6040b4aa10cc/vertex-reports-positive-data-for-new-cystic-fibrosis-drugs-1500408300?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,Vertex Pharmaceuticals shares jumped more than 20% Wednesday after the biotech firm said three cystic-fibrosis drugs showed promise in early clinical trials.
VRTX,VRTX:UW,BBG000C1SD31,Vertex (VRTX) Triple Combination CF Studies Data Positive,2017-07-19 14:26:02 +0000,https://finance.yahoo.com/news/vertex-vrtx-triple-combination-cf-142602363.html?.tsrc=rss,Vertex announced positive data from three studies evaluating three different triple combination regimens. These demonstrated pronounced improvements in lung function in CF patients.
VRTX,VRTX:UW,BBG000C1SD31,"Biotech Stock Roundup: Vertex Boosted by CF Data, FDA Nod for Gilead, Puma Drugs",2017-07-19 14:06:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vPIIyQZEiWc/biotech-stock-roundup-vertex-boosted-by-cf-data-fda-nod-for-gilead-puma-drugs-cm818047,Key highlights this week include impressive data from Vertex s VRTX cystic fibrosis CF pipeline while companies like Gilead GILD and Puma PBYI got FDA approval for their hepatitis C virus HCV and breast cancer treatments respectively 160 Recap of the Week s Most Important
VRTX,VRTX:UW,BBG000C1SD31,"Vertex stock rockets to record, boosting market cap by $8 billion",2017-07-19 13:57:04 +0000,http://finance.yahoo.com/r/37d0ce7c-f077-3b17-8fa6-a7617ab35a00/Story.aspx?guid=50045CB2-6BFC-11E7-8A31-F6BB28ACF997&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Vertex Pharmaceuticals Inc. shares soared, adding over $8 billion to the company’s value, as the biotech drug maker announced positive results from clinical studies of its cystic fibrosis treatments, and ..."
VRTX,VRTX:UW,BBG000C1SD31,More Than 30% Upside Seen For Vertex Stock On The Heels Of Phase 2 Data,2017-07-19 13:45:05 +0000,https://finance.yahoo.com/news/more-30-upside-seen-vertex-134505833.html?.tsrc=rss,Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX )'s stock soared 25 percent after the company reported encouraging phase 2 data. The company's three-drug cocktails showed an improvement in lung function ...
VRTX,VRTX:UW,BBG000C1SD31,"Stocks Up: Nasdaq Takes New High, Morgan Stanley Breaks Out",2017-07-19 13:43:29 +0000,http://finance.yahoo.com/r/8cce1752-da58-3ece-bf67-525af5629e73/stock-futures-mixed-this-biotech-leads-nasdaq-100-and-sp-500?src=A00220&yptr=yahoo&.tsrc=rss,"Stocks upshifted at the starting bell Wednesday, with the Nasdaq out front and the Dow battling losses by IBM."
VRTX,VRTX:UW,BBG000C1SD31,Biotech Movers: Vertex Continues to Move on Data for CF Regimen,2017-07-19 13:42:00 +0000,http://finance.yahoo.com/r/44c529e0-e94a-35c0-a42d-98fc81e60d63/biotech-movers-vertex-continues-to-move-on-data-for-cf-regimen.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Vertex Pharmaceuticals, FibroGen and Inovio Pharmaceuticals were among the biotech stock movers in premarket trading trading on July 19."
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pulls Back Off Best Levels But Remains Firmly Positive,2017-07-19 13:06:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2ehhMUP4WKY/vertex-pulls-back-off-best-levels-but-remains-firmly-positive-20170719-00962,Vertex Pulls Back Off Best Levels But Remains Firmly Positive
VRTX,VRTX:UW,BBG000C1SD31,"Pre-Market Most Active for Jul 19, 2017 :  MT, VRTX, RAD, BFR, SNI, MS, BABA, SNY, TVIX, MU, QQQ, FB",2017-07-19 12:52:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MJixdwXRxNA/pre-market-most-active-for-jul-19-2017-mt-vrtx-rad-bfr-sni-ms-baba-sny-tvix-mu-qqq-fb-cm817910,The NASDAQ 100 Pre Market Indicator is up 16 14 to 5 896 24 The total Pre Market volume is currently 4 131 230 shares traded The following are the most active stocks for the pre market session ArcelorMittal MT is 0 3 at 25 90 with 780 905 shares traded MT s
VRTX,VRTX:UW,BBG000C1SD31,Vertex shares soar on positive cystic fibrosis trials,2017-07-19 11:53:00 +0000,https://finance.yahoo.com/video/vertex-shares-soar-positive-cystic-115300711.html?.tsrc=rss,CNBC's Meg Tirrell reports Vertex's drug trials for cystic fibrosis were better than the Street expected.
VRTX,VRTX:UW,BBG000C1SD31,Futures: This Biotech Goes Vertical; Tech Titan&apos;s &apos;Painful&apos; Transition,2017-07-19 10:47:01 +0000,http://finance.yahoo.com/r/e7f427ff-7c7d-36ca-8d08-af8aad6a3dfc/futures-this-biotech-goes-vertical-tech-titans-painful-transition?src=A00220&yptr=yahoo&.tsrc=rss,"Nasdaq 100 futures rallied late as Vertex Pharma&apos;s promising drug data sent shares soaring. Meanwhile, IBM still hasn&apos;t turned a corner on revenue."
VRTX,VRTX:UW,BBG000C1SD31,Vertex Soars Over 20% On Positive Drug Trial Results,2017-07-19 09:38:00 +0000,http://finance.yahoo.com/r/6217f2a4-12b3-35b1-8ddd-f978d8712f28/vertex-soars-over-20-on-positive-drug-trial-results?src=A00220&yptr=yahoo&.tsrc=rss,Vertex is surging over 20% on positive drug trial results for its cystic fibrosis treatment.
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharmaceuticals Inc. (VRTX) Is Surging To A New High On Study Results,2017-07-19 09:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/05BJ24YIyTY/vertex-pharmaceuticals-inc-vrtx-is-surging-to-a-new-high-on-study-results-20170719-00716,Vertex Pharmaceuticals Inc. (VRTX) Is Surging To A New High On Study Results
VRTX,VRTX:UW,BBG000C1SD31,Stocks May Move Modestly Higher Early In The Session - U.S. Commentary,2017-07-19 08:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/L5_cQ0UTFcI/stocks-may-move-modestly-higher-early-in-the-session--u.s.-commentary-20170719-00572,Stocks May Move Modestly Higher Early In The Session - U.S. Commentary
VRTX,VRTX:UW,BBG000C1SD31,Stocks May Move Modestly Higher Early In The Session - U.S. Commentary,2017-07-19 08:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JEOupIYl94o/stocks-may-move-modestly-higher-early-in-the-session--us-commentary-20170719-00572,Stocks May Move Modestly Higher Early In The Session - U.S. Commentary
VRTX,VRTX:UW,BBG000C1SD31,"Top Stock Reports for Apple, JPMorgan & Celgene",2017-07-19 06:02:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2w6oD7_m9KU/top-stock-reports-for-apple-jpmorgan-celgene-cm817845,Tuesday July 18 2017 The Zacks Research Daily presents the best research output of our analyst team Today s Research Daily features new research reports on 16 major stocks including Apple AAPL JPMorgan JPM and Celgene CELG These research reports have been hand picked from the
VRTX,VRTX:UW,BBG000C1SD31,Vertex Reports Positive Data for New Cystic-Fibrosis Drugs,2017-07-19 04:48:28 +0000,http://finance.yahoo.com/r/756581c1-0c66-37e2-b10d-6040b4aa10cc/vertex-reports-positive-data-for-new-cystic-fibrosis-drugs-1500408300?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,Vertex Pharmaceuticals said three of its newest cystic-fibrosis drugs in development showed promise in early clinical trials treating the progressive lung disorder.
VRTX,VRTX:UW,BBG000C1SD31,"FDA Nod For GILD, It's Take 2 For AEZS' Macrilen, VRTX Soars On CF Drug Trials",2017-07-19 02:20:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YS0sruIjaK0/fda-nod-for-gild-its-take-2-for-aezs-macrilen-vrtx-soars-on-cf-drug-trials-20170719-00049,"FDA Nod For GILD, It's Take 2 For AEZS' Macrilen, VRTX Soars On CF Drug Trials"
VRTX,VRTX:UW,BBG000C1SD31,"Top Stock Reports for Apple, JPMorgan & Celgene",2017-07-18 22:09:10 +0000,https://finance.yahoo.com/news/top-stock-reports-apple-jpmorgan-220910656.html?.tsrc=rss,"Top Stock Reports for Apple, JPMorgan & Celgene"
VRTX,VRTX:UW,BBG000C1SD31,"After-hours buzz: UAL, VRTX, CSX & more",2017-07-18 21:43:01 +0000,http://finance.yahoo.com/r/0d902015-78cc-3bb8-b53e-3d61d315753b/104594132?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104594132&yptr=yahoo&.tsrc=rss,"Check out which companies are making headlines after the bell on Tuesday: UAL, VRTX, CSX & more"
VRTX,VRTX:UW,BBG000C1SD31,Vertex Catapults 24% On Strong Trial For Cystic Fibrosis Drug,2017-07-18 21:00:03 +0000,http://finance.yahoo.com/r/43d0eb7b-7e47-3f3e-a07f-7cb718b2209d/vertex-rockets-on-strong-cystic-fibrosis-drug-data?src=A00220&yptr=yahoo&.tsrc=rss,Vertex stock rocketed 24% late Tuesday after the biotech reported positive Phase 1 and 2 results of a triple-pill to treat cystic fibrosis.
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharmaceuticals Stock Surging on Positive Trial Data,2017-07-18 20:41:00 +0000,http://finance.yahoo.com/r/7142a373-8137-3b2f-92a6-0eca39340370/vertex-pharmaceuticals-stock-surging-on-positive-trial-data.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Cystic fibrosis is an inherited disorder that causes damage to the lungs, digestive system, and other organs of the body."
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharma shares rally on cystic fibrosis drug study results,2017-07-18 20:34:11 +0000,http://finance.yahoo.com/r/417e8979-96b2-3cc9-9346-2d67b1bf75bb/Story.aspx?guid=09579233-0179-4494-9FF4-5704E19D88D3&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Vertex Pharmaceuticals Inc. shares surged in the extended session Tuesday after the biotech drug maker announced positive results from clinical trials of its cystic fibrosis treatments. Vertex shares rallied ...
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharma shares surge 26%; 3-drug combo aids breathing in some cystic fibrosis patients,2017-07-18 20:24:25 +0000,http://finance.yahoo.com/r/4f1348c8-6934-3005-94db-6eca68fe4f13/104593212?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104593212&yptr=yahoo&.tsrc=rss,Vertex is attempting to expand treatment options to about 40 percent of cystic fibrosis patients.
VRTX,VRTX:UW,BBG000C1SD31,Vertex soars after drug trial results,2017-07-18 20:23:00 +0000,https://finance.yahoo.com/video/vertex-soars-drug-trial-results-202300322.html?.tsrc=rss,CNBC's Meg Tirrell reports that Vertex's cystic firbrosis drugs improve lung function and shares are popping after hours.
VRTX,VRTX:UW,BBG000C1SD31,'Just What We Dreamed.' New Vertex Drugs Show Dramatic Benefit Against Cystic Fibrosis,2017-07-18 20:14:00 +0000,http://finance.yahoo.com/r/867880b2-df0b-3ac0-b344-4ea8d7d70ebd/new-vertex-drugs-show-dramatic-benefit-in-cystic-fibrosis?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,"Three different three-drug regimens all provided dramatic results against cystic fibrosis, a fatal disease of the lungs and digestive system that afflicts 75,000 people. 'This is just what we dreamed would someday happen,' says Francis Collins, the director of the National Institutes of Health."
VRTX,VRTX:UW,BBG000C1SD31,Vertex reports results from 3-drug cystic fibrosis combos,2017-07-18 20:04:00 +0000,https://finance.yahoo.com/video/vertex-reports-results-3-drug-200400787.html?.tsrc=rss,CNBC's Meg Tirrell reports on Vertex reporting results from its 3-drug cystic fibrosis combinations.
VRTX,VRTX:UW,BBG000C1SD31,Vertex reports positive results for cystic fibrosis triple combos,2017-07-18 20:02:18 +0000,https://finance.yahoo.com/news/vertex-reports-positive-results-cystic-200218121.html?.tsrc=rss,"Vertex Pharmaceuticals Inc on  Tuesday said three different triple combinations of cystic  fibrosis treatments significantly improved patient lung function  in clinical trials, bolstering its goal of a therapy that could  help up to 90 percent of patients with the life-shortening lung  disease.  Once it has analyzed additional data and discussed  development plans with regulators, Vertex said it will begin  late stage studies of one or more of the triple combination  regimens in the first half of 2018.  Vertex already sells two treatments, Kalydeco and Orkambi,  that can treat up to 40 percent, or about 30,000 cystic fibrosis  patients, based on their specific genetic mutations."
VRTX,VRTX:UW,BBG000C1SD31,Vertex Announces Positive Phase 1 & Phase 2 Data from Three Different Triple Combination Regimens in People with Cystic Fibrosis Who Have One F508del Mutation and One Minimal Function Mutation (F508del/Min),2017-07-18 20:01:00 +0000,https://finance.yahoo.com/news/vertex-announces-positive-phase-1-200100535.html?.tsrc=rss,Vertex Pharmaceuticals Incorporated today announced positive data from Phase 1 and Phase 2 studies of three different triple combination regimens in people with cystic fibrosis who have one F508del mutation and one minimal function mutation .
VRTX,VRTX:UW,BBG000C1SD31,Vertex Reports Positive Data From Combination Regimens To Treat Cystic Fibrosis,2017-07-18 17:02:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/E4x7cz2SVhE/vertex-reports-positive-data-from-combination-regimens-to-treat-cystic-fibrosis-20170718-01294,Vertex Reports Positive Data From Combination Regimens To Treat Cystic Fibrosis
VRTX,VRTX:UW,BBG000C1SD31,Forget GW Pharmaceuticals: These 2 Stocks Are Better Buys,2017-07-18 14:05:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0hEwbZaKPts/forget-gw-pharmaceuticals-these-2-stocks-are-better-buys-cm817346,Yes GW Pharmaceuticals NASDAQ GWPH is the biggest marijuana focused biotech stock on the market The company s promising cannabinoid Epidiolex could very well become a blockbuster success story in the near future in treating children with rare forms of epilepsy But is
VRTX,VRTX:UW,BBG000C1SD31,Forget GW Pharmaceuticals: These 2 Stocks Are Better Buys,2017-07-18 12:03:00 +0000,http://finance.yahoo.com/r/d232179a-f0d4-3c9f-ad29-733472f413db/forget-gw-pharmaceuticals-these-2-stocks-are-bette.aspx?yptr=yahoo&.tsrc=rss,Here&apos;s why Vertex and Zynerba could be bigger winners than GW Pharmaceuticals.
VRTX,VRTX:UW,BBG000C1SD31,Why Gilead Won't Buy Incyte and Vertex,2017-07-18 10:00:00 +0000,http://finance.yahoo.com/r/7b999817-73f6-3844-9ff7-b322697b7c92/why-gilead-wont-buy-incyte-and-vertex?partner=YahooSA&yptr=yahoo&.tsrc=rss,"Despite rampant rumors, Gilead is not likely to acquire either Incyte or Vertex. Here's why."
VRTX,VRTX:UW,BBG000C1SD31,Wall Street’s 5 Hottest Biotech Stocks Right Now,2017-07-17 23:45:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Pr9S-b3dxaE/wall-streets-5-hottest-biotech-stocks-right-now-cm817217,InvestorPlace Stock Market News Stock Advice amp Trading Tips Biotech stocks recently experienced their best week since the start of 2017 The biotechnology sector spiked following news that President Donald Trump plans to address drug prices with an executive order rather than
VRTX,VRTX:UW,BBG000C1SD31,​Vertex raises price of top-selling cystic fibrosis drug for first time,2017-07-17 14:55:11 +0000,http://finance.yahoo.com/r/0fdbf6ad-b020-3363-a0f5-a244156e2655/vertex-raises-price-of-top-selling-cystic.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Vertex Pharmaceuticals has raised the price of its best-selling cystic fibrosis drug for the first time, in a move that could boost revenues at the Boston-based company.  The decision by Vertex (VRTX) to increase the list price of Orkambi by 5 percent, to around $273,000 per year before discounts, was first reported by Cowen analyst Phil Nadeau in a note on Wednesday morning and later confirmed by a spokeswoman for the company.  The company has raised the price of its other approved cystic fibrosis drug, Kalydeco, just once — by 4.5 percent in January 2013."
VRTX,VRTX:UW,BBG000C1SD31,Vertex Awards Two First-Generation College Students Full Scholarships to the University of Massachusetts,2017-07-17 12:45:00 +0000,https://finance.yahoo.com/news/vertex-awards-two-first-generation-124500267.html?.tsrc=rss,"Vertex, Boston Public Schools and the University of Massachusetts today announced the recipients of the annual Vertex Science Leaders Scholarship, a four-year, full-ride scholarship to pursue an education in Science, Technology, Engineering or Math at any University of Massachusetts campus."
VRTX,VRTX:UW,BBG000C1SD31,Eaton Vance fund managers see major upside for healthcare stocks -Barron's,2017-07-16 21:05:15 +0000,https://finance.yahoo.com/news/eaton-vance-fund-managers-see-210515228.html?.tsrc=rss,"The portfolio managers of the $1.2  billion Eaton Vance Worldwide Health Sciences fund are expecting  big gains from a trio of healthcare stocks.  Jason Kritzer and Samantha Pandolfi, co-managers of the  fund, highlighted Vertex Pharmaceuticals, Zoetis  and Shire for future outperformance in an  article in Barron's.  Pandolfi says she sees 15 percent upside for drugmaker  Zoetis and 40 percent upside for Dublin-based drugmaker Shire."
VRTX,VRTX:UW,BBG000C1SD31,Why You're Smart to Buy Vertex Pharmaceuticals Stock,2017-07-15 17:44:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DV_ZdeHofnI/why-youre-smart-to-buy-vertex-pharmaceuticals-stock-cm816533,You might look at Vertex Pharmaceuticals NASDAQ VRTX stock and shake your head at its valuation After soaring more than 70 so far in 2017 shares of the biotech now trade at a whopping 180 times trailing 12 month earnings That s the kind of price tag that would cause
VRTX,VRTX:UW,BBG000C1SD31,Why You&apos;re Smart to Buy Vertex Pharmaceuticals Stock,2017-07-15 16:03:00 +0000,http://finance.yahoo.com/r/5b1a79b6-9e38-35e1-a484-f324b89ab35a/why-youre-smart-to-buy-vertex-pharmaceuticals-stoc.aspx?yptr=yahoo&.tsrc=rss,Forget the sky-high valuation. Vertex Pharmaceuticals stock is a smart pick.
VRTX,VRTX:UW,BBG000C1SD31,Gilead Could Acquire This Biotech — But Vertex Is Still Better: Analyst,2017-07-14 20:44:14 +0000,http://finance.yahoo.com/r/b8063aa5-e679-3d44-8dd8-b187b9cab236/gilead-could-acquire-this-biotech-but-vertex-is-still-better-analyst?src=A00220&yptr=yahoo&.tsrc=rss,"Gilead could fill a hole in its portfolio by acquiring Incyte, an analyst suggested Friday, offering one caveat — Vertex would still be a less risky bet."
VRTX,VRTX:UW,BBG000C1SD31,These Are the Best Growth Stocks Right Now in Biotech,2017-07-14 20:11:00 +0000,http://finance.yahoo.com/r/ff21db70-042b-37f6-be12-270c76816cda/celgene-vertex-and-spark-among-jefferies-top-biotech-picks.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Top names.
VRTX,VRTX:UW,BBG000C1SD31,"The Zacks Analyst Blog Highlights: Crescent Point Energy, Vertex Pharmaceuticals, SodaStream International, Commercial Vehicle Group and Melco Crown Entertainment",2017-07-14 15:50:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/D1NWxN5kfag/the-zacks-analyst-blog-highlights-crescent-point-energy-vertex-pharmaceuticals-sodastream-international-commercial-vehicle-group-and-melco-crown-entertainment-cm816175,For Immediate Release Chicago IL July 14 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
VRTX,VRTX:UW,BBG000C1SD31,Can Novartis (NVS) Spring a Surprise This Earnings Season?,2017-07-14 13:49:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LFC_W2T1xC4/can-novartis-nvs-spring-a-surprise-this-earnings-season-cm816112,Swiss pharmaceutical company Novartis AG NVS is scheduled to report second quarter 2017 results on Jul 18 A look at Novartis share price movement year to date shows that the stock has outperformed the Zacks classified Large Cap Pharma industry Its shares have rallied 13 3 compared with
VRTX,VRTX:UW,BBG000C1SD31,"The Zacks Analyst Blog Highlights: Crescent Point Energy, Vertex Pharmaceuticals, SodaStream International, Commercial Vehicle Group and Melco Crown Entertainment",2017-07-14 13:30:01 +0000,https://finance.yahoo.com/news/zacks-analyst-blog-highlights-crescent-133001892.html?.tsrc=rss,"The Zacks Analyst Blog Highlights: Crescent Point Energy, Vertex Pharmaceuticals, SodaStream International, Commercial Vehicle Group and Melco Crown Entertainment"
VRTX,VRTX:UW,BBG000C1SD31,5 Companies That Consistently Beat Earnings Estimates,2017-07-13 21:48:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hyOO-1YwUH0/5-companies-that-consistently-beat-earnings-estimates-cm815862,As we approach the beginning of earnings season it is important to remember that earnings estimate revisions and projections are extremely important in determining the Zacks Rank and quarterly earnings reports have the ability to greatly affect a stocks financial outlook and a company s
VRTX,VRTX:UW,BBG000C1SD31,"Thursday Sector Laggards: Healthcare, Technology & Communications",2017-07-13 19:46:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/d6duhZzAGk8/thursday-sector-laggards-healthcare-technology-communications-cm815804,In afternoon trading on Thursday Healthcare stocks are the worst performing sector showing a 0 2 loss Within that group Vertex Pharmaceuticals Inc Symbol VRTX and Edwards Lifesciences Corp Symbol EW are two large stocks that are lagging showing a loss of 1 9 and 1 7
VRTX,VRTX:UW,BBG000C1SD31,5 Companies That Consistently Beat Earnings Estimates,2017-07-13 19:45:07 +0000,https://finance.yahoo.com/news/5-companies-consistently-beat-earnings-194507818.html?.tsrc=rss,"Companies that are constantly able to defeat its earnings projections usually exhibit effective management, stronger upward momentum, and more impressive future outlooks."
VRTX,VRTX:UW,BBG000C1SD31,Vertex inks another reimbursement deal in Europe for top-selling drug,2017-07-13 18:00:16 +0000,http://finance.yahoo.com/r/2a0d528a-92a3-3c28-a5a0-2ead3dbd5c03/vertex-inks-another-reimbursement-deal-in-europe.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Since winning FDA approval in 2015 for Orkambi, Vertex Pharmaceuticals has been slowly expanding access to the pricey cystic fibrosis drug across Europe by signing reimbursement deals with various countries.  On Thursday, Boston-based Vertex (VRTX) said it had inked another reimbursement deal for Orkambi, its best-selling drug, this time with officials in Italy.  The agreement with the Italian Medicines Agency will make the drug available to “hundreds of eligible patients” in the country who have two copies of a particular genetic mutation, Vertex said in a statement."
VRTX,VRTX:UW,BBG000C1SD31,Amgen's Myeloma Drug Improves Overall Survival in Phase III,2017-07-13 16:51:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4Z0zy0db-nA/amgens-myeloma-drug-improves-overall-survival-in-phase-iii-cm815681,Biotech major Amgen Inc AMGN has announced final data from the phase III ASPIRE study which showed that a combination regimen of its drug Kyprolis significantly improved overall survival OS in patients with relapsed multiple myeloma Overall survival data from the study showed
VRTX,VRTX:UW,BBG000C1SD31,Vertex to Announce Second Quarter 2017 Financial Results on July 26,2017-07-13 12:00:00 +0000,https://finance.yahoo.com/news/vertex-announce-second-quarter-2017-120000145.html?.tsrc=rss,"Vertex Pharmaceuticals Incorporated will report its second quarter 2017 financial results on Wednesday, July 26, 2017 after the financial markets close. The company will host a conference call and webcast at 5:15 p.m."
VRTX,VRTX:UW,BBG000C1SD31,InPlay from Briefing.com,2017-07-13 08:44:04 +0000,https://finance.yahoo.com/news/inplay-briefing-com-125529772.html?.tsrc=rss,InPlay from Briefing.com
VRTX,VRTX:UW,BBG000C1SD31,"Vertex Announces Reimbursement Agreement in Italy for ORKAMBI® (Lumacaftor/Ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis in People Ages 12 and Older with Two Copies of the F508del Mutation",2017-07-13 08:00:00 +0000,https://finance.yahoo.com/news/vertex-announces-reimbursement-agreement-italy-080000666.html?.tsrc=rss,"Vertex Pharmaceuticals Incorporated today announced that the Italian Medicines Agency has agreed to reimburse ORKAMBI® , the first medicine to treat the underlying cause of cystic fibrosis in people ages 12 and older who have two copies of the F508del mutation in the cystic fibrosis transmembrane conductance regulator gene."
VRTX,VRTX:UW,BBG000C1SD31,"The Zacks Analyst Blog Highlights: Vertex Pharmaceuticals, Alimera Sciences, Enzo Biochem, Sarepta Therapeutics and EXACT Sciences",2017-07-12 15:51:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yA2sXL6d-20/the-zacks-analyst-blog-highlights-vertex-pharmaceuticals-alimera-sciences-enzo-biochem-sarepta-therapeutics-and-exact-sciences-cm815145,For Immediate Release Chicago IL July 12 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog include
VRTX,VRTX:UW,BBG000C1SD31,"Biotech Stock Roundup: Arena Shoots Up on Study Data, CELG Inks Immuno-Oncology Deal",2017-07-12 15:50:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pTzy3VQLf-U/biotech-stock-roundup-arena-shoots-up-on-study-data-celg-inks-immuno-oncology-deal-cm815052,Key highlights this week include Arena s ARNA data on its experimental pulmonary arterial hypertension PAH drug while Celgene CELG struck a deal with the aim of speeding up its immuno oncology IO strategy in solid tumors 160 Recap of the Week s Most Important Stories
VRTX,VRTX:UW,BBG000C1SD31,"The Zacks Analyst Blog Highlights: Vertex Pharmaceuticals, Alimera Sciences, Enzo Biochem, Sarepta Therapeutics and EXACT Sciences",2017-07-12 13:30:01 +0000,https://finance.yahoo.com/news/zacks-analyst-blog-highlights-vertex-133001974.html?.tsrc=rss,"The Zacks Analyst Blog Highlights: Vertex Pharmaceuticals, Alimera Sciences, Enzo Biochem, Sarepta Therapeutics and EXACT Sciences"
VRTX,VRTX:UW,BBG000C1SD31,5 Top Multibagger Biotech Stocks to Buy in the 2nd Half,2017-07-11 15:51:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YuwPUF1jU7Q/5-top-multibagger-biotech-stocks-to-buy-in-the-2nd-half-cm814468,After a dreadful 2016 biotech stocks have sprung back to life this year as possibilities of a draconian crackdown on drug prices ease out The unveiling of a health care refurbish plan by Senate Republicans in the meanwhile has reinstated investors confidence in the Republicans ability
VRTX,VRTX:UW,BBG000C1SD31,"Zacks.com featured highlights: Sanderson Farms, American Woodmark, Vertex Pharmaceuticals, Baxter International and A. O. Smith",2017-07-11 15:50:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VXvUYuyqUME/zackscom-featured-highlights-sanderson-farms-american-woodmark-vertex-pharmaceuticals-baxter-international-and-a-o-smith-cm814460,For Immediate Release Chicago IL July 11 2017 Stocks in this week s article include 160 Sanderson Farms Inc NASDAQ SAFM Free Report American Woodmark Corp NASDAQ AMWD Free Report Vertex Pharmaceuticals Inc NASDAQ VRTX Free Report Baxter
VRTX,VRTX:UW,BBG000C1SD31,"Zacks.com featured highlights: Sanderson Farms, American Woodmark, Vertex Pharmaceuticals, Baxter International and A. O. Smith",2017-07-11 13:30:01 +0000,https://finance.yahoo.com/news/zacks-com-featured-highlights-sanderson-133001636.html?.tsrc=rss,"Zacks.com featured highlights: Sanderson Farms, American Woodmark, Vertex Pharmaceuticals, Baxter International and A. O. Smith"
VRTX,VRTX:UW,BBG000C1SD31,"ETFs with exposure to Vertex Pharmaceuticals, Inc. : July 10, 2017",2017-07-10 19:29:43 +0000,http://finance.yahoo.com/r/be07c116-eeae-342f-9b39-32e088d0b9b7/etfs-with-exposure-to-vertex-pharmaceuticals-inc-july-10-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Vertex Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to VRTX-US. Comparing the performance and risk of Vertex Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
VRTX,VRTX:UW,BBG000C1SD31,"BIB, BIIB, REGN, VRTX: ETF Outflow Alert",2017-07-10 16:46:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1VGbs7NDB8I/bib-biib-regn-vrtx-etf-outflow-alert-cm813872,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the ProShares Ultra Nasdaq Biotechnology Symbol BIB where we have detected an approximate 70 4 million dollar outflow that s a 14 8 decrease week over week
VRTX,VRTX:UW,BBG000C1SD31,Why CRISPR Therapeutics AG Jumped 11.7% in June,2017-07-10 16:35:00 +0000,http://finance.yahoo.com/r/d56c2df6-a4a7-34fa-8b81-9eb7a104fe83/why-crispr-therapeutics-ag-jumped-117-in-june.aspx?yptr=yahoo&.tsrc=rss,Shares rose after the company shared two pieces of good news with investors.
VRTX,VRTX:UW,BBG000C1SD31,5 Efficient Stocks to Buy for a Winning Portfolio,2017-07-10 15:50:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3hb9wph3lXs/5-efficient-stocks-to-buy-for-a-winning-portfolio-cm813794,Efficiency a company s ability to transform its inputs into outputs is a potential indicator of a company s financial health This is because a company with a favorable efficiency level is expected to provide impressive returns as it is believed to be positively correlated with the company
VRTX,VRTX:UW,BBG000C1SD31,Trading the five stocks that have risen more than 50% this year,2017-07-06 12:47:31 +0000,https://finance.yahoo.com/news/trading-five-stocks-risen-more-124731821.html?.tsrc=rss,Which of the five big year-to-date winners has the best shot at continuing its rally through the rest of 2017?
VRTX,VRTX:UW,BBG000C1SD31,Trading the five stocks that have risen more than 50% this year,2017-07-06 12:47:31 +0000,http://finance.yahoo.com/r/fc77a323-759b-34b7-a7a3-7b3f2af0c32f/104569157?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104569157&yptr=yahoo&.tsrc=rss,Which of the five big year-to-date winners has the best shot at continuing its rally through the rest of 2017?
VRTX,VRTX:UW,BBG000C1SD31,The Nasdaq 100's 3 Best Stocks in 2017's First Half,2017-07-05 14:44:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/M7Jq3-TigN0/the-nasdaq-100s-3-best-stocks-in-2017s-first-half-cm811719,The Nasdaq 100 has dramatically outperformed the broader stock market climbing 16 so far in 2017 That s roughly double the gains of benchmarks like the S amp P 500 and it reflects the strong performance of many of the technology stocks that make up the Nasdaq 100 However none
VRTX,VRTX:UW,BBG000C1SD31,The Nasdaq 100&apos;s 3 Best Stocks in 2017&apos;s First Half,2017-07-05 13:29:00 +0000,http://finance.yahoo.com/r/4bf9db41-63f4-3e94-86a7-31e4bba2a045/the-nasdaq-100s-3-best-stocks-in-2017s-first-half.aspx?yptr=yahoo&.tsrc=rss,Find out why this index has outperformed the broader market.
VRTX,VRTX:UW,BBG000C1SD31,5 Hottest Stocks Of The First Half Of 2017,2017-07-03 16:04:42 +0000,https://finance.yahoo.com/news/5-hottest-stocks-first-half-160442750.html?.tsrc=rss,"Stocks are off to a great start in 2017, with the SPDR S&P 500 ETF (NYSE: SPY ) up 8.6 percent so far this year. But some investors have had a better first half of the year than others. Related Link: Despite ..."
VRTX,VRTX:UW,BBG000C1SD31,3 Reasons Why Gilead Sciences Shouldn't Buy Vertex Pharmaceuticals,2017-07-03 15:45:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pXLFFlUxL1E/3-reasons-why-gilead-sciences-shouldnt-buy-vertex-pharmaceuticals-cm811188,The idea of a 160 marriage between Gilead Sciences NASDAQ GILD and Vertex Pharmaceuticals NASDAQ VRTX has been repeatedly floated by analysts for the better part of the last two years After all a deal to buy Vertex would easily fall within Gilead s price range and
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharmaceuticals Reaches Analyst Target Price,2017-07-03 14:45:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NdWCxCXMdMc/vertex-pharmaceuticals-reaches-analyst-target-price-cm811186,In recent trading shares of Vertex Pharmaceuticals Inc Symbol VRTX have crossed above the average analyst 12 month target price of 127 93 changing hands for 128 87 share When a stock reaches the target an analyst has set the analyst logically has two ways to react downgrade
VRTX,VRTX:UW,BBG000C1SD31,3 Reasons Why Gilead Sciences Shouldn&apos;t Buy Vertex Pharmaceuticals,2017-07-03 14:25:00 +0000,http://finance.yahoo.com/r/4281539f-848e-34f1-b0f7-c9b7eca0e929/3-reasons-why-gilead-sciences-shouldnt-buy-vertex.aspx?yptr=yahoo&.tsrc=rss,Suggestions from analysts that Gilead ought to acquire Vertex keep popping up -- but this proposed marriage is far from a match made in biotech heaven.
VRTX,VRTX:UW,BBG000C1SD31,The 3 Best S&P Stocks in 2017's First Half,2017-07-03 12:46:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/C9knP9_XoMk/the-3-best-sp-stocks-in-2017s-first-half-cm811019,The S amp P 500 SNPINDEX GSPC has done quite well in the first half of the year setting numerous records and climbing by about 8 in the year Some stocks within the S amp P 500 have done far better in leading the index higher and just a handful of stocks have produced gains
VRTX,VRTX:UW,BBG000C1SD31,The 3 Best S&P Stocks in 2017&apos;s First Half,2017-07-03 11:36:00 +0000,http://finance.yahoo.com/r/243b1b33-145a-3123-9e59-18bcd6d5ae2c/the-3-best-sp-stocks-in-2017s-first-half.aspx?yptr=yahoo&.tsrc=rss,Find out why these S&P 500 components have done so well.
VRTX,VRTX:UW,BBG000C1SD31,Gilead And Vertex Should Join — But Don&apos;t Hold Your Breath: Analyst,2017-06-30 20:13:46 +0000,http://finance.yahoo.com/r/20646e9a-04f5-3540-89b1-5cce1a03ebbf/gilead-could-forge-a-big-merger-but-dont-hold-your-breath?src=A00220&yptr=yahoo&.tsrc=rss,"Gilead would be better of acquiring Vertex than an oncology asset like Tesaro or Incyte, an analyst suggested Friday."
VRTX,VRTX:UW,BBG000C1SD31,"Yes, Gilead Should Buy Vertex",2017-06-30 13:34:00 +0000,http://finance.yahoo.com/r/5916fa78-b453-3307-9ef1-e87723e7fe64/yes-gilead-should-buy-vertex-1498829681?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"The arrow is stopping on M&A. With its hepatitis-C business slowing, Gilead ""needs a transformational acquisition soon to prop up its falling revenue and growth outlook,"" claim Leerink's Geoffrey Porges and Bradley Canino.  Gilead currently has ~$32bn in cash and a leverage ratio of ~1.2x, suggesting that the company has the potential to comfortably make a transformative acquisition such as Vertex."
VRTX,VRTX:UW,BBG000C1SD31,New cystic fibrosis biotech aims to take a different approach than Vertex,2017-06-29 20:07:01 +0000,http://finance.yahoo.com/r/4ef03818-a77f-3ec0-8780-8b4099c68352/new-cystic-fibrosis-biotech-aims-to-take-a.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"California-based Synedgen has spun out its experimental cystic fibrosis treatments into a new biotech to be based in the Boston area, with an eye toward complementing existing drugs for the lung disease.  The new company, called Synspira, launched on Thursday with $8 million in financing from an anonymous investor and an exclusive license to privately-held Synedgen’s preclinical program for cystic fibrosis.  Synspira is operating virtually — the CEO, Synedgen chief operating officer Shenda Baker, is its only current full-time employee — but the company is looking for physical office space in the Boston area."
VRTX,VRTX:UW,BBG000C1SD31,Is Vertex Pharmaceuticals Running Out of Steam or Taking a Breather?,2017-06-29 15:07:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RA92Kf1b30k/is-vertex-pharmaceuticals-running-out-of-steam-or-taking-a-breather-cm809879,Vertex Pharmaceuticals NASDAQ VRTX has enjoyed a remarkable run so far in 2017 Just last week the biotech stock was up 81 year to date There has been a lot of good news for the developer of cystic fibrosis CF drugs However over the past few days Vertex stock has
VRTX,VRTX:UW,BBG000C1SD31,Is Vertex Pharmaceuticals Running Out of Steam or Taking a Breather?,2017-06-29 13:23:00 +0000,http://finance.yahoo.com/r/0fb2a557-a738-3434-a97b-d1fb4a738c0d/is-vertex-pharmaceuticals-running-out-of-steam-or.aspx?yptr=yahoo&.tsrc=rss,"Vertex stock might be down a little from its recent highs, but don&apos;t think its tremendous run is over."
VRTX,VRTX:UW,BBG000C1SD31,Will Oil Prices Spoil Tesla Inc’s (TSLA) Model 3 Party?,2017-06-28 23:02:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lqV-XzBQTrY/will-oil-prices-spoil-tesla-incs-tsla-model-3-party-cm809673,InvestorPlace Stock Market News Stock Advice amp Trading Tips Tesla Inc NASDAQ TSLA the leading EV manufacturer in the U S is slated to launch the final Model 3 sometime in July a couple of weeks from now Tesla has a goal to start production of its first mass produced
VRTX,VRTX:UW,BBG000C1SD31,Will Oil Prices Spoil Tesla Inc’s (TSLA) Model 3 Party?,2017-06-28 18:48:00 +0000,https://finance.yahoo.com/news/oil-prices-spoil-tesla-inc-184800666.html?.tsrc=rss,"Tesla Inc (NASDAQ:TSLA), the leading EV manufacturer in the U.S., is slated to launch the final Model 3 sometime in July, a couple of weeks from now.  As we inch closer to the final stage of the launch, it’s a good idea to kick the tires a bit and check whether the Tesla bull thesis remains intact.  TSLA stock holders have rarely had to worry about Porter’s Five Forces that many startups have to contend with."
VRTX,VRTX:UW,BBG000C1SD31,Here are the winners and losers in the health-care sector,2017-06-28 12:18:00 +0000,https://finance.yahoo.com/video/winners-losers-health-care-sector-121800100.html?.tsrc=rss,CNBC's Landon Dowdy takes a look at the performance of the health-care sector.
VRTX,VRTX:UW,BBG000C1SD31,Even An Upgrade Couldn&apos;t Save Vertex From The Biotech Deluge,2017-06-23 20:20:45 +0000,http://finance.yahoo.com/r/573c7d01-11c1-393a-be4c-f31215eb106a/even-an-upgrade-couldnt-save-vertex-from-the-biotech-deluge?src=A00220&yptr=yahoo&.tsrc=rss,"Vertex stock toppled alongside the biotech sector Friday, but an analyst upgraded shares on the likelihood Vertex will succeed against competitors in cystic fibrosis."
VRTX,VRTX:UW,BBG000C1SD31,"Stocks Up, Apple Roars Back; What&apos;s The Best Growth Play For Rest Of 2017?",2017-06-23 19:45:36 +0000,http://finance.yahoo.com/r/cda4028b-c199-3051-8d3a-5aa679f82e76/stocks-up-nasdaq-vertex-pharmaceuticals-home-depot-apple?src=A00220&yptr=yahoo&.tsrc=rss,The Nasdaq is on course for a strong weekly gain and is leading the key indexes Friday. Vertex has led the biotech group higher in recent weeks.
VRTX,VRTX:UW,BBG000C1SD31,2 Reasons Vertex Pharmaceuticals Just Got Upgraded,2017-06-23 17:25:39 +0000,https://finance.yahoo.com/news/2-reasons-vertex-pharmaceuticals-just-172539863.html?.tsrc=rss,"Needham upgraded shares of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX ) from Hold to Buy, with a price target of $155. The price target, according to the firm, is based on 25 times its estimated ..."
VRTX,VRTX:UW,BBG000C1SD31,Here's Why Investors Are Glued to Vertex Pharma (VRTX) Stock,2017-06-23 15:55:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/F7hQ5x49FPA/heres-why-investors-are-glued-to-vertex-pharma-vrtx-stock-cm807445,Vertex Pharmaceuticals Inc VRTX which presently markets two cystic fibrosis CF drugs Kalydeco and Orkambi also boasts a strong CF pipeline Its broad portfolio of next generation CF correctors which could bring in multi billion dollar sales for the company if approved has
VRTX,VRTX:UW,BBG000C1SD31,3 Growth Stocks That Could Soar More Than Tesla,2017-06-23 14:53:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JyyrwABdAYQ/3-growth-stocks-that-could-soar-more-than-tesla-cm807327,Electric car maker Tesla has buoyed investors by turning in a remarkable performance since late last year doubling in value in just seven months Finding stocks that could match or surpass such gains is no easy task so we asked three top Motley Fool contributors to identify
VRTX,VRTX:UW,BBG000C1SD31,Stocks Pare Early Losses; Retail Earnings Continue To Disappoint,2017-06-23 14:14:28 +0000,http://finance.yahoo.com/r/ee6c6da1-b958-355e-af20-28afd0ebc9bb/stocks-pare-early-losses-retail-earnings-continue-to-disappoint?src=A00220&yptr=yahoo&.tsrc=rss,"The tech-heavy composite is on pace for a 1.3% weekly gain, which comes after two consecutive weeks of relatively heavy losses."
VRTX,VRTX:UW,BBG000C1SD31,Here&apos;s Why Investors Are Glued to Vertex Pharma (VRTX) Stock,2017-06-23 13:42:01 +0000,https://finance.yahoo.com/news/apos-why-investors-glued-vertex-134201199.html?.tsrc=rss,"Vertex Pharmaceuticals, Inc. (VRTX), has been attracting investor attention."
VRTX,VRTX:UW,BBG000C1SD31,3 Growth Stocks That Could Soar More Than Tesla,2017-06-23 13:35:00 +0000,http://finance.yahoo.com/r/d655c20b-816b-3b28-8f41-d9889345fe8d/3-growth-stocks-that-could-soar-more-than-tesla.aspx?yptr=yahoo&.tsrc=rss,These three growth stocks could surpass even Tesla&apos;s remarkable performance.
VRTX,VRTX:UW,BBG000C1SD31,Vertex on the Street: Analysts’ Recommendations in June 2017,2017-06-23 13:06:47 +0000,http://finance.yahoo.com/r/2c134374-b01b-3bf5-af3b-e6eddcdf0b73/vertex-on-the-street-analysts-recommendations-in-june-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Vertex (VRTX) has planned to submit a new drug application to the FDA in 3Q17 for a Tezacaftor-Ivacaftor combination treatment for cystic fibrosis.
VRTX,VRTX:UW,BBG000C1SD31,Inside Vertex Pharmaceuticals’ Clinical Pipeline,2017-06-23 11:36:17 +0000,http://finance.yahoo.com/r/45221a06-e082-396f-936f-4b46cb265161/inside-vertex-pharmaceuticals-clinical-pipeline?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In March 2017, Vertex Pharmaceuticals (VRTX) announced promising results from two phase-3 clinical trials, Evolve and Expand."
VRTX,VRTX:UW,BBG000C1SD31,Why The Biotech Rally Could Still Tack On Another 15% Upside,2017-06-22 20:05:23 +0000,http://finance.yahoo.com/r/cd0483b6-79e9-3071-aee6-c76cdab539ad/why-the-biotech-rally-could-still-tack-on-another-15-upside?src=A00220&yptr=yahoo&.tsrc=rss,"Celgene, Regeneron and Vertex could lead the biotech sector to 15% more upside following the second quarter, an analyst said Thursday."
VRTX,VRTX:UW,BBG000C1SD31,How Kalydeco Could Be Vertex’s Steady Revenue Story,2017-06-22 14:36:42 +0000,http://finance.yahoo.com/r/0cf08f09-9610-3f71-bc7c-dd09e2c711ba/how-kalydeco-could-be-vertexs-steady-revenue-story?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2016, Vertex Pharmaceuticals’ (VRTX) Kalydeco reported revenues of around $703 million, which represents ~11% growth on a YoY (year-over-year) basis."
VRTX,VRTX:UW,BBG000C1SD31,Will Vertex Pharmaceuticals’ Orkambi Continue to Be a Major Growth Driver?,2017-06-22 13:07:40 +0000,http://finance.yahoo.com/r/5d9438cb-ea98-3599-b3f5-39e74a5abcb1/will-vertex-pharmaceuticals-orkambi-continue-to-be-a-major-growth-driver?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2016, Vertex Pharmaceuticals’ (VRTX) Orkambi generated revenues of around $979 million, reflecting ~180% YoY (year-over-year) growth."
VRTX,VRTX:UW,BBG000C1SD31,Inside Vertex Pharmaceuticals’ Revenue Trend,2017-06-22 11:38:27 +0000,http://finance.yahoo.com/r/bc85f757-87a3-3d76-94f5-99c3dd2fe5a3/inside-vertex-pharmaceuticals-revenue-trend?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2016, Vertex Pharmaceuticals (VRTX) reported revenues of around ~$1.7 billion, which reflected a whopping 65% YoY (year-over-year) growth."
VRTX,VRTX:UW,BBG000C1SD31,The Funded: Four $100M-plus rounds lead flood of startup deals,2017-06-21 21:42:36 +0000,http://finance.yahoo.com/r/bb7063ea-1007-3624-8f1f-962c9ad5cd3e/the-funded-four-100m-plus-rounds-lead-flood-of.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Pinterest, a pair of security companies and a bitcoin platform scored $100 million-plus rounds but there were 17 others in the Bay Area that disclosed new funding at midweek. Here are the details: • Pinterest ..."
VRTX,VRTX:UW,BBG000C1SD31,Galapagos Stock Under Fire After Delaying Key Vertex-Rivaling Drug,2017-06-21 20:02:46 +0000,http://finance.yahoo.com/r/6b446c8b-aaf4-30f2-a16e-5ee4494e51f1/galapagos-stock-under-fire-after-delaying-key-vertex-rivaling-drug?src=A00220&yptr=yahoo&.tsrc=rss,"Galapagos has a shot at making a dent in the cystic fibrosis market but it will lag Vertex, analysts said Wednesday after Galapagos pushed out a key trial."
VRTX,VRTX:UW,BBG000C1SD31,Nasdaq Leads Again; Are These 3 Stocks The Next Apple In Biotech Land?,2017-06-21 19:45:55 +0000,http://finance.yahoo.com/r/1a30b82f-ca3e-3263-b98c-414001c5180b/nasdaq-leads-again-are-these-3-stocks-the-next-apple-in-biotech-land?src=A00220&yptr=yahoo&.tsrc=rss,"The Nasdaq composite on Wednesday deflected yet another pounding in crude oil futures and related companies in the stock market, moving moderately higher as the Dow Jones industrial average harbored light losses."
VRTX,VRTX:UW,BBG000C1SD31,Fresh Capital to Be Injected into Biotech Stocks: 5 Must-Buys,2017-06-21 16:27:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kwdfVlE_cIk/fresh-capital-to-be-injected-into-biotech-stocks-5-must-buys-cm806300,The recent rally in tech stocks makes us wonder which other sectors are in a position to lead the charge One sector that comes to our mind is biotechnology which is well positioned to move north Biotech stocks have appeared to come back to life following two years of a lull A flurry of
VRTX,VRTX:UW,BBG000C1SD31,"Biotech Stock Roundup: Clovis Soars on Rubraca Data, Seattle Hit by Study Halt",2017-06-21 13:23:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tJWlLa8XQ64/biotech-stock-roundup-clovis-soars-on-rubraca-data-seattle-hit-by-study-halt-cm806136,Clovis CLVS and Seattle Genetics SGEN were both in the news with the companies providing pipeline updates while Clovis shares soared on positive Rubraca data Seattle Genetics shares were impacted by the discontinuation of a late stage study Recap of the Week s Most Important
VRTX,VRTX:UW,BBG000C1SD31,Trump drug pricing order may be weeks away,2017-06-20 18:25:35 +0000,http://finance.yahoo.com/r/1c75e65a-e1b4-3a4a-8620-7fa0ff430c16/104540794?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104540794&yptr=yahoo&.tsrc=rss,"Donald Trump plans to make good on drug pricing promises, but any action may be weeks away."
VRTX,VRTX:UW,BBG000C1SD31,"Zacks.com featured highlights: Etsy, Live Nation Entertainment, Salesforce.com, Vertex Pharmaceuticals and NeoGenomics",2017-06-20 15:25:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/u0nZQ5gxzWw/zackscom-featured-highlights-etsy-live-nation-entertainment-salesforcecom-vertex-pharmaceuticals-and-neogenomics-cm805596,For Immediate Release Chicago IL June 20 2017 Stocks in this week s article include 160 Etsy Inc NASDAQ ETSY Free Report Live Nation Entertainment Inc NYSE LYV Free Report Salesforce com Inc NYSE CRM Free Report Vertex Pharmaceuticals Inc
VRTX,VRTX:UW,BBG000C1SD31,"Zacks.com featured highlights: Etsy, Live Nation Entertainment, Salesforce.com, Vertex Pharmaceuticals and NeoGenomics",2017-06-20 13:30:01 +0000,https://finance.yahoo.com/news/zacks-com-featured-highlights-etsy-133001398.html?.tsrc=rss,"Zacks.com featured highlights: Etsy, Live Nation Entertainment, Salesforce.com, Vertex Pharmaceuticals and NeoGenomics"
VRTX,VRTX:UW,BBG000C1SD31,"ETFs with exposure to Vertex Pharmaceuticals, Inc. : June 19, 2017",2017-06-19 20:17:57 +0000,http://finance.yahoo.com/r/f4fded33-18f3-396b-a7c8-7224398d4305/etfs-with-exposure-to-vertex-pharmaceuticals-inc-june-19-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Vertex Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to VRTX-US. Comparing the performance and risk of Vertex Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
VRTX,VRTX:UW,BBG000C1SD31,5 Toxic Stocks to Discard or Play Short for Profit,2017-06-19 14:25:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8syHw8WL5FQ/5-toxic-stocks-to-discard-or-play-short-for-profit-cm804957,One of the important keys to successful investing is the proper identification of overpriced stocks and correctly priced ones However in reality the overpriced toxic stocks and the fairly priced stocks are intermingled in the market place in such a way that it becomes extremely difficult
VRTX,VRTX:UW,BBG000C1SD31,Biotech Stocks To Watch And Pharma Industry News,2017-06-16 17:06:44 +0000,http://finance.yahoo.com/r/d95a9140-bcb4-38ab-b942-e0c45662051a/biotech-and-pharma-industry-and-stock-news-merk-bristol-myers-amgn-gilead?src=A00220&yptr=yahoo&.tsrc=rss,Track the latest trends and leading stocks in the biotech and pharmaceutical industries.
VRTX,VRTX:UW,BBG000C1SD31,"Vertex Pharmaceuticals, Inc. :VRTX-US: Earnings Analysis: Q1, 2017 By the Numbers : June 16, 2017",2017-06-16 16:03:16 +0000,http://finance.yahoo.com/r/b72f130f-c972-391a-a76c-5ff14733e5fb/vertex-pharmaceuticals-inc-vrtx-us-earnings-analysis-q1-2017-by-the-numbers-june-16-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Vertex Pharmaceuticals, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Vertex Pharmaceuticals, Inc. – Gilead Sciences, Inc., AbbVie, Inc., Merck & Co., Inc., Bristol-Myers Squibb Company, Johnson & Johnson, Enzon Pharmaceuticals, Inc., Enanta Pharmaceuticals, Inc. and SciClone Pharmaceuticals, ... Read more
<b>(Read more...)</b>"
VRTX,VRTX:UW,BBG000C1SD31,What Are Good Stocks to Invest In Now?,2017-06-14 22:08:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7LB1nB0gwZk/what-are-good-stocks-to-invest-in-now-cm803573,Which stocks to invest in right now will give the best returns It s impossible to say for sure but three good stocks to invest in now could provide great rewards to investors over the long run Colgate Palmolive Company NYSE CL Facebook NASDAQ FB and
VRTX,VRTX:UW,BBG000C1SD31,What Are Good Stocks to Invest In Now?,2017-06-14 20:23:00 +0000,http://finance.yahoo.com/r/55d01964-14ab-35e7-8abc-99173bd8a66b/what-are-good-stocks-to-invest-in-now.aspx?yptr=yahoo&.tsrc=rss,"Why Colgate-Palmolive, Facebook, and Vertex Pharmaceuticals look like good stocks to invest in right now."
VRTX,VRTX:UW,BBG000C1SD31,"Wednesday Sector Leaders: Healthcare, Utilities",2017-06-14 20:07:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/G0k8Zl_cF6s/wednesday-sector-leaders-healthcare-utilities-cm803481,In afternoon trading on Wednesday Healthcare stocks are the best performing sector up 0 8 Within that group Alexion Pharmaceuticals Inc Symbol ALXN and Vertex Pharmaceuticals Inc Symbol VRTX are two of the day s stand outs showing a gain of 8 7 and 2 5 respectively
VRTX,VRTX:UW,BBG000C1SD31,The SPDR S&P Biotech (ETF) (XBI) Is on Breakout Watch,2017-06-14 17:06:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/e0qQOP9koQM/the-spdr-sp-biotech-etf-xbi-is-on-breakout-watch-cm803418,InvestorPlace Stock Market News Stock Advice amp Trading Tips The majority of traders are laser focused on the technology sector so I decided to take a stroll around the Street to see what else was perking up I didn t have to travel far before I found the SPDR S amp P Biotech
VRTX,VRTX:UW,BBG000C1SD31,The SPDR S&P Biotech (ETF) (XBI) Is on Breakout Watch,2017-06-14 12:17:48 +0000,https://finance.yahoo.com/news/spdr-p-biotech-etf-xbi-121748768.html?.tsrc=rss,"The majority of traders are laser-focused on the technology sector, so I decided to take a stroll around the Street to see what else was perking up.  Neophyte traders may not remember this, but once upon a time, biotech stocks were all the rage.  The biotech ETF suffered a 50% haircut and has been clawing its way back ever since."
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharma. To Present At Goldman Sachs Conference; Webcast At 12:20 PM ET,2017-06-13 11:20:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/m9dNGaj3QRg/vertex-pharma-to-present-at-goldman-sachs-conference-webcast-at-1220-pm-et-20170613-00879,Vertex Pharma. To Present At Goldman Sachs Conference; Webcast At 12:20 PM ET
VRTX,VRTX:UW,BBG000C1SD31,"You Will Live to 110 or 120 Years Old, So Don't Make This One Killer Mistake About Your Retirement",2017-06-10 19:20:00 +0000,http://finance.yahoo.com/r/73df1df6-f304-36fb-bcad-1234a99c4b60/you-will-live-to-110-or-120-years-old-so-don-t-make-this-one-killer-mistake-about-your-retirement.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,You're thinking about your retirement all wrong.
VRTX,VRTX:UW,BBG000C1SD31,​Vertex shareholders reject proposal on lobbying transparency,2017-06-09 16:50:12 +0000,http://finance.yahoo.com/r/b87a32ff-8f7d-3e31-8b86-0aedc9679d3a/vertex-shareholders-reject-proposal-on-lobbying.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Shareholders of Vertex Pharmaceuticals have overwhelmingly rejected a proposal by religious groups that asked the Boston drugmaker to disclose more information about its lobbying activities.  Vertex (VRTX) said in a federal filing that nearly three-quarters of its shareholders had voted against the non-binding proposal during the company’s annual meeting on Thursday.  Vertex opposed the measure , which urged it to disclose how much it spends on lobbying, including payments to trade groups that have opposed curbs on drug pricing."
VRTX,VRTX:UW,BBG000C1SD31,Vertex to Present at the Goldman Sachs Healthcare Conference on June 13,2017-06-09 12:30:00 +0000,https://finance.yahoo.com/news/vertex-present-goldman-sachs-healthcare-123000818.html?.tsrc=rss,"Vertex Pharmaceuticals Incorporated today announced that management will present at the Goldman Sachs Healthcare Conference on Tuesday, June 13, 2017 at 12:20 p.m. ET."
VRTX,VRTX:UW,BBG000C1SD31,Weekly CFO Sells Highlight,2017-06-09 12:26:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wXmIqQGu-3Q/weekly-cfo-sells-highlight-cm801028,According to GuruFocus Insider Data the recent chief financial officer sells were Vertex Pharmaceuticals Inc VRTX Salesforce com Inc CRM and Amphenol Corp APH According to GuruFocus Insider Data the recent chief financial officer sells wereVertex Pharmaceuticals Inc
VRTX,VRTX:UW,BBG000C1SD31,InPlay from Briefing.com,2017-06-09 08:55:45 +0000,https://finance.yahoo.com/news/inplay-briefing-com-115750752.html?.tsrc=rss,InPlay from Briefing.com
VRTX,VRTX:UW,BBG000C1SD31,Vertex Announces Nine Presentations of Data on ORKAMBI® (lumacaftor/ivacaftor) and KALYDECO® (ivacaftor) at the European Cystic Fibrosis Society (ECFS) Conference,2017-06-09 08:31:00 +0000,https://finance.yahoo.com/news/vertex-announces-nine-presentations-data-083100743.html?.tsrc=rss,"Vertex Pharmaceuticals Incorporated today announced nine presentations of data on ORKAMBI® and KALYDECO® at the 40th European Cystic Fibrosis Society Conference, being held June 7-10, 2017."
VRTX,VRTX:UW,BBG000C1SD31,"Vertex Presents Data On ORKAMBI, KALYDECO At ECFS Conference - Quick Facts",2017-06-09 04:46:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_OaQj6itfNs/vertex-presents-data-on-orkambi-kalydeco-at-ecfs-conference--quick-facts-20170609-00130,"Vertex Presents Data On ORKAMBI, KALYDECO At ECFS Conference - Quick Facts"
VRTX,VRTX:UW,BBG000C1SD31,"Vertex Names Dr. Alan Garber, Provost of Harvard University, to its Board of Directors",2017-06-08 20:15:00 +0000,https://finance.yahoo.com/news/vertex-names-dr-alan-garber-201500415.html?.tsrc=rss,"Shareholders of Vertex Pharmaceuticals Incorporated  today elected Alan M. Garber, M.D., Ph.D. as an independent member of its board of directors. Dr. Garber is Provost of Harvard University, the Mallinckrodt Professor of Health Care Policy at Harvard Medical School, a Professor of Economics in the Faculty of Arts and Sciences, a Professor of Public Policy in the Harvard Kennedy School of Government, ..."
VRTX,VRTX:UW,BBG000C1SD31,3 Growth Stocks for June,2017-06-08 17:29:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pVgybwqRhtc/3-growth-stocks-for-june-cm800742,With the major indexes hitting yet another set of new all time highs over the past month some investors are getting jittery wondering how much higher things can go Yet even in this market there are stocks out that are only just getting their bearings and still have room to move up
VRTX,VRTX:UW,BBG000C1SD31,3 Growth Stocks for June,2017-06-08 15:31:00 +0000,http://finance.yahoo.com/r/e6911ae9-6f34-372b-9dfd-94e805582493/3-growth-stocks-for-june.aspx?yptr=yahoo&.tsrc=rss,"Prices in the broader market may feel a bit lofty, but Centennial Resource Development, Vertex Pharmaceuticals, and Ply Gem Holdings have room to rise."
VRTX,VRTX:UW,BBG000C1SD31,"Vertex shares soar in 2017, and the best may be yet to come",2017-06-08 14:25:09 +0000,http://finance.yahoo.com/r/5cfcb868-8d94-31eb-93f1-387eeacd5c73/vertex-shares-soar-in-2017-and-the-best-may-be-yet.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Vertex Pharmaceuticals has been the top-performing stock in the S&P 500 so far this year, and further gains could be on the horizon.  Shares of Boston-based Vertex (VRTX), which makes cystic fibrosis drugs, have increased around 70 percent since the beginning of the year.  The jump can be attributed in part to the company’s announcement in late March that a combination of its blockbuster drug Kalydeco and another cystic fibrosis drug called tezacaftor performed well in a pair of late-stage trials."
VRTX,VRTX:UW,BBG000C1SD31,Top Health Stocks to Buy Now,2017-06-06 21:18:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/co6JKKGeNcQ/top-health-stocks-to-buy-now-cm799654,What are the top health stocks to buy now There is a wide range of U S and international healthcare and medical choices to invest in Three health stocks in particular look especially intriguing
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharmaceuticals Inc (VRTX) CEO & President Jeffrey M Leiden Sold $19 million of Shares,2017-06-06 20:16:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/g2Ys4-585ys/vertex-pharmaceuticals-inc-vrtx-ceo-president-jeffrey-m-leiden-sold-19-million-of-shares-cm799641,CEO amp President of Vertex Pharmaceuticals Inc VRTX Jeffrey M Leiden sold 147 101 shares of VRTX on 06 02 2017 at an average price of 129 5 a share The total sale was 19 million CEO President of Vertex Pharmaceuticals Inc VRTX Jeffrey M Leiden sold 147 101 shares of VRTX
VRTX,VRTX:UW,BBG000C1SD31,Top Health Stocks to Buy Now,2017-06-06 19:43:00 +0000,http://finance.yahoo.com/r/ed5f3585-8556-3b0e-ac50-ecb9c764f0bb/top-health-stocks-to-buy-now.aspx?yptr=yahoo&.tsrc=rss,"Why Celgene, Intuitive Surgical, and Vertex Pharmaceuticals rank among the top health stocks to buy now."
VRTX,VRTX:UW,BBG000C1SD31,3 Highest-Growth Stocks in the Market Today,2017-06-06 17:20:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XoSAnpaoRAk/3-highest-growth-stocks-in-the-market-today-cm799535,Finding the next great growth stock is difficult but if you manage to catch lightning in a bottle the results can be life changing That s why I m constantly on the hunt for stocks that promise fast growth in the years ahead One way that I search for winning growth stock ideas is
VRTX,VRTX:UW,BBG000C1SD31,3 Highest-Growth Stocks in the Market Today,2017-06-06 15:15:00 +0000,http://finance.yahoo.com/r/2911f96b-8e99-377f-a85e-1de23b20de48/3-highest-growth-stocks-in-the-market-today.aspx?yptr=yahoo&.tsrc=rss,"These three companies are growing fast, but are any actually worth owning?"
VRTX,VRTX:UW,BBG000C1SD31,Inside the 5 Top Performing Stocks of the Nasdaq ETF,2017-06-06 14:05:02 +0000,https://finance.yahoo.com/news/inside-5-top-performing-stocks-140502776.html?.tsrc=rss,"While the tech giants no doubt delivered outstanding performances, a few gained more than 50% and emerged as the real winners in the Nasdaq ETF."
VRTX,VRTX:UW,BBG000C1SD31,"Zacks.com featured highlights: Salesforce.com, Vertex Pharmaceuticals, Live Nation Entertainment, Covanta Holding and Etsy",2017-06-05 16:06:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Mez8F6vgvv0/zackscom-featured-highlights-salesforcecom-vertex-pharmaceuticals-live-nation-entertainment-covanta-holding-and-etsy-cm798750,For Immediate Release Chicago IL June 05 2017 Stocks in this week s article include 160 Salesforce com inc NYSE CRM Free Report Vertex Pharmaceuticals Incorporated NASDAQ VRTX Free Report Live Nation Entertainment Inc NYSE LYV Free Report
VRTX,VRTX:UW,BBG000C1SD31,"Zacks.com featured highlights: Salesforce.com, Vertex Pharmaceuticals, Live Nation Entertainment, Covanta Holding and Etsy",2017-06-05 13:30:01 +0000,https://finance.yahoo.com/news/zacks-com-featured-highlights-salesforce-133001627.html?.tsrc=rss,"Zacks.com featured highlights: Salesforce.com, Vertex Pharmaceuticals, Live Nation Entertainment, Covanta Holding and Etsy"
VRTX,VRTX:UW,BBG000C1SD31,3 Biotech Stocks to Buy If You've Never Bought a Biotech Stock,2017-06-04 17:00:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0CyqCz8iXGM/3-biotech-stocks-to-buy-if-youve-never-bought-a-biotech-stock-cm798442,If you don t have biotech stocks in your investing portfolio why not For many people the answer is that they think biotech stocks are too risky Although it s true that some biotech stocks are very risky that s not the case for all of them And leaving out these stocks means that you
VRTX,VRTX:UW,BBG000C1SD31,3 Biotech Stocks to Buy If You&apos;ve Never Bought a Biotech Stock,2017-06-04 15:41:00 +0000,http://finance.yahoo.com/r/e82e4dc5-9cf4-3977-a829-724b8edae92d/3-biotech-stocks-to-buy-if-youve-never-bought-a-bi.aspx?yptr=yahoo&.tsrc=rss,"No biotech stocks in your investing portfolio? Take a look at Celgene, Regeneron, and Vertex."
VRTX,VRTX:UW,BBG000C1SD31,3 Stocks With Vertex Pharmaceuticals-Like Return Potential,2017-06-03 14:31:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ebVQOhrzjrA/3-stocks-with-vertex-pharmaceuticals-like-return-potential-cm798352,Over the past decade Vertex 160 Pharmaceuticals NASDAQ VRTX stock has tripled in value thanks in large part to the success of its core cystic fibrosis drug franchise With this biotech s shares now trading at a sky high forward price to earnings ratio of 41 however it
VRTX,VRTX:UW,BBG000C1SD31,3 Stocks With Vertex Pharmaceuticals-Like Return Potential,2017-06-03 13:01:00 +0000,http://finance.yahoo.com/r/de0cd226-5b5b-3e13-8404-d73d2c84d410/3-stocks-with-vertex-pharmaceuticals-like-return-p.aspx?yptr=yahoo&.tsrc=rss,These three biotechs may be ready for a Vertex-like run higher.
VRTX,VRTX:UW,BBG000C1SD31,"SDS, PBE: Big ETF Inflows",2017-06-02 16:33:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VivO3NYd9-o/sds-pbe-big-etf-inflows-cm798044,Comparing units outstanding versus one week ago at the coverage universe of ETFs at ETF Channel the biggest inflow was seen in the ProShares UltraShort S amp P500 which added 3 800 000 units or a 3 5 increase week over week And on a percentage change basis the ETF with the
VRTX,VRTX:UW,BBG000C1SD31,VRTX Crosses Above Average Analyst Target,2017-06-02 14:31:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HESC92W8Ba4/vrtx-crosses-above-average-analyst-target-cm797882,In recent trading shares of Vertex Pharmaceuticals Inc Symbol VRTX have crossed above the average analyst 12 month target price of 123 85 changing hands for 127 16 share When a stock reaches the target an analyst has set the analyst logically has two ways to react downgrade
VRTX,VRTX:UW,BBG000C1SD31,"Vertex Announces Long-Term Reimbursement Agreement with the Republic of Ireland for ORKAMBI® (lumacaftor/ivacaftor), KALYDECO® (ivacaftor) and Future Cystic Fibrosis Medicines",2017-06-01 17:15:00 +0000,https://finance.yahoo.com/news/vertex-announces-long-term-reimbursement-171500304.html?.tsrc=rss,Vertex Pharmaceuticals Incorporated today announced it has reached an agreement with the Health Service Executive in the Republic of Ireland to fund ORKAMBI® for all of the approximately 500 people in Ireland with cystic fibrosis ages 12 and older who have two copies of the F508del mutation.
VRTX,VRTX:UW,BBG000C1SD31,"Noteworthy ETF Outflows: XBI, VRTX, EXAS, REGN",2017-06-01 16:34:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/o_aTvkd__7I/noteworthy-etf-outflows-xbi-vrtx-exas-regn-cm797497,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the SPDR S amp P Biotech ETF Symbol XBI where we have detected an approximate 108 4 million dollar outflow that s a 3 5 decrease week over week from 45 150 000
VRTX,VRTX:UW,BBG000C1SD31,"Market Close Report: NASDAQ Composite index closes at 6,198.52 down -4.67 points",2017-05-31 20:49:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wxPe6rk4nYw/market-close-report-nasdaq-composite-index-closes-at-619852-down-467-points-cm797117,Wednesday s session closes with the NASDAQ Composite Index at 6 198 52 The total shares traded for the NASDAQ was over 2 23 billion Declining stocks led advancers by 1 04 to 1 ratio There were 1408 advancers and 1468 decliners for the day On the NASDAQ Stock Exchange 64 stocks reached a 52
VRTX,VRTX:UW,BBG000C1SD31,"Gainers & Losers Of May 30: PTGX, ECYT, NTLA, EDIT, CNCE...",2017-05-30 21:42:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JnvoyNxuJlo/gainers--losers-of-may-30-ptgx-ecyt-ntla-edit-cnce-20170530-01318,"Gainers & Losers Of May 30: PTGX, ECYT, NTLA, EDIT, CNCE..."
VRTX,VRTX:UW,BBG000C1SD31,3 Stocks the Smartest Investors Are Buying Right Now,2017-05-30 16:36:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/v2gsAPuMOU0/3-stocks-the-smartest-investors-are-buying-right-now-cm796265,What stocks are the smartest investors buying We asked three Fool contributors a version of that question Which stocks are either already getting attention from highly regarded professional investors or should be Here s why they think Vertex Pharmaceuticals NASDAQ VRTX
VRTX,VRTX:UW,BBG000C1SD31,3 Stocks the Smartest Investors Are Buying Right Now,2017-05-30 14:33:00 +0000,http://finance.yahoo.com/r/13a4ac63-c6f4-3fab-abe0-55487cf14aa3/3-stocks-the-smartest-investors-are-buying-right-n.aspx?yptr=yahoo&.tsrc=rss,Investors who want to look past the obvious choices should consider these stocks right now.
VRTX,VRTX:UW,BBG000C1SD31,Why Is Vertex (VRTX) Up 2.1% Since the Last Earnings Report?,2017-05-30 12:33:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SCQ0S1JbgSA/why-is-vertex-vrtx-up-21-since-the-last-earnings-report-cm795979,It has been about a month since the last earnings report for Vertex Pharmaceuticals Incorporated VRTX Shares have added about 2 1 in the past month outperforming the market Will the recent positive trend continue leading up to the stock s next earnings release or is it due for a
VRTX,VRTX:UW,BBG000C1SD31,Why Is Vertex (VRTX) Up 2.1% Since the Last Earnings Report?,2017-05-30 10:08:10 +0000,https://finance.yahoo.com/news/why-vertex-vrtx-2-1-100810395.html?.tsrc=rss,Vertex (VRTX) reported earnings 30 days ago. What&apos;s next for the stock? We take a look at earnings estimates for some clues.
VRTX,VRTX:UW,BBG000C1SD31,"Agree To Buy Vertex Pharmaceuticals At $80, Earn 4.9% Annualized Using Options",2017-05-24 17:33:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jN6SgS24bas/agree-to-buy-vertex-pharmaceuticals-at-80-earn-49-annualized-using-options-cm794049,Investors eyeing a purchase of Vertex Pharmaceuticals Inc Symbol VRTX shares but cautious about paying the going market price of 116 25 share might benefit from considering selling puts among the alternative strategies at their disposal One interesting put contract in particular is
VRTX,VRTX:UW,BBG000C1SD31,"Biotech Stock Roundup: FDA Nod for Regeneron RA Drug, Amgen Hit by Study Data",2017-05-24 14:19:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/H8cVVhDN_4U/biotech-stock-roundup-fda-nod-for-regeneron-ra-drug-amgen-hit-by-study-data-cm793761,Major news in the biotech sector include FDA approval for Regeneron s REGN rheumatoid arthritis RA treatment Kevzara as well as data from companies like Amgen AMGN and Celgene CELG 160 Recap of the Week s Most Important Stories Regeneron Sanofi RA Drug Gets FDA Nod
VRTX,VRTX:UW,BBG000C1SD31,Vertex CEO: Our goal is to have one medicine for all cyst...,2017-05-23 18:16:00 +0000,https://finance.yahoo.com/video/vertex-ceo-goal-one-medicine-181600042.html?.tsrc=rss,"Jeff Leiden, Vertex Pharmaceuticals CEO, speaks to CNBC's Meg Tirrell about his company's cystic fibrosis drugs and the future for biotech and pharma under the current administration."
VRTX,VRTX:UW,BBG000C1SD31,Vertex To Present At The UBS Healthcare Conference; Webcast At 11:00 AM ET,2017-05-23 10:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FHzf5Tj-fxk/vertex-to-present-at-the-ubs-healthcare-conference-webcast-at-1100-am-et-20170523-00809,Vertex To Present At The UBS Healthcare Conference; Webcast At 11:00 AM ET
VRTX,VRTX:UW,BBG000C1SD31,Vertex Undergoes FTC Scrubbing for Deal on CF Treatment,2017-05-22 22:29:00 +0000,http://finance.yahoo.com/r/abc5eb28-3972-3523-9e40-427e8f41d367/vertex-undergoes-ftc-scrubbing-for-deal-on-cf-treatment.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,The key issue for the FTC is whether the deal kills competition between Concert's treatment and Vertex's Kalydeco.
VRTX,VRTX:UW,BBG000C1SD31,Concert Pharma Gets Second FTC Request For Pending CTP-656 Deal,2017-05-22 07:18:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WU4e9t4Q-Ks/concert-pharma-gets-second-ftc-request-for-pending-ctp656-deal-20170522-00288,Concert Pharma Gets Second FTC Request For Pending CTP-656 Deal
VRTX,VRTX:UW,BBG000C1SD31,"Amgen, Gilead, Biogen Won&apos;t Lead The Biotech Boom — So Who Will?",2017-05-19 20:30:36 +0000,http://finance.yahoo.com/r/43448f46-ab61-3261-87b4-c50ada16e8c5/amgen-gilead-biogen-wont-lead-the-biotech-boom-so-who-will?src=A00220&yptr=yahoo&.tsrc=rss,"Regeneron, Vertex and Alexion look likely to catch the next wave in biotech and start a boom, an analyst says."
VRTX,VRTX:UW,BBG000C1SD31,"XBI, VRTX, REGN, EXAS: Large Inflows Detected at ETF",2017-05-19 16:12:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wk70ZAil9Fs/xbi-vrtx-regn-exas-large-inflows-detected-at-etf-cm791931,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the SPDR S amp P Biotech ETF Symbol XBI where we have detected an approximate 126 1 million dollar inflow that s a 4 2 increase week over week in outstanding
VRTX,VRTX:UW,BBG000C1SD31,"Vertex launches college scholarship program for cystic fibrosis patients, families",2017-05-19 11:20:12 +0000,http://finance.yahoo.com/r/18d222bb-622a-3250-9e17-ee84538065b4/vertex-launches-college-scholarship-program-for.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Vertex Pharmaceuticals has launched a new college scholarship program for people affected by cystic fibrosis, the debilitating and often fatal lung disease that the Boston-based company has spent decades trying to tackle.  Vertex (VRTX) said Friday it had awarded $5,000 each to 40 students nationwide — 26 cystic fibrosis patients and 14 immediate family members — for a total of $200,000.  The scholarships will help to pay for two-year, four-year and graduate degrees."
VRTX,VRTX:UW,BBG000C1SD31,"Vertex Awards 40 Scholarships Totaling $200,000 to People Living with Cystic Fibrosis and Their Immediate Family Members",2017-05-19 10:45:00 +0000,https://finance.yahoo.com/news/vertex-awards-40-scholarships-totaling-104500467.html?.tsrc=rss,"Vertex Pharmaceuticals Incorporated  today announced the first recipients of the company’s All in for CF Scholarship program. Each of the 40 scholarship recipients will be awarded $5,000 for the 2017-2018 academic year."
VRTX,VRTX:UW,BBG000C1SD31,Vertex to Present at the UBS Healthcare Conference on May 23,2017-05-18 20:01:00 +0000,https://finance.yahoo.com/news/vertex-present-ubs-healthcare-conference-200100790.html?.tsrc=rss,"Vertex Pharmaceuticals Incorporated today announced that management will present at the UBS Healthcare Conference on Tuesday, May 23, 2017 at 11:00 a.m. ET."
VRTX,VRTX:UW,BBG000C1SD31,Concert Pharma Falls After Clinical Hold on Hair Loss Drug,2017-05-18 16:14:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_EM6cDgS-Yo/concert-pharma-falls-after-clinical-hold-on-hair-loss-drug-cm791268,Concert Pharmaceuticals Inc CNCE shares were down almost 8 on Wednesday after the company announced that the FDA has placed a clinical hold on a mid stage study evaluating its pipeline candidate CTP 543 for the treatment of alopecia areata Shares of Concert Pharma have outperformed the
VRTX,VRTX:UW,BBG000C1SD31,Vertex Ups Kalydeco Sales View as FDA Okays Label Expansion,2017-05-18 13:53:01 +0000,https://finance.yahoo.com/news/vertex-ups-kalydeco-sales-view-135301988.html?.tsrc=rss,"Vertex Pharmaceuticals Incorporated???s (VRTX) announced that the FDA has approved its lead marketed drug, Kalydeco (ivacaftor) for expanded use."
VRTX,VRTX:UW,BBG000C1SD31,"Zacks.com featured highlights: Covanta Holding, PTC, Etsy, Vertex Pharmaceuticals and Live Nation Entertainment",2017-05-18 13:30:01 +0000,https://finance.yahoo.com/news/zacks-com-featured-highlights-covanta-133001858.html?.tsrc=rss,"Zacks.com featured highlights: Covanta Holding, PTC, Etsy, Vertex Pharmaceuticals and Live Nation Entertainment"
VRTX,VRTX:UW,BBG000C1SD31,A Doomed Trump Presidency Would Be a Terrifying Development for Pharmaceutical Stocks,2017-05-18 13:15:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-wkOeSsJRYM/a-doomed-trump-presidency-would-be-a-terrifying-development-for-pharmaceutical-stocks-cm791065,Controversy has clouded the brief presidency of Donald Trump especially after he fired FBI Director James Comey If for some reason Trump doesn t finish out his term in office pharmaceutical stocks could get walloped going forward The long and short of it is that the
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharmaceuticals' Shares Pop in Afterhours Trading After FDA Approval while AstraZeneca Sinks on Clovis Upgrade,2017-05-18 12:00:00 +0000,https://finance.yahoo.com/news/vertex-pharmaceuticals-shares-pop-afterhours-120000914.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / May 18, 2017 / Vertex Pharmaceuticals may have closed in the red yesterday but the stock saw a jump in share price in after-hours trading after the company reported exciting ..."
VRTX,VRTX:UW,BBG000C1SD31,Vertex boosts Kalydeco sales forecast after FDA approves for more patients,2017-05-18 10:25:08 +0000,http://finance.yahoo.com/r/4ece9e29-4469-31d7-ab92-d11f7ae21dc5/vertex-boosts-kalydeco-sales-forecast-after-fda.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Boston-based Vertex Pharmaceuticals on Wednesday raised its 2017 revenue forecast for cystic fibrosis drug Kalydeco after the FDA approved the treatment for patients with additional kinds of genetic mutations.  Vertex (VRTX) announced that the agency had approved Kalydeco for patients ages 2 and older who have any of 23 mutations that collectively affect more than 900 people in the U.S. The drug was already approved for 10 mutations.  As a result of the approval, the company said it was increasing its 2017 revenue guidance for Kalydeco to a range of $740 million to $770 million."
VRTX,VRTX:UW,BBG000C1SD31,"SNDX Rises On Entinostat Data, Kalydeco Gets FDA Nod, Concert Fails To Enthrall",2017-05-18 02:22:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HyPHxNz3ekQ/sndx-rises-on-entinostat-data-kalydeco-gets-fda-nod-concert-fails-to-enthrall-20170518-00073,"SNDX Rises On Entinostat Data, Kalydeco Gets FDA Nod, Concert Fails To Enthrall"
VRTX,VRTX:UW,BBG000C1SD31,FDA Expands Approved Use Of Kalydeco To Treat Addl Mutations Of Cystic Fibrosis,2017-05-17 21:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HX_aQnMK558/fda-expands-approved-use-of-kalydeco-to-treat-addl-mutations-of-cystic-fibrosis-20170517-01365,FDA Expands Approved Use Of Kalydeco To Treat Addl Mutations Of Cystic Fibrosis
VRTX,VRTX:UW,BBG000C1SD31,Vertex shares up more than 1% after FDA drug approval,2017-05-17 20:18:11 +0000,http://finance.yahoo.com/r/ed00d3a4-3001-31ca-b235-29c6b3ceb5b1/Story.aspx?guid=55016D80-3E1A-44D5-B39F-5E6B5D570F1F&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Shares of Vertex Pharmaceuticals Inc. rose more than 1% late Wednesday after the company said the U.S. Food and Drug Administration has approved one of its drugs for the treatment of certain mutations ...
VRTX,VRTX:UW,BBG000C1SD31,FDA Approves KALYDECO® (ivacaftor) for More Than 900 People Ages 2 and Older with Cystic Fibrosis Who Have Certain Residual Function Mutations,2017-05-17 20:08:00 +0000,https://finance.yahoo.com/news/fda-approves-kalydeco-ivacaftor-more-200800577.html?.tsrc=rss,Vertex Pharmaceuticals Incorporated today announced that the U.S. Food and Drug Administration has approved KALYDECO® for use in people with cystic fibrosis ages 2 and older who have one of 23 residual function mutations in the cystic fibrosis transmembrane conductance regulator gene.
VRTX,VRTX:UW,BBG000C1SD31,Love High-Growth? Here Are 3 Stocks to Consider,2017-05-17 13:21:00 +0000,http://finance.yahoo.com/r/11a55b6c-dfa5-3fdf-8a70-f940f8640ffc/love-high-growth-heres-3-stocks-to-consider.aspx?yptr=yahoo&.tsrc=rss,"If you&apos;re willing to pay up for explosive growth, look no further than these three stocks."
VRTX,VRTX:UW,BBG000C1SD31,"Biotech Stock Roundup: Biogen Inks Deal to Boost Pipeline, Sangamo Soars on Pfizer Deal",2017-05-17 13:18:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VWR-nTULKG0/biotech-stock-roundup-biogen-inks-deal-to-boost-pipeline-sangamo-soars-on-pfizer-deal-cm790465,Biogen BIIB was in the news this week not only for an agreement that will boost its pipeline but also for a favorable decision in a securities litigation Meanwhile Sangamo s SGMO shares skyrocketed on a collaboration with Pfizer 160 Recap of the Week s Most Important
VRTX,VRTX:UW,BBG000C1SD31,5 Toxic Stocks to Steer Clear Of or Play Short Right Now,2017-05-17 11:58:11 +0000,https://finance.yahoo.com/news/5-toxic-stocks-steer-clear-115811016.html?.tsrc=rss,High price of the toxic stocks can be ascribed to an irrational exuberance associated with them or some serious fundamental lacunae. Presence of such stocks in your portfolio may result loss of wealth.
VRTX,VRTX:UW,BBG000C1SD31,Why Is Vertex Pharma (VRTX) Stock Soaring This Year?,2017-05-16 19:31:07 +0000,https://finance.yahoo.com/news/why-vertex-pharma-vrtx-stock-193107094.html?.tsrc=rss,"Vertex Pharmaceuticals, Inc.&apos;s (VRTX) shares have risen 57.8% this year so far, outperforming the increase of 1.3% for the Zacks classified Large-Cap Pharma industry."
VRTX,VRTX:UW,BBG000C1SD31,"Henri Termeer, 'giant of biotech' and longtime CEO of Genzyme, dies at 71",2017-05-15 00:00:17 +0000,http://finance.yahoo.com/r/9c8b9b49-5646-328b-bf79-1f1a9c48020a/henri-termeer-giant-of-biotech-and-longtime-ceo-of.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Henri Termeer, the longtime chief executive of Genzyme, one of the most iconic biotechnology companies in the world, has died at the age of 71 in his Marblehead home, according to multiple reports.  In an interview Saturday, Josh Boger, founding CEO of Vertex Pharmaceuticals (VRTX), said that Termeer served as a example for how to run a biotech firm ever since he first met him in the early 1990s.  ""As a CEO, as Vertex became big enough that I could pay attention to things outside the company, Henri taught me the importance of caring about ... the community you're in,"" said Boger."
VRTX,VRTX:UW,BBG000C1SD31,3 Best Stocks in Personalized Medicine,2017-05-14 17:14:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mHgvdgPaZxQ/3-best-stocks-in-personalized-medicine-cm789008,Personalized medicine also known as precision medicine or genomic medicine is one of the most revolutionary trends shaping the future of healthcare What is personalized medicine The simple definition is that it s the customization of care to an individual s genetic profile
VRTX,VRTX:UW,BBG000C1SD31,3 Best Stocks in Personalized Medicine,2017-05-14 16:03:00 +0000,http://finance.yahoo.com/r/b14f4c8d-660b-33c1-9ff1-30023cfdc327/3-best-stocks-in-personalized-medicine.aspx?yptr=yahoo&.tsrc=rss,"Why Exact Sciences, Illumina, and Vertex Pharmaceuticals are the best stocks in personalized medicine right now."
VRTX,VRTX:UW,BBG000C1SD31,"CWALT, Inc. Mortgage Pass-Through Certificates, Series 2006-45T1 -- Moody's Affirms Seven Classes of MSC 2016-UBS11",2017-05-11 20:54:06 +0000,http://finance.yahoo.com/r/fa66fcce-75ab-35cc-8b40-ddc461e94f0f/viewresearchdoc.aspx?docid=PR_366299&WT.mc_id=AM~WWFob29fRmluYW5jZTQyX1NCX0NWX1JhdGluZ19OZXdzX0FsbF9Fbmc=~20170511_PR_366299&yptr=yahoo&.tsrc=rss,Rating Action: Moody's Affirms Seven Classes of MSC 2016- UBS11. Global Credit Research- 11 May 2017. Approximately $559 Million of Structured Securities Affected.
VRTX,VRTX:UW,BBG000C1SD31,"Notable ETF Outflow Detected - XBI, EXAS, VRTX, IONS",2017-05-11 16:01:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XPq-RtKfBIs/notable-etf-outflow-detected-xbi-exas-vrtx-ions-cm787841,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the SPDR S amp P Biotech ETF Symbol XBI where we have detected an approximate 149 2 million dollar outflow that s a 4 8 decrease week over week from 44 900 000
VRTX,VRTX:UW,BBG000C1SD31,Which Companies Are Now Outperforming 95% Of All Stocks?,2017-05-10 15:42:39 +0000,http://finance.yahoo.com/r/e06cbce3-8d73-3f78-8ca7-5ef78fa61798/companies-now-outperforming-95-of-all-stocks?src=A00220&yptr=yahoo&.tsrc=rss,Market history shows the best stocks often have a 95 or higher Composite Rating in the early stages of a big price move. See which names just reached that telltale benchmark.
VRTX,VRTX:UW,BBG000C1SD31,"I Still Can't Believe Gilead Sciences, Inc. Spent $14.8 Billion on Shareholder Rewards",2017-05-09 16:04:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lQ2lar4T_FM/i-still-cant-believe-gilead-sciences-inc-spent-148-billion-on-shareholder-rewards-cm786504,Over the past sixteen months Gilead Sciences NASDAQ GILD has doled out 11 565 billion on share repurchases and 3 187 billion on dividends for a grand total of 14 75 billion on shareholder rewards While a rich shareholder rewards program is generally a good thing Gilead has
VRTX,VRTX:UW,BBG000C1SD31,"I Still Can&apos;t Believe Gilead Sciences, Inc. Spent $14.8 Billion on Shareholder Rewards",2017-05-09 14:12:00 +0000,http://finance.yahoo.com/r/2f431235-3d89-3afd-b625-455af34d4832/i-still-cant-believe-gilead-sciences-inc-spent-147.aspx?yptr=yahoo&.tsrc=rss,Gilead&apos;s M&A targets may be limited because of its sizable shareholder rewards program.
VRTX,VRTX:UW,BBG000C1SD31,Here's Why Vertex Pharmaceuticals Incorporated Gained 8% in April,2017-05-08 19:02:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/v7dH2rDBncM/heres-why-vertex-pharmaceuticals-incorporated-gained-8-in-april-cm786020,What happened Shares of Vertex Pharmaceuticals Incorporated NASDAQ VRTX a biopharma company focused on treating cystic fibrosis rose 8 18 in April according to data from S amp P Global Market Intelligence The company entered April on the heels of positive clinical
VRTX,VRTX:UW,BBG000C1SD31,Here&apos;s Why Vertex Pharmaceuticals Incorporated Gained 8% in April,2017-05-08 17:54:00 +0000,http://finance.yahoo.com/r/911a0a0e-b6a1-3c74-bd18-5fe7abf5a10c/heres-why-vertex-pharmaceuticals-incorporated-gain.aspx?yptr=yahoo&.tsrc=rss,"The cystic fibrosis specialist vaulted across the profitability threshold, and it looks like further growth ahead."
VRTX,VRTX:UW,BBG000C1SD31,Vertex Grants $1 Million to 15 Non-profit Organizations to Advance Initiatives for People Living with Cystic Fibrosis,2017-05-04 12:30:00 +0000,http://finance.yahoo.com/news/vertex-grants-1-million-15-123000325.html?.tsrc=rss,"Vertex Pharmaceuticals Incorporated today announced the grant recipients for its 2017 Cystic Fibrosis Circle of Care program, an initiative that funds innovative, patient-centric programs for the CF community."
VRTX,VRTX:UW,BBG000C1SD31,The 3 Best Comeback Stocks to Buy in 2017,2017-05-03 23:09:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4I4R50qwavk/the-3-best-comeback-stocks-to-buy-in-2017-cm783856,InvestorPlace Stock Market News Stock Advice amp Trading Tips Some of the best stocks to own are fundamentally sound companies that have been hit with a sudden crisis Even the top names of the investment markets like Apple Inc NASDAQ AAPL and Amazon com Inc
VRTX,VRTX:UW,BBG000C1SD31,"Noteworthy ETF Inflows: XBI, VRTX, IONS, SRPT",2017-05-03 19:47:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NzBCx0d6KZg/noteworthy-etf-inflows-xbi-vrtx-ions-srpt-cm783570,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the SPDR S amp P Biotech ETF Symbol XBI where we have detected an approximate 129 9 million dollar inflow that s a 4 2 increase week over week in outstanding
VRTX,VRTX:UW,BBG000C1SD31,Durham CEO on deal with Shire valued at up to $535M,2017-05-02 13:10:09 +0000,http://finance.yahoo.com/r/c060de6e-3800-3856-a054-5548245bd321/durham-ceo-on-deal-with-shire-valued-at-up-to-535m.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Durham-based Parion Sciences has inked a deal with biotechnology giant Shire (LSE: SHP, Nasdaq: SHPG) that’s valued at up to $535 million.  Paul Boucher, president and CEO of Parion, says one important aspect of the deal – which will see Parion grant Shire the rights to develop and commercialize the former’s compound P-321 for the treatment of dry eye disease – is that it allows for Parion to stay involved in P-321 moving forward.  The deal gives Parion the opportunity to co-fund P-321 development, according to an announcement from both companies, and Shire will make a $20 million upfront payment to Parion."
VRTX,VRTX:UW,BBG000C1SD31,"Vertex Pharmaceuticals Incorporated: Solid Sales, Prepping for Next Generation",2017-05-01 20:28:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sF1NPtxB3kQ/vertex-pharmaceuticals-incorporated-solid-sales-prepping-for-next-generation-cm782235,Cystic fibrosis expert Vertex Pharmaceuticals NASDAQ VRTX reported solid first quarter earnings after the bell on Thursday and gave an update on its pipeline of next generation drugs to treat the disease Vertex Pharmaceuticals results The raw
VRTX,VRTX:UW,BBG000C1SD31,"Vertex Pharmaceuticals Incorporated: Solid Sales, Prepping for Next Generation",2017-05-01 18:37:00 +0000,http://finance.yahoo.com/r/9a05762c-ce1b-383d-86ac-475877454c19/vertex-pharmaceuticals-incorporated-solid-sales-pr.aspx?yptr=yahoo&.tsrc=rss,Sales of the biotech&apos;s cystic fibrosis drugs continue to grow as it develops next-generation drugs to treat more patients.
VRTX,VRTX:UW,BBG000C1SD31,Edited Transcript of VRTX earnings conference call or presentation 27-Apr-17 8:30pm GMT,2017-05-01 12:05:57 +0000,http://finance.yahoo.com/news/edited-transcript-vrtx-earnings-conference-063437437.html?.tsrc=rss,Q1 2017 Vertex Pharmaceuticals Inc Earnings Call
VRTX,VRTX:UW,BBG000C1SD31,3 Top Biotech Stocks to Buy Now,2017-04-29 17:26:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zMYXyaPW3zo/3-top-biotech-stocks-to-buy-now-cm781666,If you had invested 10 000 in three select biotech stocks three years ago you d now have nearly 98 000 Which three biotech stocks would have made this accomplishment possible Celgene NASDAQ CELG Jazz Pharmaceuticals NASDAQ JAZZ and Vertex Pharmaceuticals
VRTX,VRTX:UW,BBG000C1SD31,3 Top Biotech Stocks to Buy Now,2017-04-29 16:03:00 +0000,http://finance.yahoo.com/r/d462df76-a929-3e0f-a1ea-b8f4cc756912/3-top-biotech-stocks-to-buy-now.aspx?yptr=yahoo&.tsrc=rss,"Biotech stocks Celgene, Jazz Pharmaceuticals, and Vertex Pharmaceuticals are hard to beat."
VRTX,VRTX:UW,BBG000C1SD31,"Vertex Big Winner In Biopharma Q1 As AbbVie, AstraZeneca Dip",2017-04-28 20:09:23 +0000,http://finance.yahoo.com/r/2327e107-70a6-3b32-90a1-c45b4e6ea34e/vertex-big-winner-in-biopharma-q1-as-abbvie-astrazeneca-dip?src=A00220&yptr=yahoo&.tsrc=rss,Vertex was the big winner Friday following a slew of biotechs and drugmakers issuing first-quarter reports Thursday.
VRTX,VRTX:UW,BBG000C1SD31,"Vertex (VRTX) Q1 Earnings Top, CF Products Sales Strong",2017-04-28 15:31:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/K1h58bCz5X4/vertex-vrtx-q1-earnings-top-cf-products-sales-strong-cm781127,Vertex Pharmaceuticals Incorporated VRTX reported first quarter 2017 earnings per share of 13 cents including the impact of stock based compensation expense which beat the Zacks Consensus Estimate of 4 cents Notably the company had posted a loss of 13 cents in the year ago quarter
VRTX,VRTX:UW,BBG000C1SD31,"Biotech Movers: CEO Exit, Tea Leaf Reading Prompts Surge in Sarepta Shares",2017-04-28 13:39:00 +0000,http://finance.yahoo.com/r/83fff216-3cf3-3c9f-aadb-32d16788f885/biotech-movers-ceo-exit-tea-leaf-reading-prompts-surge-in-sarepta-shares.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Sarepta Therapeutics and Vertex Pharmaceuticals and Endo Pharmaceuticals were among the biotech stock movers Friday morning.
VRTX,VRTX:UW,BBG000C1SD31,"Vertex (VRTX) Q1 Earnings Top, CF Products Sales Strong",2017-04-28 13:15:01 +0000,http://finance.yahoo.com/news/vertex-vrtx-q1-earnings-top-131501155.html?.tsrc=rss,"Vertex Pharmaceuticals Incorporated (VRTX) reported first-quarter 2017 earnings per share of 13 cents (including the impact of stock-based compensation expense), which beat the Zacks Consensus Estimate of 4 cents."
VRTX,VRTX:UW,BBG000C1SD31,Mixed bag for biotech earnings,2017-04-27 21:16:00 +0000,http://finance.yahoo.com/video/mixed-bag-biotech-earnings-211600318.html?.tsrc=rss,CNBC's Meg Tirrell reports the latest from the Vertex Pharmaceuticals earnings call. The &quot;Fast Money&quot; traders weigh in on trading the pharma and biotech space.
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharma earnings beat $0.41 vs. $0.39 est.,2017-04-27 20:55:00 +0000,http://finance.yahoo.com/video/vertex-pharma-earnings-beat-0-205500047.html?.tsrc=rss,CNBC's Meg Tirrell reports Vertex Pharmaceuticals' quarterly earnings.
VRTX,VRTX:UW,BBG000C1SD31,Vertex beats Street 1Q forecasts,2017-04-27 20:52:40 +0000,http://finance.yahoo.com/news/vertex-beats-street-1q-forecasts-205240357.html?.tsrc=rss,"The Boston-based company said it had net income of 99 cents per share. Earnings, adjusted for non-recurring gains, were 41 cents per share. The results exceeded Wall Street expectations. The average estimate ..."
VRTX,VRTX:UW,BBG000C1SD31,Vertex Crushes Q1 Sales Expectations; Profit Tops By A Penny,2017-04-27 20:09:22 +0000,http://finance.yahoo.com/r/86b65a91-b3e5-3f9f-9517-6d1591b846ba/vertex-crushes-q1-sales-expectations-profit-tops-by-a-penny?src=A00220&yptr=yahoo&.tsrc=rss,"Vertex cystic fibrosis drug sales popped 22% in the first quarter, helping drive a $200 million-plus sales beat and profits that topped expectations by a penny."
VRTX,VRTX:UW,BBG000C1SD31,Vertex Reports First-Quarter 2017 Financial Results,2017-04-27 20:01:00 +0000,http://finance.yahoo.com/news/vertex-reports-first-quarter-2017-200100256.html?.tsrc=rss,"Vertex Pharmaceuticals Incorporated today reported consolidated financial results for the quarter ended March 31, 2017. Vertex also reiterated guidance for total 2017 ORKAMBI® revenues and combined GAAP and non-GAAP R&D and SG&A expenses, and increased its total 2017 guidance for KALYDECO® revenues."
VRTX,VRTX:UW,BBG000C1SD31,"After-Hours Earnings Report for April 27, 2017 :  MSFT, AMZN, GOOGL, INTC, SBUX, BIDU, AFL, VRTX, WDC, RSG, CERN, SWKS",2017-04-27 19:07:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uOa9bwMqOmw/after-hours-earnings-report-for-april-27-2017-msft-amzn-googl-intc-sbux-bidu-afl-vrtx-wdc-rsg-cern-swks-cm780570,The following companies are expected to report earnings after hours on 04 27 2017 Visit our Earnings Calendar for a full list of expected earnings releases Microsoft Corporation MSFT is reporting for the quarter ending March 31 2017 The computer
VRTX,VRTX:UW,BBG000C1SD31,"Earnings Reaction History: Vertex Pharmaceuticals Incorporated, 40.0% Follow-Through Indicator, 2.8% Sensitive",2017-04-27 19:05:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yFBMssLYQlA/earnings-reaction-history-vertex-pharmaceuticals-incorporated-400-follow-through-indicator-28-sensitive-cm780621,Expected Earnings Release 04 27 2017 After hoursExpected Earnings Release 04 27 2017 After hours Avg Extended Hours Dollar Volume 15 945 486Avg Extended Hours Dollar Volume 15 945 486 Vertex Pharmaceuticals Incorporated VRTX is due to issue its quarterly earnings report in
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharmaceuticals Inc. Q1 Profit Advances 352%,2017-04-27 16:06:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JAznq4qmhBc/vertex-pharmaceuticals-inc-q1-profit-advances-352-20170427-01962,Vertex Pharmaceuticals Inc. Q1 Profit Advances 352%
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharmaceuticals Q1 17 Earnings Conference Call At 4:30 PM ET,2017-04-27 15:04:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8ccsiIHzdSQ/vertex-pharmaceuticals-q1-17-earnings-conference-call-at-430-pm-et-20170427-01776,Vertex Pharmaceuticals Q1 17 Earnings Conference Call At 4:30 PM ET
VRTX,VRTX:UW,BBG000C1SD31,Vertex Reports Late Thursday: Cystic Fibrosis Treatment In Spotlight,2017-04-26 20:01:04 +0000,http://finance.yahoo.com/r/7ab9a026-6f9e-3e05-a245-6cd5237e25fc/vertex-reports-late-wednesday-cystic-fibrosis-doublet-in-spotlight?src=A00220&yptr=yahoo&.tsrc=rss,Vertex investors will key in for more data on cystic fibrosis drugs late Wednesday when the No. 6 biotech by market cap is set to report first-quarter earnings.
VRTX,VRTX:UW,BBG000C1SD31,What's in Store for Nivalis (NVLS) this Earnings Season?,2017-04-26 17:07:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IqxT3MFSeBI/whats-in-store-for-nivalis-nvls-this-earnings-season-cm779678,Nivalis Therapeutics Inc NVLS is expected to report first quarter 2017 results early next month Last quarter the company had a positive surprise of 9 09 Year to date Nivalis shares lost 4 while the Zacks classified Medical Drugs industry recorded an increase of 2
VRTX,VRTX:UW,BBG000C1SD31,Time for Big Cap Biotech,2017-04-26 16:14:00 +0000,http://finance.yahoo.com/r/a98dc061-b9cb-3414-8a5c-1d0ab92d0e01/time-big-cap-biotech-celg-vrtx?partner=YahooSA&yptr=yahoo&.tsrc=rss,The biotech sector is gaining ground after strong first quarter earnings and could finally be headed into a major recovery.
VRTX,VRTX:UW,BBG000C1SD31,"Notable ETF Inflow Detected - XBI, VRTX, BIVV, NBIX",2017-04-26 16:03:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Rk4xjwcSoew/notable-etf-inflow-detected-xbi-vrtx-bivv-nbix-cm779482,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the SPDR S amp P Biotech ETF Symbol XBI where we have detected an approximate 264 9 million dollar inflow that s a 8 9 increase week over week in outstanding
VRTX,VRTX:UW,BBG000C1SD31,What&apos;s in Store for Nivalis (NVLS) this Earnings Season?,2017-04-26 14:30:02 +0000,http://finance.yahoo.com/news/apos-store-nivalis-nvls-earnings-143002589.html?.tsrc=rss,"Nivalis Therapeutics, Inc. (NVLS) is expected to report first-quarter 2017 results early next month. Last quarter, the company had a positive surprise of 9.09%."
VRTX,VRTX:UW,BBG000C1SD31,"Biotech Stock Roundup: Biogen Gains on Strong Q1, NASH Data on Gilead Drug",2017-04-26 14:07:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/z8kcvhvq52c/biotech-stock-roundup-biogen-gains-on-strong-q1-nash-data-on-gilead-drug-cm779308,Earnings season for the biotech sector is off to a promising start with Biogen BIIB reporting better than expected first quarter results While focus remained on Biogen s results companies like Gilead GILD were also in the news on the presentation of pipeline data Recap of the Week s
VRTX,VRTX:UW,BBG000C1SD31,What's in Store for Vertex (VRTX) this Earnings Season?,2017-04-24 17:07:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/krnlnHozsVA/whats-in-store-for-vertex-vrtx-this-earnings-season-cm777990,Vertex Pharmaceuticals Inc VRTX is scheduled to report first quarter 2017 results on Apr 27 after the market closes Year to date Vertex s shares rose 58 4 while the Zacks classified Medical Biomed Genetics industry recorded an increase of 1 8 Vertex s track record
VRTX,VRTX:UW,BBG000C1SD31,3 Healthcare Bargain Stocks You Can Buy Right Now,2017-04-24 15:05:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/326XG6hRErs/3-healthcare-bargain-stocks-you-can-buy-right-now-cm777775,You might have heard that stock market is way overpriced And by several metrics that statement is true In particular the cyclically adjusted price to earnings CAPE ratio popularized by economist Robert Shiller is higher than it s been since 2002 That was a period when reason
VRTX,VRTX:UW,BBG000C1SD31,What&apos;s in Store for Vertex (VRTX) this Earnings Season?,2017-04-24 14:34:02 +0000,http://finance.yahoo.com/news/apos-store-vertex-vrtx-earnings-143402167.html?.tsrc=rss,"Vertex Pharmaceuticals, Inc. (VRTX) is scheduled to report first-quarter 2017 results on Apr 27, after the market closes."
VRTX,VRTX:UW,BBG000C1SD31,3 Healthcare Bargain Stocks You Can Buy Right Now,2017-04-24 13:42:00 +0000,http://finance.yahoo.com/r/9ce0c003-8946-330b-8e0f-3dd31c5c5922/3-healthcare-bargain-stocks-you-can-buy-right-now.aspx?yptr=yahoo&.tsrc=rss,"Allergan, Express Scripts, and Vertex stocks look attractive in a generally overpriced market."
VRTX,VRTX:UW,BBG000C1SD31,3 Stocks That Growth Investors Should Love,2017-04-23 17:03:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-8DunDjcPMc/3-stocks-that-growth-investors-should-love-cm777595,If you re a growth investor you love revenue growth You love earnings growth And most of all you love share price growth There are three stocks that should check off all of these boxes in the days ahead Celgene NASDAQ CELG Ionis Pharmaceuticals NASDAQ IONS
VRTX,VRTX:UW,BBG000C1SD31,3 Stocks That Growth Investors Should Love,2017-04-23 15:01:00 +0000,http://finance.yahoo.com/r/2fceb37f-e2ae-3054-b3cb-31e9d6321287/3-stocks-that-growth-investors-should-love.aspx?yptr=yahoo&.tsrc=rss,"Impressive growth could be in store for biotech stocks Celgene, Ionis, and Vertex."
VRTX,VRTX:UW,BBG000C1SD31,Trump invites ​Vertex CEO to White House for biotech summit,2017-04-21 20:45:07 +0000,http://finance.yahoo.com/r/d02ea40a-45d0-371e-be55-688bba40bcf8/trump-invites-vertex-ceo-to-white-house-for.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Vertex Pharmaceuticals CEO Jeffrey Leiden is among a group of pharmaceutical executives that have reportedly been invited to meet with top officials from the Trump Administration next month to discuss issues facing the industry — a sign of the Boston drugmaker’s growing clout.  The planned May 8 meeting at the White House was reported by Bloomberg News on Friday afternoon .  A spokesperson for Vertex (VRTX), one of the largest drug companies based in Massachusetts, confirmed that Leiden has been invited to the summit, but declined to say whether he will attend."
VRTX,VRTX:UW,BBG000C1SD31,​Vertex at odds with religious investors over lobbying disclosures,2017-04-18 23:44:14 +0000,http://finance.yahoo.com/r/2f1bd99d-62f8-3cd0-b501-1b28adce9960/vertex-at-odds-with-religious-investors-over.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Two religious organizations that own shares of Vertex Pharmaceuticals are pushing the Boston drugmaker to disclose more information about its lobbying on drug pricing and other hot-button issues, an effort that the company opposes.  Vertex (VRTX) said in a federal filing Monday that it will ask shareholders to reject the measure during its annual meeting in June.  The measure would require Vertex to disclose how much it spends on lobbying at the local, state and federal levels, including payments it makes to trade groups and spending on “grassroots” communications that seek to shape public opinion on policy issues."
VRTX,VRTX:UW,BBG000C1SD31,"Zacks.com featured highlights: PTC, Covanta Holding, Live Nation Entertainment, Incyte and Vertex Pharmaceuticals",2017-04-18 15:06:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8-o62rlcW5Q/zackscom-featured-highlights-ptc-covanta-holding-live-nation-entertainment-incyte-and-vertex-pharmaceuticals-cm775270,For Immediate Release Chicago IL April 18 2017 Stocks in this week s article include 160 PTC Inc NASDAQ PTC Free Report Covanta Holding Corporation NYSE CVA Free Report Live Nation Entertainment Inc NYSE LYV Free Report Incyte Corporation
VRTX,VRTX:UW,BBG000C1SD31,"XBI, VRTX, BIVV, EXEL: Large Inflows Detected at ETF",2017-04-18 15:04:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/T8E0Q3cUf7c/xbi-vrtx-bivv-exel-large-inflows-detected-at-etf-cm775227,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the SPDR S amp P Biotech ETF Symbol XBI where we have detected an approximate 72 2 million dollar inflow that s a 2 6 increase week over week in outstanding
VRTX,VRTX:UW,BBG000C1SD31,"Zacks.com featured highlights: PTC, Covanta Holding, Live Nation Entertainment, Incyte and Vertex Pharmaceuticals",2017-04-18 13:30:01 +0000,http://finance.yahoo.com/news/zacks-com-featured-highlights-ptc-133001850.html?.tsrc=rss,"Zacks.com featured highlights: PTC, Covanta Holding, Live Nation Entertainment, Incyte and Vertex Pharmaceuticals"
VRTX,VRTX:UW,BBG000C1SD31,"​Vertex CEO's compensation, stock value fell in 2016",2017-04-17 20:50:12 +0000,http://finance.yahoo.com/r/19c4f14a-0c4e-3920-82cf-6d8153f19c67/vertex-ceos-compensation-stock-value-fell-in-2016.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Boston-based Vertex (VRTX), one of the largest life science firms in the state, said in a federal filing on Monday that CEO Jeff Leiden had earned $17.4 million in total compensation and realized an additional $1.8 million in value from the vesting of restricted stock that he received in prior years.  Leiden has led Vertex since 2012, when the company secured FDA approval for Kalydeco, the first drug to treat the underlying cause of cystic fibrosis.  Its other approved drug for cystic fibrosis, Orkambi, was launched in the U.S. in 2015."
VRTX,VRTX:UW,BBG000C1SD31,5 Toxic Stocks to Shun or Play Short Right Now,2017-04-17 14:58:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bB9mz-COcVY/5-toxic-stocks-to-shun-or-play-short-right-now-cm774537,Successful investing calls for the appropriate identification of overpriced stocks and correctly priced stocks However in practice the overhyped toxic stocks and the fairly priced stocks are intermixed in the marketplace in such a way that it becomes difficult to distinguish between
VRTX,VRTX:UW,BBG000C1SD31,Retirement Accounts Benefit From Columbia Fund's Tech Bets,2017-04-13 22:53:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2igfF-xmqwA/retirement-accounts-benefit-from-columbia-funds-tech-bets-cm774049,Just as an ace baseball pitcher mixes his throws top mutual fund managers vary their investments Managers of Columbia Large Cap Growth Fund are mingling semiconductor stocks with biotech stocks online travel agencies and a Chinese fast food chain all to good effect That s been
VRTX,VRTX:UW,BBG000C1SD31,"Top Research Reports for Today: MSFT, BLK, NOC",2017-04-13 21:54:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/P7PSyQaqw3s/top-research-reports-for-today-msft-blk-noc-cm774106,Thursday April 13 2017 Today s Research Daily features new research reports on 16 major stocks including Microsoft MSFT BlackRock BLK and Northrop Grumman NOC Microsoft shares lagged the Zacks Tech sector through the fall but have led the way over the last six months up 13
VRTX,VRTX:UW,BBG000C1SD31,Retirement Accounts Benefit From Columbia Fund&apos;s Tech Bets,2017-04-13 20:45:03 +0000,http://finance.yahoo.com/r/999fddd8-d5ea-3838-947b-857e7b4c0e90/retirement-accounts-benefit-from-columbia-funds-tech-bets?src=A00220A&yptr=yahoo&.tsrc=rss,"Just as an ace baseball pitcher mixes his throws, top mutual fund managers vary their investments."
VRTX,VRTX:UW,BBG000C1SD31,Vertex to Announce First Quarter 2017 Financial Results on April 27,2017-04-12 20:01:00 +0000,http://finance.yahoo.com/news/vertex-announce-first-quarter-2017-200100813.html?.tsrc=rss,"Vertex Pharmaceuticals Incorporated will report its first quarter 2017 financial results on Thursday, April 27, 2017 after the financial markets close. The company will host a conference call and webcast at 4:30 p.m."
VRTX,VRTX:UW,BBG000C1SD31,"Biotech Stock Roundup: Geron Gains on Interim Data, OncoMed Slumps on Pipeline Setback",2017-04-12 13:58:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BQjIj_WyhI0/biotech-stock-roundup-geron-gains-on-interim-data-oncomed-slumps-on-pipeline-setback-cm773101,Several companies including Geron GERN and OncoMed OMED provided key pipeline updates this week While Geron s shares were up this week OncoMed s shares plunged and hit a 52 week low Recap of the Week s Most Important Stories Geron Up on Interim Data Geron s shares were up 19
VRTX,VRTX:UW,BBG000C1SD31,TherapeuticsMD Falls on Likely Delay in TX-004HR Approval,2017-04-12 13:57:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uyvOOVBQTw0/therapeuticsmd-falls-on-likely-delay-in-tx-004hr-approval-cm773181,Shares of TherapeuticsMD Inc TXMD have declined almost 25 since Monday when it received a letter from the FDA identifying deficiencies in the new drug application NDA for its dyspareunia drug TX 400HR filed last July The company s shares have slightly underperformed the Zacks
VRTX,VRTX:UW,BBG000C1SD31,Protalix Cystic Fibrosis Drug Study Results Worsen Over Time,2017-04-12 13:20:00 +0000,http://finance.yahoo.com/r/d9638806-1fa6-3279-92e1-917019973a55/protalix-cystic-fibrosis-drug-study-results-worsen-over-time.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,The Protalix medicine alidornase alfa is designed to help cystic fibrosis patients clear their lungs by making mucus thin and loose.
VRTX,VRTX:UW,BBG000C1SD31,3 Best Performing Stocks in March,2017-04-10 16:42:00 +0000,http://finance.yahoo.com/r/214dfec8-61ab-362b-8a70-40534d294746/3-best-performing-stocks-in-march.aspx?yptr=yahoo&.tsrc=rss,"Find out why Micron Technology, FMC Corporation, and Vertex Pharmaceuticals were the best-performing stocks from the S&P 500 last month."
VRTX,VRTX:UW,BBG000C1SD31,What's Next for Corbus Pharmaceuticals After Its Controversial Cystic Fibrosis Results?,2017-04-08 16:54:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nd6gNoD_88k/whats-next-for-corbus-pharmaceuticals-after-its-controversial-cystic-fibrosis-results-cm771767,Last week Corbus Pharmaceuticals NASDAQ CRBP reported positive top line data from a phase 2 study evaluating anabasum in treating cystic fibrosis CF At least the company said the data was positive Some observers disagreed saying that the results actually weren t so
VRTX,VRTX:UW,BBG000C1SD31,What&apos;s Next for Corbus Pharmaceuticals After Its Controversial Cystic Fibrosis Results?,2017-04-08 15:41:00 +0000,http://finance.yahoo.com/r/75765c5d-8505-3c46-ac25-e62c8fe5135b/whats-next-for-corbus-pharmaceuticals-after-its-co.aspx?yptr=yahoo&.tsrc=rss,What&apos;s next for Corbus after its controversial cystic fibrosis study results?
VRTX,VRTX:UW,BBG000C1SD31,"Friday Sector Leaders: Healthcare, Financial",2017-04-07 19:54:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FL1fQ0M-eJY/friday-sector-leaders-healthcare-financial-cm771571,In afternoon trading on Friday Healthcare stocks are the best performing sector up 0 4 Within the sector Incyte Corporation Symbol INCY and Vertex Pharmaceuticals Inc Symbol VRTX are two large stocks leading the way showing a gain of 3 0 and 2 8 respectively Among healthcare
VRTX,VRTX:UW,BBG000C1SD31,"The Zacks Analyst Blog Highlights: Esperion Therapeutics, Vertex Pharmaceuticals, Nektar Therapeutics, Argos Therapeutics and Cidara Therapeutics",2017-04-07 15:58:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xA5cxlOjouo/the-zacks-analyst-blog-highlights-esperion-therapeutics-vertex-pharmaceuticals-nektar-therapeutics-argos-therapeutics-and-cidara-therapeutics-cm771409,For Immediate Release Chicago IL April 07 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
VRTX,VRTX:UW,BBG000C1SD31,3 Great Stocks on Sale to Buy Today,2017-04-07 14:57:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NOJhU2raotU/3-great-stocks-on-sale-to-buy-today-cm771331,Warren Buffett is noted for saying It s far better to buy a wonderful company at a fair price than a fair company at a wonderful price to which we might add it s even better to buy wonderful companies at wonderful prices We ve tasked three Motley Fool contributors to come up
VRTX,VRTX:UW,BBG000C1SD31,"The Zacks Analyst Blog Highlights: Esperion Therapeutics, Vertex Pharmaceuticals, Nektar Therapeutics, Argos Therapeutics and Cidara Therapeutics",2017-04-07 13:30:01 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-esperion-133001625.html?.tsrc=rss,"The Zacks Analyst Blog Highlights: Esperion Therapeutics, Vertex Pharmaceuticals, Nektar Therapeutics, Argos Therapeutics and Cidara Therapeutics"
VRTX,VRTX:UW,BBG000C1SD31,3 Great Stocks on Sale to Buy Today,2017-04-07 13:11:00 +0000,http://finance.yahoo.com/r/b87295f4-f389-3c3d-a584-4af430f7b641/43-rt-3-great-stocks-on-sale-to-buy-today.aspx?yptr=yahoo&.tsrc=rss,Finding great companies at a great price is an opportunity not to be missed.
VRTX,VRTX:UW,BBG000C1SD31,15 companies with outsized sales growth and widening profit margins,2017-04-07 12:33:42 +0000,http://finance.yahoo.com/r/7d0ee165-d660-3f82-819c-525f80e5f731/Story.aspx?guid=A48F789E-1877-11E7-ACE9-1B88A12ADC17&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Biotechnology and technology companies figure prominently on the latest Deep Dive list, writes Phil van Doorn."
VRTX,VRTX:UW,BBG000C1SD31,3 Top Stocks to Buy in Q2,2017-04-06 21:54:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HJG9bRjA5Ak/3-top-stocks-to-buy-in-q2-cm771069,if you re looking for new stocks to add to your portfolio now then it might be time to consider why this could be the perfect time to be a buyer of Constellation Brands NYSE STZ Cabot Oil amp Gas NYSE COG and Vertex Pharmaceuticals NASDAQ VRTX These
VRTX,VRTX:UW,BBG000C1SD31,"Noteworthy Thursday Option Activity: VRTX, ENR, PSMT",2017-04-06 20:53:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KPMUxBhLEEQ/noteworthy-thursday-option-activity-vrtx-enr-psmt-cm771034,Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in Vertex Pharmaceuticals Inc Symbol VRTX where a total of 21 245 contracts have traded so far representing approximately 2 1 million underlying shares That amounts to about 89 7
VRTX,VRTX:UW,BBG000C1SD31,3 Top Stocks to Buy in Q2,2017-04-06 20:21:00 +0000,http://finance.yahoo.com/r/babef887-bbc9-341f-ae3a-c02cf78fe626/3-top-stocks-to-buy-in-q2.aspx?yptr=yahoo&.tsrc=rss,"Constellation Brands, Cabot Oil & Gas, and Vertex Pharmaceuticals have catalysts that could make now the right time to add them to portfolios."
VRTX,VRTX:UW,BBG000C1SD31,"Greenbrier And Vertex Maintain Bullish Bias, Stamps.com Breaking Down",2017-04-06 18:30:00 +0000,http://finance.yahoo.com/r/9cec0907-8f55-3ca7-9d58-90cb96a15ab2/greenbrier-and-vertex-maintain-bullish-bias-stamps-com-breaking-down?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,"While there are still stocks with strong technical momentum, market weakness has us looking at stocks poised for downside moves."
VRTX,VRTX:UW,BBG000C1SD31,Stocks To Watch In Market Weakness,2017-04-06 17:49:04 +0000,http://finance.yahoo.com/news/stocks-watch-market-weakness-174904840.html?.tsrc=rss,"While there are still stocks with strong technical momentum, market weakness has us looking at charts poised for downside moves. Stamps.com Inc. (NASDAQ: STMP ) broke down on Wednesday, falling $3.35 to ..."
VRTX,VRTX:UW,BBG000C1SD31,Stocks to Watch in Market Weakness,2017-04-06 17:45:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RLZwtr0pdFI/stocks-to-watch-in-market-weakness-cm770952,"By Harry Boxer   While there are still stocks with strong technical momentum, market weakness has us looking at charts poised for downside moves.   Stamps.com  Inc. ( STMP ) broke down on Wednesday, falling $3.35 to $112.85 on no news.  The stock, which broke down from a long-term up-channel last month, had been"
VRTX,VRTX:UW,BBG000C1SD31,Harry Boxer’s four stocks to watch,2017-04-06 16:51:59 +0000,http://finance.yahoo.com/r/b53de729-b2a2-3ae1-b32a-fded09379709/Story.aspx?guid=E5F09D0A-1AE7-11E7-A49C-FC6A226FDFDD&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"In focus: GBX, VRTX, CATM and UBNT."
VRTX,VRTX:UW,BBG000C1SD31,3 of the Best & Worst Performing Drug Stocks of Q1,2017-04-06 15:58:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bAYQLXpLoNg/3-of-the-best-worst-performing-drug-stocks-of-q1-cm770818,After a tough and challenging 2016 pharma and biotech stocks have been showing signs of recovery this year The sector started the year on a strong note with the NASDAQ Biotechnology Index and the NYSE ARCA Pharmaceutical Index gaining 10 7 and 5 7 respectively in the first quarter of
VRTX,VRTX:UW,BBG000C1SD31,"Vertex Pharmaceuticals (VRTX) Shares March Higher, Can It Continue?",2017-04-06 15:58:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mNNkTjLC4KU/vertex-pharmaceuticals-vrtx-shares-march-higher-can-it-continue-cm770807,As of late it has definitely been a great time to be an investor in Vertex Pharmaceuticals Incorporated VRTX The stock has moved higher by 22 9 in the past month while it is also above its 20 Day SMA too This combination of strong price performance and favorable technical could
VRTX,VRTX:UW,BBG000C1SD31,"Vertex Pharmaceuticals (VRTX) Shares March Higher, Can It Continue?",2017-04-06 13:40:01 +0000,http://finance.yahoo.com/news/vertex-pharmaceuticals-vrtx-shares-march-134001356.html?.tsrc=rss,"As of late, it has definitely been a great time to be an investor in Vertex Pharmaceuticals Incorporated (VRTX)."
VRTX,VRTX:UW,BBG000C1SD31,3 of the Best & Worst Performing Drug Stocks of Q1,2017-04-06 13:32:01 +0000,http://finance.yahoo.com/news/3-best-worst-performing-drug-133201082.html?.tsrc=rss,Here is a look at 3 of the best and worst-performing drug stocks in the first quarter of 2017.
VRTX,VRTX:UW,BBG000C1SD31,Is Vertex Pharmaceuticals the Best Biotech Stock?,2017-04-05 20:55:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/85UbbGt7lQY/is-vertex-pharmaceuticals-the-best-biotech-stock-cm770384,Growing demand for its cystic fibrosis drugs suggests Vertex Pharmaceuticals NASDAQ VRTX 160 could be on the cusp of consistent profitability and if so then investors might be wise to add it to growth portfolios especially now that the company has announced positive late
VRTX,VRTX:UW,BBG000C1SD31,Is Vertex Pharmaceuticals the Best Biotech Stock?,2017-04-05 19:42:00 +0000,http://finance.yahoo.com/r/41c9cd39-ed2e-3db9-87c7-8000d6a79e8f/is-vertex-pharmaceuticals-the-best-biotech-stock.aspx?yptr=yahoo&.tsrc=rss,News that could significantly expand sales as soon as next year could propel this company&apos;s shares to new highs.
VRTX,VRTX:UW,BBG000C1SD31,"Amgen Files for Xgeva Label Expansion, To Include Myeloma",2017-04-05 16:55:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gkx8_sYWCNc/amgen-files-for-xgeva-label-expansion-to-include-myeloma-cm770231,Amgen Inc AMGN recently announced that it has submitted a supplemental Biologics License Application sBLA to the FDA to expand the label of its key drug Xgeva Xgeva is currently approved for the prevention of skeletal related events SREs in solid tumors in patients with bone
VRTX,VRTX:UW,BBG000C1SD31,"Biotech Stock Roundup: Acorda Down on Court Ruling, Patent Challenge for CELG Drug",2017-04-05 15:27:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/diUoDB06kec/biotech-stock-roundup-acorda-down-on-court-ruling-patent-challenge-for-celg-drug-cm770134,Quite a few companies provided patent related updates this week Meanwhile Paratek s PRTK shares soared on positive late stage data Recap of the Week s Most Important Stories Acorda Slumps on Court Ruling Acorda ACOR suffered a big setback in a patent infringement lawsuit for
VRTX,VRTX:UW,BBG000C1SD31,"Amgen Files for Xgeva Label Expansion, To Include Myeloma",2017-04-05 15:20:03 +0000,http://finance.yahoo.com/news/amgen-files-xgeva-label-expansion-152003687.html?.tsrc=rss,"Amgen, Inc. (AMGN) recently announced that it has submitted a supplemental Biologics License Application (sBLA) to the FDA to expand the label of its key drug, Xgeva."
VRTX,VRTX:UW,BBG000C1SD31,Why Vertex Pharmaceuticals Rocketed 21.1% Higher in March,2017-04-05 00:23:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mUSweftTMHs/why-vertex-pharmaceuticals-rocketed-211-higher-in-march-cm769922,What happened After the company reported compelling results from a late stage trial for a combination therapy for use in cystic fibrosis patients shares in Vertex Pharmaceuticals NASDAQ VRTX skyrocketed 21 1 in March 160 according to S amp P Global Market
VRTX,VRTX:UW,BBG000C1SD31,5 Stocks that Outperformed the S&P 500 in Q1,2017-04-05 00:23:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yqFUI9FLICY/5-stocks-that-outperformed-the-sp-500-in-q1-cm769918,We have just crossed the first quarter of 2017 and now is possibly the best time to take a look at the past three months The January March quarter was quite impressive courtesy of better economic conditions bullish earnings forecasts and optimism over the Trump s policies
VRTX,VRTX:UW,BBG000C1SD31,Why Vertex Pharmaceuticals Rocketed 21.1% Higher in March,2017-04-04 22:21:00 +0000,http://finance.yahoo.com/r/9b50977e-1ab1-32b9-a03a-99e5dcf1cfe4/why-vertex-pharmaceuticals-rocketed-21-higher-in.aspx?yptr=yahoo&.tsrc=rss,Positive trial data that could lead to its drugs treating more cystic fibrosis patients stoked investors&apos; optimism.
VRTX,VRTX:UW,BBG000C1SD31,5 Stocks that Outperformed the S&P 500 in Q1,2017-04-04 21:48:09 +0000,http://finance.yahoo.com/news/5-stocks-outperformed-p-500-214809723.html?.tsrc=rss,First quarter was quite impressive and we have selected five top-ranked stocks that surpassed the S&P 500 index during the period.
VRTX,VRTX:UW,BBG000C1SD31,5 Stocks that Chaperoned Nasdaq to Double-Digit Gains in Q1,2017-04-04 21:23:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9QOZxIoGjw4/5-stocks-that-chaperoned-nasdaq-to-double-digit-gains-in-q1-cm769821,The stock market experienced strong gains in the first quarter of 2017 courtesy of positive economic data rate hike prospects earnings growth and bullish forecasts along with buoyancy over the Trump administration s policy initiatives The Dow and the S amp P 500 gained 4 6 and 5
VRTX,VRTX:UW,BBG000C1SD31,Sanofi's (SNY) Diabetes Drug Toujeo Lowers Hypoglycemia Risk,2017-04-04 15:28:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/d-0yAyv1_-I/sanofis-sny-diabetes-drug-toujeo-lowers-hypoglycemia-risk-cm769559,Sanofi SNY presented data from a real world observational study which showed that when type 2 diabetes patients on basal insulin switched to its diabetes drug Toujeo it led to a significant reduction in risk of hypoglycemia without compromising blood sugar control The study compared
VRTX,VRTX:UW,BBG000C1SD31,Sanofi&apos;s (SNY) Diabetes Drug Toujeo Lowers Hypoglycemia Risk,2017-04-04 13:19:01 +0000,http://finance.yahoo.com/news/sanofi-apos-sny-diabetes-drug-131901719.html?.tsrc=rss,"A real-world observational study showed that when type 2 diabetes patients on basal insulin switched to Toujeo, it led to a significant reduction in risk of hypoglycemia without compromising blood sugar control"
VRTX,VRTX:UW,BBG000C1SD31,"The Zacks Analyst Blog Highlights: Disney, Texas Instruments, Lockheed Martin, Bank of New York Mellon and Vertex Pharmaceuticals",2017-04-03 15:39:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wXpeu6F2ShU/the-zacks-analyst-blog-highlights-disney-texas-instruments-lockheed-martin-bank-of-new-york-mellon-and-vertex-pharmaceuticals-cm769032,For Immediate Release Chicago IL April 03 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
VRTX,VRTX:UW,BBG000C1SD31,AstraZeneca's (AZN) Lung Cancer Drug Gets Full FDA Approval,2017-04-03 15:38:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pOSu7ntj5Rs/astrazenecas-azn-lung-cancer-drug-gets-full-fda-approval-cm769010,AstraZeneca plc AZN announced that its lung cancer drug Tagrisso has received full approval from the FDA We remind investors that Tagrisso had earlier received accelerated approval in 2015 The approval of the drug will help it to become a standard for the treatment of EGFR
VRTX,VRTX:UW,BBG000C1SD31,Which Companies Are Now Outperforming 95% Of All Stocks?,2017-04-03 15:05:39 +0000,http://www.investors.com/ibd-data-stories/companies-now-outperforming-95-of-all-stocks/?src=A00220A,Which Companies Are Now Outperforming 95% Of All Stocks?
VRTX,VRTX:UW,BBG000C1SD31,AstraZeneca's (AZN) Lung Cancer Drug Gets Full FDA Approval,2017-04-03 13:50:01 +0000,http://finance.yahoo.com/news/astrazenecas-azn-lung-cancer-drug-135001105.html,AstraZeneca's (AZN) Lung Cancer Drug Gets Full FDA Approval
VRTX,VRTX:UW,BBG000C1SD31,AstraZeneca's (AZN) Lung Cancer Drug Gets Full FDA Approval,2017-04-03 13:50:01 +0000,http://finance.yahoo.com/news/astrazenecas-azn-lung-cancer-drug-135001105.html?.tsrc=rss,"AstraZeneca plc (AZN) announced that its lung cancer drug, Tagrisso has received full approval from the FDA."
VRTX,VRTX:UW,BBG000C1SD31,"The Zacks Analyst Blog Highlights: Disney, Texas Instruments, Lockheed Martin, Bank of New York Mellon and Vertex Pharmaceuticals",2017-04-03 13:30:01 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-disney-133001887.html,"The Zacks Analyst Blog Highlights: Disney, Texas Instruments, Lockheed Martin, Bank of New York Mellon and Vertex Pharmaceuticals"
VRTX,VRTX:UW,BBG000C1SD31,"The Zacks Analyst Blog Highlights: Disney, Texas Instruments, Lockheed Martin, Bank of New York Mellon and Vertex Pharmaceuticals",2017-04-03 13:30:01 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-disney-133001887.html?.tsrc=rss,"The Zacks Analyst Blog Highlights: Disney, Texas Instruments, Lockheed Martin, Bank of New York Mellon and Vertex Pharmaceuticals"
VRTX,VRTX:UW,BBG000C1SD31,3 Big Healthcare Stocks That Wall Street Predicts Will Grow the Fastest,2017-04-02 13:36:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xMTfLAR3uI4/3-big-healthcare-stocks-that-wall-street-predicts-will-grow-the-fastest-cm768773,Rapid earnings growth typically translates to higher stock prices But can big healthcare stocks grow earnings and presumably share prices at impressive levels 160 Wall Street thinks so Analysts ranked Vertex Pharmaceuticals NASDAQ VRTX Incyte NASDAQ INCY
VRTX,VRTX:UW,BBG000C1SD31,3 Big Healthcare Stocks That Wall Street Predicts Will Grow the Fastest,2017-04-02 11:41:00 +0000,https://www.fool.com/investing/2017/04/02/3-big-healthcare-stocks-that-wall-street-predicts.aspx,3 Big Healthcare Stocks That Wall Street Predicts Will Grow the Fastest
VRTX,VRTX:UW,BBG000C1SD31,3 Big Healthcare Stocks That Wall Street Predicts Will Grow the Fastest,2017-04-02 11:41:00 +0000,http://finance.yahoo.com/r/9ff0e68c-2cbc-3615-91f1-ef72b98e3e44/3-big-healthcare-stocks-that-wall-street-predicts.aspx?yptr=yahoo&.tsrc=rss,"Vertex Pharmaceuticals, Incyte, and Celgene could be headed for tremendous growth if Wall Street's projections are on target."
VRTX,VRTX:UW,BBG000C1SD31,The 5 Best Performing S&P 500 Stocks for Q1,2017-04-01 13:15:03 +0000,http://finance.yahoo.com/news/5-best-performing-p-500-131503996.html,The 5 Best Performing S&P 500 Stocks for Q1
VRTX,VRTX:UW,BBG000C1SD31,The 5 Best Performing S&P 500 Stocks for Q1,2017-04-01 13:15:03 +0000,http://finance.yahoo.com/news/5-best-performing-p-500-131503996.html?.tsrc=rss,"The first quarter's top-performing stocks in the S&P 500 index included two pharmaceutical firms, an electricity generator, a video game maker and a media company."
VRTX,VRTX:UW,BBG000C1SD31,"Top Research Reports for Today: DIS, TXN, LMT",2017-03-31 22:58:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lkCCM-ZLm7c/top-research-reports-for-today-dis-txn-lmt-cm768605,Friday March 31 2017 Today s Research Daily features new research reports on 16 major stocks including Disney DIS Texas Instruments TXN and Lockheed Martin LMT Disney shares have outperformed the Zacks Media Conglomerates sector over the past six months gaining 22 4 vs 19
VRTX,VRTX:UW,BBG000C1SD31,First Quarter Wrap: The Top 10 Stocks (You'll Never Guess Who's Number One),2017-03-31 21:16:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/31/first-quarter-wrap-the-top-10-stocks/?mod=yahoobarrons&ru=yahoo,First Quarter Wrap: The Top 10 Stocks (You'll Never Guess Who's Number One)
VRTX,VRTX:UW,BBG000C1SD31,"Market Close Report: NASDAQ Composite index closes at 5,911.74 down -2.60 points",2017-03-31 20:48:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NGlxoLyssYw/market-close-report-nasdaq-composite-index-closes-at-591174-down-260-points-cm768554,Friday s session closes with the NASDAQ Composite Index at 5 911 74 The total shares traded for the NASDAQ was over 2 18 billion Friday s session closes with the NASDAQ Composite Index at 5 911 74 The total shares traded for the NASDAQ was over 2 18 billion Advancers stocks led declining by 1
VRTX,VRTX:UW,BBG000C1SD31,AbbVie's (ABBV) Humira Drug Label Update Approved by FDA,2017-03-31 15:03:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ijmGdjs2Nd0/abbvies-abbv-humira-drug-label-update-approved-by-fda-cm768272,AbbVie Inc s ABBV announced that the FDA has approved the inclusion of moderate to severe fingernail psoriasis data on the label of AbbVie s multi utility TNF blocker drug Humira With this approval Humira becomes the first and the only drug to include data on fingernail psoriasis in
VRTX,VRTX:UW,BBG000C1SD31,Can Vertex Keep Climbing?,2017-03-31 13:43:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/31/can-vertex-keep-climbing/?mod=yahoobarrons&ru=yahoo,Can Vertex Keep Climbing?
VRTX,VRTX:UW,BBG000C1SD31,AbbVie's (ABBV) Humira Drug Label Update Approved by FDA,2017-03-31 12:41:12 +0000,http://finance.yahoo.com/news/abbvies-abbv-humira-drug-label-124112552.html,AbbVie's (ABBV) Humira Drug Label Update Approved by FDA
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharma upgraded by Maxim Group,2017-03-31 11:47:48 +0000,http://finance.yahoo.com/q/ud?s=VRTX,Vertex Pharma upgraded by Maxim Group
VRTX,VRTX:UW,BBG000C1SD31,Corbus Pharma Drug Shows No Clinical Benefit for Cystic Fibrosis Patients,2017-03-31 00:30:00 +0000,https://www.thestreet.com/story/14065618/1/corbus-pharma-drug-shows-no-clinical-benefit-for-cystic-fibrosis-patients.html?puc=yahoo&cm_ven=YAHOO,Corbus Pharma Drug Shows No Clinical Benefit for Cystic Fibrosis Patients
VRTX,VRTX:UW,BBG000C1SD31,Vetr Turns Bearish On Vertex After Drug Trial Success,2017-03-30 21:04:04 +0000,http://finance.yahoo.com/news/vetr-turns-bearish-vertex-drug-210404579.html,Vetr Turns Bearish On Vertex After Drug Trial Success
VRTX,VRTX:UW,BBG000C1SD31,"Why ""Positive"" Data Knocked Down Corbus Pharmaceuticals Holdings Inc Today",2017-03-30 17:08:00 +0000,https://www.fool.com/investing/2017/03/30/why-positive-data-knocked-down-corbus-pharmaceutic.aspx,"Why ""Positive"" Data Knocked Down Corbus Pharmaceuticals Holdings Inc Today"
VRTX,VRTX:UW,BBG000C1SD31,"Company News for March 30, 2017",2017-03-30 16:01:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5Y-RHYDmwLw/company-news-for-march-30-2017-cm767718,Shares of Restoration Hardware RH increased 15 0 after reporting its adjusted fourth quarter profit of 0 68 per share beating Zacks Consensus Estimate of a 0 65 per share Dave amp Buster s Entertainment Inc s PLAY shares declined 3 4 after posting fiscal fourth
VRTX,VRTX:UW,BBG000C1SD31,No. 5-Ranked Biotech Bolts Higher On Drug Results,2017-03-30 15:03:36 +0000,http://www.investors.com/ibd-data-stories/no-5-ranked-biotech-bolts-higher-on-drug-results/?src=A00220A,No. 5-Ranked Biotech Bolts Higher On Drug Results
VRTX,VRTX:UW,BBG000C1SD31,Vertex: 'Calling Results Strong Does Not Make Them So',2017-03-30 14:14:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/30/vertex-calling-results-strong-does-not-make-them-so/?mod=yahoobarrons&ru=yahoo,Vertex: 'Calling Results Strong Does Not Make Them So'
VRTX,VRTX:UW,BBG000C1SD31,VRTX Crosses Above Average Analyst Target,2017-03-30 14:10:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_7Ji9NKxjV0/vrtx-crosses-above-average-analyst-target-cm767607,In recent trading shares of Vertex Pharmaceuticals Inc Symbol VRTX have crossed above the average analyst 12 month target price of 104 27 changing hands for 108 01 share When a stock reaches the target an analyst has set the analyst logically has two ways to react downgrade
VRTX,VRTX:UW,BBG000C1SD31,"Company News for March 30, 2017",2017-03-30 14:10:02 +0000,http://finance.yahoo.com/news/company-news-march-30-2017-141002314.html,"Company News for March 30, 2017"
VRTX,VRTX:UW,BBG000C1SD31,CombiMatrix and Vertex Pharmaceuticals Make Gains,2017-03-30 13:30:00 +0000,http://finance.yahoo.com/news/combimatrix-vertex-pharmaceuticals-gains-133000974.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / March 30, 2017 / CombiMatrix and Vertex Pharmaceuticals have made investors optimistic about the future of their companies as both stocks find broader markets for their products. ..."
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharma shares soar 21% as company ups its cystic fibrosis offerings,2017-03-30 11:13:46 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=AF551AFE-147B-11E7-B160-D160BC2EF42A&siteid=yhoof2,Vertex Pharma shares soar 21% as company ups its cystic fibrosis offerings
VRTX,VRTX:UW,BBG000C1SD31,"Corbus drug aces second mid-stage trial, this time in cystic fibrosis",2017-03-30 10:25:09 +0000,http://www.bizjournals.com/boston/news/2017/03/30/corbus-drug-aces-second-mid-stage-trial-this-time.html?ana=yahoo,"Corbus drug aces second mid-stage trial, this time in cystic fibrosis"
VRTX,VRTX:UW,BBG000C1SD31,Corbus drug shows promise as add-on therapy for cystic fibrosis,2017-03-30 10:00:00 +0000,http://finance.yahoo.com/news/corbus-drug-shows-promise-add-100000183.html,Corbus drug shows promise as add-on therapy for cystic fibrosis
VRTX,VRTX:UW,BBG000C1SD31,The Hot Stock: Vertex Pharmaceuticals Soars 20%,2017-03-29 21:34:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/29/the-hot-stock-vertex-pharmaceuticals-soars-20/?mod=yahoobarrons&ru=yahoo,The Hot Stock: Vertex Pharmaceuticals Soars 20%
VRTX,VRTX:UW,BBG000C1SD31,"Market Close Report: NASDAQ Composite index closes at 5,897.55 up 22.41 points",2017-03-29 20:49:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rfqRjaKQu8U/market-close-report-nasdaq-composite-index-closes-at-589755-up-2241-points-cm767468,Wednesday s session closes with the NASDAQ Composite Index at 5 897 55 The total shares traded for the NASDAQ was over 1 8 billion Wednesday s session closes with the NASDAQ Composite Index at 5 897 55 The total shares traded for the NASDAQ was over 1 8 billion Advancers stocks led declining
VRTX,VRTX:UW,BBG000C1SD31,"US STOCKS-Energy, consumer shares lift S&P 500 to slight gain",2017-03-29 20:24:57 +0000,http://uk.finance.yahoo.com/news/us-stocks-energy-consumer-shares-202457465.html,"US STOCKS-Energy, consumer shares lift S&P 500 to slight gain"
VRTX,VRTX:UW,BBG000C1SD31,Mid-Afternoon Market Update: RH Gains After Strong Q4 Results; Quorum Health Shares Plummet,2017-03-29 19:54:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/B9QgroFNxTI/mid-afternoon-market-update-rh-gains-after-strong-q4-results-quorum-health-shares-plummet-cm767447,Toward the end of trading Wednesday the Dow traded down 0 15 percent to 20 670 50 while the NASDAQ rose 0 35 percent to 5 895 93 The S amp P also rose gaining 0 12 percent to 2 361 32 Leading and Lagging Sectors Wednesday afternoon the energy sector proved to be a source
VRTX,VRTX:UW,BBG000C1SD31,"S&P edges up as energy gains, Vertex soars",2017-03-29 19:47:00 +0000,http://www.investopedia.com/partner/reuters/sp-edges-energy-gains-vertex-soars/?partner=YahooSA,"S&P edges up as energy gains, Vertex soars"
VRTX,VRTX:UW,BBG000C1SD31,"US STOCKS-S&P edges up as energy gains, Vertex soars",2017-03-29 18:47:51 +0000,http://uk.finance.yahoo.com/news/us-stocks-p-edges-energy-184751376.html,"US STOCKS-S&P edges up as energy gains, Vertex soars"
VRTX,VRTX:UW,BBG000C1SD31,"Health Care Sector Update for 03/29/2017: VRTX,TNXP,RTTR",2017-03-29 18:18:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Qahiz1hC4Co/health-care-sector-update-for-03292017-vrtxtnxprttr-cm767395,Top Health Care StocksTop Health Care Stocks JNJ 0 38 JNJ 0 38 PFE 0 83 PFE 0 83 MRK 0 18 MRK 0 18 ABT 0 96 ABT 0 96 AMGN 0 27 AMGN 0 27 Health care stocks were narrowly higher Wednesday with the NYSE Health Care Index rising about 0 1 while shares of health care companies in
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharmaceuticals Reaches Upside Price Target,2017-03-29 17:31:00 +0000,http://realmoney.thestreet.com/articles/03/29/2017/vertex-pharmaceuticals-reaches-upside-price-target?puc=yahoo&cm_ven=YAHOO,Vertex Pharmaceuticals Reaches Upside Price Target
VRTX,VRTX:UW,BBG000C1SD31,Mid-Day Market Update: Crude Oil Up 1.5%; Alliqua Biomedical Shares Slide,2017-03-29 17:24:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7KNbdniSipk/mid-day-market-update-crude-oil-up-15-alliqua-biomedical-shares-slide-cm767376,Midway through trading Wednesday the Dow traded down 0 21 percent to 20 657 73 while the NASDAQ rose 0 22 percent to 5 888 10 The S amp P also rose gaining 0 05 percent to 2 359 67 Leading and Lagging Sectors On Wednesday the energy sector proved to be a source of strength
VRTX,VRTX:UW,BBG000C1SD31,"US STOCKS-S&P, Dow weighed down by financial stocks; Nasdaq up",2017-03-29 17:09:08 +0000,http://finance.yahoo.com/news/us-stocks-p-dow-weighed-170908290.html,"US STOCKS-S&P, Dow weighed down by financial stocks; Nasdaq up"
VRTX,VRTX:UW,BBG000C1SD31,Here's Why Vertex Pharmaceuticals Is Flying High Today,2017-03-29 17:00:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Yh0yx7TSZ3o/heres-why-vertex-pharmaceuticals-is-flying-high-today-cm767297,What happened In response to a report of upbeat clinical data from two phase 3 trials shares of Vertex Pharmaceuticals NASDAQ VRTX rose by 23 as of 11 15 a m EDT on Wednesday Image source Getty Images So what Vertex announced results from its phase 3
VRTX,VRTX:UW,BBG000C1SD31,Vertex Combo Data on Kalydeco+VX-661 Positive in Phase III,2017-03-29 17:00:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oaDmeJW_mVk/vertex-combo-data-on-kalydecovx-661-positive-in-phase-iii-cm767316,Vertex Pharmaceuticals Incorporated s VRTX shares were up almost 19 in pre market trading after the company announced positive data from two phase III studies evaluating its lead marketed drug Kalydeco ivacaftor in combination with tezacaftor VX 661 tezacaftor in patients suffering
VRTX,VRTX:UW,BBG000C1SD31,Buy Wells Fargo & Co (WFC) Stock on Any Dips,2017-03-29 16:59:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1DWyw49WtTM/buy-wells-fargo-co-wfc-stock-on-any-dips-cm767356,InvestorPlace Stock Market News Stock Advice amp Trading Tips Bank stocks like Wells Fargo amp Co NYSE WFC bounced hard on Tuesday March 28 after notable weakness over the past week and a half From both a chart perspective and a structural
VRTX,VRTX:UW,BBG000C1SD31,"S&P 500 Movers: FFIV, VRTX",2017-03-29 16:00:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FZIYsjJqchs/sp-500-movers-ffiv-vrtx-cm767238,In early trading on Wednesday shares of Vertex Pharmaceuticals VRTX topped the list of the day s best performing components of the S amp P 500 index trading up 23 2 Year to date Vertex Pharmaceuticals registers a 49 9 gain And the worst performing S amp P 500 component thus far
VRTX,VRTX:UW,BBG000C1SD31,"Nasdaq 100 Movers: BIIB, VRTX",2017-03-29 15:59:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/I6RUKJaugCg/nasdaq-100-movers-biib-vrtx-cm767233,In early trading on Wednesday shares of Vertex Pharmaceuticals VRTX topped the list of the day s best performing components of the Nasdaq 100 index trading up 24 6 Year to date Vertex Pharmaceuticals registers a 51 7 gain And the worst performing Nasdaq 100 component thus far
VRTX,VRTX:UW,BBG000C1SD31,"3 Stocks to Watch on Wednesday: RH (RH), Vertex Pharmaceuticals Incorporated (VRTX) and Ollie’s Bargain Outlet Holdings Inc (OLLI)",2017-03-29 15:58:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/F-HpsnckRTA/3-stocks-to-watch-on-wednesday-rh-rh-vertex-pharmaceuticals-incorporated-vrtx-and-ollies-bargain-outlet-holdings-inc-olli-cm767295,InvestorPlace Stock Market News Stock Advice amp Trading Tips U S stock markets finally got their spirit back on Tuesday snapping out of a funk that lasted more than a week The 160 S amp P 500 Index moved ahead by 0 7 yesterday the 160 Dow Jones Industrial
VRTX,VRTX:UW,BBG000C1SD31,Vertex Rockets To 14-Month High On Cystic Fibrosis Drug Results,2017-03-29 15:55:33 +0000,http://www.investors.com/news/technology/vertex-stock-rockets-on-strong-cystic-fibrosis-data-branch/?src=A00220A,Vertex Rockets To 14-Month High On Cystic Fibrosis Drug Results
VRTX,VRTX:UW,BBG000C1SD31,Here's Why Vertex Pharmaceuticals Is Flying High Today,2017-03-29 15:54:00 +0000,https://www.fool.com/investing/2017/03/29/heres-why-vertex-pharmaceuticals-is-flying-high-to.aspx,Here's Why Vertex Pharmaceuticals Is Flying High Today
VRTX,VRTX:UW,BBG000C1SD31,A Little Vertex Goes a Long Way For Biotechnology,2017-03-29 15:37:00 +0000,http://blogs.barrons.com/focusonfunds/2017/03/29/a-little-vertex-goes-a-long-way-for-biotechnology/?mod=yahoobarrons&ru=yahoo,A Little Vertex Goes a Long Way For Biotechnology
VRTX,VRTX:UW,BBG000C1SD31,Why Vertex Has Soared 24%,2017-03-29 14:59:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/29/why-vertex-has-soared-24/?mod=yahoobarrons&ru=yahoo,Why Vertex Has Soared 24%
VRTX,VRTX:UW,BBG000C1SD31,Vertex Combo Data on Kalydeco+VX-661 Positive in Phase III,2017-03-29 14:45:02 +0000,http://finance.yahoo.com/news/vertex-combo-data-kalydeco-vx-144502502.html,Vertex Combo Data on Kalydeco+VX-661 Positive in Phase III
VRTX,VRTX:UW,BBG000C1SD31,"Nasdaq Up On Amazon, Alibaba And This Biotech",2017-03-29 14:31:45 +0000,http://www.investors.com/market-trend/stock-market-today/stocks-mixed-as-brexit-begins-nasdaq-leads-on-amazon-alibaba-this-biotech/?src=A00220A,"Nasdaq Up On Amazon, Alibaba And This Biotech"
VRTX,VRTX:UW,BBG000C1SD31,Tuesday’s Top Biopharma Movers,2017-03-29 14:10:44 +0000,http://finance.yahoo.com/news/tuesday-top-biopharma-movers-141044831.html,Tuesday’s Top Biopharma Movers
VRTX,VRTX:UW,BBG000C1SD31,"Wells Fargo settlement, another chip merger, Vertex surges on positive drug trial",2017-03-29 14:08:37 +0000,http://finance.yahoo.com/news/wells-fargo-settlement-another-chip-merger-vertex-surges-on-positive-drug-trial-140837824.html,"Wells Fargo settlement, another chip merger, Vertex surges on positive drug trial"
VRTX,VRTX:UW,BBG000C1SD31,US STOCKS-Wall Street flat; Fed officials in focus,2017-03-29 14:05:45 +0000,http://finance.yahoo.com/news/us-stocks-wall-street-flat-140545239.html,US STOCKS-Wall Street flat; Fed officials in focus
VRTX,VRTX:UW,BBG000C1SD31,"Biotech Stock Roundup: Regeneron, Tesaro Drugs Approved, Vertex Scores Big in Study",2017-03-29 14:02:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kkJcVYj4Ifo/biotech-stock-roundup-regeneron-tesaro-drugs-approved-vertex-scores-big-in-study-cm767052,Key highlights this week include FDA approval of two highly awaited drugs Regeneron REGN Sanofi s Dupixent and Tesaro s TSRO Zejula Both drugs have blockbuster potential Vertex VRTX also got a boost with positive data being generated from a couple of late stage studies Recap of
VRTX,VRTX:UW,BBG000C1SD31,"Stocks Mixed; Vertex Spikes, FANGs Get Overweight Rating",2017-03-29 13:55:59 +0000,http://www.investors.com/market-trend/stock-market-today/stock-futures-flatten-vertex-spikes-alphabet-gets-upgrade/?src=A00220A,"Stocks Mixed; Vertex Spikes, FANGs Get Overweight Rating"
VRTX,VRTX:UW,BBG000C1SD31,"Biotech Premarket Movers: Vertex, Sangamo, Depomed",2017-03-29 13:31:00 +0000,https://www.thestreet.com/story/14064112/1/biotech-premarket-movers-vertex-sangamo-depomed.html?puc=yahoo&cm_ven=YAHOO,"Biotech Premarket Movers: Vertex, Sangamo, Depomed"
VRTX,VRTX:UW,BBG000C1SD31,Vertex Stock Rockets On Strong Cystic Fibrosis Data,2017-03-29 13:29:33 +0000,http://www.investors.com/news/technology/vertex-stock-rockets-on-strong-cystic-fibrosis-data/?src=A00220A,Vertex Stock Rockets On Strong Cystic Fibrosis Data
VRTX,VRTX:UW,BBG000C1SD31,Investors look for direction as Britain starts heading for the EU exit ramp,2017-03-29 13:16:05 +0000,http://finance.yahoo.com/news/investors-look-for-direction-as-britain-starts-heading-for-the-eu-exit-ramp-131605239.html,Investors look for direction as Britain starts heading for the EU exit ramp
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharma Cystic Fibrosis Combo Succeeds (VRTX),2017-03-29 13:01:00 +0000,http://www.investopedia.com/news/vertex-pharma-cystic-fibrosis-combo-succeeds-vrtx-nvls/?partner=YahooSA,Vertex Pharma Cystic Fibrosis Combo Succeeds (VRTX)
VRTX,VRTX:UW,BBG000C1SD31,"Pre-Market Most Active for Mar 29, 2017 :  EXAR, ATH, TNXP, SNAP, MT, ASX, NOK, VRTX, QQQ, VOD, XIV, AAPL",2017-03-29 12:59:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2Ldn-ZL8H58/pre-market-most-active-for-mar-29-2017-exar-ath-tnxp-snap-mt-asx-nok-vrtx-qqq-vod-xiv-aapl-cm767039,The NASDAQ 100 Pre Market Indicator is up 5 73 to 5 412 94 The total Pre Market volume is currently 15 311 728 shares traded The following are the most active stocks for the pre market session Exar Corporation EXAR is 2 36 at 12 98 with 9 029 743 shares traded
VRTX,VRTX:UW,BBG000C1SD31,Stock Futures Edge Higher as U.K. Invokes Article 50 in First Step of Brexit,2017-03-29 12:56:00 +0000,https://www.thestreet.com/story/14062712/1/stock-futures-waver-as-u-k-invokes-article-50-in-first-step-of-brexit.html?puc=yahoo&cm_ven=YAHOO,[at TheStreet] - Stock futures are narrowly mixed on Wednesday as markets await the United Kingdom taking the first step to formally remove itself from the European Union.
VRTX,VRTX:UW,BBG000C1SD31,US STOCKS-Wall Street set to open little changed,2017-03-29 12:40:20 +0000,http://finance.yahoo.com/news/us-stocks-wall-street-set-124020755.html,US STOCKS-Wall Street set to open little changed
VRTX,VRTX:UW,BBG000C1SD31,Blog Coverage Cara Therapeutics Reported Positive Top-line Results,2017-03-29 12:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-cara-therapeutics-reported-121500021.html,"[Accesswire] - Upcoming AWS Coverage on Vertex Pharmaceuticals LONDON, UK / ACCESSWIRE / March 29, 2017 / Active Wall St. blog coverage looks at the headline from Cara Therapeutics, Inc. (NASDAQ: CARA ) as the Company ..."
VRTX,VRTX:UW,BBG000C1SD31,Stocks Continue To Turn In A Lackluster Performance - U.S. Commentary,2017-03-29 11:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QN8xF6SY52w/stocks-continue-to-turn-in-a-lackluster-performance--us-commentary-20170329-00857,Stocks Continue To Turn In A Lackluster Performance - U.S. Commentary
VRTX,VRTX:UW,BBG000C1SD31,"VERTEX PHARMACEUTICALS INC / MA Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2017-03-29 11:28:24 +0000,http://biz.yahoo.com/e/170329/vrtx8-k.html,"VERTEX PHARMACEUTICALS INC / MA Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharmaceuticals Inc. (VRTX) Has Surged To A New High On Study Results,2017-03-29 09:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QLUiWgogFTA/vertex-pharmaceuticals-inc-vrtx-has-surged-to-a-new-high-on-study-results-20170329-00687,Vertex Pharmaceuticals Inc. (VRTX) Has Surged To A New High On Study Results
VRTX,VRTX:UW,BBG000C1SD31,Dow Futures Steady: Banks Retake Support; This Drug Stock Is Set To Soar,2017-03-29 04:42:32 +0000,http://www.investors.com/market-trend/stock-market-today/dow-sp-500-futures-hold-steady-bank-stocks-begin-retaking-50-day/?src=A00220A,Dow Futures Steady: Banks Retake Support; This Drug Stock Is Set To Soar
VRTX,VRTX:UW,BBG000C1SD31,"First Drug For 2 Forms Of MS Gets FDA Nod, RTTR Abuzz, VRTX Gains On Trial Data",2017-03-29 02:47:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ODH4o3dW8uQ/first-drug-for-2-forms-of-ms-gets-fda-nod-rttr-abuzz-vrtx-gains-on-trial-data-20170329-00071,"First Drug For 2 Forms Of MS Gets FDA Nod, RTTR Abuzz, VRTX Gains On Trial Data"
VRTX,VRTX:UW,BBG000C1SD31,[$$] Vertex Pharmaceuticals hails new cystic fibrosis drug,2017-03-29 01:08:08 +0000,"http://www.ft.com/cms/s/aa944954-13f4-11e7-b0c1-37e417ee6c76,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Vertex Pharmaceuticals said that a combination of two of its medicines had successfully treated cystic fibrosis in a closely watched clinical trial, paving the way for regulators to approve a new option ..."
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharma Shares Higher on Impressive Trial Results for New Cystic Fibrosis Drug,2017-03-28 23:00:00 +0000,https://www.thestreet.com/story/14063412/1/vertex-next-gen-cystic-fibrosis-drug-passes-key-efficacy-safety-hurdle.html?puc=yahoo&cm_ven=YAHOO,Vertex Pharma Shares Higher on Impressive Trial Results for New Cystic Fibrosis Drug
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharma shares jump more than 20% on cystic fibrosis study results,2017-03-28 22:51:25 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=F2FD64AD-F1B7-413F-9172-EE291DAC2918&siteid=yhoof2,Vertex Pharma shares jump more than 20% on cystic fibrosis study results
VRTX,VRTX:UW,BBG000C1SD31,[$$] Vertex Seeks Approval for Experimental Cystic-Fibrosis Drug,2017-03-28 22:26:39 +0000,https://www.wsj.com/articles/vertex-seeks-approval-for-experimental-cystic-fibrosis-drug-1490735880?mod=yahoo_hs,[$$] Vertex Seeks Approval for Experimental Cystic-Fibrosis Drug
VRTX,VRTX:UW,BBG000C1SD31,Two Phase 3 Studies of the Tezacaftor/Ivacaftor Combination Treatment Met Primary Endpoints with Statistically Significant Improvements in Lung Function (FEV1) in People with Cystic Fibrosis,2017-03-28 22:21:00 +0000,http://uk.finance.yahoo.com/news/two-phase-3-studies-tezacaftor-222100285.html,Two Phase 3 Studies of the Tezacaftor/Ivacaftor Combination Treatment Met Primary Endpoints with Statistically Significant Improvements in Lung Function (FEV1) in People with Cystic Fibrosis
VRTX,VRTX:UW,BBG000C1SD31,6:21 pm Vertex Pharma confirms two Phase 3 Studies of the tezacaftor/ivacaftor combination treatment met primary endpoints with statistically significant improvements in lung function in people with cystic fibrosis (halted),2017-03-28 22:21:00 +0000,http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#vrtx,6:21 pm Vertex Pharma confirms two Phase 3 Studies of the tezacaftor/ivacaftor combination treatment met primary endpoints with statistically significant improvements in lung function in people with cystic fibrosis (halted)
VRTX,VRTX:UW,BBG000C1SD31,Vertex cystic fibrosis combination succeeds in late stage trials,2017-03-28 21:41:39 +0000,http://finance.yahoo.com/news/vertex-cystic-fibrosis-combination-succeeds-214139528.html,[Reuters] - Vertex Pharmaceuticals Inc on Tuesday said its Kalydeco cystic fibrosis treatment given with an experimental drug demonstrated significant improvements in lung function in a pair of late stage trials the ...
VRTX,VRTX:UW,BBG000C1SD31,"NASDAQ Composite Index closes up 11.64 points for the week, rising for the 3rd straight day",2017-03-28 20:49:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/D-ijPFiL3Pk/nasdaq-composite-index-closes-up-1164-points-for-the-week-rising-for-the-3rd-straight-day-cm766900,Tuesday s session closes with the NASDAQ Composite Index 34 77 This is the 3rd straight day of increase for the index The total shares traded for the NASDAQ was over 1 86 billion Tuesday s session closes with the NASDAQ Composite Index 34 77 This is the 3rd straight day of increase for the
VRTX,VRTX:UW,BBG000C1SD31,"Nasdaq 100 Movers: VRTX, TSLA",2017-03-28 16:00:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TEv6uCAKp0g/nasdaq-100-movers-vrtx-tsla-cm766636,In early trading on Tuesday shares of Tesla TSLA topped the list of the day s best performing components of the Nasdaq 100 index trading up 2 4 Year to date Tesla registers a 29 5 gain And the worst performing Nasdaq 100 component thus far on the day is Vertex
VRTX,VRTX:UW,BBG000C1SD31,Why Concert Pharmaceuticals Is Music to Investors' Ears,2017-03-26 18:00:00 +0000,https://www.thestreet.com/story/14037741/1/why-concert-pharmaceuticals-is-music-to-investors-ears.html?puc=yahoo&cm_ven=YAHOO,Why Concert Pharmaceuticals Is Music to Investors' Ears
VRTX,VRTX:UW,BBG000C1SD31,Concert rebuffed $250M buyout offer from Vertex before CF drug deal,2017-03-24 14:50:08 +0000,http://www.bizjournals.com/boston/news/2017/03/24/concert-rebuffed-250m-buyout-offer-from-vertex.html?ana=yahoo,Concert rebuffed $250M buyout offer from Vertex before CF drug deal
VRTX,VRTX:UW,BBG000C1SD31,A Look at Ionis Pharmaceuticals’ Spinraza,2017-03-22 11:37:25 +0000,http://marketrealist.com/2017/03/a-look-at-ionis-pharmaceuticals-spinraza/?utm_source=yahoo&utm_medium=feed,A Look at Ionis Pharmaceuticals’ Spinraza
VRTX,VRTX:UW,BBG000C1SD31,"Noteworthy Friday Option Activity: VRTX, GILD, HD",2017-03-17 19:06:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UrBTSuCzsYM/noteworthy-friday-option-activity-vrtx-gild-hd-cm762374,Looking at options trading activity among components of the S amp P 500 index there is noteworthy activity today in Vertex Pharmaceuticals Inc Symbol VRTX where a total volume of 8 192 contracts has been traded thus far today a contract volume which is representative of
VRTX,VRTX:UW,BBG000C1SD31,Inside the small Norwood biotech that's making investors swoon,2017-03-17 11:30:10 +0000,http://www.bizjournals.com/boston/news/2017/03/17/inside-the-small-norwood-biotech-thats-making.html?ana=yahoo,Inside the small Norwood biotech that's making investors swoon
VRTX,VRTX:UW,BBG000C1SD31,"Zacks.com featured highlights: Covanta Holding,  Etsy, PTC, Incyte and Vertex Pharmaceuticals",2017-03-16 15:09:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dttIvgMFOtE/zackscom-featured-highlights-covanta-holding-etsy-ptc-incyte-and-vertex-pharmaceuticals-cm761720,For Immediate Release Chicago IL March 16 2017 Stocks in this week s article include Covanta Holding Corporation NYSE CVA Free Report Etsy Inc NASDAQ ETSY Free Report PTC Inc NASDAQ PTC Free Report Incyte Corporation NASDAQ INCY
VRTX,VRTX:UW,BBG000C1SD31,"Zacks.com featured highlights: Covanta Holding, Etsy, PTC, Incyte and Vertex Pharmaceuticals",2017-03-16 13:30:01 +0000,http://finance.yahoo.com/news/zacks-com-featured-highlights-covanta-133001813.html,"Zacks.com featured highlights: Covanta Holding, Etsy, PTC, Incyte and Vertex Pharmaceuticals"
VRTX,VRTX:UW,BBG000C1SD31,5 Toxic Stocks to Dump or Play Short to Make Gains,2017-03-15 16:09:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vG9wgFU41aU/5-toxic-stocks-to-dump-or-play-short-to-make-gains-cm761111,One of the important aspects of successful investing is the accurate identification of overpriced and fairly priced stocks However it is not easy to distinguish between overvalued stocks and the correctly priced ones as they are all intermingled in the marketplace Investors who can identify
VRTX,VRTX:UW,BBG000C1SD31,"Once paid by Vertex, Trump's FDA pick would be tasked with regulating it",2017-03-15 09:45:08 +0000,http://www.bizjournals.com/boston/news/2017/03/15/once-paid-by-vertex-trumps-fda-pick-would-be.html?ana=yahoo,"Once paid by Vertex, Trump's FDA pick would be tasked with regulating it"
VRTX,VRTX:UW,BBG000C1SD31,Biotech stocks are turning bullish—here's how to profit,2017-03-13 18:08:34 +0000,http://finance.yahoo.com/news/biotech-stocks-are-turning-bullish-heres-how-to-profit-190834183.html,Biotech stocks are turning bullish—here's how to profit
VRTX,VRTX:UW,BBG000C1SD31,3 Biotech Stocks to Buy in March,2017-03-11 00:18:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KwMCTFA5GVg/3-biotech-stocks-to-buy-in-march-cm759560,Which biotech stocks look like smart picks right now 160 That s the question we posed to three of The Motley Fool s healthcare contributors All three answered with small cap biotech stocks Spark Therapeutics NASDAQ ONCE Albany Molecular Research NASDAQ AMRI
VRTX,VRTX:UW,BBG000C1SD31,3 Biotech Stocks to Buy in March,2017-03-10 17:07:00 +0000,http://www.fool.com/investing/2017/03/10/3-biotech-stocks-to-buy-in-march.aspx,3 Biotech Stocks to Buy in March
VRTX,VRTX:UW,BBG000C1SD31,"Drugs, travel, jewelry and social media in the blitz",2017-03-09 18:40:00 +0000,http://finance.yahoo.com/video/drugs-travel-jewelry-social-media-184000942.html,"Drugs, travel, jewelry and social media in the blitz"
VRTX,VRTX:UW,BBG000C1SD31,"Biotech Stock Roundup: Trump Tweet Hits Biotech Stocks, Concert Gains on Vertex Deal",2017-03-08 15:17:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XBWuHu8s6qM/biotech-stock-roundup-trump-tweet-hits-biotech-stocks-concert-gains-on-vertex-deal-cm757792,Once again a tweet kept the biotech industry on edge with President Donald Trump declaring that he is working on a new system where there will be competition in the Drug Industry and pricing for the American people will come way down The tweet triggered a 1 6 decline in the
VRTX,VRTX:UW,BBG000C1SD31,Harry Boxer’s six biotechnology stocks to watch,2017-03-07 18:55:50 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=30E80700-0362-11E7-918D-62B4A59FE2AC&siteid=yhoof2,Harry Boxer’s six biotechnology stocks to watch
VRTX,VRTX:UW,BBG000C1SD31,Vertex to Buy Concert's Cystic Fibrosis Candidate for $160M,2017-03-07 18:13:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1nMvaq1SZ6M/vertex-to-buy-concerts-cystic-fibrosis-candidate-for-160m-cm757339,Vertex Pharmaceuticals Incorporated VRTX announced a definitive deal to buy the worldwide development and commercialization rights of Concert Pharmaceuticals CNCE cystic fibrosis CF pipeline candidate CTP 656 for an upfront payment of 160 million in cash Shares of Concert Pharma
VRTX,VRTX:UW,BBG000C1SD31,Vertex to Buy Concert's Cystic Fibrosis Candidate for $160M,2017-03-07 15:53:03 +0000,http://finance.yahoo.com/news/vertex-buy-concerts-cystic-fibrosis-155303084.html,Vertex to Buy Concert's Cystic Fibrosis Candidate for $160M
VRTX,VRTX:UW,BBG000C1SD31,"VERTEX PHARMACEUTICALS INC / MA Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements",2017-03-06 21:55:50 +0000,http://biz.yahoo.com/e/170306/vrtx8-k.html,"VERTEX PHARMACEUTICALS INC / MA Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements"
VRTX,VRTX:UW,BBG000C1SD31,"Health Care Sector Update for 03/06/2017: CNCE,VTRX,TGTX,IONS",2017-03-06 21:32:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aFkYFljUkq8/health-care-sector-update-for-03062017-cncevtrxtgtxions-cm756874,Top Health Care StocksTop Health Care Stocks JNJ 0 07 JNJ 0 07 PFE 0 25 PFE 0 25 MRK 0 06 MRK 0 06 ABT 0 05 ABT 0 05 AMGN 0 21 AMGN 0 21 Health care stocks were moderately lower late Monday with the NYSE Health Care Index posting a 0 3 retreat while shares of health care
VRTX,VRTX:UW,BBG000C1SD31,Mid-Afternoon Market Update: GoPro Slides Following Goldman Sachs Downgrade; TG Therapeutics Shares Spike Higher,2017-03-06 21:03:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pZ7JBjkxU-g/mid-afternoon-market-update-gopro-slides-following-goldman-sachs-downgrade-tg-therapeutics-shares-spike-higher-cm756863,Toward the end of trading Monday the Dow traded down 0 19 percent to 20 965 95 while the NASDAQ declined 0 35 percent to 5 850 34 The S amp P also fell dropping 0 30 percent to 2 375 93 Leading and Lagging Sectors Energy shares rose 0 02 percent in trading on Monday
VRTX,VRTX:UW,BBG000C1SD31,"Gainers & Losers Of Mar.6: TGTX, CNCE, DXTR, KURA, ARGS...",2017-03-06 20:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-FtD2qL1YxA/gainers--losers-of-mar6-tgtx-cnce-dxtr-kura-args-20170306-01394,"Gainers & Losers Of Mar.6: TGTX, CNCE, DXTR, KURA, ARGS..."
VRTX,VRTX:UW,BBG000C1SD31,Monday’s Top Health Care Stocks Screaming Higher,2017-03-06 18:45:34 +0000,http://finance.yahoo.com/news/monday-top-health-care-stocks-184534179.html,Monday’s Top Health Care Stocks Screaming Higher
VRTX,VRTX:UW,BBG000C1SD31,Mid-Day Market Update: Dow Falls 80 Points; Concert Pharma Shares Spike Higher,2017-03-06 18:32:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fN5s1tfCBE0/mid-day-market-update-dow-falls-80-points-concert-pharma-shares-spike-higher-cm756798,Midway through trading Monday the Dow traded down 0 41 percent to 20 920 47 while the NASDAQ declined 0 71 percent to 5 829 17 The S amp P also fell dropping 0 60 percent to 2 368 89 Leading and Lagging Sectors Non cyclical consumer goods amp services shares slipped by just 0
VRTX,VRTX:UW,BBG000C1SD31,Why Concert Pharmaceuticals Stock Is Soaring Today,2017-03-06 18:15:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rtYli1NqB5E/why-concert-pharmaceuticals-stock-is-soaring-today-cm756714,What happened Shares of Concert Pharmaceuticals NASDAQ CNCE 160 surged as much as 91 5 in morning trading on Monday as the result of a deal with Vertex Pharmaceuticals NASDAQ VRTX for the experimental cystic fibrosis CF drug 160 CTP 656 As of 11 45 a m EST the
VRTX,VRTX:UW,BBG000C1SD31,$160M deal with Concert helps Vertex maintain dominance in cystic fibrosis,2017-03-06 17:45:08 +0000,http://www.bizjournals.com/boston/news/2017/03/06/160m-deal-with-concert-helps-vertex-maintain.html?ana=yahoo,$160M deal with Concert helps Vertex maintain dominance in cystic fibrosis
VRTX,VRTX:UW,BBG000C1SD31,Why Concert Pharmaceuticals Stock Is Soaring Today,2017-03-06 16:53:52 +0000,http://www.fool.com/investing/2017/03/06/why-concert-pharmaceuticals-stock-is-soaring-today.aspx,Why Concert Pharmaceuticals Stock Is Soaring Today
VRTX,VRTX:UW,BBG000C1SD31,Mid-Morning Market Update: Markets Open Lower; Deutsche Bank Plans to Raise Capital,2017-03-06 16:32:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eEuk6PmwJ0k/mid-morning-market-update-markets-open-lower-deutsche-bank-plans-to-raise-capital-cm756695,Following the market opening Monday the Dow traded down 0 25 percent to 20 954 18 while the NASDAQ declined 0 54 percent to 5 838 83 The S amp P also fell dropping 0 46 percent to 2 372 14 Leading and Lagging Sectors Non cyclical consumer goods amp services shares slipped
VRTX,VRTX:UW,BBG000C1SD31,The Probable Reason Behind Vertex Pharmaceuticals 5% Jump in February,2017-03-06 16:16:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GI5yNhJqGoE/the-probable-reason-behind-vertex-pharmaceuticals-5-jump-in-february-cm756622,What happened According to data from S amp P Global Market Intelligence 160 shares of Vertex Pharmaceuticals NASDAQ VRTX a large cap biotech focused on rare diseases rose by 5 in February So what It was a quiet month for Vertex The company didn t issue
VRTX,VRTX:UW,BBG000C1SD31,The Probable Reason Behind Vertex Pharmaceuticals 5% Jump in February,2017-03-06 14:09:00 +0000,http://www.fool.com/investing/2017/03/06/the-probable-reason-behind-vertex-pharmaceuticals.aspx,The Probable Reason Behind Vertex Pharmaceuticals 5% Jump in February
VRTX,VRTX:UW,BBG000C1SD31,Concert Pharma shares rally 34% on news Vertex to pay up to $250 million for cystic fibrosis drug,2017-03-06 12:56:48 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=906BEC42-AED4-4608-8DB8-29715B0638F3&siteid=yhoof2,Concert Pharma shares rally 34% on news Vertex to pay up to $250 million for cystic fibrosis drug
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharma Acquires Long-Acting Version of Cystic Fibrosis Drug From Concert Pharma,2017-03-06 12:01:00 +0000,https://www.thestreet.com/story/14027440/1/vertex-pharma-acquires-long-acting-version-of-cystic-fibrosis-drug-from-concert-pharma.html?puc=yahoo&cm_ven=YAHOO,Vertex Pharma Acquires Long-Acting Version of Cystic Fibrosis Drug From Concert Pharma
VRTX,VRTX:UW,BBG000C1SD31,Vertex to Acquire CTP-656 from Concert Pharmaceuticals for the Treatment of Cystic Fibrosis,2017-03-06 12:00:00 +0000,http://finance.yahoo.com/news/vertex-acquire-ctp-656-concert-120000347.html,[Business Wire] - Vertex Pharmaceuticals Incorporated today announced that it has signed a definitive asset purchase agreement to acquire CTP-656 from Concert Pharmaceuticals .
VRTX,VRTX:UW,BBG000C1SD31,Concert Pharmaceuticals (CNCE) Has Jumped To A 9-Month High,2017-03-06 09:39:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/d5X7WZCwzvE/concert-pharmaceuticals-cnce-has-jumped-to-a-9month-high-20170306-00750,Concert Pharmaceuticals (CNCE) Has Jumped To A 9-Month High
VRTX,VRTX:UW,BBG000C1SD31,Vertex To Buy CTP-656 From Concert Pharma For Treatment Of Cystic Fibrosis,2017-03-06 07:04:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xNGuT3WQ_9Q/vertex-to-buy-ctp656-from-concert-pharma-for-treatment-of-cystic-fibrosis-20170306-00321,Vertex To Buy CTP-656 From Concert Pharma For Treatment Of Cystic Fibrosis
VRTX,VRTX:UW,BBG000C1SD31,Vertex to Present at the Cowen Healthcare Conference on March 6,2017-03-02 21:01:00 +0000,http://finance.yahoo.com/news/vertex-present-cowen-healthcare-conference-210100966.html,"[Business Wire] - Vertex Pharmaceuticals Incorporated today announced that management will present at the Cowen Healthcare Conference on Monday, March 6th at 2:00 p.m. ET"
VRTX,VRTX:UW,BBG000C1SD31,Drug Companies Block Shareholder Votes on Price Transparency Proposals,2017-03-02 05:37:30 +0000,https://www.wsj.com/articles/drug-companies-block-shareholder-votes-on-price-transparency-proposals-1488406027?ru=yahoo?mod=yahoo_itp,Drug Companies Block Shareholder Votes on Price Transparency Proposals
VRTX,VRTX:UW,BBG000C1SD31,[$$] Drug Companies Block Shareholders' Voting on Price Transparency,2017-03-01 22:07:10 +0000,https://www.wsj.com/articles/drug-companies-block-shareholder-votes-on-price-transparency-proposals-1488406027?mod=yahoo_hs,[$$] Drug Companies Block Shareholders' Voting on Price Transparency
VRTX,VRTX:UW,BBG000C1SD31,VERTEX PHARMACEUTICALS INC / MA Financials,2017-03-01 18:04:12 +0000,http://finance.yahoo.com/q/is?s=vrtx,VERTEX PHARMACEUTICALS INC / MA Financials
VRTX,VRTX:UW,BBG000C1SD31,Trump gives Genzyme rare disease drug a shout-out in speech to Congress,2017-03-01 15:04:58 +0000,http://www.bizjournals.com/boston/news/2017/03/01/trump-gives-genzyme-rare-disease-drug-a-shout-out.html?ana=yahoo,Trump gives Genzyme rare disease drug a shout-out in speech to Congress
VRTX,VRTX:UW,BBG000C1SD31,"Biotech Stock Roundup: Kite Soars on CAR-T Data, EXEL in Immuno-Oncology Deals",2017-03-01 14:15:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7159NqQxPQk/biotech-stock-roundup-kite-soars-on-car-t-data-exel-in-immuno-oncology-deals-cm754656,Key updates in the biotech sector included earnings results from several companies like BioMarin BMRN and Sarepta while Kite KITE saw its shares soaring on positive data on its lead pipeline candidate Recap of the Week s Most Important Stories Kite Shoots up on CAR T Data
VRTX,VRTX:UW,BBG000C1SD31,Analyst Recommendations for Regeneron Pharmaceuticals in 2017,2017-03-01 12:38:37 +0000,http://marketrealist.com/2017/02/analysts-recommendations-regeneron-pharmaceuticals-2017/?utm_source=yahoo&utm_medium=feed,Analyst Recommendations for Regeneron Pharmaceuticals in 2017
VRTX,VRTX:UW,BBG000C1SD31,"Zacks.com featured highlights: Abercrombie & Fitch, Live Nation Entertainment, Vertex Pharmaceuticals, Etsy and Incyte",2017-02-28 16:52:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-ehBoq5T4Y4/zackscom-featured-highlights-abercrombie-fitch-live-nation-entertainment-vertex-pharmaceuticals-etsy-and-incyte-cm754238,For Immediate Release Chicago IL February 28 2017 Stocks in this week s article include 160 Abercrombie amp Fitch Co NYSE ANF Free Report Live Nation Entertainment Inc NYSE LYV Free Report Vertex Pharmaceuticals Inc NASDAQ VRTX Free
VRTX,VRTX:UW,BBG000C1SD31,"Zacks.com featured highlights: Abercrombie & Fitch, Live Nation Entertainment, Vertex Pharmaceuticals, Etsy and Incyte",2017-02-28 14:30:02 +0000,http://finance.yahoo.com/news/zacks-com-featured-highlights-abercrombie-143002354.html,"Zacks.com featured highlights: Abercrombie & Fitch, Live Nation Entertainment, Vertex Pharmaceuticals, Etsy and Incyte"
VRTX,VRTX:UW,BBG000C1SD31,VRTX Makes Bullish Cross Above Critical Moving Average,2017-02-27 22:49:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2KOdPm2ETOs/vrtx-makes-bullish-cross-above-critical-moving-average-cm753841,In trading on Monday shares of Vertex Pharmaceuticals Inc Symbol VRTX crossed above their 200 day moving average of 87 32 changing hands as high as 88 95 per share Vertex Pharmaceuticals Inc shares are currently trading up about 3 3 on the day The chart below shows the one
VRTX,VRTX:UW,BBG000C1SD31,5 Toxic Stocks to Abandon or Play Short Right Now,2017-02-27 13:50:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KHEMJEkiKaQ/5-toxic-stocks-to-abandon-or-play-short-right-now-cm753398,Making a proper distinction between fairly priced stocks and overpriced stocks is the key to investing success However the correctly priced and the overhyped toxic stocks are mingled in such a way in the marketplace that it is not easy to separate them Investors who can figure out the
VRTX,VRTX:UW,BBG000C1SD31,Why Vertex Expects Its Profit Margin to Rise in 2017,2017-02-27 12:37:39 +0000,http://marketrealist.com/2017/02/vertex-pharmaceuticals-expected-witness-rise-profit-margin-2017/?utm_source=yahoo&utm_medium=feed,Why Vertex Expects Its Profit Margin to Rise in 2017
VRTX,VRTX:UW,BBG000C1SD31,Inside Vertex’s Revenue Expectations for 2017,2017-02-24 20:35:48 +0000,http://marketrealist.com/2017/02/vertex-pharmaceuticals-expected-witness-solid-revenue-growth-2017/?utm_source=yahoo&utm_medium=feed,Inside Vertex’s Revenue Expectations for 2017
VRTX,VRTX:UW,BBG000C1SD31,Vertex Expects Modest Revenue Growth in This,2017-02-24 19:06:02 +0000,http://marketrealist.com/2017/02/vertex-pharmaceuticals-expects-modest-revenue-growth-orkambi-2017/?utm_source=yahoo&utm_medium=feed,Vertex Expects Modest Revenue Growth in This
VRTX,VRTX:UW,BBG000C1SD31,Understanding Vertex’s Analyst Recommendations,2017-02-24 17:34:40 +0000,http://marketrealist.com/2017/02/analyst-recommendations-vertex-pharmaceuticals-2017/?utm_source=yahoo&utm_medium=feed,Understanding Vertex’s Analyst Recommendations
VRTX,VRTX:UW,BBG000C1SD31,"Headcount at ​Vertex surges in 2016, hitting four-year high",2017-02-24 02:30:08 +0000,http://www.bizjournals.com/boston/news/2017/02/23/headcount-at-vertex-surges-in-2016-hitting-four.html?ana=yahoo,"Headcount at ​Vertex surges in 2016, hitting four-year high"
VRTX,VRTX:UW,BBG000C1SD31,How High Can Corbus Pharmaceuticals Stock Go?,2017-02-23 23:43:38 +0000,http://www.fool.com/investing/2017/02/22/how-high-can-corbus-pharmaceuticals-stock-go.aspx,How High Can Corbus Pharmaceuticals Stock Go?
VRTX,VRTX:UW,BBG000C1SD31,"VERTEX PHARMACEUTICALS INC / MA Files SEC form 10-K, Annual Report",2017-02-23 20:38:15 +0000,http://biz.yahoo.com/e/170223/vrtx10-k.html,"VERTEX PHARMACEUTICALS INC / MA Files SEC form 10-K, Annual Report"
VRTX,VRTX:UW,BBG000C1SD31,Mass. tech leaders to Baker: Do more to counter Trump's immigration policies,2017-02-23 01:53:43 +0000,http://www.bizjournals.com/boston/news/2017/02/22/mass-tech-leaders-to-baker-do-more-to-counter.html?ana=yahoo,"[at American City Business Journals] - The Alliance for Business Leadership, a progressive business group based in Boston, co-wrote the letter with the American Civil Liberties Union of Massachusetts. The letter first applauds Baker for speaking out against an executive order Trump signed in late January temporarily banning refugees and immigrants from seven majority-Muslim countries."
VRTX,VRTX:UW,BBG000C1SD31,How High Can Corbus Pharmaceuticals Stock Go?,2017-02-22 22:50:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dh7wbwjUkPU/how-high-can-corbus-pharmaceuticals-stock-go-cm751669,Corbus Pharmaceuticals NASDAQ CRBP managed to become one of the top performing biotech stocks on the market in 2016 Over the last 12 months Corbus share price has soared 550 It was a bumpy ride for shareholders though Corbus stock had some big drops along the way
VRTX,VRTX:UW,BBG000C1SD31,First Week of VRTX October 20th Options Trading,2017-02-22 15:51:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ylwlGgFrfMU/first-week-of-vrtx-october-20th-options-trading-cm751334,Investors in Vertex Pharmaceuticals Inc Symbol VRTX saw new options become available this week for the October 20th expiration One of the key data points that goes into the price an option buyer is willing to pay is the time value so with 240 days until expiration the newly
VRTX,VRTX:UW,BBG000C1SD31,"Market Close Report: Historical high reached as NASDAQ Composite Index closes at 5,865.95.",2017-02-21 21:48:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fzRaRBACoe0/market-close-report-historical-high-reached-as-nasdaq-composite-index-closes-at-586595-cm750926,Tuesday s session closes with the NASDAQ Composite Index reaching a historical high The index closed at 5 865 95 up 27 37 for the day The index first reached the 5000 mark on 02 17 2017 The total shares traded for the NASDAQ was over 2 1 billion Tuesday s session closes with the NASDAQ
VRTX,VRTX:UW,BBG000C1SD31,20 companies that have met a high bar this earnings season,2017-02-15 19:09:43 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=EBA380FC-F2C7-11E6-9546-7567D09D9D1E&siteid=yhoof2,20 companies that have met a high bar this earnings season
VRTX,VRTX:UW,BBG000C1SD31,Is Gilead Sciences Getting Ready for a Massive Acquisition?,2017-02-13 17:14:11 +0000,http://www.fool.com/investing/2017/02/12/is-gilead-sciences-getting-ready-for-a-massive-acq.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Is Gilead Sciences Getting Ready for a Massive Acquisition?
VRTX,VRTX:UW,BBG000C1SD31,"Zacks.com featured highlights: Ets, Incyte, Abercrombie & Fitch, Vertex Pharmaceuticals and Bottomline Technologies",2017-02-13 16:22:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zOSw2zXkxII/zackscom-featured-highlights-ets-incyte-abercrombie-fitch-vertex-pharmaceuticals-and-bottomline-technologies-cm746998,For Immediate Release Chicago IL February 13 2017 Stocks in this week s article include Etsy Inc NASDAQ ETSY Free Report Incyte Corporation NASDAQ INCY Free Report Abercrombie amp Fitch Co NYSE ANF Free
VRTX,VRTX:UW,BBG000C1SD31,"Zacks.com featured highlights: Ets, Incyte, Abercrombie & Fitch, Vertex Pharmaceuticals and Bottomline Technologies",2017-02-13 14:30:02 +0000,http://finance.yahoo.com/news/zacks-com-featured-highlights-ets-143002708.html,"Zacks.com featured highlights: Ets, Incyte, Abercrombie & Fitch, Vertex Pharmaceuticals and Bottomline Technologies"
VRTX,VRTX:UW,BBG000C1SD31,Is Gilead Sciences Getting Ready for a Massive Acquisition?,2017-02-12 18:17:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_rarwiDRtLg/is-gilead-sciences-getting-ready-for-a-massive-acquisition-cm746773,Gilead Sciences NASDAQ GILD reported enough bad news on Tuesday to inspire a blues song Falling revenue Sinking earnings Horrible outlook for this year Perhaps the big biotech needs to develop an antidepressant just to give to its shareholders On the other hand
VRTX,VRTX:UW,BBG000C1SD31,Biotech ETFs Powered by Q4 Earnings,2017-02-10 15:22:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OJuFssEKJO8/biotech-etfs-powered-by-q4-earnings-cm746320,The biotech industry which was shunned by investors last year made a strong comeback following Trump s victory in anticipation of softer regulation Though Trump spooked the industry by saying that drugmakers are getting away with murder and pledging to initiate a bidding process for
VRTX,VRTX:UW,BBG000C1SD31,Why Vertex Pharmaceuticals Stock Surged Higher in January,2017-02-09 23:19:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MuoyD2_2540/why-vertex-pharmaceuticals-stock-surged-higher-in-january-cm745897,What happened According to data from S amp P Global Market Intelligence shares of the rare disease specialist Vertex Pharmaceuticals NASDAQ VRTX rose by 16 6 last month The drugmaker s shares appear to have benefited from both the company s presentation at the 35th
VRTX,VRTX:UW,BBG000C1SD31,Why Vertex Pharmaceuticals Stock Surged Higher in January,2017-02-09 21:40:41 +0000,http://www.fool.com/investing/2017/02/09/why-vertex-pharmaceuticals-stock-surged-higher-in.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why Vertex Pharmaceuticals Stock Surged Higher in January
VRTX,VRTX:UW,BBG000C1SD31,5 Toxic Stocks to Dump or Play Short for Gains,2017-02-09 14:19:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/K5ddafma94U/5-toxic-stocks-to-dump-or-play-short-for-gains-cm745407,Precise identification of overpriced stocks and rightly priced stocks holds the key to successful investing However it is not easy to do so as the correctly priced stocks and the bubble stocks are deceptively intermixed in the market place Investors who can figure out the overpriced toxic
VRTX,VRTX:UW,BBG000C1SD31,5 Toxic Stocks to Dump or Play Short for Gains,2017-02-09 13:09:01 +0000,http://finance.yahoo.com/news/5-toxic-stocks-dump-play-130901931.html,5 Toxic Stocks to Dump or Play Short for Gains
VRTX,VRTX:UW,BBG000C1SD31,"Top Analyst Reports for Alphabet, Citigroup, Chevron & Others",2017-01-31 21:31:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yIG0m8U-lAc/top-analyst-reports-for-alphabet-citigroup-chevron-others-cm741163,Tuesday January 31 2017 Today s Research Daily features new research reports on 16 major stocks including Alphabet GOOGL Chevron CVX and Citigroup C You can see all of today s research reports here gt gt gt Buy rated Alphabet shares have lagged the broader market
VRTX,VRTX:UW,BBG000C1SD31,"Premarket Biotech Movers: Neurocrine Biosciences, Aralez Pharmaceuticals, Qiagen",2017-01-27 14:46:00 +0000,https://www.thestreet.com/story/13969574/1/premarket-biotech-movers-neurocrine-biosciences-aralez-pharmaceuticals-qiagen.html?puc=yahoo&cm_ven=YAHOO,"Premarket Biotech Movers: Neurocrine Biosciences, Aralez Pharmaceuticals, Qiagen"
VRTX,VRTX:UW,BBG000C1SD31,Biotech M&A Activity Expected to Rise in 2017: Latest Reports on Exelixis and Vertex Pharmaceuticals,2017-01-27 14:45:00 +0000,http://finance.yahoo.com/news/biotech-m-activity-expected-rise-144500106.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / January 27, 2017 / The Biotech Industry witnessed a drop in mergers and acquisitions (M&A) activity amidst a slump in 2016. The Nasdaq Biotech Index declined roughly 22 percent ..."
VRTX,VRTX:UW,BBG000C1SD31,Blog Coverage Celgene Acquires Delinia; Set to Expand Inflammation and Immunology Portfolio,2017-01-27 13:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-celgene-acquires-delinia-131500797.html,"[Accesswire] - Upcoming AWS Coverage on Vertex Pharmaceuticals Post-Earnings Results LONDON, UK / ACCESSWIRE / January 27, 2017 / Active Wall St. blog coverage looks at the headline from Celgene Corp. (NASDAQ: CELG ) ..."
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharmaceuticals Incorporated Turns a Profit,2017-01-26 21:32:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VqNrFSHt-nI/vertex-pharmaceuticals-incorporated-turns-a-profit-cm738960,The fourth quarter revenue numbers for Vertex Pharmaceuticals NASDAQ VRTX weren t a big surprise since the biotech had previously announced preliminary results earlier this month at the JP Morgan Healthcare Conference Nevertheless Wednesday s earnings release contained details
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharmaceuticals Incorporated Turns a Profit,2017-01-26 19:43:55 +0000,http://www.fool.com/investing/2017/01/26/vertex-pharmaceuticals-incorporated-turns-a-profit.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Vertex Pharmaceuticals Incorporated Turns a Profit
VRTX,VRTX:UW,BBG000C1SD31,"Health Care Sector Update for 01/26/2017: VRTX,AVGR,ENTL",2017-01-26 19:10:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6-Jmj1ZGkPY/health-care-sector-update-for-01262017-vrtxavgrentl-cm738892,Top Health Care StocksTop Health Care Stocks JNJ 0 34 JNJ 0 34 PFE 0 21 PFE 0 21 MRK 1 61 MRK 1 61 ABT 0 03 ABT 0 03 AMGN 0 42 AMGN 0 42 Health care stocks still were extending their prior declines Thursday with the NYSE Health Care Index in a 0 3 slump while shares of health
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharma's (VRTX) Q4 Earnings & Sales Beat; Stock Up,2017-01-26 16:34:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TdoTuN4bIz8/vertex-pharmas-vrtx-q4-earnings-sales-beat-stock-up-cm738667,Vertex Pharmaceuticals Inc VRTX reported fourth quarter 2016 earnings of 11 cents per share including the impact of stock based compensation expenses The Zacks Consensus Estimate was of a loss of 1 cent per share Notably the company had posted breakeven results in the year ago
VRTX,VRTX:UW,BBG000C1SD31,"Vertex Pharmaceuticals, Inc. :VRTX-US: Earnings Analysis: Q4, 2016 By the Numbers : January 26, 2017",2017-01-26 15:32:47 +0000,http://www.capitalcube.com/blog/index.php/vertex-pharmaceuticals-inc-vrtx-us-earnings-analysis-q4-2016-by-the-numbers-january-26-2017/,"Vertex Pharmaceuticals, Inc. :VRTX-US: Earnings Analysis: Q4, 2016 By the Numbers : January 26, 2017"
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharma's (VRTX) Q4 Earnings & Sales Beat; Stock Up,2017-01-26 14:36:02 +0000,http://finance.yahoo.com/news/vertex-pharmas-vrtx-q4-earnings-143602302.html,Vertex Pharma's (VRTX) Q4 Earnings & Sales Beat; Stock Up
VRTX,VRTX:UW,BBG000C1SD31,Edited Transcript of VRTX earnings conference call or presentation 25-Jan-17 9:30pm GMT,2017-01-26 03:02:43 +0000,http://finance.yahoo.com/news/edited-transcript-vrtx-earnings-conference-030243280.html,Edited Transcript of VRTX earnings conference call or presentation 25-Jan-17 9:30pm GMT
VRTX,VRTX:UW,BBG000C1SD31,Vertex tops Street 4Q forecasts,2017-01-25 22:19:20 +0000,http://sg.finance.yahoo.com/news/vertex-tops-street-4q-forecasts-211931182.html,Vertex tops Street 4Q forecasts
VRTX,VRTX:UW,BBG000C1SD31,[$$] Vertex Pharmaceuticals Swings to Profit,2017-01-25 21:38:44 +0000,http://www.wsj.com/articles/vertex-pharmaceuticals-swings-to-quarterly-profit-1485380321?mod=yahoo_hs,[$$] Vertex Pharmaceuticals Swings to Profit
VRTX,VRTX:UW,BBG000C1SD31,"VERTEX PHARMACEUTICALS INC / MA Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statemen",2017-01-25 21:26:29 +0000,http://biz.yahoo.com/e/170125/vrtx8-k.html,"VERTEX PHARMACEUTICALS INC / MA Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statemen"
VRTX,VRTX:UW,BBG000C1SD31,Vertex Reports Full-Year and Fourth-Quarter 2016 Financial Results,2017-01-25 21:01:00 +0000,http://finance.yahoo.com/news/vertex-reports-full-fourth-quarter-210100205.html,"[Business Wire] - Vertex Pharmaceuticals Incorporated today reported consolidated financial results for the full-year and quarter-ended December 31, 2016. On January 8, 2017, Vertex provided a comprehensive update on its ongoing research and development programs in cystic fibrosis ."
VRTX,VRTX:UW,BBG000C1SD31,"After-Hours Earnings Report for January 25, 2017 :  T, QCOM, LVS, MCK, EBAY, CCI, WDC, VRTX, LRCX, XLNX, CTXS, NOW",2017-01-25 20:16:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/I2OrZY4wmfs/after-hours-earnings-report-for-january-25-2017-t-qcom-lvs-mck-ebay-cci-wdc-vrtx-lrcx-xlnx-ctxs-now-cm738237,The following companies are expected to report earnings after hours on 01 25 2017 Visit our Earnings Calendar for a full list of expected earnings releases AT amp T Inc T is reporting for the quarter ending December 31 2016 The wireless
VRTX,VRTX:UW,BBG000C1SD31,What Lies in Store for Pfizer (PFE) this Earnings Season?,2017-01-25 17:35:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9o6-j0c3Tt0/what-lies-in-store-for-pfizer-pfe-this-earnings-season-cm738132,Pfizer Inc PFE will be reporting fourth quarter and full year 2016 earnings results on Jan 31 before market open Last quarter the company delivered a negative earnings surprise of 1 61 Nonetheless the pharma giant has been consistently beating earnings expectations The company s
VRTX,VRTX:UW,BBG000C1SD31,Will Eli Lilly's (LLY) Earnings Surpass Estimates in Q4?,2017-01-25 17:35:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YtmLGFJ0mU8/will-eli-lillys-lly-earnings-surpass-estimates-in-q4-cm738127,We expect Eli Lilly and Company LLY to beat expectations when it reports fourth quarter and full year 2016 earnings results on Jan 31 before market opens So far this year Lilly s share price has improved 1 7 as against a decrease of 1 6 for the Zacks classified Large Cap Pharma
VRTX,VRTX:UW,BBG000C1SD31,"The Zacks Analyst Blog Highlights: RedHill Biopharma, Cempra, Vertex Pharmaceuticals, Acorda Therapeutics and Kite Pharma",2017-01-25 16:36:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FCzExf8pWWM/the-zacks-analyst-blog-highlights-redhill-biopharma-cempra-vertex-pharmaceuticals-acorda-therapeutics-and-kite-pharma-cm738022,For Immediate Release Chicago IL January 25 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharmaceuticals Inc. Reveals 100% Rise In Q4 Earnings,2017-01-25 16:21:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oAHC6MUu6bo/vertex-pharmaceuticals-inc-reveals-100-rise-in-q4-earnings-20170125-01244,Vertex Pharmaceuticals Inc. Reveals 100% Rise In Q4 Earnings
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharmaceuticals Q4 16 Earnings Conference Call At 4:30 PM ET,2017-01-25 15:02:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SkdiLfIvOEs/vertex-pharmaceuticals-q4-16-earnings-conference-call-at-430-pm-et-20170125-01066,Vertex Pharmaceuticals Q4 16 Earnings Conference Call At 4:30 PM ET
VRTX,VRTX:UW,BBG000C1SD31,"The Zacks Analyst Blog Highlights: RedHill Biopharma, Cempra, Vertex Pharmaceuticals, Acorda Therapeutics and Kite Pharma",2017-01-25 14:30:02 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-redhill-143002093.html,"The Zacks Analyst Blog Highlights: RedHill Biopharma, Cempra, Vertex Pharmaceuticals, Acorda Therapeutics and Kite Pharma"
VRTX,VRTX:UW,BBG000C1SD31,"Biotech Stock Roundup: Synergy Drug Gets FDA Nod, AbbVie, GILD HCV Drugs under EU Review",2017-01-25 13:32:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/K9TilylyjZM/biotech-stock-roundup-synergy-drug-gets-fda-nod-abbvie-gild-hcv-drugs-under-eu-review-cm737784,There were quite a few updates on the regulatory front this week with Synergy SGYP gaining FDA approval for its constipation drug while both Gilead GILD and AbbVie ABBV got accelerated assessment for their HCV drugs in the EU Recap of the Week s Most Important Stories AbbVie
VRTX,VRTX:UW,BBG000C1SD31,Q4 2016 Vertex Pharmaceuticals Inc Earnings Release - After Market Close,2017-01-25 12:07:05 +0000,http://biz.yahoo.com/research/earncal/20170125.html?t=vrtx,Q4 2016 Vertex Pharmaceuticals Inc Earnings Release - After Market Close
VRTX,VRTX:UW,BBG000C1SD31,Can AbbVie (ABBV) Spring a Surprise This Earnings Season?,2017-01-24 23:32:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Kk9B-RTCfo0/can-abbvie-abbv-spring-a-surprise-this-earnings-season-cm737701,AbbVie Inc ABBV is slated to release fourth quarter and full year 2016 earnings results before the opening bell on Jan 27 AbbVie s shares improved 4 0 in the past one year while the Zacks classified Biomed Genetics industry recorded a decline of 1 6 Last quarter the
VRTX,VRTX:UW,BBG000C1SD31,Why Vertex (VRTX) Might Surprise This Earnings Season,2017-01-24 15:34:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lz0VSWlGhfk/why-vertex-vrtx-might-surprise-this-earnings-season-cm737243,Investors are always looking for stocks that are poised to beat at earnings season and Vertex Pharmaceuticals Incorporated VRTX may be one such company The firm has earnings coming up pretty soon and events are shaping up quite nicely for their report That is because Vertex is
VRTX,VRTX:UW,BBG000C1SD31,Will These 5 Drug Stocks Be Big Winners in the Q4 Earnings Season?,2017-01-24 14:34:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nYaiSLmbbL0/will-these-5-drug-stocks-be-big-winners-in-the-q4-earnings-season-cm737283,The fourth quarter earnings season has started on a good note with both earnings and revenue growth improving compared to recent quarters Banks in particular have been reporting better than expected year over year growth While Q3 was a turnaround quarter for the S amp P 500 index after
VRTX,VRTX:UW,BBG000C1SD31,Why Vertex (VRTX) Might Surprise This Earnings Season,2017-01-24 13:51:01 +0000,http://finance.yahoo.com/news/why-vertex-vrtx-might-surprise-135101846.html,Why Vertex (VRTX) Might Surprise This Earnings Season
VRTX,VRTX:UW,BBG000C1SD31,Will These 5 Drug Stocks Be Big Winners in the Q4 Earnings Season?,2017-01-24 13:14:01 +0000,http://finance.yahoo.com/news/5-drug-stocks-big-winners-131401859.html,Will These 5 Drug Stocks Be Big Winners in the Q4 Earnings Season?
VRTX,VRTX:UW,BBG000C1SD31,Concert's (CNCE) CTP-656 Gets Orphan Drug Status in U.S.,2017-01-24 00:31:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NVc_2RTfDn4/concerts-cnce-ctp-656-gets-orphan-drug-status-in-us-cm737056,Concert Pharmaceuticals Inc CNCE announced that the FDA has granted orphan drug designation to its candidate CTP 656 for the treatment of cystic fibrosis We note that orphan drug designation is granted to drugs capable of treating diseases affecting less than 200 000 people in the U
VRTX,VRTX:UW,BBG000C1SD31,Concert's (CNCE) CTP-656 Gets Orphan Drug Status in U.S.,2017-01-23 22:32:10 +0000,http://finance.yahoo.com/news/concerts-cnce-ctp-656-gets-223210433.html,Concert's (CNCE) CTP-656 Gets Orphan Drug Status in U.S.
VRTX,VRTX:UW,BBG000C1SD31,4 Drug Stocks Poised to Surprise this Earnings Season,2017-01-20 21:37:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vsXrsR8Pacs/4-drug-stocks-poised-to-surprise-this-earnings-season-cm736210,In the biotech sector investor focus will now shift from the annual J P Morgan Healthcare Conference to the Q4 earnings season The sector has faced challenging conditions for more than a year due to media and political focus on steep drug pricing issues Meanwhile merger
VRTX,VRTX:UW,BBG000C1SD31,4 Drug Stocks Poised to Surprise this Earnings Season,2017-01-20 19:41:07 +0000,http://finance.yahoo.com/news/4-drug-stocks-poised-surprise-194107646.html,4 Drug Stocks Poised to Surprise this Earnings Season
VRTX,VRTX:UW,BBG000C1SD31,3 Beaten-Down Biotech Stocks You Can Buy Right Now,2017-01-20 15:41:30 +0000,http://www.fool.com/investing/2017/01/19/3-beaten-down-biotech-stocks-you-can-buy-right-now.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Beaten-Down Biotech Stocks You Can Buy Right Now
VRTX,VRTX:UW,BBG000C1SD31,"Vertex Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : VRTX-US : January 20, 2017",2017-01-20 13:35:16 +0000,http://www.capitalcube.com/blog/index.php/vertex-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bearish-manner-vrtx-us-january-20-2017/,"Vertex Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : VRTX-US : January 20, 2017"
VRTX,VRTX:UW,BBG000C1SD31,"Biotech Stocks Might Catalyze, Or Plunge, On 4 Key Sectors In 2017",2017-01-20 12:00:47 +0000,http://www.investors.com/news/technology/biotech-stocks-might-catalyze-or-plunge-on-4-key-sectors-in-2017/,"Biotech Stocks Might Catalyze, Or Plunge, On 4 Key Sectors In 2017"
VRTX,VRTX:UW,BBG000C1SD31,Seaport traffic gets dose of relief as Vertex joins shuttle program,2017-01-20 03:15:05 +0000,http://www.bizjournals.com/boston/news/2017/01/19/seaport-traffic-gets-dose-of-relief-as-vertex.html?ana=yahoo,Seaport traffic gets dose of relief as Vertex joins shuttle program
VRTX,VRTX:UW,BBG000C1SD31,3 Beaten-Down Biotech Stocks You Can Buy Right Now,2017-01-19 17:58:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BmQxdkPYbXY/3-beaten-down-biotech-stocks-you-can-buy-right-now-cm735531,What goes up must come down But what about the other way around That could be the case for three beaten down biotech stocks Celldex Therapeutics NASDAQ CLDX Geron NASDAQ GERN and Vertex Pharmaceuticals NASDAQ VRTX Here s why buying these biotech stocks
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharma (VRTX) Q4 Earnings: Stock Likely to Beat?,2017-01-19 15:42:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FBxpCbvYNfY/vertex-pharma-vrtx-q4-earnings-stock-likely-to-beat-cm735337,We expect biotech company Vertex Pharmaceuticals Inc VRTX to beat expectations when it reports fourth quarter 2016 and full year earnings results on Jan 25 after the market closes Vertex s share price lost 14 9 in the past one year comparing unfavorably with the 12 9 decline
VRTX,VRTX:UW,BBG000C1SD31,Baird Has 4 Red-Hot Biotechs to Buy for 2017 With Huge Upside Potential,2017-01-19 13:40:50 +0000,http://finance.yahoo.com/news/baird-4-red-hot-biotechs-134050054.html,Baird Has 4 Red-Hot Biotechs to Buy for 2017 With Huge Upside Potential
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharma (VRTX) Q4 Earnings: Stock Likely to Beat?,2017-01-19 13:37:01 +0000,http://finance.yahoo.com/news/vertex-pharma-vrtx-q4-earnings-133701470.html,Vertex Pharma (VRTX) Q4 Earnings: Stock Likely to Beat?
VRTX,VRTX:UW,BBG000C1SD31,Blog Coverage Paratek Announced Enrollment Completion in Omadacycline Phase-3 Community-Acquired Bacterial Pneumonia Study,2017-01-19 13:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-paratek-announced-enrollment-131500319.html,"[Accesswire] - Upcoming AWS Coverage on Vertex Pharmaceuticals Post-Earnings Results LONDON, UK / ACCESSWIRE / January 19, 2017 / Active Wall St. blog coverage looks at the headline from Paratek Pharmaceuticals, Inc. ..."
VRTX,VRTX:UW,BBG000C1SD31,"Gilead 2017 Outlook Hamstrung On Hep C, But RBC Bullish On Amgen, Biogen",2017-01-18 21:33:27 +0000,http://www.investors.com/news/technology/gilead-2017-outlook-hamstrung-on-hep-c-but-rbc-bullish-on-amgen-biogen/,"Gilead 2017 Outlook Hamstrung On Hep C, But RBC Bullish On Amgen, Biogen"
VRTX,VRTX:UW,BBG000C1SD31,"Concert Offers Update on Cystic Fibrosis Drug, Stock Down",2017-01-18 19:37:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7VWpcltxQaQ/concert-offers-update-on-cystic-fibrosis-drug-stock-down-cm734972,Concert Pharmaceuticals Inc CNCE provided update on the development plan of its next generation CFTR potentiator CTP 656 for the treatment of cystic fibrosis in the U S and Europe Shares of the company were down approximately 14 on the news Moreover Concert s share price has
VRTX,VRTX:UW,BBG000C1SD31,"Concert Offers Update on Cystic Fibrosis Drug, Stock Down",2017-01-18 17:38:05 +0000,http://finance.yahoo.com/news/concert-offers-cystic-fibrosis-drug-173805741.html,"Concert Offers Update on Cystic Fibrosis Drug, Stock Down"
VRTX,VRTX:UW,BBG000C1SD31,Why Vertex Pharmaceuticals (VRTX) Could Be Positioned for a Surge,2017-01-18 15:41:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/swkrHZAhb_8/why-vertex-pharmaceuticals-vrtx-could-be-positioned-for-a-surge-cm734737,Vertex Pharmaceuticals Incorporated VRTX discovers develops and markets small molecule drugs that address major unmet medical needs that could be an interesting play for investors That is because not only does the stock have decent short term momentum but it is seeing solid activity on
VRTX,VRTX:UW,BBG000C1SD31,Why Vertex Pharmaceuticals (VRTX) Could Be Positioned for a Surge,2017-01-18 13:38:01 +0000,http://finance.yahoo.com/news/why-vertex-pharmaceuticals-vrtx-could-133801461.html,Why Vertex Pharmaceuticals (VRTX) Could Be Positioned for a Surge
VRTX,VRTX:UW,BBG000C1SD31,Why Vertex Pharmaceuticals Stock Sank 42% in 2016,2017-01-17 15:39:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fOLnl-iUDlk/why-vertex-pharmaceuticals-stock-sank-42-in-2016-cm734143,Image source Getty Images What happened Shares of Vertex Pharmaceuticals Incorporated NASDAQ VRTX a biopharmaceutical company with a leading role in cystic fibrosis treatment sank 42 5 last year according to 160 data from S amp P Global Market
VRTX,VRTX:UW,BBG000C1SD31,Why Vertex Pharmaceuticals Stock Sank 42% in 2016,2017-01-17 13:55:33 +0000,http://www.fool.com/investing/2017/01/17/why-vertex-pharmaceuticals-stock-sank-42-in-2016.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why Vertex Pharmaceuticals Stock Sank 42% in 2016
VRTX,VRTX:UW,BBG000C1SD31,Biotech ETFs Continue To Bleed,2017-01-12 17:01:00 +0000,http://blogs.barrons.com/focusonfunds/2017/01/12/biotech-etfs-continue-to-bleed/?mod=yahoobarrons&ru=yahoo,Biotech ETFs Continue To Bleed
VRTX,VRTX:UW,BBG000C1SD31,"Merck KGaA, Vertex Announce Tie-Up for Oncology Programs",2017-01-12 16:02:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QoUywuSfh2I/merck-kgaa-vertex-announce-tie-up-for-oncology-programs-cm732689,Germany based Merck KGaA MKGAF announced that it has entered into a licensing agreement with Vertex Pharmaceuticals Incorporated VRTX for the global development and commercialization of four research and development programs for the treatment of cancer A look at Merck KGaA s share
VRTX,VRTX:UW,BBG000C1SD31,"Merck KGaA, Vertex Announce Tie-Up for Oncology Programs",2017-01-12 13:43:01 +0000,http://finance.yahoo.com/news/merck-kgaa-vertex-announce-tie-134301180.html,"Merck KGaA, Vertex Announce Tie-Up for Oncology Programs"
VRTX,VRTX:UW,BBG000C1SD31,"Vertex Pharmaceuticals, Inc. – Value Analysis (NASDAQ:VRTX) : January 11, 2017",2017-01-11 16:49:06 +0000,http://www.capitalcube.com/blog/index.php/vertex-pharmaceuticals-inc-value-analysis-nasdaqvrtx-january-11-2017/,"Vertex Pharmaceuticals, Inc. – Value Analysis (NASDAQ:VRTX) : January 11, 2017"
VRTX,VRTX:UW,BBG000C1SD31,Vertex deals cancer drug programs to Merck KGaA for $230M,2017-01-11 16:35:06 +0000,http://www.bizjournals.com/boston/news/2017/01/11/vertex-deals-cancer-drug-programs-to-merck-for.html?ana=yahoo,Vertex deals cancer drug programs to Merck KGaA for $230M
VRTX,VRTX:UW,BBG000C1SD31,"Biotech Stock Roundup: ARIAD to be Acquired for $5.2B, Vertex Outlook Falls Short",2017-01-11 15:59:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/p5QQEtaGVTI/biotech-stock-roundup-ariad-to-be-acquired-for-52b-vertex-outlook-falls-short-cm732170,The big news in the biotech sector this week is the acquisition agreement under which Japanese firm Takeda will be acquiring cancer focused ARIAD ARIA for a whopping 5 2 billion Several other licensing deals and agreements were announced this week as well Recap of the Week s Most
VRTX,VRTX:UW,BBG000C1SD31,"VERTEX PHARMACEUTICALS INC / MA Files SEC form 8-K, Entry into a Material Definitive Agreement",2017-01-11 14:10:13 +0000,http://biz.yahoo.com/e/170111/vrtx8-k.html,"VERTEX PHARMACEUTICALS INC / MA Files SEC form 8-K, Entry into a Material Definitive Agreement"
VRTX,VRTX:UW,BBG000C1SD31,"Merck KGaA, Darmstadt, Germany Licenses Four Oncology Research and Development Programs from Vertex",2017-01-11 14:00:00 +0000,http://uk.finance.yahoo.com/news/merck-kgaa-darmstadt-germany-licenses-140000097.html,"Merck KGaA, Darmstadt, Germany Licenses Four Oncology Research and Development Programs from Vertex"
VRTX,VRTX:UW,BBG000C1SD31,Merck KGaA Licenses Four Oncology R&D Programs From Vertex,2017-01-11 09:11:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_eU_lZRfTSo/merck-kgaa-licenses-four-oncology-rd-programs-from-vertex-20170111-00441,Merck KGaA Licenses Four Oncology R&D Programs From Vertex
VRTX,VRTX:UW,BBG000C1SD31,Merck KGaA Licenses Four Oncology R&D Programs From Vertex,2017-01-11 09:11:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GBrHG7dfd3M/merck-kgaa-licenses-four-oncology-rd-programs-from-vertex-20170111-00442,Merck KGaA Licenses Four Oncology R&D Programs From Vertex
VRTX,VRTX:UW,BBG000C1SD31,Jefferies Has 5 Top Biotech Stocks to Buy for 2017,2017-01-10 13:35:34 +0000,http://finance.yahoo.com/news/jefferies-5-top-biotech-stocks-133534894.html,Jefferies Has 5 Top Biotech Stocks to Buy for 2017
VRTX,VRTX:UW,BBG000C1SD31,"Vertex Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : VRTX-US : January 10, 2017",2017-01-10 12:23:56 +0000,http://www.capitalcube.com/blog/index.php/vertex-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bullish-manner-vrtx-us-january-10-2017/,"Vertex Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : VRTX-US : January 10, 2017"
VRTX,VRTX:UW,BBG000C1SD31,5 Ways Vertex Pharmaceuticals Plans to Grow in 2017 and Beyond,2017-01-10 04:48:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-n0b-Qz3wEc/5-ways-vertex-pharmaceuticals-plans-to-grow-in-2017-and-beyond-cm731389,Last year wasn t so hot for Vertex Pharmaceuticals NASDAQ VRTX The biotech s shares dropped 40 However Vertex CEO Jeff Leiden said on Monday at the J P Morgan Healthcare Conference that business has never been stronger He also emphasized that the company has a clear pathway
VRTX,VRTX:UW,BBG000C1SD31,5 Ways Vertex Pharmaceuticals Plans to Grow in 2017 and Beyond,2017-01-10 03:08:55 +0000,http://www.fool.com/investing/2017/01/09/4-ways-vertex-pharmaceuticals-plans-to-grow-in-201.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,5 Ways Vertex Pharmaceuticals Plans to Grow in 2017 and Beyond
VRTX,VRTX:UW,BBG000C1SD31,Vertex Sales Guidance For Cystic Fibrosis Drug Orkambi Misses,2017-01-09 21:04:23 +0000,http://www.investors.com/news/technology/vertex-sales-guidance-for-cystic-fibrosis-drug-orkambi-misses/,Vertex Sales Guidance For Cystic Fibrosis Drug Orkambi Misses
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharmaceuticals to Rely on Acquisitions to Diversify Its Business,2017-01-09 20:12:00 +0000,http://www.thestreet.com/video/13947345/vertex-pharmaceuticals-to-rely-on-acquisitions-to-diversify-its-business.html?puc=yahoov&cm_ven=YAHOOV,Vertex Pharmaceuticals to Rely on Acquisitions to Diversify Its Business
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharma Will Use Deals to Diversify Beyond Cystic Fibrosis,2017-01-09 18:15:00 +0000,https://www.thestreet.com/story/13947173/1/vertex-pharma-will-use-deals-to-diversity-beyond-cystic-fibrosis.html?puc=yahoo&cm_ven=YAHOO,Vertex Pharma Will Use Deals to Diversify Beyond Cystic Fibrosis
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharmaceuticals Sees Sales of Cystic Fibrosis Drug Lower Than Expected,2017-01-09 15:31:00 +0000,http://www.thestreet.com/video/13946789/vertex-pharmaceuticals-sees-sales-of-cystic-fibrosis-drug-lower-than-expected.html?puc=yahoov&cm_ven=YAHOOV,Vertex Pharmaceuticals Sees Sales of Cystic Fibrosis Drug Lower Than Expected
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharma Issues Disappointing 2017 Orkambi Outlook,2017-01-09 14:53:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XRFldYnM1xk/vertex-pharma-issues-disappointing-2017-orkambi-outlook-cm730899,Vertex Pharmaceuticals Incorporated VRTX announced preliminary financial results for 2016 and issued a financial outlook for 2017 on Jan 8 ahead of a Jan 9 presentation at the JP Morgan healthcare conference in San Francisco Vertex s main therapeutic area of focus is cystic fibrosis
VRTX,VRTX:UW,BBG000C1SD31,"VERTEX PHARMACEUTICALS INC / MA Files SEC form 8-K/A, Results of Operations and Financial Condition, Financial Statem",2017-01-09 14:18:43 +0000,http://biz.yahoo.com/e/170109/vrtx8-k_a.html,"VERTEX PHARMACEUTICALS INC / MA Files SEC form 8-K/A, Results of Operations and Financial Condition, Financial Statem"
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharma Issues Disappointing 2017 Orkambi Outlook,2017-01-09 13:10:01 +0000,http://finance.yahoo.com/news/vertex-pharma-issues-disappointing-2017-131001196.html,Vertex Pharma Issues Disappointing 2017 Orkambi Outlook
VRTX,VRTX:UW,BBG000C1SD31,"VERTEX PHARMACEUTICALS INC / MA Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statemen",2017-01-09 12:22:59 +0000,http://biz.yahoo.com/e/170109/vrtx8-k.html,"VERTEX PHARMACEUTICALS INC / MA Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statemen"
VRTX,VRTX:UW,BBG000C1SD31,Vertex issues revenue outlook for cystic fibrosis treatments,2017-01-09 01:20:23 +0000,http://finance.yahoo.com/news/vertex-issues-revenue-outlook-cystic-012023779.html,Vertex issues revenue outlook for cystic fibrosis treatments
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharmaceuticals revenue outlook for cystic fibrosis treatments,2017-01-09 00:52:36 +0000,http://finance.yahoo.com/news/vertex-pharmaceuticals-revenue-outlook-cystic-005236128.html,Vertex Pharmaceuticals revenue outlook for cystic fibrosis treatments
VRTX,VRTX:UW,BBG000C1SD31,​Vertex sales prediction for top-selling drug lower than hoped,2017-01-08 23:11:06 +0000,http://www.bizjournals.com/boston/news/2017/01/08/vertex-sales-prediction-for-top-selling-drug.html?ana=yahoo,​Vertex sales prediction for top-selling drug lower than hoped
VRTX,VRTX:UW,BBG000C1SD31,Vertex View into Cystic Fibrosis Sales Growth Still Limited by European Reimbursement,2017-01-08 22:01:00 +0000,https://www.thestreet.com/story/13945900/1/vertex-view-into-cystic-fibrosis-sales-growth-still-limited-by-european-reimbursement.html?puc=yahoo&cm_ven=YAHOO,Vertex View into Cystic Fibrosis Sales Growth Still Limited by European Reimbursement
VRTX,VRTX:UW,BBG000C1SD31,Vertex Provides Update on Business and Financial Performance and Research and Development Programs,2017-01-08 22:00:00 +0000,http://finance.yahoo.com/news/vertex-provides-business-financial-performance-220000571.html,"[Business Wire] - Vertex Pharmaceuticals Incorporated today provided an update on its business performance, including preliminary financial results for 2016 and a financial outlook for 2017, and an update on its ongoing research and development programs."
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharma Provides Update On Business And Financial Performance,2017-01-08 19:16:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BnE1_AEhZm4/vertex-pharma-provides-update-on-business-and-financial-performance-20170108-00023,Vertex Pharma Provides Update On Business And Financial Performance
VRTX,VRTX:UW,BBG000C1SD31,Here Are 6 Things to Watch Out for at J.P. Morgan's Healthcare Conference Next Week,2017-01-07 15:13:00 +0000,https://www.thestreet.com/story/13942819/1/six-happenings-you-won-t-want-to-miss-when-frisco-takes-center-stage-in-healthcare.html?puc=yahoo&cm_ven=YAHOO,Here Are 6 Things to Watch Out for at J.P. Morgan's Healthcare Conference Next Week
VRTX,VRTX:UW,BBG000C1SD31,Here's what to expect from Mass. biotechs at this weekend's J.P. Morgan conference,2017-01-05 19:40:11 +0000,http://www.bizjournals.com/boston/news/2017/01/05/heres-what-to-expect-from-mass-biotechs-at-this.html?ana=yahoo,Here's what to expect from Mass. biotechs at this weekend's J.P. Morgan conference
VRTX,VRTX:UW,BBG000C1SD31,Vertex Announces Upcoming Presentation at the J.P. Morgan Healthcare Conference and Date of Fourth Quarter and Full Year 2016 Financial Results,2017-01-04 21:33:11 +0000,http://www.publicnow.com/view/F116F24747D3315DDECBE1511F04CEBA1D184C10,"[at noodls] - January 4, 2017 BOSTON--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it will webcast its corporate presentation at the 35th Annual J.P. Morgan Healthcare Conference ..."
VRTX,VRTX:UW,BBG000C1SD31,Vertex Announces Upcoming Presentation at the J.P. Morgan Healthcare Conference and Date of Fourth Quarter and Full Year 2016 Financial Results,2017-01-04 21:01:00 +0000,http://finance.yahoo.com/news/vertex-announces-upcoming-presentation-j-210100555.html,"[Business Wire] - Vertex Pharmaceuticals Incorporated today announced that it will webcast its corporate presentation at the 35th Annual J.P. Morgan Healthcare Conference on Monday, January 9 at 12:30 p.m."
VRTX,VRTX:UW,BBG000C1SD31,"Biotech Stock Roundup: Inotek Plunges on Pipeline Setback, Kite Files IND for Study Initiation",2017-01-04 13:38:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1Nr2bJB8Qk8/biotech-stock-roundup-inotek-plunges-on-pipeline-setback-kite-files-ind-for-study-initiation-cm729122,It was a relatively slow week for the biotech sector though companies like Inotek ITEK and OPKO OPK made it to the headlines due to pipeline setbacks Recap of the Week s Most Important Stories Inotek Shares Hit by Disappointing Data Inotek s shares plunged 71 3 on news that
VRTX,VRTX:UW,BBG000C1SD31,"Biotech Stock Roundup: Inotek Plunges on Pipeline Setback, Kite Files IND for Study Initiation",2017-01-04 12:21:12 +0000,http://finance.yahoo.com/news/biotech-stock-roundup-inotek-plunges-122112679.html,"Biotech Stock Roundup: Inotek Plunges on Pipeline Setback, Kite Files IND for Study Initiation"
VRTX,VRTX:UW,BBG000C1SD31,Is Vertex Pharma (VRTX) Poised for a Turnaround in 2017?,2017-01-03 16:03:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xAzmQKPsjGA/is-vertex-pharma-vrtx-poised-for-a-turnaround-in-2017-cm728603,Vertex Pharmaceuticals Inc s VRTX main therapeutic area of focus is cystic fibrosis CF Presently the company markets two medicines for the disease Kalydeco and Orkambi How did Vertex Perform in 2016 Vertex has had a rough run last year It recorded negative earnings
VRTX,VRTX:UW,BBG000C1SD31,Is Vertex Pharma (VRTX) Poised for a Turnaround in 2017?,2017-01-03 13:53:01 +0000,http://finance.yahoo.com/news/vertex-pharma-vrtx-poised-turnaround-135301375.html,Is Vertex Pharma (VRTX) Poised for a Turnaround in 2017?
VRTX,VRTX:UW,BBG000C1SD31,5 Worst Performers in the S&P 500 in 2016,2016-12-30 21:18:44 +0000,http://blogs.wsj.com/briefly/2016/12/30/5-worst-performers-in-the-sp-500-in-2016/?mod=yahoo_hs,5 Worst Performers in the S&P 500 in 2016
VRTX,VRTX:UW,BBG000C1SD31,Combination Therapy Could Boost Vertex Pharmaceuticals’ Revenues,2016-12-30 15:36:31 +0000,http://marketrealist.com/2016/12/combination-therapy-vx-661-ivacaftor-may-boost-vertex-pharmaceuticals-revenues-future/?utm_source=yahoo&utm_medium=feed,Combination Therapy Could Boost Vertex Pharmaceuticals’ Revenues
VRTX,VRTX:UW,BBG000C1SD31,Vertex Has Adopted Multiple Approaches to Treat Cystic Fibrosis,2016-12-30 14:07:05 +0000,http://marketrealist.com/2016/12/vertex-pharmaceuticals-adopts-multiple-approaches-treat-cystic-fibrosis-patients/?utm_source=yahoo&utm_medium=feed,Vertex Has Adopted Multiple Approaches to Treat Cystic Fibrosis
VRTX,VRTX:UW,BBG000C1SD31,Cystic Fibrosis Strategy: Will It Boost Vertex’s Future Revenues?,2016-12-30 12:37:54 +0000,http://marketrealist.com/2016/12/cystic-fibrosis-strategy-expected-boost-vertex-pharmaceuticals-revenues-future-years/?utm_source=yahoo&utm_medium=feed,Cystic Fibrosis Strategy: Will It Boost Vertex’s Future Revenues?
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharmaceuticals’ Kalydeco May See Stable Patient Demand,2016-12-29 21:35:28 +0000,http://marketrealist.com/2016/12/kalydeco-may-witness-stable-patient-demand-2017/?utm_source=yahoo&utm_medium=feed,Vertex Pharmaceuticals’ Kalydeco May See Stable Patient Demand
VRTX,VRTX:UW,BBG000C1SD31,Orkambi Is Still Strong Revenue Driver for Vertex Pharmaceuticals,2016-12-29 20:05:28 +0000,http://marketrealist.com/2016/12/orkambi-continues-strong-revenue-driver-vertex-pharmaceuticals-2016/?utm_source=yahoo&utm_medium=feed,Orkambi Is Still Strong Revenue Driver for Vertex Pharmaceuticals
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharmaceuticals Expects Strong Revenue Growth in 2016,2016-12-29 18:14:25 +0000,http://marketrealist.com/2016/12/vertex-pharmaceuticals-expects-strong-revenue-growth-2016/?utm_source=yahoo&utm_medium=feed,Vertex Pharmaceuticals Expects Strong Revenue Growth in 2016
VRTX,VRTX:UW,BBG000C1SD31,Regeneron vs. Vertex: Which Stock is a Better Pick?,2016-12-29 13:59:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_nT6q-LYuBI/regeneron-vs-vertex-which-stock-is-a-better-pick-cm727275,Biotech stocks have had a rough year with the sector remaining under pressure for a major part of 2016 mainly due to political rhetoric regarding the high prices of drugs Although the sector responded favorably to the election of Donald Trump a lot of uncertainty prevails especially
VRTX,VRTX:UW,BBG000C1SD31,Regeneron vs. Vertex: Which Stock is a Better Pick?,2016-12-29 12:12:12 +0000,http://finance.yahoo.com/news/regeneron-vs-vertex-stock-better-121212798.html,Regeneron vs. Vertex: Which Stock is a Better Pick?
VRTX,VRTX:UW,BBG000C1SD31,Why United Therapeutics Expects Strong Revenue Growth,2016-12-28 15:55:16 +0000,http://marketrealist.com/2016/12/united-therapeutics-expects-strong-revenue-growth-2016/?utm_source=yahoo&utm_medium=feed,Why United Therapeutics Expects Strong Revenue Growth
VRTX,VRTX:UW,BBG000C1SD31,"Biotech Stock Roundup: FDA Nod for Biogen/Ionis Drug, Seattle Genetics Hit by Clinical Hold",2016-12-28 15:02:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5Jkz0UVgKkE/biotech-stock-roundup-fda-nod-for-biogenionis-drug-seattle-genetics-hit-by-clinical-hold-cm726791,Biogen BIIB and Ionis IONS got an early Christmas gift with the FDA approving their spinal muscular atrophy SMA treatment Spinraza three months within the filing of the regulatory application Meanwhile Seattle Genetics SGEN has been hit by clinical holds on several early stage
VRTX,VRTX:UW,BBG000C1SD31,3 Precision Medicine Stocks to Buy in January,2016-12-27 20:07:34 +0000,http://www.fool.com/investing/2016/12/27/3-precision-medicine-stocks-to-buy-in-january.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Precision Medicine Stocks to Buy in January
VRTX,VRTX:UW,BBG000C1SD31,Galapagos NV Announces Results From Cystic Fibrosis Treatment Study,2016-12-27 19:48:20 +0000,http://finance.yahoo.com/news/galapagos-nv-announces-results-cystic-194820826.html,Galapagos NV Announces Results From Cystic Fibrosis Treatment Study
VRTX,VRTX:UW,BBG000C1SD31,Time for biotech to boom ... or bust?,2016-12-27 19:45:00 +0000,http://finance.yahoo.com/video/time-biotech-boom-bust-194500895.html,Time for biotech to boom ... or bust?
VRTX,VRTX:UW,BBG000C1SD31,"Stock Market News for December 27, 2016",2016-12-27 17:57:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MaTwsn2mxUU/stock-market-news-for-december-27-2016-cm726524,Major U S benchmarks ended the last trading session ahead of Christmas holiday on a positive note as investors continued to cheer Trump s promises Encouraging economic data also played a vital role in boosting stocks on Friday While healthcare sector emerged as the biggest gainer decline
VRTX,VRTX:UW,BBG000C1SD31,3 Precision Medicine Stocks to Buy in January,2016-12-27 13:57:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Egsu_sEbeRo/3-precision-medicine-stocks-to-buy-in-january-cm726145,Precision medicine The term might sound futuristic but the future has arrived The National Institutes of Health defines precision medicine as an emerging approach for disease treatment and prevention that takes into account individual variability in genes environment and
VRTX,VRTX:UW,BBG000C1SD31,"Market Close Report: NASDAQ Composite index closes at 5,462.69 up 15.27 points",2016-12-23 21:49:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RNwpa_rgPdQ/market-close-report-nasdaq-composite-index-closes-at-546269-up-1527-points-cm725884,Friday s session closes with the NASDAQ Composite Index at 5 462 69 The total shares traded for the NASDAQ was over 1 18 billion Friday s session closes with the NASDAQ Composite Index at 5 462 69 The total shares traded for the NASDAQ was over 1 18 billion Advancers stocks led declining by 2
VRTX,VRTX:UW,BBG000C1SD31,"Nasdaq 100 Movers: CTAS, NTES",2016-12-23 16:59:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jNGvNUaMqFo/nasdaq-100-movers-ctas-ntes-cm725749,In early trading on Friday shares of NetEase NTES topped the list of the day s best performing components of the Nasdaq 100 index trading up 2 6 Year to date NetEase registers a 22 9 gain And the worst performing Nasdaq 100 component thus far on the day is Cintas
VRTX,VRTX:UW,BBG000C1SD31,"Zacks.com featured highlights: Abercrombie & Fitch, Live Nation Entertainment, Herc Holdings, Conns and Vertex Pharmaceuticals",2016-12-23 16:58:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dUJfywr-z5Y/zackscom-featured-highlights-abercrombie-fitch-live-nation-entertainment-herc-holdings-conns-and-vertex-pharmaceuticals-cm725706,For Immediate Release Chicago IL December 23 2016 Stocks in this week s article include Abercrombie amp Fitch Co 160 NYSE ANF Free Report Live Nation Entertainment Inc NYSE LYV Free Report Herc Holdings Inc 160 NYSE HRI Free Report Conns
VRTX,VRTX:UW,BBG000C1SD31,"Zacks.com featured highlights: Abercrombie & Fitch, Live Nation Entertainment, Herc Holdings, Conns and Vertex Pharmaceuticals",2016-12-23 14:30:02 +0000,http://finance.yahoo.com/news/zacks-com-featured-highlights-abercrombie-143002617.html,"Zacks.com featured highlights: Abercrombie & Fitch, Live Nation Entertainment, Herc Holdings, Conns and Vertex Pharmaceuticals"
VRTX,VRTX:UW,BBG000C1SD31,Are These 3 Stocks the Biggest Comeback Opportunities of 2017?,2016-12-23 11:36:39 +0000,http://www.fool.com/investing/2016/12/22/are-these-3-stocks-the-biggest-comeback-opportunit.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Are These 3 Stocks the Biggest Comeback Opportunities of 2017?
VRTX,VRTX:UW,BBG000C1SD31,"ETFs with exposure to Vertex Pharmaceuticals, Inc. : December 22, 2016",2016-12-22 19:22:17 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-vertex-pharmaceuticals-inc-december-22-2016/,"ETFs with exposure to Vertex Pharmaceuticals, Inc. : December 22, 2016"
VRTX,VRTX:UW,BBG000C1SD31,Are These 3 Stocks the Biggest Comeback Opportunities of 2017?,2016-12-22 17:01:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JqWGDEjmx7c/are-these-3-stocks-the-biggest-comeback-opportunities-of-2017-cm725176,Don t try to catch a falling knife That s good advice literally and figuratively when it comes to buying stocks You never know if a plunging stock will go down a lot more Three stocks that have certainly fallen this year are Alexion Pharmaceuticals NASDAQ ALXN
VRTX,VRTX:UW,BBG000C1SD31,Health Care Sector Impacted Markets on December 21,2016-12-22 14:04:19 +0000,http://marketrealist.com/2016/12/health-care-sector-weigh-markets-december-21/?utm_source=yahoo&utm_medium=feed,Health Care Sector Impacted Markets on December 21
VRTX,VRTX:UW,BBG000C1SD31,5 Toxic Stocks to Remove from Your Portfolio or Play Short,2016-12-22 14:00:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/v8KQ_vSmRBs/5-toxic-stocks-to-remove-from-your-portfolio-or-play-short-cm724954,Accuracy in distinguishing overhyped stocks from the fairly priced ones leads to profitable investing In a complicated market place the overpriced stocks and the correctly priced ones are intermixed in such a way that differentiating between the two is a tough task Nonetheless figuring
VRTX,VRTX:UW,BBG000C1SD31,RBC Likes Large Cap Biotech Leaders for 2017,2016-12-22 13:25:48 +0000,http://247wallst.com/healthcare-business/2016/12/22/rbc-likes-large-cap-biotech-leaders-for-2017/,RBC Likes Large Cap Biotech Leaders for 2017
VRTX,VRTX:UW,BBG000C1SD31,"Regeneron Likely To Jump On Amgen LDL-Buster, But Expectations Too High",2016-12-20 21:32:30 +0000,http://www.investors.com/news/technology/regeneron-likely-to-jump-on-amgen-ldl-buster-but-expectations-too-high/,"Regeneron Likely To Jump On Amgen LDL-Buster, But Expectations Too High"
VRTX,VRTX:UW,BBG000C1SD31,Biotech Stocks: There Go the Generalists,2016-12-20 18:28:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/12/20/biotech-stocks-there-go-the-generalists/?mod=yahoobarrons&ru=yahoo,Biotech Stocks: There Go the Generalists
VRTX,VRTX:UW,BBG000C1SD31,First Week of VRTX February 2017 Options Trading,2016-12-20 15:59:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3PctTvjxJeE/first-week-of-vrtx-february-2017-options-trading-cm723997,Investors in Vertex Pharmaceuticals Inc Symbol VRTX saw new options become available this week for the February 2017 expiration At Stock Options Channel our YieldBoost formula has looked up and down the VRTX options chain for the new February 2017 contracts and identified one put and
VRTX,VRTX:UW,BBG000C1SD31,This Mass. tech company was one of the worst performing in the S&P 500 this year,2016-12-20 11:40:11 +0000,http://www.bizjournals.com/boston/news/2016/12/20/this-mass-tech-company-was-one-of-the-worst.html?ana=yahoo,This Mass. tech company was one of the worst performing in the S&P 500 this year
VRTX,VRTX:UW,BBG000C1SD31,"Vertex Announces German Reimbursement Agreement for ORKAMBI® (Lumacaftor/Ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis in People Ages 12 and Older with Two Copies of the F508del Mutation",2016-12-19 10:11:10 +0000,http://www.publicnow.com/view/341C58D21CB50D9B86E4A8365BF5D1BCECDE7EA2,"[at noodls] - December 19, 2016 LONDON--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (Nasdaq:VRTX) today announced it has reached a pricing and reimbursement agreement for ORKAMBI® (lumacaftor/ivacaftor) with ..."
VRTX,VRTX:UW,BBG000C1SD31,Vertex Announces German Pricing And Reimbursement Deal For CF Drug ORKAMBI,2016-12-19 05:18:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3nltnM5pge0/vertex-announces-german-pricing-and-reimbursement-deal-for-cf-drug-orkambi-20161219-00091,Vertex Announces German Pricing And Reimbursement Deal For CF Drug ORKAMBI
VRTX,VRTX:UW,BBG000C1SD31,We Did The Math PBE Can Go To $52,2016-12-15 14:58:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-qNiQn7hdF0/we-did-the-math-pbe-can-go-to-52-cm721898,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For
VRTX,VRTX:UW,BBG000C1SD31,"Despite A Downgrade, Vetr Still Bullish On Vertex",2016-12-14 20:16:38 +0000,http://finance.yahoo.com/news/despite-downgrade-vetr-still-bullish-201638821.html,"Despite A Downgrade, Vetr Still Bullish On Vertex"
VRTX,VRTX:UW,BBG000C1SD31,These Growth Stocks Could Double in 2017,2016-12-14 13:36:25 +0000,http://www.fool.com/investing/2016/12/13/these-growth-stocks-could-double-in-2017.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,These Growth Stocks Could Double in 2017
VRTX,VRTX:UW,BBG000C1SD31,These Growth Stocks Could Double in 2017,2016-12-13 17:00:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dbCSd7vmqGw/these-growth-stocks-could-double-in-2017-cm720851,How would you like to double your money in 2017 While it s rare for a company s stock to double in a single year it can happe particularly in the world of biotech Image source Getty Images But which companies have the greatest potential to generate jaw
VRTX,VRTX:UW,BBG000C1SD31,4 Red-Hot Biotechs Highlight Jefferies Top Stocks to Buy,2016-12-12 13:20:29 +0000,http://247wallst.com/healthcare-business/2016/12/12/4-red-hot-biotechs-highlight-jefferies-top-stocks-to-buy/,4 Red-Hot Biotechs Highlight Jefferies Top Stocks to Buy
VRTX,VRTX:UW,BBG000C1SD31,"Why Celgene Corporation (CELG), Nu Skin Enterprises, Inc. (NUS) and Pioneer Energy Services Corp (PES) Are 3 of Today’s Worst Stocks",2016-12-08 01:55:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JWWOhDcsVWY/why-celgene-corporation-celg-nu-skin-enterprises-inc-nus-and-pioneer-energy-services-corp-pes-are-3-of-todays-worst-stocks-cm718399,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Despite the slow start to the effort once the bulls got going later in the session they didn t look back The S amp P 500 ended the day at 2 241 35 up 1 32 That close was an all
VRTX,VRTX:UW,BBG000C1SD31,"Biotech Stock Roundup: Actelion Remains in M&A Spotlight, ASH Data in Focus",2016-12-07 16:00:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hCwvJS9FNHo/biotech-stock-roundup-actelion-remains-in-ma-spotlight-ash-data-in-focus-cm717971,Several companies like Celgene Read more Acceleron Celgene Present Myelodysplastic Syndromes Data Alexion Read more Alexion Presents Data from Ultra Rare Blood Disorder Study Juno and Kite KITE were present at the annual meeting of the American Society of Hematology ASH with data
VRTX,VRTX:UW,BBG000C1SD31,The Worst American Stocks of 2016,2016-12-07 15:58:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kXUuVSAE4Tg/the-worst-american-stocks-of-2016-cm717934,Image credit Getty Images All things considered it s been a pretty good year to be an investor in American stocks The S amp P 500 has returned 10 2 including dividends But that s the average there are plenty of stocks that have suffered substantial losses in 2016 All three
VRTX,VRTX:UW,BBG000C1SD31,The Worst American Stocks of 2016,2016-12-07 14:22:05 +0000,http://www.fool.com/investing/2016/12/07/the-worst-american-stocks-of-2016.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,The Worst American Stocks of 2016
VRTX,VRTX:UW,BBG000C1SD31,"ETFs with exposure to Vertex Pharmaceuticals, Inc. : December 2, 2016",2016-12-02 16:11:42 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-vertex-pharmaceuticals-inc-december-2-2016/,"ETFs with exposure to Vertex Pharmaceuticals, Inc. : December 2, 2016"
VRTX,VRTX:UW,BBG000C1SD31,"VERTEX PHARMACEUTICALS INC / MA Files SEC form 8-K, Change in Directors or Principal Officers",2016-12-02 13:42:27 +0000,http://biz.yahoo.com/e/161202/vrtx8-k.html,"VERTEX PHARMACEUTICALS INC / MA Files SEC form 8-K, Change in Directors or Principal Officers"
VRTX,VRTX:UW,BBG000C1SD31,Is State Street Corp (STT) Going to Burn These Hedge Funds?,2016-12-01 22:42:23 +0000,http://www.insidermonkey.com/blog/is-state-street-corp-stt-going-to-burn-these-hedge-funds-492234/,Is State Street Corp (STT) Going to Burn These Hedge Funds?
VRTX,VRTX:UW,BBG000C1SD31,"Vertex Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : VRTX-US : December 1, 2016",2016-12-01 12:38:14 +0000,http://www.capitalcube.com/blog/index.php/vertex-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bearish-manner-vrtx-us-december-1-2016/,"Vertex Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : VRTX-US : December 1, 2016"
VRTX,VRTX:UW,BBG000C1SD31,"Market Close Report: NASDAQ Composite index closes at 5,323.68 down -56.24 points",2016-11-30 21:49:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/w3mwd2e9b-0/market-close-report-nasdaq-composite-index-closes-at-532368-down-5624-points-cm716038,Wednesday s session closes with the NASDAQ Composite Index at 5 323 68 The total shares traded for the NASDAQ was over 1 97 billion Declining stocks led advancers by 1 81 to 1 ratio There were 1024 advancers and 1851 decliners for the day On the NASDAQ Stock Exchange 83 stocks reached a 52
VRTX,VRTX:UW,BBG000C1SD31,The Biggest Loser: Vertex Pharmaceuticals Drops 4.7%,2016-11-30 21:48:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/30/the-biggest-loser-vertex-pharmaceuticals-drops-4-7/?mod=yahoobarrons&ru=yahoo,The Biggest Loser: Vertex Pharmaceuticals Drops 4.7%
VRTX,VRTX:UW,BBG000C1SD31,Testing of Treatment for Cystic Fibrosis Patients Begins,2016-11-29 21:19:37 +0000,http://finance.yahoo.com/news/testing-treatment-cystic-fibrosis-patients-211937554.html,Testing of Treatment for Cystic Fibrosis Patients Begins
VRTX,VRTX:UW,BBG000C1SD31,More Base Building Ahead for Vertex Pharmaceuticals,2016-11-29 18:34:00 +0000,http://realmoney.thestreet.com/articles/11/29/2016/more-base-building-ahead-vertex-pharmaceuticals?puc=yahoo&cm_ven=YAHOO,More Base Building Ahead for Vertex Pharmaceuticals
VRTX,VRTX:UW,BBG000C1SD31,"Nasdaq 100 Movers: BMRN, NFLX",2016-11-29 16:54:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Orhc7QXLPGc/nasdaq-100-movers-bmrn-nflx-cm715113,In early trading on Tuesday shares of Netflix NFLX topped the list of the day s best performing components of the Nasdaq 100 index trading up 1 9 Year to date Netflix registers a 4 2 gain And the worst performing Nasdaq 100 component thus far on the day is BioMarin
VRTX,VRTX:UW,BBG000C1SD31,Nivalis (NVLS) Cystic Fibrosis Study Misses Primary Endpoint,2016-11-29 15:58:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LHel40-AbGA/nivalis-nvls-cystic-fibrosis-study-misses-primary-endpoint-cm715066,Nivalis Therapeutics Inc s NVLS shares plunged almost 53 in after hours trading on Nov 28 after the company announced disappointing top line data from a phase II study on its lead candidate cavosonstat for the treatment of cystic fibrosis CF The double blinded
VRTX,VRTX:UW,BBG000C1SD31,Top-performing Mass. biotech Corbus extends study of promising drug,2016-11-29 15:50:08 +0000,http://www.bizjournals.com/boston/news/2016/11/29/top-performing-mass-biotech-corbus-extends-study.html?ana=yahoo,Top-performing Mass. biotech Corbus extends study of promising drug
VRTX,VRTX:UW,BBG000C1SD31,"The Market In 5 Minutes: OPEC, Tiffany's And More Theranos Trouble",2016-11-29 14:02:38 +0000,http://finance.yahoo.com/news/market-5-minutes-opec-tiffanys-140238826.html,"The Market In 5 Minutes: OPEC, Tiffany's And More Theranos Trouble"
VRTX,VRTX:UW,BBG000C1SD31,Nivalis (NVLS) Cystic Fibrosis Study Misses Primary Endpoint,2016-11-29 13:57:01 +0000,http://finance.yahoo.com/news/nivalis-nvls-cystic-fibrosis-study-135701389.html,Nivalis (NVLS) Cystic Fibrosis Study Misses Primary Endpoint
VRTX,VRTX:UW,BBG000C1SD31,"FOLD Shrinks, JAZZ On Right Track, NVLS Choked Up, AAAP On Watch, NVRO Sues BSX",2016-11-29 00:22:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_blUfWqs7IM/fold-shrinks-jazz-on-right-track-nvls-choked-up-aaap-on-watch-nvro-sues-bsx-20161129-00005,"FOLD Shrinks, JAZZ On Right Track, NVLS Choked Up, AAAP On Watch, NVRO Sues BSX"
VRTX,VRTX:UW,BBG000C1SD31,Is Vertex Pharmaceuticals Incorporated (VRTX) Going to Burn These Hedge Funds?,2016-11-25 15:30:02 +0000,http://www.insidermonkey.com/blog/is-vertex-pharmaceuticals-incorporated-vrtx-going-to-burn-these-hedge-funds-491835/,Is Vertex Pharmaceuticals Incorporated (VRTX) Going to Burn These Hedge Funds?
VRTX,VRTX:UW,BBG000C1SD31,"Biotech Stock Roundup: Acorda Stops Ampyra PSWD Development, CRL for Spectrum's Qapzola",2016-11-23 13:05:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eaUft2HOB78/biotech-stock-roundup-acorda-stops-ampyra-pswd-development-crl-for-spectrums-qapzola-cm713105,With elections over and third quarter earnings season drawing to a close focus is back on pipeline and regulatory updates This week Acorda ACOR announced that it won t be continuing with the development of Ampyra for post stroke walking difficulties PSWD Meanwhile Spectrum SPPI got
VRTX,VRTX:UW,BBG000C1SD31,"Zacks.com featured highlights: Allegheny Technologies, salesforce.com, United States Steel, Vertex Pharmaceuticals and Continental Resources",2016-11-22 17:22:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/08W5g_lISEI/zackscom-featured-highlights-allegheny-technologies-salesforcecom-united-states-steel-vertex-pharmaceuticals-and-continental-resources-cm712766,For Immediate Release Chicago IL November 22 2016 Stocks in this week s article include Allegheny Technologies Inc NYSE ATI Free Report salesforce com inc NYSE CRM Free Report United States Steel Corp NYSE X Free Report
VRTX,VRTX:UW,BBG000C1SD31,"Zacks.com featured highlights: Allegheny Technologies, salesforce.com, United States Steel, Vertex Pharmaceuticals and Continental Resources",2016-11-22 14:30:02 +0000,http://finance.yahoo.com/news/zacks-com-featured-highlights-allegheny-143002219.html,"Zacks.com featured highlights: Allegheny Technologies, salesforce.com, United States Steel, Vertex Pharmaceuticals and Continental Resources"
VRTX,VRTX:UW,BBG000C1SD31,"Amgen, Biogen, Celgene Eye M&A In Trump's 'Pro-Biotech' World",2016-11-21 21:07:25 +0000,http://www.investors.com/news/technology/amgen-biogen-celgene-eye-ma-in-trumps-pro-biotech-world/,"Amgen, Biogen, Celgene Eye M&A In Trump's 'Pro-Biotech' World"
VRTX,VRTX:UW,BBG000C1SD31,5 Toxic Stocks to Get Rid Of or Play Short Right Now,2016-11-21 15:52:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FFvRaDSzkQ0/5-toxic-stocks-to-get-rid-of-or-play-short-right-now-cm711886,The ability to differentiate overhyped stocks from the fairly priced ones makes the investing foolproof But in the complex market place correctly priced stocks and over bubble stocks are mingled in such a way that making a distinction between them becomes very difficult Nevertheless
VRTX,VRTX:UW,BBG000C1SD31,"Baker to life science, tech firms: Hire more high school interns",2016-11-21 13:50:09 +0000,http://www.bizjournals.com/boston/news/2016/11/21/baker-to-life-science-tech-firms-hire-more-high.html?ana=yahoo,"Baker to life science, tech firms: Hire more high school interns"
VRTX,VRTX:UW,BBG000C1SD31,"10 biotech companies ripe for a buyout, courtesy of Donald Trump",2016-11-17 14:28:16 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=9AEFC198-ACC7-11E6-A769-02A54265C928&siteid=yhoof2,"10 biotech companies ripe for a buyout, courtesy of Donald Trump"
VRTX,VRTX:UW,BBG000C1SD31,"Biotech Stock Roundup: Biotech Stocks Soar on Election Results, Gilead HBV Drug Approved",2016-11-16 14:52:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/H6n1m2qsSWo/biotech-stock-roundup-biotech-stocks-soar-on-election-results-gilead-hbv-drug-approved-cm710023,Earnings reports pipeline updates and regulatory news were overshadowed by the run up to the Presidential election and the surprise win of Donald Trump In fact the biotech sector responded favorably to Trump s victory on hopes that there will be fewer drug pricing headwinds considering Trump
VRTX,VRTX:UW,BBG000C1SD31,"IBB, REGN, ALXN, VRTX: ETF Inflow Alert",2016-11-15 17:29:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Syp8GhNKWDU/ibb-regn-alxn-vrtx-etf-inflow-alert-cm709519,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Nasdaq Biotechnology ETF Symbol IBB where we have detected an approximate 1 5 billion dollar inflow that s a 21 4 increase week over week
VRTX,VRTX:UW,BBG000C1SD31,"FDA Snubs DVAX, Keep An Eye On OCUL, It''s All Green For BLUE",2016-11-15 01:21:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5kdvVrziyXY/fda-snubs-dvax-keep-an-eye-on-ocul-its-all-green-for-blue-20161115-00027,"FDA Snubs DVAX, Keep An Eye On OCUL, It''s All Green For BLUE"
VRTX,VRTX:UW,BBG000C1SD31,"FDA Snubs DVAX, Keep An Eye On OCUL, It's All Green For BLUE",2016-11-15 01:21:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_6PcBqSY1LI/fda-snubs-dvax-keep-an-eye-on-ocul-its-all-green-for-blue-20161115-00028,"FDA Snubs DVAX, Keep An Eye On OCUL, It's All Green For BLUE"
VRTX,VRTX:UW,BBG000C1SD31,Recent IPO Airgain Flies To New High After Strong Earnings,2016-11-14 21:38:13 +0000,http://www.investors.com/news/technology/recent-ipo-airgain-continues-to-fly-after-strong-earnings/,Recent IPO Airgain Flies To New High After Strong Earnings
VRTX,VRTX:UW,BBG000C1SD31,Norwood's Corbus regains title as state's top-performing biotech on drug study results,2016-11-14 15:03:22 +0000,http://www.bizjournals.com/boston/news/2016/11/14/norwoods-corbus-regains-title-as-states-top.html?ana=yahoo,Norwood's Corbus regains title as state's top-performing biotech on drug study results
VRTX,VRTX:UW,BBG000C1SD31,Peek Under The Hood: SPYX Has 10% Upside,2016-11-14 14:28:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qi0pAVpHZew/peek-under-the-hood-spyx-has-10-upside-cm708550,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
VRTX,VRTX:UW,BBG000C1SD31,"Nasdaq 100 Movers: ALXN, NVDA",2016-11-11 16:28:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/O1gFSp7Lpqs/nasdaq-100-movers-alxn-nvda-cm707853,In early trading on Friday shares of NVIDIA NVDA topped the list of the day s best performing components of the Nasdaq 100 index trading up 24 1 Year to date NVIDIA registers a 155 1 gain And the worst performing Nasdaq 100 component thus far on the day is Alexion
VRTX,VRTX:UW,BBG000C1SD31,"Vertex Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : VRTX-US : November 11, 2016",2016-11-11 12:17:08 +0000,http://www.capitalcube.com/blog/index.php/vertex-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bullish-manner-vrtx-us-november-11-2016/,"Vertex Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : VRTX-US : November 11, 2016"
VRTX,VRTX:UW,BBG000C1SD31,5 Health Care Stocks Set to Bounce,2016-11-10 20:00:00 +0000,http://realmoney.thestreet.com/articles/11/10/2016/5-health-care-stocks-set-bounce?puc=yahoo&cm_ven=YAHOO,5 Health Care Stocks Set to Bounce
VRTX,VRTX:UW,BBG000C1SD31,Why Vertex Pharmaceuticals Stock Slipped 13% in October,2016-11-10 18:03:03 +0000,http://www.fool.com/investing/2016/11/10/why-vertex-pharmaceuticals-stock-slipped-13-in-oct.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why Vertex Pharmaceuticals Stock Slipped 13% in October
VRTX,VRTX:UW,BBG000C1SD31,3 Reasons Trump Victory Brings New Day for Biotech,2016-11-10 17:30:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/10/3-reasons-its-a-new-day-for-biotech/?mod=yahoobarrons&ru=yahoo,3 Reasons Trump Victory Brings New Day for Biotech
VRTX,VRTX:UW,BBG000C1SD31,Why Vertex Pharmaceuticals Stock Slipped 13% in October,2016-11-10 15:55:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/B4rYO8bpIoU/why-vertex-pharmaceuticals-stock-slipped-13-in-october-cm707171,Image source Getty Images What happened Shares of cystic fibrosis drugmaker Vertex Pharmaceuticals NASDAQ VRTX fell 13 in October according to data from S amp P Global Market Intelligence Despite some fairly positive news an earnings report that failed to
VRTX,VRTX:UW,BBG000C1SD31,Why These Biotechs Are Soaring Today,2016-11-09 22:54:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZJGGZxGdoIE/why-these-biotechs-are-soaring-today-cm706827,Image source Getty Images What happened Juno Therapeutics NASDAQ JUNO Vertex Pharmaceuticals NASDAQ VRTX BioMarin Pharmaceutical NASDAQ BMRN and Celgene NASDAQ CELG were all up at least 10 as of 2 58 p m after Donald Trump won the U
VRTX,VRTX:UW,BBG000C1SD31,"Biotech, Drug Stocks Fly On Clinton Loss, But 'Trump Uncertainty'",2016-11-09 21:33:40 +0000,http://www.investors.com/research/ibd-industry-themes/biotechs-drugs-fly-on-clinton-defeat-but-trump-uncertainty-lingers/,"Biotech, Drug Stocks Fly On Clinton Loss, But 'Trump Uncertainty'"
VRTX,VRTX:UW,BBG000C1SD31,Why These Biotechs Are Soaring Today,2016-11-09 21:10:59 +0000,http://www.fool.com/investing/2016/11/09/why-these-biotechs-are-soaring-today.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why These Biotechs Are Soaring Today
VRTX,VRTX:UW,BBG000C1SD31,VRTX Crosses Above Key Moving Average Level,2016-11-09 19:54:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4NjvqRWBvV4/vrtx-crosses-above-key-moving-average-level-cm706690,In trading on Wednesday shares of Vertex Pharmaceuticals Inc Symbol VRTX crossed above their 200 day moving average of 88 21 changing hands as high as 93 80 per share Vertex Pharmaceuticals Inc shares are currently trading up about 10 5 on the day The chart below shows the one
VRTX,VRTX:UW,BBG000C1SD31,What Do Analysts Say about Regeneron after 3Q16 Earnings?,2016-11-09 19:04:05 +0000,http://marketrealist.com/2016/11/what-do-analysts-say-about-regeneron-after-3q16-earnings/?utm_source=yahoo&utm_medium=feed,What Do Analysts Say about Regeneron after 3Q16 Earnings?
VRTX,VRTX:UW,BBG000C1SD31,Vertex To Present At Credit Suisse Healthcare Conferenc; Webcast At 3:30 PM ET,2016-11-08 14:30:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CpFKYFlQeMc/vertex-to-present-at-credit-suisse-healthcare-conferenc-webcast-at-330-pm-et-20161108-00988,Vertex To Present At Credit Suisse Healthcare Conferenc; Webcast At 3:30 PM ET
VRTX,VRTX:UW,BBG000C1SD31,"The Zacks Analyst Blog Highlights: Cabot Oil & Gas, Zayo Group Holdings, Etsy, Live Nation Entertainment and Vertex Pharmaceuticals",2016-11-07 17:23:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2KNdQtQn_z0/the-zacks-analyst-blog-highlights-cabot-oil-gas-zayo-group-holdings-etsy-live-nation-entertainment-and-vertex-pharmaceuticals-cm705011,For Immediate Release Chicago IL November 07 2016 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
VRTX,VRTX:UW,BBG000C1SD31,"Zacks Industry Outlook Highlights: Amgen, Vertex, Valeant Pharmaceuticals International, Mylan N.V. and Gilead Sciences",2016-11-07 17:21:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0OZAYe2gkVc/zacks-industry-outlook-highlights-amgen-vertex-valeant-pharmaceuticals-international-mylan-nv-and-gilead-sciences-cm705009,For Immediate Release Chicago IL November 07 2016 Today Zacks Equity Research discusses the Pharmaceuticals Part 3 including Amgen NASDAQ AMGN Free Report Vertex NASDAQ VRTX Free Report Valeant Pharmaceuticals International Inc NYSE VRX Free
VRTX,VRTX:UW,BBG000C1SD31,"Health Care Sector Update for 11/07/2016: HZNP, VRTX",2016-11-07 15:02:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Y9iLcXEsvAE/health-care-sector-update-for-11072016-hznp-vrtx-cm704804,Top Health care stocks Top Health care stocks JNJ 1 1 JNJ 1 1 PFE 1 3 PFE 1 3 ABT flatABT flat MRK 1 2 MRK 1 2 AMGN 1 3 AMGN 1 3 Health care shares were mainly higher in pre market trade on Monday Health care shares were mainly higher in pre market trade on Monday
VRTX,VRTX:UW,BBG000C1SD31,"The Zacks Analyst Blog Highlights: Cabot Oil & Gas, Zayo Group Holdings, Etsy, Live Nation Entertainment and Vertex Pharmaceuticals",2016-11-07 14:30:02 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-cabot-143002625.html,"The Zacks Analyst Blog Highlights: Cabot Oil & Gas, Zayo Group Holdings, Etsy, Live Nation Entertainment and Vertex Pharmaceuticals"
VRTX,VRTX:UW,BBG000C1SD31,Positive Phase 3 Study of ORKAMBI® in Children With Cystic Fibrosis Ages 6-11 Who Have Two Copies of the F508del Mutation Supports a Submission to the European Medicines Agency in the First Half of 2017,2016-11-07 13:30:00 +0000,http://uk.finance.yahoo.com/news/positive-phase-3-study-orkambi-133000047.html,Positive Phase 3 Study of ORKAMBI® in Children With Cystic Fibrosis Ages 6-11 Who Have Two Copies of the F508del Mutation Supports a Submission to the European Medicines Agency in the First Half of 2017
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharma: ORKAMBI Study Meets Endpoint In Children With Cystic Fibrosis,2016-11-07 08:43:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Z88R8vM78kU/vertex-pharma-orkambi-study-meets-endpoint-in-children-with-cystic-fibrosis-20161107-00634,Vertex Pharma: ORKAMBI Study Meets Endpoint In Children With Cystic Fibrosis
VRTX,VRTX:UW,BBG000C1SD31,5 Toxic Stocks to Cast Aside or Play Short,2016-11-04 15:49:03 +0000,http://finance.yahoo.com/news/5-toxic-stocks-cast-aside-144902930.html,5 Toxic Stocks to Cast Aside or Play Short
VRTX,VRTX:UW,BBG000C1SD31,Vertex to Present at the Credit Suisse Healthcare Conference on November 8,2016-11-02 20:01:00 +0000,http://finance.yahoo.com/news/vertex-present-credit-suisse-healthcare-200100533.html,"[Business Wire] - Vertex Pharmaceuticals Incorporated today announced that management will present at the Credit Suisse Healthcare Conference on Tuesday, November 8th at 3:30 p.m. ET"
VRTX,VRTX:UW,BBG000C1SD31,Strensiq: A Potential Driver for Alexion,2016-11-02 14:05:12 +0000,http://marketrealist.com/2016/10/strensiq-a-potential-driver-for-alexion/?utm_source=yahoo&utm_medium=feed,Strensiq: A Potential Driver for Alexion
VRTX,VRTX:UW,BBG000C1SD31,An Update on Phase 3 Studies for Soliris,2016-11-02 12:05:45 +0000,http://marketrealist.com/2016/10/an-update-on-phase-3-studies-for-soliris/?utm_source=yahoo&utm_medium=feed,An Update on Phase 3 Studies for Soliris
VRTX,VRTX:UW,BBG000C1SD31,3 Value Stocks Near 52-Week Lows Worth Buying,2016-11-01 13:15:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OILVE7wU860/3-value-stocks-near-52-week-lows-worth-buying-cm701523,Image source Getty Images While many companies shares are rising 160 past their fair values now others are trading at potentially bargain prices The difficulty with bargain shopping though is that you may be understandably hesitant to buy stocks wallowing near their 52 week
VRTX,VRTX:UW,BBG000C1SD31,3 Value Stocks Near 52-Week Lows Worth Buying,2016-11-01 12:06:12 +0000,http://www.fool.com/investing/2016/11/01/3-value-stocks-near-52-week-lows-worth-buying.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Value Stocks Near 52-Week Lows Worth Buying
VRTX,VRTX:UW,BBG000C1SD31,Analyst Recommendations for BioMarin after Its 3Q16 Earnings,2016-10-31 22:04:05 +0000,http://marketrealist.com/2016/10/analyst-recommendations-for-biomarin-after-its-3q16-earnings-2/?utm_source=yahoo&utm_medium=feed,Analyst Recommendations for BioMarin after Its 3Q16 Earnings
VRTX,VRTX:UW,BBG000C1SD31,"VERTEX PHARMACEUTICALS INC / MA Files SEC form 10-Q, Quarterly Report",2016-10-31 20:51:16 +0000,http://biz.yahoo.com/e/161031/vrtx10-q.html,"VERTEX PHARMACEUTICALS INC / MA Files SEC form 10-Q, Quarterly Report"
VRTX,VRTX:UW,BBG000C1SD31,Nivalis (NVLS) Q3 Earnings Preview: Can the Stock Surprise?,2016-10-31 15:18:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HsrTiEy1PL4/nivalis-nvls-q3-earnings-preview-can-the-stock-surprise-cm700957,Nivalis Therapeutics Inc NVLS is expected to report third quarter 2016 results on Nov 7 Last quarter the company posted a negative surprise of 5 77 Let s see how things are shaping up for this announcement Nivalis performance has been disappointing so far Over the four
VRTX,VRTX:UW,BBG000C1SD31,Nivalis (NVLS) Q3 Earnings Preview: Can the Stock Surprise?,2016-10-31 13:25:01 +0000,http://finance.yahoo.com/news/nivalis-nvls-q3-earnings-preview-132501014.html,Nivalis (NVLS) Q3 Earnings Preview: Can the Stock Surprise?
VRTX,VRTX:UW,BBG000C1SD31,"ETF’s with exposure to Vertex Pharmaceuticals, Inc. : October 28, 2016",2016-10-28 19:24:56 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-vertex-pharmaceuticals-inc-october-28-2016/,"ETF’s with exposure to Vertex Pharmaceuticals, Inc. : October 28, 2016"
VRTX,VRTX:UW,BBG000C1SD31,"Vertex Pharmaceuticals Incorporated Pushes Forward With Drug Combinations (and Reports Earnings, Too)",2016-10-27 20:44:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IWgfvcBkYoo/vertex-pharmaceuticals-incorporated-pushes-forward-with-drug-combinations-and-reports-earnings-too-cm699745,Image source Getty Images Vertex Pharmaceuticals NASDAQ VRTX reported earnings on Tuesday after the bell but it was a plan to move its next generation cystic fibrosis drugs into proof of concept studies that garnered most of the excitement on the third quarter earnings
VRTX,VRTX:UW,BBG000C1SD31,Galapagos Cystic Fibrosis Drug Trails Vertex's 'Mega-Franchise': RBC,2016-10-27 20:29:39 +0000,http://www.investors.com/news/technology/galapagos-cystic-fibrosis-drug-trails-vertexs-mega-franchise-rbc/,Galapagos Cystic Fibrosis Drug Trails Vertex's 'Mega-Franchise': RBC
VRTX,VRTX:UW,BBG000C1SD31,"Vertex Pharmaceuticals Incorporated Pushes Forward With Drug Combinations (and Reports Earnings, Too)",2016-10-27 18:46:54 +0000,http://www.fool.com/investing/2016/10/27/vertex-pharmaceuticals-incorporated-pushes-forward.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Vertex Pharmaceuticals Incorporated Pushes Forward With Drug Combinations (and Reports Earnings, Too)"
VRTX,VRTX:UW,BBG000C1SD31,"Vertex Pharmaceuticals, Inc. :VRTX-US: Earnings Analysis: Q3, 2016 By the Numbers : October 27, 2016",2016-10-27 13:40:34 +0000,http://www.capitalcube.com/blog/index.php/vertex-pharmaceuticals-inc-vrtx-us-earnings-analysis-q3-2016-by-the-numbers-october-27-2016/,"Vertex Pharmaceuticals, Inc. :VRTX-US: Earnings Analysis: Q3, 2016 By the Numbers : October 27, 2016"
VRTX,VRTX:UW,BBG000C1SD31,"ProQR Cystic Fibrosis Drug Passes First, Early Efficacy Test",2016-10-27 13:24:00 +0000,https://www.thestreet.com/story/13869848/1/proqr-cystic-fibrosis-drug-passes-first-early-efficacy-test.html?puc=yahoo&cm_ven=YAHOO,"ProQR Cystic Fibrosis Drug Passes First, Early Efficacy Test"
VRTX,VRTX:UW,BBG000C1SD31,Vertex Presents Long-Term Data Demonstrating that ORKAMBI® (lumacaftor/ivacaftor) and KALYDECO® (ivacaftor) Show the Potential to Modify the Progression of CF,2016-10-27 13:06:03 +0000,http://www.publicnow.com/view/71A849A0F2A41CB491C6B733D655149D3634E796,"[at noodls] - October 27, 2016 - 12 abstracts presented at 30th Annual North American Cystic Fibrosis Conference highlight data from Vertex's CF program - ORLANDO, Fla.--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated ..."
VRTX,VRTX:UW,BBG000C1SD31,Peek Into Drug Stocks' Earnings on Oct 28: ABBV & IMGN,2016-10-27 12:43:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9v6PELMb3YI/peek-into-drug-stocks-earnings-on-oct-28-abbv-imgn-cm699144,The third quarter earnings season is seeing possibly the best growth pace since the first quarter of 2015 As of Oct 26 198 S amp P 500 members as of Oct 26 accounting for 48 9 of the index s total market capitalization have reported results according to the Earnings Trends report
VRTX,VRTX:UW,BBG000C1SD31,Peek Into Drug Stocks' Earnings on Oct 28: ABBV & IMGN,2016-10-27 12:04:12 +0000,http://finance.yahoo.com/news/peek-drug-stocks-earnings-oct-120412492.html,Peek Into Drug Stocks' Earnings on Oct 28: ABBV & IMGN
VRTX,VRTX:UW,BBG000C1SD31,"Vertex Presents Long-term Data Showing Orkambi, Kalydeco Potential To Treat CF",2016-10-27 09:16:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/X_BPgIr3uEE/vertex-presents-longterm-data-showing-orkambi-kalydeco-potential-to-treat-cf-20161027-01858,"Vertex Presents Long-term Data Showing Orkambi, Kalydeco Potential To Treat CF"
VRTX,VRTX:UW,BBG000C1SD31,"Vertex Q3 Misses, But Company Eyes $1 Billion 'Mega Franchise'",2016-10-26 20:24:57 +0000,http://www.investors.com/news/technology/vertex-rebounds-after-q3-miss-on-1-billion-mega-franchise/,"Vertex Q3 Misses, But Company Eyes $1 Billion 'Mega Franchise'"
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharma (VRTX) Stock Lower on Q3 Miss,2016-10-26 16:41:00 +0000,https://www.thestreet.com/story/13868138/1/vertex-pharma-vrtx-stock-lower-on-q3-miss.html?puc=yahoo&cm_ven=YAHOO,Vertex Pharma (VRTX) Stock Lower on Q3 Miss
VRTX,VRTX:UW,BBG000C1SD31,Vertex Posts 3Q Loss of $42 Million (VRTX),2016-10-26 15:57:00 +0000,http://www.investopedia.com/news/vertex-3q-loss-was-below-analyst-estimates-vrtx/?partner=YahooSA,Vertex Posts 3Q Loss of $42 Million (VRTX)
VRTX,VRTX:UW,BBG000C1SD31,"Pardon Me, but I Have a Few Things to Say... Vertex, Biogen, Ariad, Sarepta",2016-10-26 15:54:00 +0000,https://www.thestreet.com/story/13868013/1/pardon-me-but-i-have-a-few-things-to-say-vertex-biogen-ariad-sarepta.html?puc=yahoo&cm_ven=YAHOO,"Pardon Me, but I Have a Few Things to Say... Vertex, Biogen, Ariad, Sarepta"
VRTX,VRTX:UW,BBG000C1SD31,"Biotech Stock Roundup: Clinical Holds Hit Inovio & Aduro, Vertex Q3 Results Miss Estimates",2016-10-26 15:53:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XPVh1FUgdLQ/biotech-stock-roundup-clinical-holds-hit-inovio-aduro-vertex-q3-results-miss-estimates-cm698538,Vertex VRTX reported results earlier this week though the company missed estimates Vertex s pipeline update regarding its next generation correctors brought some relief Meanwhile a couple of companies Inovio INO and Aduro ADRO were hit by clinical holds placed by the FDA on
VRTX,VRTX:UW,BBG000C1SD31,Vertex Begins Two Cystic Fibrosis Studies (VRTX),2016-10-26 15:41:00 +0000,http://www.investopedia.com/news/vertex-launches-phase-2-cystic-fibrosis-vrtx/?partner=YahooSA,Vertex Begins Two Cystic Fibrosis Studies (VRTX)
VRTX,VRTX:UW,BBG000C1SD31,"Vertex's (VRTX) Q3 Loss Wider than Expected, Sales Miss",2016-10-26 13:50:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ynaMS2__G10/vertexs-vrtx-q3-loss-wider-than-expected-sales-miss-cm698458,Vertex Pharmaceuticals Inc VRTX reported third quarter 2016 loss of 8 cents per share including the impact of stock based compensation expense wider than the Zacks Consensus Estimate of a loss of 6 cents However the loss was narrower than a loss of 40 cents reported in the year ago
VRTX,VRTX:UW,BBG000C1SD31,"Vertex's (VRTX) Q3 Loss Wider than Expected, Sales Miss",2016-10-26 12:49:12 +0000,http://finance.yahoo.com/news/vertexs-vrtx-q3-loss-wider-124912337.html,"Vertex's (VRTX) Q3 Loss Wider than Expected, Sales Miss"
VRTX,VRTX:UW,BBG000C1SD31,​Vertex boosts market cap on plan for cystic fibrosis 'triple combo',2016-10-26 11:25:11 +0000,http://www.bizjournals.com/boston/blog/bioflash/2016/10/vertex-boosts-market-cap-on-plan-for-cystic.html?ana=yahoo,​Vertex boosts market cap on plan for cystic fibrosis 'triple combo'
VRTX,VRTX:UW,BBG000C1SD31,Edited Transcript of VRTX earnings conference call or presentation 25-Oct-16 8:30pm GMT,2016-10-26 01:17:37 +0000,http://finance.yahoo.com/news/edited-transcript-vrtx-earnings-conference-011737861.html,Edited Transcript of VRTX earnings conference call or presentation 25-Oct-16 8:30pm GMT
VRTX,VRTX:UW,BBG000C1SD31,"OGXI Up On Phase II Results, DPRX Falters On Missed Steps, LXRX Awaits Dec Data",2016-10-26 00:33:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cH9v1AOSuL8/ogxi-up-on-phase-ii-results-dprx-falters-on-missed-steps-lxrx-awaits-dec-data-20161026-00006,"OGXI Up On Phase II Results, DPRX Falters On Missed Steps, LXRX Awaits Dec Data"
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharma reports 3Q loss,2016-10-25 23:00:42 +0000,http://sg.finance.yahoo.com/news/vertex-reports-3q-loss-201439766.html,Vertex Pharma reports 3Q loss
VRTX,VRTX:UW,BBG000C1SD31,[$$] Vertex Pharmaceutical Reports Narrower Loss,2016-10-25 21:07:59 +0000,http://www.wsj.com/articles/vertex-pharmaceutical-reports-narrower-loss-1477429676?mod=yahoo_hs,[$$] Vertex Pharmaceutical Reports Narrower Loss
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharma Moves Next-Generation Cystic Fibrosis Drugs Into New Clinical Trials,2016-10-25 21:03:00 +0000,https://www.thestreet.com/story/13866789/1/vertex-pharma-moves-next-generation-cystic-fibrosis-drugs-into-new-clinical-trials.html?puc=yahoo&cm_ven=YAHOO,Vertex Pharma Moves Next-Generation Cystic Fibrosis Drugs Into New Clinical Trials
VRTX,VRTX:UW,BBG000C1SD31,Vertex Announces Planned Initiation of Phase 2 Studies Evaluating the Next-Generation Correctors VX-440 and VX-152 in Triple Combination Regimens to Treat the Underlying Cause of Cystic Fibrosis,2016-10-25 20:35:29 +0000,http://www.publicnow.com/view/3DF92A3E830B1361C651B65142994011DD10BBB8,"[at noodls] - October 25, 2016 -VX-440 to be evaluated as part of 4-week triple combination dosing with tezacaftor (VX-661) and ivacaftor; VX-152 to be evaluated as part of 2-week triple combination dosing- -Studies ..."
VRTX,VRTX:UW,BBG000C1SD31,Vertex Reports Third Quarter 2016 Financial Results,2016-10-25 20:35:29 +0000,http://www.publicnow.com/view/00B52FD311BADF593EB2A432136AE2844155417D,"[at noodls] - October 25, 2016 -Third quarter 2016 cystic fibrosis product revenues of $410 million; $234 million for ORKAMBI® (lumacaftor/ivacaftor) and $176 million for KALYDECO® (ivacaftor)- BOSTON--(BUSINESS WIRE)-- ..."
VRTX,VRTX:UW,BBG000C1SD31,"VERTEX PHARMACEUTICALS INC / MA Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statemen",2016-10-25 20:13:00 +0000,http://biz.yahoo.com/e/161025/vrtx8-k.html,"VERTEX PHARMACEUTICALS INC / MA Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statemen"
VRTX,VRTX:UW,BBG000C1SD31,"After-Hours Earnings Report for October 25, 2016 :  AAPL, CB, CNI, ESRX, COF, EW, DFS, EQR, VRTX, BXP, BCR, AMP",2016-10-25 19:10:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NLsiN8Kq6rg/after-hours-earnings-report-for-october-25-2016-aapl-cb-cni-esrx-cof-ew-dfs-eqr-vrtx-bxp-bcr-amp-cm698088,The following companies are expected to report earnings after hours on 10 25 2016 Visit our Earnings Calendar for a full list of expected earnings releases Apple Inc AAPL is reporting for the quarter ending September 30 2016 The computer company
VRTX,VRTX:UW,BBG000C1SD31,"Earnings Reaction History: Vertex Pharmaceuticals Incorporated, 55.6% Follow-Through Indicator, 3.5% Sensitive",2016-10-25 18:44:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vCyIxTqKwjM/earnings-reaction-history-vertex-pharmaceuticals-incorporated-556-follow-through-indicator-35-sensitive-cm698123,Expected Earnings Release 10 25 2016 After hoursExpected Earnings Release 10 25 2016 After hours Avg Extended Hours Dollar Volume 12 493 573Avg Extended Hours Dollar Volume 12 493 573 Vertex Pharmaceuticals Incorporated VRTX is due to issue its quarterly earnings report in
VRTX,VRTX:UW,BBG000C1SD31,"Here's the big news we're likely to hear when Vertex, Biogen report Q3 this week",2016-10-25 15:26:52 +0000,http://www.bizjournals.com/boston/news/2016/10/23/heres-the-big-news-were-likely-to-hear-when-vertex.html?ana=yahoo,"Here's the big news we're likely to hear when Vertex, Biogen report Q3 this week"
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharmaceuticals Q3 16 Earnings Conference Call At 4:30 PM ET,2016-10-25 15:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mlb0B2qwvZo/vertex-pharmaceuticals-q3-16-earnings-conference-call-at-430-pm-et-20161025-00855,Vertex Pharmaceuticals Q3 16 Earnings Conference Call At 4:30 PM ET
VRTX,VRTX:UW,BBG000C1SD31,Q3 2016 Vertex Pharmaceuticals Inc Earnings Release - After Market Close,2016-10-25 11:07:04 +0000,http://biz.yahoo.com/research/earncal/20161025.html?t=vrtx,Q3 2016 Vertex Pharmaceuticals Inc Earnings Release - After Market Close
VRTX,VRTX:UW,BBG000C1SD31,"Market Close Report: NASDAQ Composite index closes at 5,309.83 up 52.43 points",2016-10-24 20:48:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3LPiDa2jYWo/market-close-report-nasdaq-composite-index-closes-at-530983-up-5243-points-cm697476,Monday s session closes with the NASDAQ Composite Index at 5 309 83 The total shares traded for the NASDAQ was over 1 56 billion Monday s session closes with the NASDAQ Composite Index at 5 309 83 The total shares traded for the NASDAQ was over 1 56 billion Advancers stocks led declining by 1
VRTX,VRTX:UW,BBG000C1SD31,"S&P 500 Movers: COL, QRVO",2016-10-24 15:24:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6W5GZV6XaPM/sp-500-movers-col-qrvo-cm697067,In early trading on Monday shares of Qorvo QRVO topped the list of the day s best performing components of the S amp P 500 index trading up 4 3 Year to date Qorvo registers a 12 1 gain And the worst performing S amp P 500 component thus far on the day is Rockwell Collins
VRTX,VRTX:UW,BBG000C1SD31,"Nasdaq 100 Movers: VRTX, TMUS",2016-10-24 15:23:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jdiWOb3Mg_c/nasdaq-100-movers-vrtx-tmus-cm697066,In early trading on Monday shares of T Mobile US TMUS topped the list of the day s best performing components of the Nasdaq 100 index trading up 6 4 Year to date T Mobile US registers a 27 1 gain And the worst performing Nasdaq 100 component thus far on the day is
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharmaceuticals Relapses To A Neutral Rating At H.C. Wainwright,2016-10-24 13:06:30 +0000,http://finance.yahoo.com/news/vertex-pharmaceuticals-relapses-neutral-rating-130630538.html,Vertex Pharmaceuticals Relapses To A Neutral Rating At H.C. Wainwright
VRTX,VRTX:UW,BBG000C1SD31,"Drug Stocks Q3 Earnings Roster for Oct 25: MRK, LLY & More",2016-10-24 12:28:12 +0000,http://finance.yahoo.com/news/drug-stocks-q3-earnings-roster-122812341.html,"Drug Stocks Q3 Earnings Roster for Oct 25: MRK, LLY & More"
VRTX,VRTX:UW,BBG000C1SD31,Vertex (VRTX) Q3 Earnings: What's in Store for the Stock?,2016-10-20 14:52:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JQ7hEh4CwZE/vertex-vrtx-q3-earnings-whats-in-store-for-the-stock-cm695825,Biotech company Vertex Pharmaceuticals VRTX will be reporting third quarter 2016 results on Oct 25 after the market closes Vertex s track record is mixed with the company delivering positive surprises in three of the last four quarters and missing expectations in one The average
VRTX,VRTX:UW,BBG000C1SD31,Vertex (VRTX) Q3 Earnings: What's in Store for the Stock?,2016-10-20 12:54:12 +0000,http://finance.yahoo.com/news/vertex-vrtx-q3-earnings-whats-125412242.html,Vertex (VRTX) Q3 Earnings: What's in Store for the Stock?
VRTX,VRTX:UW,BBG000C1SD31,[$$] Crispr Therapeutics Ends Barely Higher in IPO,2016-10-19 22:17:17 +0000,http://www.wsj.com/articles/crispr-therapeutics-ends-barely-higher-in-ipo-1476915433?mod=yahoo_hs,[$$] Crispr Therapeutics Ends Barely Higher in IPO
VRTX,VRTX:UW,BBG000C1SD31,How Much Return Could Alexion Offer over the Next 12 months?,2016-10-19 19:55:01 +0000,http://marketrealist.com/2016/10/how-much-return-could-alexion-offer-over-the-next-12-months/?utm_source=yahoo&utm_medium=feed,How Much Return Could Alexion Offer over the Next 12 months?
VRTX,VRTX:UW,BBG000C1SD31,"Biotech Stock Roundup: ARIAD Down on Drug Pricing Tweet, Regeneron Study on Clinical Hold",2016-10-19 16:51:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6egD9qN3o2A/biotech-stock-roundup-ariad-down-on-drug-pricing-tweet-regeneron-study-on-clinical-hold-cm695455,Once again a single tweet on drug pricing resulted in weakness in the biotech sector with ARIAD ARIA losing ground on a tweet regarding the company s price hikes for cancer drug Iclusig Meanwhile Regeneron REGN suffered a pipeline setback with the FDA putting a clinical hold on one of
VRTX,VRTX:UW,BBG000C1SD31,Why Europe Is an Important Market for Vertex’s Orkambi,2016-10-19 14:05:21 +0000,http://marketrealist.com/2016/10/why-europe-is-an-important-market-for-vertexs-orkambi/?utm_source=yahoo&utm_medium=feed,Why Europe Is an Important Market for Vertex’s Orkambi
VRTX,VRTX:UW,BBG000C1SD31,Why Vertex Lowered Its Guidance for Orkambi,2016-10-19 12:05:31 +0000,http://marketrealist.com/2016/10/why-vertex-lowered-its-guidance-for-orkambi/?utm_source=yahoo&utm_medium=feed,Why Vertex Lowered Its Guidance for Orkambi
VRTX,VRTX:UW,BBG000C1SD31,How Much Revenue Growth Could Vertex See in 3Q16?,2016-10-18 19:04:05 +0000,http://marketrealist.com/2016/10/how-much-revenue-growth-could-vertex-have-seen-in-3q16/?utm_source=yahoo&utm_medium=feed,How Much Revenue Growth Could Vertex See in 3Q16?
VRTX,VRTX:UW,BBG000C1SD31,Vertex Not the Only Pharmaceutical to See Its Share Price Fall,2016-10-18 17:04:14 +0000,http://marketrealist.com/2016/10/vertex-not-the-only-pharmaceutical-to-see-its-share-price-fall/?utm_source=yahoo&utm_medium=feed,Vertex Not the Only Pharmaceutical to See Its Share Price Fall
VRTX,VRTX:UW,BBG000C1SD31,Weighing Vertex Pharmaceuticals’ Attributes before It Reports,2016-10-18 15:12:16 +0000,http://marketrealist.com/2016/10/weighing-vertex-pharmaceuticals-attributes-before-it-reports/?utm_source=yahoo&utm_medium=feed,Weighing Vertex Pharmaceuticals’ Attributes before It Reports
VRTX,VRTX:UW,BBG000C1SD31,"Eli Lilly, AbbVie Top 2017 Rankings; Pfizer, AstraZeneca Flailing",2016-10-17 20:13:21 +0000,http://www.investors.com/news/technology/eli-lilly-abbvie-top-2017-rankings-pfizer-astrazeneca-flailing/,"Eli Lilly, AbbVie Top 2017 Rankings; Pfizer, AstraZeneca Flailing"
VRTX,VRTX:UW,BBG000C1SD31,"VERTEX PHARMACEUTICALS INC / MA Files SEC form 8-K, Entry into a Material Definitive Agreement",2016-10-17 12:40:34 +0000,http://biz.yahoo.com/e/161017/vrtx8-k.html,"VERTEX PHARMACEUTICALS INC / MA Files SEC form 8-K, Entry into a Material Definitive Agreement"
VRTX,VRTX:UW,BBG000C1SD31,"VERTEX PHARMACEUTICALS INC / MA Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events",2016-10-14 12:05:21 +0000,http://biz.yahoo.com/e/161014/vrtx8-k.html,"VERTEX PHARMACEUTICALS INC / MA Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events"
VRTX,VRTX:UW,BBG000C1SD31,The Math Shows QUS Can Go To $69,2016-10-13 19:42:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GUh4N6aNCsk/the-math-shows-qus-can-go-to-69-cm692920,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
VRTX,VRTX:UW,BBG000C1SD31,What Makes Vertex Pharmaceuticals (VRTX) a Strong Sell?,2016-10-13 16:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uAZ6EyzqCfo/what-makes-vertex-pharmaceuticals-vrtx-a-strong-sell-cm692937,Similar to wise buying decisions exiting certain underperformers at the right time helps maximize portfolio returns Selling off losers can be difficult but if both the share price and estimates are falling it could be time to get rid of the security before more losses hit your portfolio
VRTX,VRTX:UW,BBG000C1SD31,What Makes Vertex Pharmaceuticals (VRTX) a Strong Sell?,2016-10-13 14:16:02 +0000,http://finance.yahoo.com/news/makes-vertex-pharmaceuticals-vrtx-strong-141602998.html,What Makes Vertex Pharmaceuticals (VRTX) a Strong Sell?
VRTX,VRTX:UW,BBG000C1SD31,"Biotech Stock Roundup: Alnylam Slumps on Revusiran Update, TESARO Impresses at ESMO",2016-10-12 14:21:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xRxdEZs_O1o/biotech-stock-roundup-alnylam-slumps-on-revusiran-update-tesaro-impresses-at-esmo-cm692293,Alnylam ALNY focused on developing novel therapeutics based on RNA interference RNAi saw its shares slump on its decision to discontinue the development of a late stage pipeline candidate Meanwhile several biotech companies were present at the congress of the European Society for
VRTX,VRTX:UW,BBG000C1SD31,"ETF’s with exposure to Vertex Pharmaceuticals, Inc. : October 11, 2016",2016-10-11 14:54:31 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-vertex-pharmaceuticals-inc-october-11-2016/,"ETF’s with exposure to Vertex Pharmaceuticals, Inc. : October 11, 2016"
VRTX,VRTX:UW,BBG000C1SD31,[$$] Crispr Therapeutics Plans $75M IPO,2016-10-07 22:58:18 +0000,http://www.wsj.com/articles/crispr-therapeutics-plans-75m-ipo-1475881095?mod=yahoo_hs,[$$] Crispr Therapeutics Plans $75M IPO
VRTX,VRTX:UW,BBG000C1SD31,Cautious Investors Focus On Cloud Computing And Other Steady Stocks,2016-10-07 15:54:41 +0000,http://www.investors.com/etfs-and-funds/mutual-funds/cautious-investors-focusing-on-cloud-computing-stocks-and-other-sturdy-secular-trends/,Cautious Investors Focus On Cloud Computing And Other Steady Stocks
VRTX,VRTX:UW,BBG000C1SD31,Vertex to Announce Third Quarter 2016 Financial Results on October 25,2016-10-07 13:19:01 +0000,http://www.publicnow.com/view/D0740D12CCF0940D7FB011D8D34C647140F88809,"[at noodls] - October 7, 2016 BOSTON--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its third quarter 2016 financial results on Tuesday, October 25, 2016 after the financial markets ..."
VRTX,VRTX:UW,BBG000C1SD31,Big Pharma and Top Biotechs Highlight Jefferies Stocks to Buy Now,2016-10-06 13:50:39 +0000,http://247wallst.com/healthcare-business/2016/10/06/big-pharma-and-top-biotechs-highlight-jefferies-stocks-to-buy-now/,Big Pharma and Top Biotechs Highlight Jefferies Stocks to Buy Now
VRTX,VRTX:UW,BBG000C1SD31,America’s 15 Fastest Shrinking Companies,2016-10-06 10:00:12 +0000,http://finance.yahoo.com/news/america-15-fastest-shrinking-companies-100012013.html,America’s 15 Fastest Shrinking Companies
VRTX,VRTX:UW,BBG000C1SD31,"Biotech Stock Roundup: Summit Soars on Sarepta Deal, Regeneron Presents Data",2016-10-05 15:48:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-rcJwyaDxNo/biotech-stock-roundup-summit-soars-on-sarepta-deal-regeneron-presents-data-cm689126,It was an eventful week for the biotech sector with companies like Regeneron REGN and Intra Cellular Therapies ITCI presenting data while Summit SMMT shot up on a collaboration agreement with Sarepta SRPT Recap of the Week s Most Important Stories Summit Shoots Up on
VRTX,VRTX:UW,BBG000C1SD31,When Does Vertex Pharmaceuticals Become a Buy?,2016-10-05 11:52:00 +0000,https://www.thestreet.com/story/13841654/1/when-does-vertex-pharmaceuticals-become-a-buy.html?puc=yahoo&cm_ven=YAHOO,When Does Vertex Pharmaceuticals Become a Buy?
VRTX,VRTX:UW,BBG000C1SD31,"Focus on Bluebird Bio, Not Vertex, J.P. Morgan Says",2016-10-04 17:04:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/10/04/focus-on-bluebird-bio-not-vertex-j-p-morgan-says/?mod=yahoobarrons&ru=yahoo,"Focus on Bluebird Bio, Not Vertex, J.P. Morgan Says"
VRTX,VRTX:UW,BBG000C1SD31,What Will Gilead Try Buying Next? Polls Offer Some 'Incyte',2016-09-30 20:20:31 +0000,http://www.investors.com/news/technology/post-medivation-flop-to-pfizer-what-will-gilead-try-buying-next/,What Will Gilead Try Buying Next? Polls Offer Some 'Incyte'
VRTX,VRTX:UW,BBG000C1SD31,"Vertex Orkambi's Label Expanded in U.S., Outlook Revised",2016-09-30 16:23:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/G3mWAg7IzEQ/vertex-orkambis-label-expanded-in-us-outlook-revised-cm687140,Vertex Pharmaceuticals Incorporated VRTX announced that its cystic fibrosis CF drug Orkambi was approved in the U S for the treatment of CF in patients aged 6 11 years who have two copies of the F508del mutation The company said that the drug will be available to the eligible
VRTX,VRTX:UW,BBG000C1SD31,"Vertex Orkambi's Label Expanded in U.S., Outlook Revised",2016-09-30 14:40:02 +0000,http://finance.yahoo.com/news/vertex-orkambis-label-expanded-u-144002863.html,"Vertex Orkambi's Label Expanded in U.S., Outlook Revised"
VRTX,VRTX:UW,BBG000C1SD31,What Do Analysts Say about Regeneron’s Upside Potential?,2016-09-30 14:05:05 +0000,http://marketrealist.com/2016/09/what-do-analysts-say-about-regenerons-upside-potential/?utm_source=yahoo&utm_medium=feed,What Do Analysts Say about Regeneron’s Upside Potential?
VRTX,VRTX:UW,BBG000C1SD31,"Amgen, Biogen, Gilead Could Spike VA Pricing To Skirt California Measure",2016-09-29 20:26:08 +0000,http://www.investors.com/news/technology/amgen-biogen-gilead-could-spike-va-pricing-to-skirt-california-measure/,"Amgen, Biogen, Gilead Could Spike VA Pricing To Skirt California Measure"
VRTX,VRTX:UW,BBG000C1SD31,​Vertex confirms fears that latest drug launch is slower than hoped,2016-09-29 10:30:11 +0000,http://www.bizjournals.com/boston/blog/bioflash/2016/09/vertex-confirms-concern-that-latest-drug-launch.html?ana=yahoo,​Vertex confirms fears that latest drug launch is slower than hoped
VRTX,VRTX:UW,BBG000C1SD31,"ADHD Doesn''t MEASURE Up, AMGN ARISEs To The Occasion, ITCI Misses Study Goal",2016-09-29 01:31:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OfY1JuLkPtY/adhd-doesnt-measure-up-amgn-arises-to-the-occasion-itci-misses-study-goal-20160929-00034,"ADHD Doesn''t MEASURE Up, AMGN ARISEs To The Occasion, ITCI Misses Study Goal"
VRTX,VRTX:UW,BBG000C1SD31,FDA approves expanded use of Vertex Pharma's cystic fibrosis drug,2016-09-28 22:16:31 +0000,http://finance.yahoo.com/news/fda-approves-expanded-vertex-pharmas-221631057.html,"[Reuters] - Vertex Pharamceuticals Inc said the U.S. Food and Drug Administration expanded the use of its cystic fibrosis drug to treat a new subgroup of patients with the rare genetic disorder. The FDA approved the use of Orkambi in children with cystic fibrosis aged 6-11 who have a type of the mutation. Cystic fibrosis is a life-threatening condition, where a defective gene disrupts the function of the lungs and digestive system, producing a build-up of thick, sticky mucus leading to inflammation and recurrent bacterial infections."
VRTX,VRTX:UW,BBG000C1SD31,Vertex Says FDA Approves ORKAMBI; Cuts 2016 ORKAMBI Revenue Guidance,2016-09-28 21:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HmYxmfEy1vY/vertex-says-fda-approves-orkambi-cuts-2016-orkambi-revenue-guidance-20160928-01098,Vertex Says FDA Approves ORKAMBI; Cuts 2016 ORKAMBI Revenue Guidance
VRTX,VRTX:UW,BBG000C1SD31,U.S. Food and Drug Administration Approves ORKAMBI® (lumacaftor/ivacaftor) for Use in Children with Cystic Fibrosis Ages 6 through 11 who have Two Copies of the F508del Mutation,2016-09-28 20:59:04 +0000,http://www.publicnow.com/view/951EA9E3893B8F19C0D565F206C26630AE71EC1C,"[at noodls] - September 28, 2016 -Approximately 2,400 children ages 6 through 11 have two copies of the F508del mutation in the U.S.- - Vertex revises ORKAMBI revenue guidance for 2016 - BOSTON--(BUSINESS WIRE)-- Vertex ..."
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharma To Present At Leerink Partners Conference; Webcast At 3:40 PM ET,2016-09-28 14:40:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zWlNPaZK6lA/vertex-pharma-to-present-at-leerink-partners-conference-webcast-at-340-pm-et-20160928-00807,Vertex Pharma To Present At Leerink Partners Conference; Webcast At 3:40 PM ET
VRTX,VRTX:UW,BBG000C1SD31,What’s the Upward Return Potential for BioMarin?,2016-09-28 14:04:58 +0000,http://marketrealist.com/2016/09/whats-the-upward-return-potential-for-biomarin/?utm_source=yahoo&utm_medium=feed,What’s the Upward Return Potential for BioMarin?
VRTX,VRTX:UW,BBG000C1SD31,What’s the Word on Street for Vertex?,2016-09-28 14:04:36 +0000,http://marketrealist.com/2016/09/whats-the-word-on-street-for-vertex/?utm_source=yahoo&utm_medium=feed,What’s the Word on Street for Vertex?
VRTX,VRTX:UW,BBG000C1SD31,Vertex Looks to Improve Its Gross and Net Margins,2016-09-28 12:04:49 +0000,http://marketrealist.com/2016/09/vertex-looks-to-improve-its-gross-and-net-margins/?utm_source=yahoo&utm_medium=feed,Vertex Looks to Improve Its Gross and Net Margins
VRTX,VRTX:UW,BBG000C1SD31,3 Critical FDA Decisions You Can't Afford to Miss,2016-09-27 23:21:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NeoTDXwt8EY/3-critical-fda-decisions-you-cant-afford-to-miss-cm685678,Image source U S Food and Drug Administration via Flickr Some think the U S Food and Drug Administration has an excessively long list of regulations designed to make it all but impossible for experimental therapies to make it to pharmacy shelves but that s just not the case The
VRTX,VRTX:UW,BBG000C1SD31,3 Critical FDA Decisions You Can't Afford to Miss,2016-09-27 21:42:00 +0000,http://www.fool.com/investing/2016/09/27/3-critical-fda-decisions-you-cant-afford-to-miss.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Critical FDA Decisions You Can't Afford to Miss
VRTX,VRTX:UW,BBG000C1SD31,Pharmaceuticals Deal with End of Key Cystic Fibrosis Study,2016-09-27 15:05:27 +0000,http://marketrealist.com/2016/09/pharmaceuticals-deal-with-end-of-key-cystic-fibrosis-study/?utm_source=yahoo&utm_medium=feed,Pharmaceuticals Deal with End of Key Cystic Fibrosis Study
VRTX,VRTX:UW,BBG000C1SD31,Cystic Fibrosis Treatment Is a Space Where Vertex Could Thrive,2016-09-27 14:05:27 +0000,http://marketrealist.com/2016/09/cystic-fibrosis-treatment-is-a-space-where-vertex-could-thrive/?utm_source=yahoo&utm_medium=feed,Cystic Fibrosis Treatment Is a Space Where Vertex Could Thrive
VRTX,VRTX:UW,BBG000C1SD31,Is Kalydeco Positioned Well Enough to Achieve Sustained Growth?,2016-09-27 12:06:09 +0000,http://marketrealist.com/2016/09/is-kalydeco-positioned-well-enough-to-achieve-sustained-growth/?utm_source=yahoo&utm_medium=feed,Is Kalydeco Positioned Well Enough to Achieve Sustained Growth?
VRTX,VRTX:UW,BBG000C1SD31,Higher Discontinuations Are among Orkambi’s Concerns,2016-09-26 23:04:23 +0000,http://marketrealist.com/2016/09/higher-discontinuations-are-among-orkambis-concerns/?utm_source=yahoo&utm_medium=feed,Higher Discontinuations Are among Orkambi’s Concerns
VRTX,VRTX:UW,BBG000C1SD31,How Much Revenue May Vertex Generate in the Long Term?,2016-09-26 20:54:36 +0000,http://marketrealist.com/2016/09/how-much-revenue-may-vertex-generate-in-the-long-term/?utm_source=yahoo&utm_medium=feed,How Much Revenue May Vertex Generate in the Long Term?
VRTX,VRTX:UW,BBG000C1SD31,"Nasdaq 100 Movers: BMRN, BBBY",2016-09-22 16:22:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fT84dDUtiW8/nasdaq-100-movers-bmrn-bbby-cm683221,In early trading on Thursday shares of Bed Bath amp Beyond topped the list of the day s best performing components of the Nasdaq 100 index trading up 3 5 Year to date Bed Bath amp Beyond has lost about 7 6 of its value And the worst performing Nasdaq 100 component thus far on
VRTX,VRTX:UW,BBG000C1SD31,"Biotech Stock Roundup: Tobira Soars on Acquisition Deal, FDA Says Yes to Sarepta DMD Drug",2016-09-21 14:25:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zMySh2T-KSs/biotech-stock-roundup-tobira-soars-on-acquisition-deal-fda-says-yes-to-sarepta-dmd-drug-cm682518,It was an exceptionally good week for the biotech sector with the market reacting positively to pharma company Allergan s acquisition deals with biotech stocks Expectations are that more such deals will be announced with biotech companies like ARIAD seeing their shares prices increasing
VRTX,VRTX:UW,BBG000C1SD31,[$$] Chilled Vertex Could Heat Up Quickly,2016-09-21 04:50:01 +0000,http://www.wsj.com/articles/chilled-vertex-could-heat-up-quickly-1474382162?ru=yahoo?mod=yahoo_itp,[at The Wall Street Journal] - A rough year for Vertex Pharmaceuticals gives biotech investors an opening.
VRTX,VRTX:UW,BBG000C1SD31,Buy Allows Horizon to Further Expand into Orphan Drug Space,2016-09-20 18:04:06 +0000,http://marketrealist.com/2016/09/buy-allows-horizon-to-further-expand-into-orphan-drug-space/?utm_source=yahoo&utm_medium=feed,Buy Allows Horizon to Further Expand into Orphan Drug Space
VRTX,VRTX:UW,BBG000C1SD31,First Week of VRTX November 18th Options Trading,2016-09-20 16:24:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7povasSgSpE/first-week-of-vrtx-november-18th-options-trading-cm682055,Investors in Vertex Pharmaceuticals Inc Symbol VRTX saw new options become available this week for the November 18th expiration At Stock Options Channel our YieldBoost formula has looked up and down the VRTX options chain for the new November 18th contracts and identified one put and
VRTX,VRTX:UW,BBG000C1SD31,[$$] Chilled Vertex Could Heat Up Quickly,2016-09-20 14:36:05 +0000,http://www.wsj.com/articles/chilled-vertex-could-heat-up-quickly-1474382162?mod=yahoo_hs,[$$] Chilled Vertex Could Heat Up Quickly
VRTX,VRTX:UW,BBG000C1SD31,M&A: Acquirers Love Dividends Too,2016-09-19 17:44:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/09/19/ma-acquirers-love-dividends-too/?mod=yahoobarrons&ru=yahoo,M&A: Acquirers Love Dividends Too
VRTX,VRTX:UW,BBG000C1SD31,Vertex: Did Management Deliver Investors a Backhanded Slap?,2016-09-16 16:49:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/09/16/vertex-did-management-deliver-investors-a-backhanded-slap/?mod=yahoobarrons&ru=yahoo,Vertex: Did Management Deliver Investors a Backhanded Slap?
VRTX,VRTX:UW,BBG000C1SD31,"Nasdaq 100 Movers: EXPE, WDC",2016-09-16 16:19:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/d4UC1W3omP4/nasdaq-100-movers-expe-wdc-cm680600,In early trading on Friday shares of Western Digital WDC topped the list of the day s best performing components of the Nasdaq 100 index trading up 3 9 Year to date Western Digital has lost about 7 8 of its value And the worst performing Nasdaq 100 component thus far on the day
VRTX,VRTX:UW,BBG000C1SD31,[$$] Vertex Looks to Cash In On Its Rich Drug Pipeline,2016-09-16 11:00:00 +0000,http://www.barrons.com/articles/vertex-looks-to-cash-in-on-its-rich-drug-pipeline-1474023600?mod=yahoobarrons&ru=yahoo,[$$] Vertex Looks to Cash In On Its Rich Drug Pipeline
VRTX,VRTX:UW,BBG000C1SD31,Vertex shares fall after company reports lag in refills of cystic fibrosis drug,2016-09-14 20:24:13 +0000,http://www.cnbc.com/id/103940700?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=103940700,Vertex shares fall after company reports lag in refills of cystic fibrosis drug
VRTX,VRTX:UW,BBG000C1SD31,Vertex: News Creates Opportunity in Shares,2016-09-14 19:43:00 +0000,http://finance.yahoo.com/news/vertex-news-creates-opportunity-shares-194300922.html,Vertex: News Creates Opportunity in Shares
VRTX,VRTX:UW,BBG000C1SD31,Why Vertex Pharmaceuticals is Tanking,2016-09-14 18:23:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/09/14/why-vertex-pharmaceuticals-is-tanking/?mod=yahoobarrons&ru=yahoo,Why Vertex Pharmaceuticals is Tanking
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharma stock drops 5% after company predicts slower Q3,2016-09-14 18:01:27 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=4A813043-A38B-4128-A837-1D114F725C42&siteid=yhoof2,Vertex Pharma stock drops 5% after company predicts slower Q3
VRTX,VRTX:UW,BBG000C1SD31,"Vertex Pharmaceuticals, Inc. – Value Analysis (NASDAQ:VRTX) : September 14, 2016",2016-09-14 17:12:47 +0000,http://www.capitalcube.com/blog/index.php/vertex-pharmaceuticals-inc-value-analysis-nasdaqvrtx-september-14-2016/,"Vertex Pharmaceuticals, Inc. – Value Analysis (NASDAQ:VRTX) : September 14, 2016"
VRTX,VRTX:UW,BBG000C1SD31,Vertex Stock Tumbles,2016-09-14 17:04:09 +0000,http://finance.yahoo.com/tumblr/blog-vertex-stock-tumbles-170419888.html,Vertex Stock Tumbles
VRTX,VRTX:UW,BBG000C1SD31,Key FDA Decisions and Trial Results Coming in the Next 2 Months,2016-09-14 12:20:11 +0000,http://247wallst.com/healthcare-business/2016/09/14/key-fda-decisions-and-trial-results-coming-in-the-next-2-months/,Key FDA Decisions and Trial Results Coming in the Next 2 Months
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharma To Present At Morgan Stanley Conference; Webcast At 11:40 AM ET,2016-09-14 10:40:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eMgpu5KqrAI/vertex-pharma-to-present-at-morgan-stanley-conference-webcast-at-1140-am-et-20160914-00667,Vertex Pharma To Present At Morgan Stanley Conference; Webcast At 11:40 AM ET
VRTX,VRTX:UW,BBG000C1SD31,"The Zacks Analyst Blog Highlights: Spectrum Pharmaceuticals, Amgen, AbbVie and Vertex Pharmaceuticals",2016-09-13 16:50:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9mr6uoZJP00/the-zacks-analyst-blog-highlights-spectrum-pharmaceuticals-amgen-abbvie-and-vertex-pharmaceuticals-cm678868,For Immediate Release Chicago IL September 13 2016 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
VRTX,VRTX:UW,BBG000C1SD31,"Vertex Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : VRTX-US : September 13, 2016",2016-09-13 12:21:54 +0000,http://www.capitalcube.com/blog/index.php/vertex-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bullish-manner-vrtx-us-september-13-2016/,"Vertex Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : VRTX-US : September 13, 2016"
VRTX,VRTX:UW,BBG000C1SD31,3 Drug Stocks That Could Benefit from Key FDA Events in Sep 2016,2016-09-12 15:35:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NlOksVuLwPU/3-drug-stocks-that-could-benefit-from-key-fda-events-in-sep-2016-cm677945,The drug development process is often lengthy and time consuming and requires the utilization of a lot of funds and resources It may well take a drug anything between 10 12 years to be successfully developed and reach the market In such a scenario key pipeline events including data readouts
VRTX,VRTX:UW,BBG000C1SD31,3 Drug Stocks That Could Benefit from Key FDA Events in Sep 2016,2016-09-12 13:23:01 +0000,http://finance.yahoo.com/news/3-drug-stocks-could-benefit-132301550.html,3 Drug Stocks That Could Benefit from Key FDA Events in Sep 2016
VRTX,VRTX:UW,BBG000C1SD31,Vertex to Present at Upcoming Investor Conferences,2016-09-09 20:10:03 +0000,http://www.publicnow.com/view/C0EED6F8BD8CB97CCBE1080ACF864F3B853BBB12,"[at noodls] - September 9, 2016 BOSTON--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that management will present at The Morgan Stanley Global Healthcare Conference in New York, ..."
VRTX,VRTX:UW,BBG000C1SD31,3 Growth Stocks That Could Double,2016-09-08 19:15:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-qvEP4seja0/3-growth-stocks-that-could-double-cm676318,Image source Getty Images Every growth investor wants to buy a stock that will go on to double in value quickly but finding those companies before they go on a huge run is both difficult and risky After all companies that stand the best chances of doubling are likely to be
VRTX,VRTX:UW,BBG000C1SD31,Drug Stocks Remain in Focus as Pricing Debate Continues,2016-09-05 15:17:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Zaf-TReFEgo/drug-stocks-remain-in-focus-as-pricing-debate-continues-cm674655,The drug pricing controversy continues to make news with lawmakers now questioning Medicaid rebates for Mylan N V s MYL EpiPen and Democratic Presidential candidate Hillary Clinton announcing a health care plan that will address the excessive price hikes of treatments that have been available
VRTX,VRTX:UW,BBG000C1SD31,3 Biotech Stocks That Could Make Big Moves In September,2016-09-02 20:12:40 +0000,http://www.investors.com/news/technology/3-biotech-stocks-that-could-make-big-moves-in-september/,3 Biotech Stocks That Could Make Big Moves In September
VRTX,VRTX:UW,BBG000C1SD31,Biotech Stocks: Look At Those Takeover Premiums!,2016-09-01 17:53:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/09/01/biotech-stocks-look-at-those-takeover-premiums/?mod=yahoobarrons&ru=yahoo,Biotech Stocks: Look At Those Takeover Premiums!
VRTX,VRTX:UW,BBG000C1SD31,"Zacks.com featured highlights: Covanta Holding, ZELTIQ Aesthetics, Capital Senior Living, Live Nation Entertainment and Vertex Pharmaceuticals",2016-08-31 16:17:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GKFJw8jA_a8/zackscom-featured-highlights-covanta-holding-zeltiq-aesthetics-capital-senior-living-live-nation-entertainment-and-vertex-pharmaceuticals-cm672910,"For Immediate Release  Chicago, IL   August 31, 2016   Stocks in this week's article include  Covanta Holding Corporation ( CVA ), ZELTIQ Aesthetics, Inc. ( ZLTQ ), Capital Senior Living Corp. ("
VRTX,VRTX:UW,BBG000C1SD31,"Zacks.com featured highlights: Covanta Holding, ZELTIQ Aesthetics, Capital Senior Living, Live Nation Entertainment and Vertex Pharmaceuticals",2016-08-31 13:30:01 +0000,http://finance.yahoo.com/news/zacks-com-featured-highlights-covanta-133001071.html,"Zacks.com featured highlights: Covanta Holding, ZELTIQ Aesthetics, Capital Senior Living, Live Nation Entertainment and Vertex Pharmaceuticals"
VRTX,VRTX:UW,BBG000C1SD31,5 Toxic Stocks to Steer Clear Of Before It's Too Late,2016-08-30 14:16:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ADduNdfJbUM/5-toxic-stocks-to-steer-clear-of-before-its-too-late-cm672081,"Not all stocks that recently scaled lofty heights will be able to sustain their good show. In fact, some of these stocks, whose current value surpassed their actual potential, are bound to result in loss for investors"
VRTX,VRTX:UW,BBG000C1SD31,5 Toxic Stocks to Steer Clear Of Before It's Too Late,2016-08-30 12:25:12 +0000,http://finance.yahoo.com/news/5-toxic-stocks-steer-clear-122512673.html,5 Toxic Stocks to Steer Clear Of Before It's Too Late
VRTX,VRTX:UW,BBG000C1SD31,Biotech Stocks Facing FDA Decision In September,2016-08-30 03:06:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JLuJRoV-b_w/biotech-stocks-facing-fda-decision-in-september-20160830-00044,Biotech Stocks Facing FDA Decision In September
VRTX,VRTX:UW,BBG000C1SD31,"Nasdaq 100 Movers: GILD, TMUS",2016-08-29 16:12:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kE3k6XJ2yvQ/nasdaq-100-movers-gild-tmus-cm671663,"In early trading on Monday, shares of T Mobile US topped the list of the day's best performing components of the Nasdaq 100 index, trading up 2.5%. Year to date, T"
VRTX,VRTX:UW,BBG000C1SD31,S&P 500 Analyst Moves: VRTX,2016-08-25 18:46:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/T1LrecPwxVg/sp-500-analyst-moves-vrtx-cm670233,"S&P 500 Analyst Moves VRTX The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, Vertex Pharmaceuticals is now the #81 analyst pick, moving up by 3 spots."
VRTX,VRTX:UW,BBG000C1SD31,What’s BioMarin’s Expected Revenue Growth in 2016 and 2017?,2016-08-25 17:04:05 +0000,http://marketrealist.com/2016/08/whats-biomarins-expected-revenue-growth-2016-2017/?utm_source=yahoo&utm_medium=feed,What’s BioMarin’s Expected Revenue Growth in 2016 and 2017?
VRTX,VRTX:UW,BBG000C1SD31,"Stock Market News for August 25, 2016",2016-08-25 15:45:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/30Hxk34kJsQ/stock-market-news-for-august-25-2016-cm670084,"Benchmarks ended in the red on Wednesday following decline in Mylan's shares, which had a negative impact on the biotech stocks and eventually on the broader healthcare sector. Strong political pressure on Mylan for over pricing its"
VRTX,VRTX:UW,BBG000C1SD31,"Biotech Stocks: Oops, She Did It Again",2016-08-25 13:38:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/08/25/biotech-stocks-oops-she-did-it-again/?mod=yahoobarrons&ru=yahoo,"Biotech Stocks: Oops, She Did It Again"
VRTX,VRTX:UW,BBG000C1SD31,Biotech's next big deal?,2016-08-22 21:25:00 +0000,http://finance.yahoo.com/video/biotechs-next-big-deal-212500006.html,Biotech's next big deal?
VRTX,VRTX:UW,BBG000C1SD31,Pfizer-Medivation Deal Reignites Biotech Buyout Speculation,2016-08-22 20:29:12 +0000,http://www.investors.com/news/technology/pfizer-medivation-deal-reignites-biotech-buyout-speculation/,Pfizer-Medivation Deal Reignites Biotech Buyout Speculation
VRTX,VRTX:UW,BBG000C1SD31,"S&P 500 Movers: MRO, REGN",2016-08-22 15:44:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/k-nbhWKjtjo/sp-500-movers-mro-regn-cm668412,"In early trading on Monday, shares of Regeneron Pharmaceuticals topped the list of the day's best performing components of the S&P 500 index, trading up 2.1%. Year to date, Regeneron Pharmaceuticals"
VRTX,VRTX:UW,BBG000C1SD31,P-s-s-st! Here's What Fidelity Has Been Buying And Selling,2016-08-19 18:46:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wRju0XDXE_E/p-s-s-st-heres-what-fidelity-has-been-buying-and-selling-cm667658,Do you invest as successfully as Fidelity Investments does? Would it help your game to know in which large cap stocks Fidelity's approximately 200 stock and stock plus bond mutual funds made some of their biggest second
VRTX,VRTX:UW,BBG000C1SD31,P-s-s-st! Here's What Fidelity Has Been Buying And Selling,2016-08-19 17:03:40 +0000,http://www.investors.com/etfs-and-funds/mutual-funds/p-s-s-st-heres-what-fidelity-has-been-buying-and-selling/,P-s-s-st! Here's What Fidelity Has Been Buying And Selling
VRTX,VRTX:UW,BBG000C1SD31,Horizon’s Orphan Drug Business Faces These Opportunities,2016-08-19 15:04:43 +0000,http://marketrealist.com/2016/08/horizons-orphan-drug-business-faces-these-opportunities/?utm_source=yahoo&utm_medium=feed,Horizon’s Orphan Drug Business Faces These Opportunities
VRTX,VRTX:UW,BBG000C1SD31,"The Zacks Analyst Blog Highlights: Vertex, Aurinia, AVEO and Amgen",2016-08-18 16:49:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/L2jQfLGz1Fo/the-zacks-analyst-blog-highlights-vertex-aurinia-aveo-and-amgen-cm667214,"For Immediate Release  Chicago, IL   August 18, 2016   Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events"
VRTX,VRTX:UW,BBG000C1SD31,"The Zacks Analyst Blog Highlights: Vertex, Aurinia, AVEO and Amgen",2016-08-18 13:30:01 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-vertex-133001411.html,"The Zacks Analyst Blog Highlights: Vertex, Aurinia, AVEO and Amgen"
VRTX,VRTX:UW,BBG000C1SD31,"Biotech Stock Roundup: Vertex Slips on Study Halt, Aurinia Plunges on Lupus Data",2016-08-17 21:51:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xwlv_yWF1Cc/biotech-stock-roundup-vertex-slips-on-study-halt-aurinia-plunges-on-lupus-data-cm666783,"With second quarter earnings season drawing to a close, focus is back on pipeline and regulatory updates. Companies like Vertex VRTX , OncoGenex OGXI and Aurinia AUPH were in focus this week with the companies losing ground on pipeline"
VRTX,VRTX:UW,BBG000C1SD31,"Vertex Stock Slips On Drug Trial Failure, Though Not A Surprise",2016-08-16 20:38:30 +0000,http://www.investors.com/news/technology/vertex-stock-slips-on-drug-trial-failure-though-not-a-surprise/,"Vertex Stock Slips On Drug Trial Failure, Though Not A Surprise"
VRTX,VRTX:UW,BBG000C1SD31,"Vertex (VRTX) To Stop VX-661-Ivacaftor Study, Stock Down",2016-08-16 16:40:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pLs_j9CqXII/vertex-vrtx-to-stop-vx-661-ivacaftor-study-stock-down-cm665986,Vertex Pharmaceuticals Incorporated'sVRTX shares were down in pre market trading on news that the company will be stopping one of the phase III studies being conducted on a VX 661 ivacaftor (trade name Kalydeco) combination. The company announced that
VRTX,VRTX:UW,BBG000C1SD31,"Vertex (VRTX) To Stop VX-661-Ivacaftor Study, Stock Down",2016-08-16 14:25:02 +0000,http://finance.yahoo.com/news/vertex-vrtx-stop-vx-661-142502488.html,"Vertex (VRTX) To Stop VX-661-Ivacaftor Study, Stock Down"
VRTX,VRTX:UW,BBG000C1SD31,"After-hours buzz: HAIN, FN, VRTX & more",2016-08-15 22:25:34 +0000,http://www.cnbc.com/id/103870292?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=103870292,"After-hours buzz: HAIN, FN, VRTX & more"
VRTX,VRTX:UW,BBG000C1SD31,Vertex Provides Update on Ongoing Phase 3 Program for VX-661 in Combination with Ivacaftor for the Treatment of Cystic Fibrosis,2016-08-15 20:31:10 +0000,http://www.publicnow.com/view/9FE36902C2E265AA41CA9579542EB77E991EBB87,"[at noodls] - August 15, 2016 -Results from Part A of Phase 3 study in people with a mutation that results in minimal cystic fibrosis transmembrane conductance regulator (CFTR) protein function do not support continuation ..."
VRTX,VRTX:UW,BBG000C1SD31,"ETF’s with exposure to Vertex Pharmaceuticals, Inc. : August 15, 2016",2016-08-15 14:58:07 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-vertex-pharmaceuticals-inc-august-15-2016/,"ETF’s with exposure to Vertex Pharmaceuticals, Inc. : August 15, 2016"
VRTX,VRTX:UW,BBG000C1SD31,These 2 Catalysts Lifted Vertex Pharmaceuticals Incorporated 13% in July,2016-08-10 17:53:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hokzXrlcxVQ/these-2-catalysts-lifted-vertex-pharmaceuticals-incorporated-13-in-july-cm663551,"Image source  Getty Images.  What  Shares of Vertex Pharmaceuticals (NASDAQ  VRTX) , a biotech company primarily focused on the development of medicines to treat cystic fibrosis and cancer, surged 13% in"
VRTX,VRTX:UW,BBG000C1SD31,Are High Composite Ratings An Automatic 'Buy' Signal? No. Here's Why,2016-08-10 16:41:38 +0000,http://www.investors.com/how-to-invest/investors-corner/294578/,Are High Composite Ratings An Automatic 'Buy' Signal? No. Here's Why
VRTX,VRTX:UW,BBG000C1SD31,AstraZeneca bets another $140 million on Moderna's 'messenger' drugs,2016-08-10 14:43:26 +0000,http://sg.finance.yahoo.com/news/astrazeneca-bets-another-140-million-144326868.html,AstraZeneca bets another $140 million on Moderna's 'messenger' drugs
VRTX,VRTX:UW,BBG000C1SD31,Biotech Stocks: Blame Gilead?,2016-08-09 14:49:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/08/09/biotech-stocks-blame-gilead/?mod=yahoobarrons&ru=yahoo,Biotech Stocks: Blame Gilead?
VRTX,VRTX:UW,BBG000C1SD31,What Do Analysts Recommend for Regeneron after 2Q16 Earnings?,2016-08-09 13:08:47 +0000,http://marketrealist.com/2016/08/what-do-analysts-recommend-for-regeneron-after-2q16-earnings/?utm_source=yahoo&utm_medium=feed,What Do Analysts Recommend for Regeneron after 2Q16 Earnings?
VRTX,VRTX:UW,BBG000C1SD31,"We’re in another lousy earnings season, but these companies have grown sales by at least 28%",2016-08-06 15:55:34 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=476FBA30-597C-11E6-AB81-4C3597F08A15&siteid=yhoof2,"We’re in another lousy earnings season, but these companies have grown sales by at least 28%"
VRTX,VRTX:UW,BBG000C1SD31,"ETF’s with exposure to Vertex Pharmaceuticals, Inc. : August 4, 2016",2016-08-04 19:27:28 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-vertex-pharmaceuticals-inc-august-4-2016/,"ETF’s with exposure to Vertex Pharmaceuticals, Inc. : August 4, 2016"
VRTX,VRTX:UW,BBG000C1SD31,"Vertex Pharmaceuticals, Inc. :VRTX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 3, 2016",2016-08-03 15:42:10 +0000,http://www.capitalcube.com/blog/index.php/vertex-pharmaceuticals-inc-vrtx-us-earnings-analysis-q2-2016-by-the-numbers-august-3-2016/,"Vertex Pharmaceuticals, Inc. :VRTX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 3, 2016"
VRTX,VRTX:UW,BBG000C1SD31,Update on Analyst Recommendations for Alexion,2016-08-03 13:04:49 +0000,http://marketrealist.com/2016/07/update-analyst-recommendations-alexion/?utm_source=yahoo&utm_medium=feed,Update on Analyst Recommendations for Alexion
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharmaceuticals Incorporated Prepares for (More) Growth,2016-08-02 22:57:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fcx4VQG71d8/vertex-pharmaceuticals-incorporated-prepares-for-more-growth-cm659194,Image source  Getty Images.  Vertex Pharmaceuticals (NASDAQ  VRTX) reported second quarter earnings last week as the company continues to grow sales of its cystic fibrosis franchise.  Vertex Pharmaceuticals results  The
VRTX,VRTX:UW,BBG000C1SD31,Nivalis (NVLS) Reports Wider-than-Expected Loss in Q2,2016-08-02 16:59:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2sJ2qfkpff8/nivalis-nvls-reports-wider-than-expected-loss-in-q2-cm658978,"Nivalis Therapeutics, Inc.NVLS reported a second quarter 2016 loss of 55 cents per share, wider than the Zacks Consensus Estimate of a loss of 52 cents. The reported loss was, however, narrower than the year ago loss of $1.41"
VRTX,VRTX:UW,BBG000C1SD31,Analyst Recommendations for Vertex Pharmaceuticals after 2Q16 Earnings,2016-08-02 15:05:11 +0000,http://marketrealist.com/2016/07/analyst-recommendations-vertex-pharmaceuticals-2q16-earnings/?utm_source=yahoo&utm_medium=feed,Analyst Recommendations for Vertex Pharmaceuticals after 2Q16 Earnings
VRTX,VRTX:UW,BBG000C1SD31,Nivalis (NVLS) Reports Wider-than-Expected Loss in Q2,2016-08-02 14:28:02 +0000,http://finance.yahoo.com/news/nivalis-nvls-reports-wider-expected-142802449.html,Nivalis (NVLS) Reports Wider-than-Expected Loss in Q2
VRTX,VRTX:UW,BBG000C1SD31,How Vertex Is Strategizing to Continue Its Growth,2016-08-02 13:05:36 +0000,http://marketrealist.com/2016/07/vertex-strategizing-continue-growth/?utm_source=yahoo&utm_medium=feed,How Vertex Is Strategizing to Continue Its Growth
VRTX,VRTX:UW,BBG000C1SD31,Will the biotech rally will continue?,2016-08-01 21:49:00 +0000,http://finance.yahoo.com/video/biotech-rally-continue-214900864.html,Will the biotech rally will continue?
VRTX,VRTX:UW,BBG000C1SD31,"VERTEX PHARMACEUTICALS INC / MA Files SEC form 10-Q, Quarterly Report",2016-08-01 20:53:37 +0000,http://biz.yahoo.com/e/160801/vrtx10-q.html,"VERTEX PHARMACEUTICALS INC / MA Files SEC form 10-Q, Quarterly Report"
VRTX,VRTX:UW,BBG000C1SD31,How Much Did Kalydeco Add to Vertex’s Top Line?,2016-08-01 15:07:37 +0000,http://marketrealist.com/2016/07/much-kalydeco-add-vertexs-top-line/?utm_source=yahoo&utm_medium=feed,How Much Did Kalydeco Add to Vertex’s Top Line?
VRTX,VRTX:UW,BBG000C1SD31,Vertex’s Orkambi to Treat Cystic Fibrosis Drives Company’s Growth,2016-08-01 13:09:16 +0000,http://marketrealist.com/2016/07/vertexs-orkambi-treat-cystic-fibrosis-drives-companys-growth/?utm_source=yahoo&utm_medium=feed,Vertex’s Orkambi to Treat Cystic Fibrosis Drives Company’s Growth
VRTX,VRTX:UW,BBG000C1SD31,Vertex’s Cystic Fibrosis Drugs Drove Revenue Growth in 2Q16,2016-07-29 17:20:16 +0000,http://marketrealist.com/2016/07/vertexs-cystic-fibrosis-drugs-drove-revenue-growth-2q16/?utm_source=yahoo&utm_medium=feed,Vertex’s Cystic Fibrosis Drugs Drove Revenue Growth in 2Q16
VRTX,VRTX:UW,BBG000C1SD31,"Vertex (VRTX) Posts Narrower Q2 Loss, Revenues Fall Short",2016-07-28 12:26:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XI3chC9OF34/vertex-vrtx-posts-narrower-q2-loss-revenues-fall-short-cm656285,"Vertex Pharmaceuticals Inc.VRTX posted a second quarter 2016 loss of 1 cent per share (including the impact of stock based compensation expense), narrower than the year ago loss of 81 cents per share and the Zacks Consensus Estimate of"
VRTX,VRTX:UW,BBG000C1SD31,U.S. Hot Stocks: Hot Stocks to Watch,2016-07-28 09:27:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0rtxEsVfnRE/us-hot-stocks-hot-stocks-to-watch-20160728-01028,U.S. Hot Stocks: Hot Stocks to Watch
VRTX,VRTX:UW,BBG000C1SD31,Nivalis (NVLS): Can the Stock Surprise This Earnings Season?,2016-07-28 00:23:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NPnTyXf_utU/nivalis-nvls-can-the-stock-surprise-this-earnings-season-cm656083,"Nivalis Therapeutics, Inc.NVLS is expected to report second quarter 2016 results on Aug 1. Last quarter, the company had posted a negative surprise of 15.91%. Let's see how things are shaping up for this announcement. Factors at Play Nivalis,"
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharmaceuticals reports 2Q loss,2016-07-27 21:53:54 +0000,http://sg.finance.yahoo.com/news/vertex-reports-2q-loss-200947081.html,Vertex Pharmaceuticals reports 2Q loss
VRTX,VRTX:UW,BBG000C1SD31,"Biotech Stock Roundup: Biogen Q2 Results Impress, Gilead HCV Franchise Under Pressure",2016-07-27 21:27:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SHmIJ6MBYHA/biotech-stock-roundup-biogen-q2-results-impress-gilead-hcv-franchise-under-pressure-cm655979,"Earnings season for the biotech sector has kicked off with two big biotech names, Biogen BIIB and Gilead GILD reporting second quarter results. Meanwhile, companies like AbbVie ABBV and Amgen AMGN provided updates on their pipeline efforts.Recap of the"
VRTX,VRTX:UW,BBG000C1SD31,Vertex Reports Second Quarter 2016 Financial Results,2016-07-27 20:28:18 +0000,http://www.publicnow.com/view/92C38CFAA80FF452E270F1AE2B85D4FCC251A3C0,"[at noodls] - July 27, 2016 -Second quarter 2016 cystic fibrosis product revenues of $426 million; $245 million for ORKAMBI® (lumacaftor/ivacaftor) and $180 million for KALYDECO® (ivacaftor)- -Vertex reiterates 2016 ..."
VRTX,VRTX:UW,BBG000C1SD31,"After-Hours Earnings Report for July 27, 2016 :  FB, AMGN, MCK, PSA, SU, NXPI, ORLY, PXD, ABX, VRTX, MAR, O",2016-07-27 19:29:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/J-5D8JH9Rzo/after-hours-earnings-report-for-july-27-2016-fb-amgn-mck-psa-su-nxpi-orly-pxd-abx-vrtx-mar-o-cm655868,"The following companies are expected to report earnings after hours on 07 27 2016. Visit our Earnings Calendar for a full list of expected earnings releases.  Facebook, Inc. ( FB ) is reporting for the quarter"
VRTX,VRTX:UW,BBG000C1SD31,"Earnings Reaction History: Vertex Pharmaceuticals Incorporated, 66.7% Follow-Through Indicator, 3.7% Sensitive",2016-07-27 18:38:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/521tzJzhUfs/earnings-reaction-history-vertex-pharmaceuticals-incorporated-667-follow-through-indicator-37-sensitive-cm655907,"Expected Earnings Release 07 27 2016, After hours Avg. Extended Hours Dollar Volume $10,368,331 Vertex Pharmaceuticals Incorporated ( VRTX ) is due to issue its quarterly earnings report in the upcoming extended hours session. Given its history, traders can"
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharma Loss Narrows as Cystic Fibrosis Drug Sales Grow,2016-07-27 17:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iOHBg6Nlkrk/vertex-pharma-loss-narrows-as-cystic-fibrosis-drug-sales-grow-20160727-01530,Vertex Pharma Loss Narrows as Cystic Fibrosis Drug Sales Grow
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharmaceuticals Q2 16 Earnings Conference Call At 4:30 PM ET,2016-07-27 15:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TTGbwws-8T8/vertex-pharmaceuticals-q2-16-earnings-conference-call-at-430-pm-et-20160727-01109,Vertex Pharmaceuticals Q2 16 Earnings Conference Call At 4:30 PM ET
VRTX,VRTX:UW,BBG000C1SD31,"5 Drug Stocks' Earnings on Jul 27: AMGN, VRTX & More",2016-07-26 16:29:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fREEVb1_5bM/5-drug-stocks-earnings-on-jul-27-amgn-vrtx-more-cm654920,"With Q2 earnings picking up pace, approximately 126 S&P 500 members (representing 32.7% of the index's total market capitalization) have reported quarterly results as of Jul 22. An impressive 70.6% of these companies managed to record an earnings beat,"
VRTX,VRTX:UW,BBG000C1SD31,Vertex (VRTX) to Report Q2 Earnings: Is a Surprise in Store?,2016-07-25 13:13:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NrNm-iZHJoQ/vertex-vrtx-to-report-q2-earnings-is-a-surprise-in-store-cm653978,"Biotech company Vertex PharmaceuticalsVRTX will be reporting second quarter 2016 results on Jul 27, after the market closes . Vertex's track record is mixed with the company delivering positive surprises in two of the last four quarters and missing"
VRTX,VRTX:UW,BBG000C1SD31,I Just Bought These 4 Fast-Growing Biotech Stocks,2016-07-23 12:07:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uzorTLE_6As/i-just-bought-these-4-fast-growing-biotech-stocks-cm653701,"Image source  Getty Images.  The S&P 500 is currently trading near its all time high, but that doesn't mean there aren't bargains on the market today. That's especially true when you consider that"
VRTX,VRTX:UW,BBG000C1SD31,7 Biotech Stocks to Watch for Runaway Gains,2016-07-22 12:12:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NmC661ss1Ng/7-biotech-stocks-to-watch-for-runaway-gains-cm653121,"Biotech stocks are among the riskiest places for you to invest, but it is also one of the most lucrative. Source Pixelbay (Modified)A great cure for a dreaded disease can"
VRTX,VRTX:UW,BBG000C1SD31,"Sorry, You Can't Buy This Hot Biotech -- At Least Not Directly",2016-07-21 22:10:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EKbGyIp9Cpk/sorry-you-cant-buy-this-hot-biotech-at-least-not-directly-cm652964,"Image source  Getty Images.  You're excused if you've never heard of Moderna Therapeutics. The company is still private, so unless you've got enough money to invest in a venture capital fund, you're out"
VRTX,VRTX:UW,BBG000C1SD31,Vertex to Announce Second Quarter 2016 Financial Results on July 27,2016-07-14 13:28:07 +0000,http://www.publicnow.com/view/74669C91B0D19DF674075AE34788D82CBDB32FC9,"[at noodls] - b20d29ae-3f95-475e-a41c-efd443bea25b.pdf July 14, 2016 BOSTON--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its second quarter 2016 financial results on Wednesday, July ..."
VRTX,VRTX:UW,BBG000C1SD31,Implied QQXT Analyst Target Price: $46,2016-07-11 13:48:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ybkjivP632U/implied-qqxt-analyst-target-price-46-cm647018,"Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel , we have compared the trading price of each holding against the average analyst 12 month forward target price, and computed the weighted average"
VRTX,VRTX:UW,BBG000C1SD31,"Friday Sector Laggards: Utilities, Healthcare",2016-07-08 20:36:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OJN37ywGpzk/friday-sector-laggards-utilities-healthcare-cm646609,"The worst performing sector as of midday Friday is the Utilities sector, higher by 0.6%. Within that group, NiSource Inc. (Symbol NI) and Pinnacle West Capital Corp (Symbol PNW) are two of the day's laggards, showing a loss of"
VRTX,VRTX:UW,BBG000C1SD31,"Nanobiotix Takes A Big Step, VRTX Broadens Pipeline, PFE Aims High With Javelin",2016-07-08 09:41:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2LJ0BZgHc-8/nanobiotix-takes-a-big-step-vrtx-broadens-pipeline-pfe-aims-high-with-javelin-20160708-00339,"Nanobiotix Takes A Big Step, VRTX Broadens Pipeline, PFE Aims High With Javelin"
VRTX,VRTX:UW,BBG000C1SD31,"Nanobiotix Takes A Big Step, VRTX Broadens Pipeline, PFE Aims High With Javelin",2016-07-08 09:41:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wkyoFYzb1tE/nanobiotix-takes-a-big-step-vrtx-broadens-pipeline-pfe-aims-high-with-javelin-20160708-00340,"Nanobiotix Takes A Big Step, VRTX Broadens Pipeline, PFE Aims High With Javelin"
VRTX,VRTX:UW,BBG000C1SD31,Vertex and Moderna Establish Exclusive Collaboration to Discover and Develop mRNA Therapeutics™ for Cystic Fibrosis,2016-07-06 12:41:02 +0000,http://www.publicnow.com/view/96075DCF2381DB8AC0E36DFD212D4BD11A92D2B8,"[at noodls] - 5ea68f4c-e579-4cd3-b54e-1bf09c3775bf.pdf July 6, 2016 -Collaboration to explore use of mRNA Therapeutics to treat the underlying cause of CF by enabling cells to produce functional CFTR proteins in the ..."
VRTX,VRTX:UW,BBG000C1SD31,"Vertex, Moderna Collaborate To Develop MRNA Therapeutics For Cystic Fibrosis",2016-07-06 08:30:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fuxVNLqc5L4/vertex-moderna-collaborate-to-develop-mrna-therapeutics-for-cystic-fibrosis-20160706-00361,"Vertex, Moderna Collaborate To Develop MRNA Therapeutics For Cystic Fibrosis"
VRTX,VRTX:UW,BBG000C1SD31,Vertex Announces Presentations of Data for KALYDECO® (ivacaftor) and ORKAMBI® (lumacaftor/ivacaftor) at European Cystic Fibrosis Society (ECFS) Conference,2016-06-10 15:19:04 +0000,http://www.publicnow.com/view/44F1CAF79A67801C6B6758A8D25D5C083C557F06,"[at noodls] - 034bc69e-33ec-4a4e-ba96-1d4b01ea8850.pdf June 10, 2016 -Real-world data presented at ECFS show long-term impact of KALYDECO across multiple measures of disease- -Data from Phase 3 safety study of ORKAMBI ..."
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharma. To Participate At Goldman Sachs Conference; Webcast At 1:40 PM,2016-06-07 12:40:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VUmHAFLkokg/vertex-pharma-to-participate-at-goldman-sachs-conference-webcast-at-140-pm-20160607-00851,Vertex Pharma. To Participate At Goldman Sachs Conference; Webcast At 1:40 PM
VRTX,VRTX:UW,BBG000C1SD31,"BMRN Pulls The Plug On DMD Drug, LXRX To Face FDA In Nov, TEVA Snubbed",2016-06-01 03:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Nh43xCMKM2E/bmrn-pulls-the-plug-on-dmd-drug-lxrx-to-face-fda-in-nov-teva-snubbed-20160601-00087,"BMRN Pulls The Plug On DMD Drug, LXRX To Face FDA In Nov, TEVA Snubbed"
VRTX,VRTX:UW,BBG000C1SD31,U.S. FDA Accepts for Priority Review Supplemental New Drug Application for the Use of ORKAMBI® (lumacaftor/ivacaftor) in Children with Cystic Fibrosis Ages 6 to 11 who have Two Copies of the F508del Mutation,2016-05-31 12:22:06 +0000,http://www.publicnow.com/view/EB1E425340045E8865D122E84C1125CDF33284D1,"[at noodls] - ca5df0f0-2282-4663-b7c4-76ffd2cd5a64.pdf May 31, 2016 -Approximately 2,400 children ages 6 to 11 have two copies of the F508del mutation in the U.S.- -Target review date of September 30, 2016 set for the ..."
VRTX,VRTX:UW,BBG000C1SD31,Vertex Says FDA Accepts For Priority Review SNDA For Use Of ORKAMBI In Children,2016-05-31 08:11:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/H5PTVE8WRwI/vertex-says-fda-accepts-for-priority-review-snda-for-use-of-orkambi-in-children-20160531-00391,Vertex Says FDA Accepts For Priority Review SNDA For Use Of ORKAMBI In Children
VRTX,VRTX:UW,BBG000C1SD31,Vertex Reports First Quarter 2016 Financial Results,2016-04-27 20:27:36 +0000,http://www.publicnow.com/view/370715E63486C623A2982D44A2050021ABE489EA,"[at noodls] - a59fcaee-564e-4483-a79e-329accbe6b7c.pdf April 27, 2016 -First quarter 2016 cystic fibrosis product revenues of $394 million; $223 million for ORKAMBI® (lumacaftor/ivacaftor) and $171 million for KALYDECO® ..."
VRTX,VRTX:UW,BBG000C1SD31,Vertex reports 1Q loss,2016-04-27 20:15:45 +0000,http://sg.finance.yahoo.com/news/vertex-reports-1q-loss-201545055.html,Vertex reports 1Q loss
VRTX,VRTX:UW,BBG000C1SD31,Vertex to Announce First Quarter 2016 Financial Results on April 27,2016-04-15 12:51:21 +0000,http://www.publicnow.com/view/F423FD1F249AFDFAA4F44A7AA18250B8C9611671,"[at noodls] - 907c6f3a-c1e2-403c-9c42-8d2233f7b2c8.pdf April 15, 2016 BOSTON--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its first quarter 2016 financial results on Wednesday, April ..."
VRTX,VRTX:UW,BBG000C1SD31,"UK cost agency says ""no"" to pricey Vertex cystic fibrosis drug",2016-03-23 00:01:01 +0000,http://uk.finance.yahoo.com/news/uk-cost-agency-says-no-000101825.html,"UK cost agency says ""no"" to pricey Vertex cystic fibrosis drug"
VRTX,VRTX:UW,BBG000C1SD31,"Vertex Receives Australian Approval for ORKAMBI® (lumacaftor/ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis in People Ages 12 and Older with Two Copies of the F508del Mutation",2016-03-08 20:05:00 +0000,http://au.finance.yahoo.com/news/vertex-receives-australian-approval-orkambi-200500794.html,"[Business Wire] - LONDON--(BUSINESSWIRE)-- Vertex Pharmaceuticals Incorporated (Nasdaq:VRTX - News) today announced that the Therapeutic Goods Administration (TGA) of Australia has approved ORKAMBI® 200/125 (lumacaftor 200mg and ivacaftor 125mg), the first medicine to treat the underlying cause of cystic fibrosis (CF) in people ages 12 and older who have two copies of the F508del mutation. In Australia, there are approximately 1,000 people with CF ages 12 and older who have two copies of this mutation. The Australian reimbursement process for ORKAMBI is already underway as part of the parallel regulatory and reimbursement processes between the TGA and the Pharmaceutical Benefits Advisory Committee (PBAC)."
VRTX,VRTX:UW,BBG000C1SD31,Vertex 4Q tops expectations on strong Orkambi sales,2016-01-28 00:37:11 +0000,http://sg.finance.yahoo.com/news/vertex-4q-tops-expectations-strong-003711168.html,Vertex 4Q tops expectations on strong Orkambi sales
VRTX,VRTX:UW,BBG000C1SD31,Vertex Reports Full-Year and Fourth Quarter 2015 Financial Results,2016-01-27 21:34:38 +0000,http://www.publicnow.com/view/4E82BB63F3B32889B6EB7CAFCE57740F396756B7,"[at noodls] - 296381ef-ad1f-4bde-89ae-4f85223ce958.pdf January 27, 2016 -Full-year 2015 total non-GAAP revenues of $1.01 billion, including net product revenues of $351 million for ORKAMBI® (lumacaftor/ivacaftor) and ..."
VRTX,VRTX:UW,BBG000C1SD31,Vertex Outlines 2016 Business Priorities to Support the Discovery and Development of New Transformative Medicines for the Treatment of Cystic Fibrosis and Other Serious Diseases,2016-01-10 21:36:08 +0000,http://www.noodls.com/view/C8F704B47C3F4C9F837C2A678986EC9DF4EB0651,"[at noodls] - 3de22e02-4d47-46f9-9c49-f74ce962df4e.pdf January 10, 2016 -Approximately 25,000 people with cystic fibrosis worldwide currently eligible for treatment with ORKAMBI® (lumacaftor/ivacaftor) or KALYDECO® ..."
VRTX,VRTX:UW,BBG000C1SD31,Vertex Appoints Michael J. Parini as Executive Vice President and Chief Legal Officer,2015-11-23 15:39:21 +0000,http://www.noodls.com/view/CC6D33CA3D7A89167A419641A4E28F5561858907,"[at noodls] - 1e0c5050-9c1e-46ca-96bb-f96d69d543b8.pdf November 23, 2015 BOSTON--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the appointment of Michael J. Parini to the role ..."
VRTX,VRTX:UW,BBG000C1SD31,"Vertex Receives EU Approval for ORKAMBI® (lumacaftor/ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis in People Ages 12 and Older with Two Copies of the F508del Mutation",2015-11-20 09:02:29 +0000,http://www.noodls.com/view/42BD920178DE50A913560CEA135F733F247B0CCA,"[at noodls] - 10c03cc5-7565-4082-9282-26bfd7b33949.pdf November 20, 2015 -In Europe, approximately 12,000 people with CF ages 12 and older have two copies of the F508del mutation- -Positive CHMP Opinion was received ..."
VRTX,VRTX:UW,BBG000C1SD31,Vertex Receives Two EU Approvals for KALYDECO® (ivacaftor) for People with Cystic Fibrosis,2015-11-18 09:06:38 +0000,http://www.noodls.com/view/6A9733F3E8DE82BED8151F56E19CB2E8ED52B8E4,"[at noodls] - 2590dd3c-a9ce-4feb-a2dc-c6a5480372e3.pdf November 18, 2015 -European Commission approves expanded use of ivacaftor in children with cystic fibrosis ages 2 to 5 who have one of 9 gating mutations; approximately ..."
VRTX,VRTX:UW,BBG000C1SD31,Vertex Reports Third Quarter 2015 Financial Results,2015-10-28 20:47:24 +0000,http://www.noodls.com/view/DEADE6AEF35C3BDD58263A1CC8AC7ABF0DFF2165,"[at noodls] - 5da181da-c164-4be5-bf49-83e7dc0e411d.pdf October 28, 2015 -Third quarter 2015 revenues of $310 million, including net product revenues of $131 million for ORKAMBI® (lumacaftor/ivacaftor) and $166 million ..."
VRTX,VRTX:UW,BBG000C1SD31,Vertex reports 3Q loss,2015-10-28 20:46:54 +0000,http://sg.finance.yahoo.com/news/vertex-reports-3q-loss-200833384.html,Vertex reports 3Q loss
VRTX,VRTX:UW,BBG000C1SD31,Vertex and CRISPR Therapeutics Establish Collaboration to Use CRISPR-Cas9 Gene Editing Technology to Discover and Develop New Treatments for Genetic Diseases,2015-10-26 12:35:04 +0000,http://www.noodls.com/view/38346E2E067E9CEBEA363C8CC1B09181D022A851,"[at noodls] - 9754c907-35cc-4252-ab23-d87fa11317ce.pdf October 26, 2015 -Gene editing technology to be used to discover treatments to address the mutations and genes known to cause and contribute to cystic fibrosis- ..."
VRTX,VRTX:UW,BBG000C1SD31,Vertex to Announce Third Quarter 2015 Financial Results on October 28,2015-10-09 13:27:14 +0000,http://www.noodls.com/view/7EFAF3B553EEE2C0794AD887B0F6F00760F3AD59,"[at noodls] - 7a44c982b5fabc45f7af69.pdf October 9, 2015 BOSTON--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its third quarter 2015 financial results on Wednesday, October 28, 2015 ..."
VRTX,VRTX:UW,BBG000C1SD31,Vertex Announces Significant Progress in Its Development Efforts to Treat the Cause of Cystic Fibrosis in the Vast Majority of People with the Disease,2015-10-08 13:24:21 +0000,http://www.noodls.com/view/F14555213D9A5FB871B38CA4E56771405E8C7BD9,"[at noodls] - 324a7aa201a6338d17f6ae.pdf October 8, 2015 -Two next-generation correctors to enter clinical development in November; studies of a triple combination of a next-generation corrector with VX-661/ivacaftor ..."
VRTX,VRTX:UW,BBG000C1SD31,Supplemental New Drug Application for Use of KALYDECO® (ivacaftor) in People with Cystic Fibrosis Ages 2 and Older who have One of 23 Residual Function Mutations Accepted for Priority Review by U.S. FDA,2015-10-07 21:24:04 +0000,http://www.noodls.com/view/8BB937DE166B85A9291BDA6C0BFFB07EA246195B,"[at noodls] - 4640c0bc0e10fa83a2c2c6.pdf October 7, 2015 -More than 1,500 people with CF are ages two and older and have one of these 23 residual function mutations in the U.S.- BOSTON--(BUSINESS WIRE)-- Vertex Pharmaceuticals ..."
VRTX,VRTX:UW,BBG000C1SD31,Vertex Receives CHMP Positive Opinions for ORKAMBI™ (lumacaftor/ivacaftor) and KALYDECO® (ivacaftor) in the European Union,2015-09-25 11:44:02 +0000,http://www.noodls.com/view/553962640756DE82E8202A910F4CBA67C4F386EC,"[at noodls] - September 25, 2015 Vertex Receives CHMP Positive Opinions for ORKAMBI™ (lumacaftor/ivacaftor) and KALYDECO® (ivacaftor) in the European Union -CHMP recommends Marketing Authorization for lumacaftor in ..."
VRTX,VRTX:UW,BBG000C1SD31,Vertex Receives CHMP Positive Opinions for ORKAMBI™ (lumacaftor/ivacaftor) and KALYDECO® (ivacaftor) in the European Union,2015-09-25 11:17:00 +0000,http://uk.finance.yahoo.com/news/vertex-receives-chmp-positive-opinions-111700623.html,Vertex Receives CHMP Positive Opinions for ORKAMBI™ (lumacaftor/ivacaftor) and KALYDECO® (ivacaftor) in the European Union
VRTX,VRTX:UW,BBG000C1SD31,Biotech stocks fall on Clinton vow to fight 'price gouging',2015-09-21 23:01:59 +0000,http://sg.finance.yahoo.com/news/biotech-stocks-fall-clinton-vow-215651071.html,Biotech stocks fall on Clinton vow to fight 'price gouging'
VRTX,VRTX:UW,BBG000C1SD31,Vertex reports 2Q loss,2015-07-29 20:12:59 +0000,http://sg.finance.yahoo.com/news/vertex-reports-2q-loss-201259786.html,Vertex reports 2Q loss
VRTX,VRTX:UW,BBG000C1SD31,FDA clears drug for leading form of cystic fibrosis,2015-07-02 20:50:22 +0000,http://sg.finance.yahoo.com/news/fda-clears-drug-leading-form-162237818.html,FDA clears drug for leading form of cystic fibrosis
VRTX,VRTX:UW,BBG000C1SD31,FDA panel backs Vertex combination pill for cystic fibrosis,2015-05-12 20:49:44 +0000,http://sg.finance.yahoo.com/news/fda-panel-backs-vertex-combination-200851395.html,FDA panel backs Vertex combination pill for cystic fibrosis
VRTX,VRTX:UW,BBG000C1SD31,FDA questions benefit of cystic fibrosis drug from Vertex,2015-05-08 15:32:14 +0000,http://sg.finance.yahoo.com/news/fda-questions-benefit-cystic-fibrosis-132048120.html,FDA questions benefit of cystic fibrosis drug from Vertex
VRTX,VRTX:UW,BBG000C1SD31,Vertex says 1Q sales of cystic fibrosis drug grew 31 percent,2015-04-29 21:41:29 +0000,http://sg.finance.yahoo.com/news/vertex-says-1q-sales-cystic-214129418.html,Vertex says 1Q sales of cystic fibrosis drug grew 31 percent
VRTX,VRTX:UW,BBG000C1SD31,Vertex reports 4Q loss,2015-01-28 21:16:20 +0000,http://sg.finance.yahoo.com/news/vertex-reports-4q-loss-211331627.html,Vertex reports 4Q loss
VRTX,VRTX:UW,BBG000C1SD31,Foundation sells $3.3B in Vertex drug royalties,2014-11-19 20:29:42 +0000,http://sg.finance.yahoo.com/news/foundation-sells-3-3b-vertex-202942368.html,Foundation sells $3.3B in Vertex drug royalties
VRTX,VRTX:UW,BBG000C1SD31,Vertex tops Street 3Q forecasts,2014-10-28 22:58:13 +0000,http://sg.finance.yahoo.com/news/vertex-tops-street-3q-forecasts-203715960--finance.html,Vertex tops Street 3Q forecasts
VRTX,VRTX:UW,BBG000C1SD31,"US STOCKS-Wall St rallies, S&P back above 14-day moving average",2014-09-24 20:20:58 +0000,http://uk.finance.yahoo.com/news/us-stocks-wall-st-rallies-202058624.html,"US STOCKS-Wall St rallies, S&P back above 14-day moving average"
VRTX,VRTX:UW,BBG000C1SD31,"US STOCKS-Biotech shares drop, Amarin plunges 20 pct",2014-09-12 16:49:03 +0000,http://uk.finance.yahoo.com/news/us-stocks-biotech-shares-drop-164903869.html,"US STOCKS-Biotech shares drop, Amarin plunges 20 pct"
VRTX,VRTX:UW,BBG000C1SD31,US STOCKS-S&P 500 rebounds with energy shares; Dow dips,2014-09-11 20:49:25 +0000,http://uk.finance.yahoo.com/news/us-stocks-p-500-rebounds-204925007.html,US STOCKS-S&P 500 rebounds with energy shares; Dow dips
VRTX,VRTX:UW,BBG000C1SD31,"US STOCKS-Wall St down slightly, financials help limit losses",2014-09-11 19:16:27 +0000,http://uk.finance.yahoo.com/news/us-stocks-wall-st-down-191627460.html,"US STOCKS-Wall St down slightly, financials help limit losses"
VRTX,VRTX:UW,BBG000C1SD31,Vertex Pharma posts bigger 2Q loss,2014-07-29 21:07:59 +0000,http://sg.finance.yahoo.com/news/vertex-pharma-posts-bigger-2q-210759439--finance.html,Vertex Pharma posts bigger 2Q loss
VRTX,VRTX:UW,BBG000C1SD31,Ahead of the Bell: Vertex soars on study,2014-06-24 12:32:54 +0000,http://sg.finance.yahoo.com/news/ahead-bell-vertex-soars-study-123254672--finance.html,Ahead of the Bell: Vertex soars on study
